data_5tlq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5tlq _Structure_validation_residue.Date_analyzed 2017-04-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.631 -0.588 . . . . 2.47 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 65.1 168.74 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.279 0.632 . . . . 2.13 111.28 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.77 9.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.213 -0.449 . . . . 1.97 111.321 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.64 159.14 40.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.901 0.381 . . . . 1.65 110.836 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 132.4 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.092 -0.504 . . . . 1.83 111.227 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.42 126.34 29.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 1.4 110.363 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.55 -21.74 41.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.769 -0.729 . . . . 1.14 111.724 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -94.21 -57.94 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.28 -0.267 . . . . 2.3 110.28 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -90.6 -50.67 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 1.55 110.321 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.14 147.04 52.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 1.33 110.027 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.51 131.86 60.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.795 0.331 . . . . 1.42 110.449 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.29 132.57 40.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.65 -0.5 . . . . 1.82 109.65 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 3.0 mt -82.02 133.61 35.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.459 -0.337 . . . . 1.53 110.702 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -39.12 93.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.187 0.518 . . . . 1.9 109.882 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -109.48 96.3 22.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.15 -0.685 . . . . 1.63 109.15 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.7 154.61 34.76 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.709 2.273 . . . . 1.12 112.964 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.45 126.99 27.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.027 -0.533 . . . . 1.37 110.224 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.33 144.58 18.28 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.624 2.216 . . . . 1.35 112.692 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.16 165.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 1.58 110.508 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -56.3 11.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 2.09 111.214 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -118.88 130.5 24.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.434 -0.348 . . . . 3.88 110.396 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.68 179.93 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.671 2.248 . . . . 1.66 112.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.77 -48.68 1.08 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.788 -0.72 . . . . 1.12 112.587 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.19 152.87 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.581 0.229 . . . . 2.9 110.4 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.9 mm -87.77 133.85 29.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.307 -0.406 . . . . 1.22 110.473 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -88.8 125.72 35.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 2.69 111.677 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.5 105.33 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.558 -0.904 . . . . 1.19 108.558 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.53 133.93 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 1.36 111.779 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -119.19 119.27 33.63 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.306 -0.998 . . . . 2.43 108.306 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -94.84 93.7 7.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.571 . . . . 1.37 111.03 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -93.72 168.69 10.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.138 -0.937 . . . . 2.24 110.503 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 2.1 t90 -145.09 163.81 33.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.098 -0.501 . . . . 1.29 110.259 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -79.66 2.34 22.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 4.86 111.197 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.49 15.88 6.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.299 -0.953 . . . . 1.62 113.583 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 25.9 p -111.59 107.8 56.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.521 0.66 . . . . 1.12 110.937 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.38 -31.08 43.78 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.16 . . . . 1.16 111.957 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.16 70.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.62 -0.718 . . . . 1.81 111.126 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.88 -29.53 63.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 1.32 111.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.39 -40.28 70.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 3.17 110.996 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.04 -9.7 58.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.052 0.453 . . . . 1.44 111.327 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -89.59 -26.01 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.097 -0.501 . . . . 0.81 110.855 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.06 -58.15 12.42 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.889 0.7 . . . . 2.69 112.889 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.36 2.87 2.01 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.231 1.954 . . . . 0.9 113.549 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.8 -33.4 5.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.809 0.337 . . . . 1.29 111.352 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 tt -85.92 -29.81 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 111.835 0.309 . . . . 1.48 111.835 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 42.3 t -56.41 -55.62 40.54 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.571 0.582 . . . . 1.47 112.571 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 18.5 Cg_endo -58.38 -22.59 59.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.352 2.035 . . . . 0.95 112.89 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.7 t90 -86.99 -47.73 8.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.988 0.423 . . . . 0.9 110.501 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -65.25 -41.18 94.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 1.68 112.165 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -79.7 10.05 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 2.14 111.704 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.43 6.91 6.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.04 0.448 . . . . 2.64 110.181 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.55 147.15 86.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.772 -0.649 . . . . 1.29 110.873 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' C ' ' H ' ' A' ' 57' ' ' ASP . 57.7 Cg_endo -72.36 173.5 13.03 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.757 2.304 . . . . 1.09 111.459 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 32.1 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 1.57 111.516 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 187' ' ' ARG . 4.6 t0 -125.04 -2.24 7.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.222 0.534 . . . . 1.65 110.364 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 137.69 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.402 -0.817 . . . . 1.35 109.769 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.91 121.52 26.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 1.69 110.861 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -93.07 135.23 34.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 2.1 110.292 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.64 137.63 52.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.851 0.357 . . . . 1.33 110.552 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -96.44 102.92 14.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 4.84 109.879 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 81.7 mt -125.04 129.95 24.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.484 0.183 . . . . 1.24 110.635 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.4 Cg_endo -84.57 160.57 12.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.442 2.095 . . . . 0.7 112.068 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.01 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.233 0.54 . . . . 1.11 110.973 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 20.6 mt -87.72 81.84 7.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 1.04 110.965 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -112.66 46.15 1.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 2.49 111.209 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.35 -156.91 52.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 1.39 112.112 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.08 -133.18 5.24 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 124.0 0.47 . . . . 1.35 113.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.61 -4.84 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.338 0.59 . . . . 1.66 109.859 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 53.5 m95 -65.02 -53.93 38.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.246 -0.888 . . . . 0.87 110.726 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.29 -30.15 71.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 2.57 111.111 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.03 -35.92 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.425 0.631 . . . . 1.49 109.812 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -89.34 46.9 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.588 -0.733 . . . . 1.5 110.507 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.78 -31.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.263 -0.97 . . . . 0.78 113.166 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.83 -35.09 61.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.342 . . . . 2.36 111.53 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 ttt -54.3 -40.51 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.771 -0.65 . . . . 1.99 111.52 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -48.96 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 1.28 111.447 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.47 -32.06 72.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.419 . . . . 1.36 110.784 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.9 m -64.1 -42.75 96.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.727 -0.67 . . . . 1.23 110.617 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.27 -42.58 83.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 2.19 111.322 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.11 -28.36 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 2.19 111.096 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 m -86.36 -5.82 59.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.779 0.323 . . . . 1.91 111.653 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mmm -79.07 -21.78 46.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.828 0.347 . . . . 2.22 110.678 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.94 28.36 21.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 2.2 112.918 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 m -103.09 135.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.856 0.36 . . . . 2.76 110.629 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.17 143.32 50.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.138 -0.483 . . . . 5.28 110.083 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 38.3 m80 56.75 41.36 28.3 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.184 0.516 . . . . 6.1 110.124 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -96.74 25.68 5.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.707 -0.679 . . . . 5.45 111.035 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t 60.63 66.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.682 0.754 . . . . 4.19 109.395 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -28.35 68.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.096 -0.956 . . . . 5.03 111.569 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -66.38 -28.42 68.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 2.88 111.568 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.17 -26.7 67.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.951 0.405 . . . . 2.25 111.117 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.78 -44.81 85.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.172 -0.467 . . . . 2.07 109.939 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -30.64 71.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.037 -0.528 . . . . 3.95 110.549 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.31 -50.57 69.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 2.61 110.651 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.5 -12.96 61.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 2.1 111.737 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.14 -44.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.175 0.435 . . . . 2.35 112.175 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -100.66 -25.0 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.682 0.993 . . . . 2.62 113.682 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -92.03 -46.78 7.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.046 0.451 . . . . 3.06 110.226 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.43 -52.27 4.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 2.59 110.868 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 60.41 59.66 2.2 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.986 -0.552 . . . . 2.81 110.24 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -83.49 40.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.997 -0.547 . . . . 2.69 111.569 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 44.97 58.91 3.72 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.961 0.788 . . . . 3.02 112.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.79 75.01 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.229 0.538 . . . . 1.73 109.717 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.01 -0.57 10.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.659 . . . . 1.34 111.58 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.67 145.79 57.68 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.304 -0.407 . . . . 1.67 110.372 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.08 -33.23 72.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.18 2.587 . . . . 1.09 113.644 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.94 -55.72 29.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 2.62 110.77 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -59.53 -37.71 79.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 2.51 110.913 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.4 mtt -63.01 -54.35 39.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.731 -0.668 . . . . 1.38 110.803 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.2 93.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 1.41 111.476 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.87 -39.35 81.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.47 . . . . 1.83 111.186 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.41 -44.91 23.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.904 -0.589 . . . . 1.74 110.812 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.77 -32.25 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 1.41 112.132 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -18.8 59.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.515 -0.311 . . . . 1.44 111.751 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.76 1.22 78.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.788 -0.72 . . . . 1.63 113.333 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -124.21 6.59 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.377 0.589 . . . . 3.56 111.371 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.29 65.58 0.87 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.424 -0.893 . . . . 1.63 112.29 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.4 t -146.2 125.66 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 1.47 109.605 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.696 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 18.2 t0 -79.8 123.09 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 1.56 110.333 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -60.57 -35.9 77.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.563 -0.744 . . . . 1.93 111.252 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.61 -50.84 63.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 2.29 111.248 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.696 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 41.2 mmtm -60.32 -45.43 93.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.966 0.413 . . . . 3.12 110.174 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.81 -59.25 4.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.387 -0.824 . . . . 2.28 111.208 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.08 -32.54 74.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.992 0.367 . . . . 1.64 111.992 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.9 t -59.32 -50.92 72.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.737 0.304 . . . . 1.84 111.343 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -84.03 -25.33 29.98 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.675 -0.41 . . . . 2.19 111.181 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.88 -43.81 94.55 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.991 0.424 . . . . 2.31 111.078 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -95.78 24.75 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.32 -0.4 . . . . 1.91 111.314 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.3 m -108.99 162.62 14.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.922 0.391 . . . . 1.82 110.653 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -68.2 -23.24 64.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 1.65 111.418 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.88 51.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.108 0.48 . . . . 1.39 111.816 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.0 mm -82.5 -36.9 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.252 -0.431 . . . . 1.85 110.484 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.15 -39.41 86.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 2.48 110.878 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.76 81.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.75 111.717 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -79.71 -36.41 37.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 2.14 110.046 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.3 mmm -61.16 -50.86 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 1.95 111.141 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -33.35 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.641 0.258 . . . . 2.03 110.599 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -60.94 -50.45 73.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 3.52 110.612 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.67 -35.35 67.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.489 . . . . 1.03 111.415 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -57.59 -50.63 72.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.363 -0.38 . . . . 2.16 112.021 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -72.85 -18.92 61.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.543 -0.299 . . . . 2.58 111.762 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.57 -39.78 15.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 1.16 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.35 79.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 1.17 111.609 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -71.95 -19.82 61.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 3.03 111.201 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.36 29.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.96 110.475 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -84.88 4.7 32.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.896 -0.593 . . . . 1.11 110.416 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 62.09 30.76 17.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.708 -0.678 . . . . 1.49 111.645 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.03 98.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.19 -0.459 . . . . 1.26 110.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.53 12.63 32.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.296 -0.411 . . . . 1.76 111.628 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.71 175.77 40.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.563 -0.827 . . . . 0.81 112.294 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.65 134.93 18.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.062 -0.347 . . . . 1.3 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.5 -175.91 17.67 Favored 'Cis proline' 0 C--O 1.235 0.348 0 C-N-CA 123.328 -1.53 . . . . 0.73 112.641 -0.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -165.85 114.47 0.97 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.955 0.407 . . . . 1.31 110.625 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.9 mtp -94.09 123.29 37.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.57 . . . . 1.49 109.598 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.1 t -114.69 130.34 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.033 -0.531 . . . . 1.19 109.618 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.23 117.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 1.26 111.048 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.12 30.69 14.87 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.261 -0.882 . . . . 1.4 112.188 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.34 32.39 29.76 Favored Glycine 0 CA--C 1.52 0.384 0 O-C-N 123.559 0.537 . . . . 0.51 113.459 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 59.5 mtpt -130.03 -41.47 1.28 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 2.3 111.703 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -109.72 129.0 55.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 2.27 110.949 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -119.06 128.57 54.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 2.19 110.027 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -153.28 175.92 12.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.192 -0.458 . . . . 0.72 110.03 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.35 -177.24 3.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.643 -0.502 . . . . 1.35 109.643 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.36 -43.9 78.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.651 0.594 . . . . 1.36 111.81 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.52 -45.48 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.73 112.943 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -64.71 -45.72 85.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 1.68 111.021 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.28 83.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.325 -0.398 . . . . 1.13 111.164 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.73 27.7 3.97 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.701 -0.762 . . . . 1.1 112.796 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.13 154.81 6.25 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.101 -0.571 . . . . 0.95 112.13 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.63 -40.07 87.44 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.176 2.584 . . . . 1.0 112.351 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.09 -39.5 75.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.182 0.515 . . . . 2.52 110.019 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.31 -28.89 70.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.733 -0.667 . . . . 1.82 110.196 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.834 -0.621 . . . . 1.21 109.837 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.48 -35.3 77.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.872 -0.604 . . . . 1.24 109.942 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -61.92 -49.14 77.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 2.73 110.449 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.54 -42.35 98.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.553 -0.749 . . . . 1.28 110.825 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.65 64.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 1.12 111.529 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -40.28 93.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 1.91 111.187 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -63.42 -46.55 85.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 2.65 110.877 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.92 -30.09 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.345 -0.389 . . . . 1.37 111.59 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.91 -47.94 91.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.652 -0.499 . . . . 1.36 109.652 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -27.91 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.6 -0.727 . . . . 2.17 110.369 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -60.71 -49.33 77.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 2.86 109.936 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -74.75 -37.69 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 1.64 110.755 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.538 ' HD2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 2.24 110.743 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.27 -21.93 64.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 1.43 111.848 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.29 -7.55 57.34 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.347 0.594 . . . . 1.52 110.796 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -152.16 56.08 0.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 1.84 109.356 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -100.62 57.03 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.637 -0.711 . . . . 6.86 110.448 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 59.9 pttt . . . . . 0 C--O 1.25 1.096 0 O-C-N 124.264 0.978 . . . . 7.8 111.93 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.432 -0.667 . . . . 2.47 111.432 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -124.1 122.98 39.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.86 0.362 . . . . 2.13 111.167 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -93.29 5.51 51.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.787 0.803 . . . . 1.97 109.702 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -120.85 148.05 44.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.309 -0.859 . . . . 1.65 109.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.83 140.2 53.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.081 0.467 . . . . 1.83 111.655 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.75 130.41 40.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.918 -0.583 . . . . 1.4 109.942 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.39 0.62 67.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 1.14 111.647 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -124.81 -59.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.688 -0.486 . . . . 2.3 109.688 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -92.38 -50.45 5.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.403 0.621 . . . . 1.55 109.981 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -127.42 153.65 46.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.752 -0.658 . . . . 1.33 110.074 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -109.43 131.49 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.722 0.296 . . . . 1.42 111.211 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.19 127.01 37.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.9 -0.778 . . . . 1.82 108.9 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -74.52 134.22 42.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.467 -0.333 . . . . 1.53 111.259 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -41.88 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 1.9 110.275 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.32 94.78 14.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.747 -0.66 . . . . 1.63 109.818 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.12 146.16 69.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.418 2.079 . . . . 1.12 112.649 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -98.46 117.38 64.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.21 -0.45 . . . . 1.37 110.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.5 104.68 1.94 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.641 2.227 . . . . 1.35 112.269 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.49 148.01 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 1.58 111.352 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -16.35 59.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.945 -0.57 . . . . 2.09 111.576 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.3 102.03 46.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 3.88 111.0 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.63 167.34 16.97 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.669 2.246 . . . . 1.66 112.654 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.19 -70.78 0.75 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.897 -0.668 . . . . 1.12 112.447 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -82.07 142.63 32.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.668 0.27 . . . . 2.9 110.403 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.43 HG21 ' ND2' ' A' ' 159' ' ' ASN . 44.9 mm -71.96 121.3 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.129 -0.487 . . . . 1.22 110.723 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 59' ' ' HIS . 3.8 tp10 -90.21 115.37 27.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.134 -0.485 . . . . 2.69 110.712 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.77 109.64 29.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.156 -0.475 . . . . 1.19 109.818 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.13 128.62 55.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.07 -0.514 . . . . 1.36 111.333 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -107.18 134.18 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.612 -0.722 . . . . 2.43 109.419 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.6 mp -113.62 119.31 37.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.787 0.327 . . . . 1.37 110.439 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -120.42 165.03 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 2.24 110.887 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 15.6 t90 -147.31 -179.89 7.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.64 -0.709 . . . . 1.29 109.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -87.65 -52.21 5.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.79 0.329 . . . . 4.86 111.283 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.7 4.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.16 -0.543 . . . . 1.62 113.596 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.8 p -146.36 98.9 4.24 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.267 0.556 . . . . 1.12 110.169 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.84 -27.7 67.49 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.488 2.126 . . . . 1.16 112.403 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -66.97 -22.9 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.81 111.197 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 m -76.23 -23.39 54.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.264 0.554 . . . . 1.32 110.33 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -80.51 -45.79 16.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.815 -0.629 . . . . 3.17 110.655 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.03 -8.71 47.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 1.44 111.577 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.2 t80 -97.52 -11.41 23.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.382 -0.372 . . . . 0.81 111.184 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 10.9 tt0 -55.92 -56.12 33.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 119.497 -0.287 . . . . 2.69 111.677 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 44' ' ' GLU . 65.1 Cg_endo -72.07 13.77 0.49 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.094 1.863 . . . . 0.9 113.184 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.92 -42.42 2.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.709 0.29 . . . . 1.29 111.306 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 HG21 ' O ' ' A' ' 43' ' ' PHE . 15.6 tt -83.28 -35.29 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 112.452 0.538 . . . . 1.48 112.452 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 96.7 t -62.08 -55.85 36.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.269 0.47 . . . . 1.47 112.269 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.7 Cg_endo -56.55 -41.95 70.61 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.882 1.721 . . . . 0.95 111.952 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.24 -41.55 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.9 110.871 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 t -62.05 -32.21 72.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 1.68 111.136 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -84.1 0.55 47.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.061 0.458 . . . . 2.14 110.746 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.78 17.8 14.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.093 0.473 . . . . 2.64 110.287 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.4 mt -74.24 147.12 85.22 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 1.29 110.733 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 57' ' ' ASP . 40.1 Cg_exo -56.06 160.3 10.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 1.09 112.501 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.4 26.09 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 1.57 111.682 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -142.04 21.65 2.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.355 0.598 . . . . 1.65 110.228 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.84 142.59 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 1.35 109.487 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.404 ' HB3' ' OE1' ' A' ' 28' ' ' GLU . 20.8 t60 -118.11 131.49 56.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.432 -0.581 . . . . 1.69 109.432 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -116.26 127.03 54.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.744 0.306 . . . . 2.1 110.587 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 t -128.24 129.51 69.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 1.33 110.611 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -99.2 113.76 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.858 -0.793 . . . . 4.84 108.858 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.3 mt -123.84 132.45 24.29 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 1.24 111.115 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.34 145.15 52.99 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.443 2.096 . . . . 0.7 111.579 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.83 80.21 4.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.152 0.501 . . . . 1.11 110.997 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.6 mt -79.68 79.05 6.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 1.04 110.891 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.43 21.3 13.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.535 . . . . 2.49 111.217 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 89.77 176.66 45.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.755 -0.736 . . . . 1.39 112.102 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.5 -135.63 51.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.737 . . . . 1.35 112.4 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.7 tp -76.03 -13.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 1.66 110.763 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 43.1 m95 -65.91 -40.28 91.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.12 0.486 . . . . 0.87 109.786 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.41 -44.21 65.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 2.57 110.183 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.61 -48.83 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.396 -0.82 . . . . 1.49 111.114 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -84.35 49.62 1.71 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 1.5 111.098 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.12 -33.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.377 -0.829 . . . . 0.78 111.289 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -55.5 -34.56 64.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 2.36 112.207 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.6 ttp -54.32 -42.86 70.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.747 0.308 . . . . 1.99 111.499 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.45 -46.05 90.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 1.28 110.674 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.27 -36.81 79.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 1.36 110.992 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.8 m -62.0 -45.78 92.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.598 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.28 -38.24 79.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.098 0.475 . . . . 2.19 110.633 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -41.29 75.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.856 -0.611 . . . . 2.19 110.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -69.32 -13.89 62.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.91 111.19 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.509 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 81.3 mtp -88.1 -20.45 25.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.382 -0.372 . . . . 2.22 110.88 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.76 60.99 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.887 -0.673 . . . . 2.2 111.827 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.65 165.1 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 2.76 111.281 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.32 172.58 8.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.998 -0.547 . . . . 5.28 110.349 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 74.52 115.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.023 0.827 . . . . 6.1 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.56 54.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 5.45 111.363 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.52 61.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.312 0.577 . . . . 4.19 111.112 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -69.99 -12.7 61.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 5.03 111.712 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 1.1 t30 -95.89 -35.82 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.573 0.225 . . . . 2.88 110.934 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.24 71.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.144 -0.48 . . . . 2.25 111.828 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.38 -45.71 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 2.07 110.751 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 3.95 110.746 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 39.7 mt-10 -65.43 -36.65 84.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.621 . . . . 2.61 110.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.94 64.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.241 0.543 . . . . 2.1 110.384 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.38 -50.62 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.588 -0.733 . . . . 2.35 112.465 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -95.44 -48.98 5.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.546 0.943 . . . . 2.62 113.546 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 77.7 mttt -68.52 -56.01 9.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.144 -0.222 . . . . 3.06 111.451 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.62 -47.19 73.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.626 -0.509 . . . . 2.59 109.626 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 57.36 58.29 3.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.839 -0.618 . . . . 2.81 111.464 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -92.66 33.77 1.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.659 -0.246 . . . . 2.69 111.261 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt 68.85 -68.69 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.649 0.593 . . . . 3.02 111.139 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt 53.48 59.84 4.09 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.122 0.569 . . . . 1.73 111.301 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.77 -57.69 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.909 0.385 . . . . 1.34 111.174 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.6 145.04 50.1 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.275 -0.42 . . . . 1.67 111.125 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.97 -36.65 96.18 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.7 2.267 . . . . 1.09 112.099 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.82 -33.3 74.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.1 -0.5 . . . . 2.62 110.372 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.56 -40.34 80.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.51 109.52 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.93 -53.71 46.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.447 -0.797 . . . . 1.38 109.854 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -31.01 69.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.161 -0.927 . . . . 1.41 111.927 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.69 -40.96 89.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.374 . . . . 1.83 111.432 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.1 -40.77 19.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.74 110.669 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 70.8 mt -65.73 -23.31 66.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.57 . . . . 1.41 111.568 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -56.62 -34.45 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.44 111.574 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.6 -4.28 73.41 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.773 -0.727 . . . . 1.63 112.21 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -98.04 22.29 9.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.856 0.36 . . . . 3.56 111.094 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.16 18.66 71.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 1.63 112.137 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 59.8 t -109.73 128.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.593 0.235 . . . . 1.47 110.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.5 122.64 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.93 0.395 . . . . 1.56 110.476 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -60.02 -37.3 79.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.521 -0.763 . . . . 1.93 111.058 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.91 -54.55 29.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.434 -0.348 . . . . 2.29 110.716 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -55.5 -39.16 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.32 -0.4 . . . . 3.12 110.957 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 75.5 t80 -62.13 -54.64 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 2.28 110.745 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.6 -37.59 86.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.64 111.388 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 m -65.3 -45.65 83.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 1.84 111.032 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.5 m -71.98 -32.89 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 2.19 111.037 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.4 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.335 0.588 . . . . 2.31 110.282 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -115.92 34.0 5.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.785 . . . . 1.91 109.704 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.8 t -115.92 145.02 43.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.458 -0.792 . . . . 1.82 110.682 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.11 -20.53 66.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.021 -0.536 . . . . 1.65 110.626 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.83 78.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.39 110.667 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -31.33 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 1.85 110.287 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -65.45 -36.17 83.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 2.48 110.533 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.88 -28.44 68.49 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.75 112.35 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -91.43 -35.53 14.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 2.14 110.138 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 ttm -62.12 -47.07 86.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 1.95 111.311 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.44 -36.71 84.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.689 -0.232 . . . . 2.03 110.929 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.8 tmtp? -65.52 -43.68 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.347 -0.388 . . . . 3.52 110.011 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.38 75.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.245 -0.434 . . . . 1.03 111.158 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -62.93 -48.71 77.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 2.16 111.112 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -66.88 -23.93 66.06 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.988 -0.285 . . . . 2.58 111.203 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.4 mt -75.82 -51.12 13.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.926 -0.398 . . . . 1.16 109.926 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.17 111.65 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.5 mtm -69.7 -24.98 63.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 3.03 111.389 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.64 -17.58 35.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.96 111.33 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -83.64 -3.56 57.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.109 -0.496 . . . . 1.11 111.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 56.51 32.92 21.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.968 -0.56 . . . . 1.49 111.391 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.42 123.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 1.26 110.745 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 13.94 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.195 0.522 . . . . 1.76 111.061 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.45 171.67 37.49 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.701 -0.761 . . . . 0.81 111.951 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.15 144.59 35.29 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.625 0.25 . . . . 1.3 110.736 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.12 173.09 57.16 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.175 -1.594 . . . . 0.73 112.045 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.4 m -157.68 138.51 13.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.72 0.295 . . . . 1.31 110.787 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.0 mtp -115.53 136.7 52.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.145 -0.687 . . . . 1.49 109.145 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.68 127.6 71.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.68 0.276 . . . . 1.19 110.559 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.66 120.9 54.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 1.26 110.478 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.43 ' ND2' HG21 ' A' ' 27' ' ' ILE . 61.3 m-80 51.26 20.61 0.95 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.987 0.804 . . . . 1.4 113.082 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.0 27.56 70.61 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.921 -0.657 . . . . 0.51 112.726 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -123.39 -38.34 2.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.826 0.313 . . . . 2.3 110.995 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -114.75 130.9 56.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.998 0.427 . . . . 2.27 111.63 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.7 ttp85 -119.32 134.17 55.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.668 -0.696 . . . . 2.19 110.366 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.43 171.68 19.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.72 110.352 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.58 -176.9 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.425 -0.352 . . . . 1.35 110.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.494 ' HA ' ' HG1' ' A' ' 175' ' ' THR . 89.0 mt -58.43 -48.47 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 1.36 111.297 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.92 -39.84 89.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.268 -0.491 . . . . 0.73 112.495 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.7 t -65.4 -39.39 92.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 1.68 110.843 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -44.03 21.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.834 0.349 . . . . 1.13 111.354 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 137.8 -43.34 1.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.996 -0.621 . . . . 1.1 111.826 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.5 170.14 34.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.568 -0.613 . . . . 0.95 111.568 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.74 -42.52 67.8 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.165 2.577 . . . . 1.0 113.126 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.48 -28.94 64.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 2.52 110.299 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.42 -32.99 70.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.82 109.71 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.494 ' HG1' ' HA ' ' A' ' 166' ' ' ILE . 1.6 m -61.26 -45.17 95.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.85 -0.614 . . . . 1.21 109.944 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.73 -39.65 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 1.24 110.23 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -62.29 -47.06 85.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.96 -0.564 . . . . 2.73 110.268 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.34 -40.77 98.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 1.28 110.436 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.312 -0.404 . . . . 1.12 110.982 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.86 -40.41 84.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 1.91 110.373 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -67.05 -46.64 73.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.636 -0.711 . . . . 2.65 111.099 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.93 -41.45 99.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.571 -0.286 . . . . 1.37 110.966 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 82.1 mt -58.12 -39.19 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 1.36 109.758 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -41.44 67.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.698 -0.683 . . . . 2.17 110.756 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -62.91 -48.54 78.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 2.86 111.469 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.45 -23.95 62.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 1.64 111.365 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -7.9 54.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 2.24 110.818 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.43 -24.34 67.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.943 0.401 . . . . 1.43 110.538 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.06 0.55 39.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 1.52 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.78 -4.08 5.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.533 -0.303 . . . . 1.84 111.388 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.5 tptt 64.03 44.03 4.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.815 -0.63 . . . . 6.86 110.958 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 52.0 mttp . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.505 -0.77 . . . . 7.8 111.701 179.618 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.827 -0.509 . . . . 2.47 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.27 152.03 20.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 2.13 110.317 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -112.62 -15.91 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 1.97 111.319 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -114.56 159.2 20.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.989 0.423 . . . . 1.65 111.181 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 132.5 55.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.134 -0.484 . . . . 1.83 111.416 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.97 132.24 48.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.4 110.446 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.46 -12.77 67.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.895 -0.669 . . . . 1.14 112.055 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -114.48 -49.58 2.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.922 0.392 . . . . 2.3 110.064 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -100.75 -47.68 4.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 1.55 111.021 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.68 159.36 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 1.33 110.095 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.28 124.12 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.484 -0.325 . . . . 1.42 110.55 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -101.4 114.3 28.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.083 -0.508 . . . . 1.82 109.912 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 136.42 49.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.435 -0.348 . . . . 1.53 110.25 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -73.03 -14.56 61.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.146 -0.479 . . . . 1.9 110.793 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -119.92 86.13 35.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.198 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.79 168.53 24.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.583 2.189 . . . . 1.12 112.457 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.6 115.15 58.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.37 110.041 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.13 115.27 4.07 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.351 2.034 . . . . 1.35 112.396 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.51 159.23 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 1.58 111.216 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -50.81 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 2.09 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.34 124.7 19.38 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.515 -0.311 . . . . 3.88 110.255 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.51 142.41 16.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.577 2.184 . . . . 1.66 112.399 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.56 -78.08 0.22 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 1.12 111.807 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -79.14 156.07 28.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.784 0.326 . . . . 2.9 110.369 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.6 mm -94.45 123.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.846 -0.427 . . . . 1.22 109.846 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -103.45 117.9 35.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 2.69 110.636 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -105.49 113.9 43.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.137 -0.483 . . . . 1.19 109.974 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.16 131.12 50.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.995 -0.548 . . . . 1.36 111.223 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -111.18 131.14 55.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 2.43 109.678 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.47 110.81 22.41 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.25 -0.432 . . . . 1.37 110.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -110.03 160.2 16.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.943 -0.571 . . . . 2.24 111.048 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -143.57 -178.87 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.69 . . . . 1.29 109.789 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.09 -40.31 10.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.767 0.318 . . . . 4.86 111.334 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.29 40.24 3.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.994 -0.622 . . . . 1.62 113.264 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 p -129.81 99.48 20.35 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.066 0.46 . . . . 1.12 110.082 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.75 -28.34 59.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.465 2.11 . . . . 1.16 112.254 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -66.22 -25.54 66.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.256 -0.429 . . . . 1.81 110.965 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 54.1 m -69.63 -34.28 73.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.429 . . . . 1.32 110.133 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.88 -39.04 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 3.17 110.433 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.99 -16.66 63.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 1.44 111.379 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.97 -12.53 21.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.288 . . . . 0.81 111.215 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 3.7 tt0 -52.36 -54.95 36.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.619 0.599 . . . . 2.69 112.619 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 38.2 Cg_endo -65.8 -2.78 7.02 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.478 2.119 . . . . 0.9 113.774 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.5 -40.01 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.058 0.392 . . . . 1.29 112.058 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -75.71 -36.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.329 0.492 . . . . 1.48 112.329 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.59 -58.89 16.04 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.56 0.578 . . . . 1.47 112.56 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.38 -28.8 88.53 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.954 1.769 . . . . 0.95 112.451 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -73.81 -48.02 34.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.9 110.685 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.3 -33.97 77.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 1.68 111.308 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -78.2 0.33 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.091 -0.504 . . . . 2.14 111.099 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -130.78 41.39 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 2.64 110.456 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 mt -93.77 148.89 36.16 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.736 -0.665 . . . . 1.29 110.438 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.37 156.64 7.89 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.951 2.434 . . . . 1.09 112.383 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.85 56.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 1.57 112.898 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -106.25 15.38 26.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.24 0.543 . . . . 1.65 111.694 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -127.62 139.22 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 1.35 109.617 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -118.68 152.93 35.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.626 0.251 . . . . 1.69 110.589 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.81 129.07 41.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 2.1 110.242 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.3 t -131.11 129.38 63.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.883 0.373 . . . . 1.33 110.932 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -97.06 118.89 34.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.374 -0.602 . . . . 4.84 109.374 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.3 mt -123.78 127.45 25.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.729 0.299 . . . . 1.24 110.437 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.66 146.12 78.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.347 2.032 . . . . 0.7 111.671 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.13 73.98 2.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.992 0.425 . . . . 1.11 110.733 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.7 mt -76.21 76.55 3.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.989 -0.55 . . . . 1.04 110.814 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -104.32 32.96 3.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 2.49 110.993 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 80.72 166.77 35.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.901 -0.666 . . . . 1.39 112.885 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 -138.08 47.7 Favored Glycine 0 C--O 1.235 0.162 0 C-N-CA 121.264 -0.493 . . . . 1.35 112.779 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 tp -68.22 -16.97 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.79 0.329 . . . . 1.66 111.141 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.593 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 56.5 m95 -66.75 -33.52 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.87 109.688 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.03 -42.75 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.538 -0.755 . . . . 2.57 110.238 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.82 -51.06 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 1.49 110.944 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -82.68 61.7 5.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.213 0.53 . . . . 1.5 111.101 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.36 -33.7 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.78 111.534 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.402 HE22 HD12 ' A' ' 134' ' ' ILE . 2.3 mm100 -56.69 -32.09 65.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.647 0.379 . . . . 2.36 111.932 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.4 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 31.9 ttp -54.96 -39.98 69.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.343 -0.389 . . . . 1.99 111.49 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -65.34 -44.54 87.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.28 111.388 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.92 -37.51 78.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.337 -0.392 . . . . 1.36 111.243 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.5 m -59.8 -36.58 77.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 1.23 111.158 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 77' ' ' MET . 89.4 mt -62.38 -47.47 84.03 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.908 0.385 . . . . 2.19 110.777 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -68.58 -33.15 73.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 2.19 110.261 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -66.68 -32.49 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 1.91 110.653 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.4 mtp -73.58 -34.45 65.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.388 -0.369 . . . . 2.22 110.928 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.71 56.42 4.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.593 -0.813 . . . . 2.2 111.435 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.79 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.803 0.335 . . . . 2.76 110.903 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -109.16 171.03 7.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.413 -0.358 . . . . 5.28 110.452 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 75.0 124.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.85 0.719 . . . . 6.1 111.458 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -82.68 68.49 9.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.45 110.39 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' HG21 ' A' ' 94' ' ' VAL . 4.8 m -100.15 47.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 4.19 111.072 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.96 -11.19 58.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 5.03 111.858 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.519 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 2.0 t30 -90.29 -53.74 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.466 -0.334 . . . . 2.88 110.658 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.97 -35.46 46.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.55 0.574 . . . . 2.25 112.55 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 90' ' ' VAL . 96.2 t -58.42 -49.94 80.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.389 . . . . 2.07 110.974 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -66.38 -35.27 79.92 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.283 -0.417 . . . . 3.95 110.488 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 31.0 mt-10 -63.47 -39.82 95.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 2.61 110.654 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -68.53 -27.46 66.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.247 0.546 . . . . 2.1 110.67 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.24 -49.94 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 2.35 112.09 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -99.15 -52.48 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.401 0.889 . . . . 2.62 113.401 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 75.8 mttt -61.68 -54.01 48.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 3.06 111.337 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 29.8 mm-40 -69.64 -50.7 41.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.587 -0.523 . . . . 2.59 109.587 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 60.35 57.3 2.91 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.573 -0.739 . . . . 2.81 111.324 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -91.57 32.33 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.519 -0.31 . . . . 2.69 110.988 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 69.3 -73.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.506 0.722 . . . . 3.02 111.288 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.05 54.74 7.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.021 0.438 . . . . 1.73 110.644 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.73 -3.06 36.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.245 -0.434 . . . . 1.34 111.503 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 p -137.48 146.14 52.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.385 -0.371 . . . . 1.67 110.763 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.76 -35.54 93.63 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.743 2.296 . . . . 1.09 111.822 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -63.24 -42.32 99.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.944 -0.571 . . . . 2.62 110.088 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -67.26 -41.42 85.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 2.51 109.914 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtt -63.8 -52.96 57.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.596 -0.729 . . . . 1.38 110.581 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -39.27 86.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.43 -0.804 . . . . 1.41 112.319 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.47 -42.98 97.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.07 0.462 . . . . 1.83 110.443 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -71.59 -48.25 49.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 1.74 110.915 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.15 -24.3 67.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.202 -0.454 . . . . 1.41 112.112 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -58.41 -35.86 72.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 1.44 110.859 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.11 10.69 73.24 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.859 -0.686 . . . . 1.63 112.114 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -114.01 6.15 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 3.56 110.885 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.42 1.92 55.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 1.63 113.014 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.9 t -97.35 128.48 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.172 -0.306 . . . . 1.47 110.172 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -70.43 119.21 14.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 1.56 110.61 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -61.98 -38.46 88.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.602 -0.726 . . . . 1.93 111.446 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.19 -58.14 9.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.299 -0.41 . . . . 2.29 110.974 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -59.19 -35.37 73.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.429 -0.35 . . . . 3.12 111.384 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -61.42 -54.22 46.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 2.28 110.668 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.02 -35.11 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.64 110.817 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -67.14 -49.78 63.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.466 . . . . 1.84 110.755 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.1 m -65.49 -33.49 76.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 2.19 111.038 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -61.74 -33.94 74.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.108 0.48 . . . . 2.31 110.364 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -99.15 18.93 16.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 1.91 110.765 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.2 m -104.29 156.81 17.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 1.82 111.31 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -73.97 -24.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 1.65 110.184 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.72 -37.7 68.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 1.39 110.776 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.402 HD12 HE22 ' A' ' 76' ' ' GLN . 0.4 OUTLIER -79.01 -28.72 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.802 -0.635 . . . . 1.85 110.491 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -63.44 -37.15 86.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 2.48 110.873 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.44 91.22 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.75 112.079 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -78.21 -35.53 48.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 2.14 110.19 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.7 ttm -59.74 -52.29 66.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.363 -0.835 . . . . 1.95 111.686 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -68.53 -32.55 72.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.549 -0.296 . . . . 2.03 111.186 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -63.18 -44.92 94.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.85 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.72 -37.09 65.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.379 -0.373 . . . . 1.03 110.947 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -59.19 -51.0 71.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.059 -0.518 . . . . 2.16 111.802 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -63.66 -35.54 80.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.029 -0.268 . . . . 2.58 111.309 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.94 -49.28 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.124 -0.324 . . . . 1.16 110.124 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.29 84.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 1.17 110.969 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 74.9 mmm -67.08 -39.36 86.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 3.03 111.141 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.88 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.357 -0.383 . . . . 0.96 111.851 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.29 -6.17 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 1.11 111.018 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 58.93 27.55 16.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.061 -0.518 . . . . 1.49 111.648 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.45 119.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 1.26 110.732 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.91 39.83 3.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.876 -0.602 . . . . 1.76 111.116 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.22 166.53 30.99 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.594 -0.812 . . . . 0.81 112.424 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.63 144.79 37.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.495 0.188 . . . . 1.3 110.6 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.459 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.8 Cg_endo -80.98 163.39 80.05 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 123.25 -1.563 . . . . 0.73 112.236 -0.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -157.0 139.38 14.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.279 -0.419 . . . . 1.31 110.434 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -116.69 138.11 51.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.6 -0.518 . . . . 1.49 109.6 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.1 130.92 74.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.316 -0.402 . . . . 1.19 110.728 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.4 t -102.73 112.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 1.26 110.707 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 53.8 13.81 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.322 0.86 . . . . 1.4 113.322 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.36 16.0 78.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.61 -0.805 . . . . 0.51 112.117 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -104.79 -44.11 4.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 2.3 110.576 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -119.14 138.1 53.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.036 -0.529 . . . . 2.27 111.319 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.42 117.1 26.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 2.19 109.425 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -135.14 161.01 36.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.883 0.373 . . . . 0.72 110.899 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.69 178.12 10.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 1.35 109.701 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.02 -37.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 1.36 111.765 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.79 94.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.031 -0.604 . . . . 0.73 112.665 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -72.87 -45.73 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 1.68 110.84 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.66 76.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.989 -0.551 . . . . 1.13 111.503 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.65 16.65 38.7 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.737 -0.744 . . . . 1.1 112.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.06 153.49 6.93 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.995 -0.621 . . . . 0.95 112.321 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.06 -46.21 27.08 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.759 2.306 . . . . 1.0 112.579 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.49 -37.25 86.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.417 0.627 . . . . 2.52 109.418 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.66 -36.12 81.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 1.82 109.977 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 17.2 m -60.15 -44.93 94.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 1.21 111.179 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.9 mt -64.01 -38.14 90.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.351 . . . . 1.24 111.002 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -69.16 -34.76 75.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.488 . . . . 2.73 110.479 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.13 -37.27 83.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.602 -0.518 . . . . 1.28 109.602 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -59.08 -52.73 64.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.722 -0.672 . . . . 1.12 110.832 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -57.97 -38.83 76.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.051 -0.522 . . . . 1.91 110.623 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -62.51 -47.15 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.524 -0.762 . . . . 2.65 110.938 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.33 -45.12 85.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.48 -0.327 . . . . 1.37 110.536 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 90.9 mt -58.38 -41.29 81.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 1.36 110.449 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.67 -47.58 80.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 2.17 110.769 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -62.19 -47.6 83.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 2.86 111.413 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.8 -27.54 66.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 1.64 111.138 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.539 ' CG ' ' HA ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -65.4 -18.1 65.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 2.24 111.483 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.76 68.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 1.43 111.443 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.59 -22.08 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.411 . . . . 1.52 111.251 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.09 9.13 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.84 110.8 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 191' ' ' LYS . 24.5 tptt 62.69 35.56 13.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.434 -0.803 . . . . 6.86 111.418 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.539 ' HA ' ' CG ' ' A' ' 187' ' ' ARG . 54.5 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.442 -0.799 . . . . 7.8 111.92 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.678 -0.569 . . . . 2.47 111.678 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 59.75 59.51 2.49 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.556 0.693 . . . . 2.13 110.455 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.52 -13.73 57.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.844 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -98.57 138.67 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 1.65 110.665 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m -95.69 128.88 42.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.393 . . . . 1.83 110.82 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.49 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 1.4 110.436 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.31 -39.62 2.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.836 -0.697 . . . . 1.14 111.658 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -93.49 -51.96 4.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.603 0.24 . . . . 2.3 110.437 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.93 -63.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 1.55 110.724 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -120.23 155.56 32.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.107 -0.497 . . . . 1.33 110.308 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -103.31 126.79 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 1.42 110.683 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.38 124.19 46.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.886 -0.783 . . . . 1.82 108.886 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -82.53 127.15 33.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.773 0.321 . . . . 1.53 110.875 -179.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -68.56 -19.37 64.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 1.9 110.203 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 86.74 9.33 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.579 -0.737 . . . . 1.63 109.047 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.13 141.13 62.21 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.455 2.104 . . . . 1.12 112.988 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 t -100.43 128.96 28.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 1.37 110.137 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.0 143.47 72.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.377 2.051 . . . . 1.35 112.85 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.53 173.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.691 . . . . 1.58 110.52 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -76.99 -40.99 44.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.821 0.344 . . . . 2.09 111.018 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.55 113.9 16.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 3.88 110.948 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.18 100.62 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.457 2.104 . . . . 1.66 112.13 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.84 -48.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.51 -0.636 . . . . 1.12 111.51 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -100.81 155.69 17.78 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.662 -0.496 . . . . 2.9 109.662 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -79.22 113.32 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.778 0.323 . . . . 1.22 110.401 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.81 114.33 26.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 2.69 110.458 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.15 126.09 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.985 -0.552 . . . . 1.19 110.05 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.51 126.72 55.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 1.36 111.297 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -102.42 123.5 46.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.75 -0.659 . . . . 2.43 109.86 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.39 120.49 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.186 -0.301 . . . . 1.37 110.186 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -132.62 171.03 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 2.24 111.404 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -138.98 172.18 13.23 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.545 -0.752 . . . . 1.29 109.526 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -94.28 -12.85 27.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 4.86 111.564 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.19 29.29 7.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.512 -0.851 . . . . 1.62 113.135 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.4 p -112.98 107.93 53.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.841 0.353 . . . . 1.12 110.471 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.99 -28.83 28.52 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.303 2.002 . . . . 1.16 111.464 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -23.41 67.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.313 -0.858 . . . . 1.81 110.842 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.77 -41.1 68.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 1.32 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.63 -28.2 68.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.978 0.418 . . . . 3.17 111.077 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.08 25.23 2.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.367 0.603 . . . . 1.44 109.881 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -145.47 -35.88 0.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.81 110.941 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 48' ' ' VAL . 9.9 mt-10 -48.51 -56.54 14.12 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.022 0.749 . . . . 2.69 113.022 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.54 -11.14 18.72 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.908 1.738 . . . . 0.9 113.157 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -100.68 -37.08 8.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.747 0.308 . . . . 1.29 111.284 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.7 tt -81.21 -34.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.203 0.446 . . . . 1.48 112.203 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 44' ' ' GLU . 75.1 t -53.24 -56.59 22.63 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.433 -0.318 . . . . 1.47 111.483 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 12.3 Cg_endo -57.88 -31.49 92.68 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.117 1.878 . . . . 0.95 111.879 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -63.76 -47.57 80.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.9 109.888 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -27.84 65.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 1.68 111.139 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -76.0 -18.28 59.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 2.14 110.776 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -114.55 24.67 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.577 0.227 . . . . 2.64 111.348 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.21 144.05 70.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.655 -0.248 . . . . 1.29 110.816 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.04 -179.99 3.93 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.549 2.166 . . . . 1.09 112.272 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.1 9.78 7.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 1.57 111.888 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.62 10.19 19.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 1.65 111.134 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.74 139.15 52.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.862 0.363 . . . . 1.35 110.826 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -113.72 137.19 51.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.123 -0.695 . . . . 1.69 109.123 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -117.69 117.63 29.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 2.1 111.542 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.3 t -111.65 129.5 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.064 -0.517 . . . . 1.33 110.158 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 118.18 36.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.678 -0.49 . . . . 4.84 109.678 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.7 mt -129.31 139.99 37.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.87 0.366 . . . . 1.24 111.277 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.41 149.69 21.75 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.518 2.145 . . . . 0.7 112.019 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -75.48 94.09 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.438 . . . . 1.11 110.266 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.84 84.06 4.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 1.04 111.25 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -106.62 6.88 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.609 . . . . 2.49 110.563 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.82 -169.58 32.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 1.39 111.89 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.26 -123.37 31.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.143 -0.551 . . . . 1.35 113.177 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.57 -8.09 10.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.249 0.547 . . . . 1.66 111.09 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 18.8 m95 -67.92 -54.7 16.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.849 -0.614 . . . . 0.87 110.029 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.32 -38.41 74.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.296 -0.866 . . . . 2.57 111.599 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.68 -37.9 55.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.062 -0.517 . . . . 1.49 111.334 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -86.61 -14.07 43.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.29 -0.414 . . . . 1.5 111.213 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.84 -32.2 54.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.686 -0.768 . . . . 0.78 111.657 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.94 -39.77 90.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.594 -0.303 . . . . 2.36 110.806 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.41 -50.39 65.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.009 -0.541 . . . . 1.99 111.506 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.86 -45.51 92.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 1.28 111.082 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.91 -40.46 96.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 1.36 111.203 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -60.35 -35.41 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 1.23 111.529 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.63 -51.34 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.414 -0.357 . . . . 2.19 110.75 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -71.21 -28.1 63.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.175 -0.466 . . . . 2.19 111.844 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 m -77.46 -3.87 42.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.9 0.333 . . . . 1.91 111.9 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.9 ttm -82.88 -9.44 59.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 2.22 110.358 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.83 64.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.069 -0.586 . . . . 2.2 112.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.8 m -98.18 158.56 3.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.61 0.243 . . . . 2.76 110.43 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -122.07 -69.5 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.779 -0.452 . . . . 5.28 109.779 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.6 t60 68.32 150.67 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.513 0.673 . . . . 6.1 111.638 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -106.91 -164.46 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.443 -0.577 . . . . 5.45 109.443 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.2 m 37.6 59.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.37 1.068 . . . . 4.19 112.941 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -78.78 44.77 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 5.03 110.691 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.656 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 64.7 m-80 -80.8 -43.7 19.67 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.827 -0.624 . . . . 2.88 110.603 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.31 -23.73 62.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 2.25 111.821 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.83 -54.04 34.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 2.07 111.491 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.656 ' CE2' ' HA ' ' A' ' 92' ' ' ASN . 23.0 p90 -78.15 -13.0 60.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.674 -0.41 . . . . 3.95 111.516 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 32.6 mm-40 -62.76 -43.48 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 2.61 110.377 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.07 15.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 2.1 110.941 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.1 mt -109.84 -46.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.59 -0.732 . . . . 2.35 110.788 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -99.25 -42.39 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.165 0.432 . . . . 2.62 112.165 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -80.88 -70.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 3.06 110.562 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.97 68.68 6.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.953 -0.567 . . . . 2.59 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -56.28 95.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 2.81 111.714 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -90.97 4.86 50.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 2.69 111.163 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 74.58 -56.81 0.63 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.504 0.721 . . . . 3.02 110.407 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.7 mt 59.93 44.6 13.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.54 . . . . 1.73 111.446 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.85 -23.77 22.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.269 0.557 . . . . 1.34 110.134 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.84 138.23 19.47 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.58 -0.736 . . . . 1.67 110.541 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.51 -37.31 95.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.89 2.393 . . . . 1.09 112.384 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -61.76 -34.35 75.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 2.62 110.742 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -69.83 -45.53 67.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.502 . . . . 2.51 110.392 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 62.6 mtm -65.2 -43.77 90.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 1.38 110.714 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.29 -38.43 85.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.788 -0.642 . . . . 1.41 111.434 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.94 -48.21 82.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 1.83 111.59 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -64.09 -49.13 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 1.74 111.211 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.25 -30.63 71.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.07 0.396 . . . . 1.41 112.07 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.57 -36.77 72.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 1.44 111.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.4 6.1 82.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.579 -0.82 . . . . 1.63 112.511 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -107.83 1.64 22.97 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.718 -0.283 . . . . 3.56 111.362 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.67 21.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.513 -0.851 . . . . 1.63 112.864 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 21.3 t -93.67 144.02 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.109 -0.33 . . . . 1.47 110.109 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 24.7 t0 -84.02 124.07 30.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.701 0.286 . . . . 1.56 110.576 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 1.93 111.049 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 73.2 mt-10 -64.88 -65.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.171 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -56.6 -34.6 67.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.762 -0.654 . . . . 3.12 111.741 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -62.5 -56.9 13.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.756 -0.202 . . . . 2.28 111.088 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.15 -38.47 89.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.887 0.329 . . . . 1.64 111.887 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -64.0 -47.79 78.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.71 0.29 . . . . 1.84 110.621 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.6 m -68.93 -35.98 77.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 2.19 111.068 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -57.33 -32.57 66.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.555 . . . . 2.31 110.627 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -99.36 13.76 32.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.869 -0.605 . . . . 1.91 111.432 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -97.63 163.71 12.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 1.82 111.29 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -18.23 61.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.813 -0.63 . . . . 1.65 111.082 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.41 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 1.39 111.611 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.86 -41.85 39.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.099 -0.5 . . . . 1.85 110.216 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -56.46 -45.11 81.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 2.48 111.558 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.83 89.63 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.021 -0.609 . . . . 0.75 113.052 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.66 -37.69 35.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 2.14 110.182 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 mmm -58.27 -50.93 71.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 1.95 111.059 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -67.79 -24.62 65.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.073 -0.512 . . . . 2.03 111.756 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 87.0 tttt -79.02 -44.02 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 3.52 111.088 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.69 65.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 1.03 110.792 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.32 -48.41 79.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.47 -0.786 . . . . 2.16 111.758 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -69.5 -37.7 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.535 -0.302 . . . . 2.58 111.305 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.73 -40.81 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 1.16 111.08 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.54 87.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.025 0.441 . . . . 1.17 110.777 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 38.5 mmt -68.47 -34.91 76.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.813 -0.63 . . . . 3.03 110.472 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.69 71.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.84 -0.618 . . . . 0.96 111.206 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -76.54 4.62 8.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.45 -0.341 . . . . 1.11 111.173 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 59.44 30.41 20.09 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.71 -0.677 . . . . 1.49 112.448 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.85 113.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 1.26 109.657 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.32 -11.05 14.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.856 0.317 . . . . 1.76 111.856 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.88 179.29 32.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.57 -0.824 . . . . 0.81 111.958 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.67 141.43 38.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.614 0.245 . . . . 1.3 111.266 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.79 173.83 52.09 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.953 -1.686 . . . . 0.73 111.967 -0.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -156.28 135.56 12.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.376 -0.374 . . . . 1.31 110.127 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -117.19 133.14 56.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.627 -0.508 . . . . 1.49 109.627 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.6 t -121.36 128.12 75.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 1.19 110.311 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.2 t -109.04 115.78 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.352 -0.386 . . . . 1.26 111.286 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.25 21.24 3.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.337 -0.847 . . . . 1.4 113.04 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.48 26.52 64.52 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.094 -0.574 . . . . 0.51 113.214 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.505 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 39.9 mttp -118.07 -40.73 2.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.871 0.367 . . . . 2.3 111.168 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -121.38 138.75 54.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.256 -0.429 . . . . 2.27 111.03 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -120.87 131.94 54.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.743 -0.662 . . . . 2.19 109.282 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.61 168.14 22.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.978 0.418 . . . . 0.72 110.65 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.08 179.41 7.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 1.35 109.515 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.41 -35.42 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.269 0.356 . . . . 1.36 111.324 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.4 89.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.008 -0.615 . . . . 0.73 112.25 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.6 m -74.01 -42.69 59.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.608 0.242 . . . . 1.68 111.544 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.09 -43.19 58.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.849 0.314 . . . . 1.13 111.849 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.1 -51.3 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.039 -0.601 . . . . 1.1 111.888 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.14 164.45 25.57 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.182 -0.532 . . . . 0.95 111.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.29 -49.99 14.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.47 2.78 . . . . 1.0 112.423 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.98 -37.48 87.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 2.52 110.442 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -66.35 -28.32 68.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.657 . . . . 1.82 110.167 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.9 m -65.47 -44.08 88.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 1.21 109.536 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.8 mt -68.66 -32.3 72.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.881 -0.599 . . . . 1.24 109.998 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -62.27 -39.48 93.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 2.73 109.903 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.66 -42.54 86.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.684 -0.689 . . . . 1.28 109.718 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.95 83.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.662 -0.699 . . . . 1.12 111.067 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.24 72.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.028 -0.533 . . . . 1.91 110.924 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -71.86 -44.73 63.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 2.65 110.6 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.48 -29.45 70.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 1.37 111.229 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 53.2 mt -59.21 -47.08 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.792 -0.447 . . . . 1.36 109.792 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -74.51 -34.16 62.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 2.17 110.19 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -54.55 -44.33 72.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 2.86 111.054 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.87 -29.94 23.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.377 . . . . 1.64 111.412 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -72.19 -23.54 61.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.617 -0.265 . . . . 2.24 111.016 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.71 -20.74 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.511 -0.313 . . . . 1.43 111.47 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 1.52 110.77 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.32 22.68 5.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.092 0.557 . . . . 1.84 112.01 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.77 51.81 10.4 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.283 0.564 . . . . 6.86 110.811 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.454 -0.784 . . . . 7.8 110.413 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.925 -0.47 . . . . 2.47 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 62.35 75.21 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.021 0.529 . . . . 2.13 111.292 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -118.59 21.6 12.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.294 0.569 . . . . 1.97 110.386 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -134.41 155.62 49.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 1.65 109.537 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 134.93 54.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.191 0.52 . . . . 1.83 111.683 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.1 23.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 1.4 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.63 -23.28 35.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.88 -0.676 . . . . 1.14 111.776 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -93.73 -75.81 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.193 -0.299 . . . . 2.3 110.193 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -75.28 -44.06 47.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.568 -0.287 . . . . 1.55 111.576 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -133.46 151.12 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.59 0.233 . . . . 1.33 110.45 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.38 121.05 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.961 0.41 . . . . 1.42 110.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -87.42 131.18 34.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.116 -0.493 . . . . 1.82 109.836 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.22 128.37 35.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.398 -0.364 . . . . 1.53 110.577 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -69.23 -26.52 64.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 1.9 110.147 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 m -114.61 97.55 47.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.634 -0.712 . . . . 1.63 109.365 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.24 151.63 15.83 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.837 2.358 . . . . 1.12 113.133 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 t -115.1 121.84 34.42 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 1.37 110.215 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.31 122.69 8.56 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.273 1.982 . . . . 1.35 111.774 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.38 158.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.12 -0.491 . . . . 1.58 111.898 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.14 -11.08 57.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 2.09 110.999 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.82 96.25 43.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.447 -0.342 . . . . 3.88 111.154 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.64 149.36 12.76 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.703 2.268 . . . . 1.66 112.019 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.07 -26.3 7.87 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.816 -0.707 . . . . 1.12 112.972 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 137.68 44.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.687 -0.486 . . . . 2.9 109.687 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.16 119.66 24.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.47 . . . . 1.22 110.464 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -85.95 121.21 28.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.592 -0.731 . . . . 2.69 110.973 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -127.45 94.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.648 -0.871 . . . . 1.19 108.648 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 32.5 t -99.85 129.55 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.054 -0.521 . . . . 1.36 111.319 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.9 OUTLIER -111.26 116.7 31.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.576 -0.898 . . . . 2.43 108.576 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.8 mp -101.37 110.34 22.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.488 . . . . 1.37 110.463 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -114.52 175.39 5.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 2.24 110.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -151.6 171.0 18.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 1.29 110.234 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -80.83 -20.45 42.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.064 0.459 . . . . 4.86 110.593 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.23 19.33 43.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.683 -0.77 . . . . 1.62 114.312 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.416 ' O ' ' HE1' ' A' ' 99' ' ' HIS . 27.2 p -109.23 106.17 58.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 117.716 0.758 . . . . 1.12 110.238 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.44 -37.34 30.64 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.392 2.061 . . . . 1.16 113.015 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -24.93 66.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.396 -0.366 . . . . 1.81 111.948 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 54.7 m -67.99 -36.43 79.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.947 0.403 . . . . 1.32 110.629 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.66 -33.0 74.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 3.17 110.862 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.08 3.15 47.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.44 111.346 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.92 -27.49 12.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.81 110.579 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -49.18 -56.48 15.65 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 112.743 0.646 . . . . 2.69 112.743 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.38 -1.69 5.98 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.997 1.798 . . . . 0.9 113.695 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 m -109.52 -39.95 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.317 . . . . 1.29 111.855 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 tt -82.92 -31.1 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.548 0.573 . . . . 1.48 112.548 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 55.6 t -58.67 -54.14 59.25 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.107 0.41 . . . . 1.47 112.107 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 38.6 Cg_endo -67.29 -2.79 8.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.04 1.827 . . . . 0.95 112.771 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -101.72 -46.95 4.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.9 110.076 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -63.88 -32.3 73.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.68 111.978 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.31 -6.61 55.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.788 0.328 . . . . 2.14 111.215 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.21 7.37 23.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.983 0.421 . . . . 2.64 110.518 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.96 145.34 69.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.13 -0.486 . . . . 1.29 111.079 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 57' ' ' ASP . 42.2 Cg_endo -68.8 168.77 19.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.197 . . . . 1.09 111.721 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.41 27.91 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.0 0.428 . . . . 1.57 111.835 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 27.9 t70 -112.54 -11.16 13.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.547 0.689 . . . . 1.65 109.922 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.12 138.69 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.324 -0.853 . . . . 1.35 110.794 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -116.55 92.43 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.591 -0.522 . . . . 1.69 109.591 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.32 128.55 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.814 -0.63 . . . . 2.1 110.686 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 78.7 t -132.62 131.54 59.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 1.33 109.738 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -114.23 124.44 52.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.679 -0.489 . . . . 4.84 109.679 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 95.2 mt -126.98 151.63 74.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.281 -0.418 . . . . 1.24 110.539 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.34 156.52 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.631 2.221 . . . . 0.7 111.922 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.73 79.43 3.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 1.11 110.567 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.0 78.6 9.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.04 111.254 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -102.95 26.32 8.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 2.49 110.943 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 84.11 -173.66 50.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.799 -0.715 . . . . 1.39 111.777 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.98 -135.37 39.54 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.174 -0.536 . . . . 1.35 112.755 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.8 tp -78.04 -16.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 1.66 110.807 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.496 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 40.3 m95 -62.98 -46.16 88.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.87 110.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -34.94 75.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.703 -0.68 . . . . 2.57 110.956 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.57 -41.61 88.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.365 0.602 . . . . 1.49 109.759 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -86.41 51.31 2.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.704 -0.68 . . . . 1.5 110.34 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.64 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.679 -0.691 . . . . 0.78 112.412 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -56.16 -37.98 70.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 2.36 111.215 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.3 ttt -55.49 -38.07 68.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.038 -0.528 . . . . 1.99 111.499 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.42 -52.5 63.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.28 111.285 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.74 -25.31 68.13 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.271 -0.422 . . . . 1.36 111.561 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.5 m -67.14 -38.89 86.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.433 . . . . 1.23 110.716 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.6 mt -72.96 -40.93 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 2.19 111.006 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.515 . . . . 2.19 111.214 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -92.69 12.86 21.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.392 0.516 . . . . 1.91 112.392 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.1 ttm -93.65 -17.95 22.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.054 0.454 . . . . 2.22 110.668 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.51 65.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.951 -0.642 . . . . 2.2 112.504 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.61 149.44 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 2.76 111.037 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' CD ' ' HD1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -155.48 156.34 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.441 -0.577 . . . . 5.28 109.441 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.402 ' HD1' ' CD ' ' A' ' 87' ' ' GLU . 36.7 m80 57.58 41.86 25.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.251 0.548 . . . . 6.1 110.279 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -104.44 15.5 28.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 5.45 110.574 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.1 t 66.05 69.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.631 0.729 . . . . 4.19 109.256 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -22.08 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.344 -0.844 . . . . 5.03 111.029 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -69.23 -23.07 63.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 2.88 111.02 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.78 69.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.939 0.399 . . . . 2.25 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.83 -38.12 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 2.07 109.767 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.56 -33.6 75.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.887 -0.597 . . . . 3.95 110.247 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 5.4 mm-40 -65.98 -46.58 77.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 2.61 111.043 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.7 -23.49 65.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 2.1 111.553 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.6 mt -88.82 -47.21 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.334 -0.394 . . . . 2.35 112.058 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.416 ' HE1' ' O ' ' A' ' 37' ' ' CYS . 56.8 m-70 -86.45 -52.82 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.362 0.875 . . . . 2.62 113.362 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 1.3 mmmm -75.9 -57.54 3.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.628 0.232 . . . . 3.06 111.628 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.9 mm-40 -68.81 -58.57 3.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.533 -0.303 . . . . 2.59 110.707 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 59.29 57.74 3.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 2.81 109.594 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -81.36 22.33 0.69 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.555 -0.748 . . . . 2.69 112.023 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 55.41 78.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.321 0.581 . . . . 3.02 110.375 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.3 mt -96.92 77.36 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.029 -0.532 . . . . 1.73 110.049 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.91 -54.45 2.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 1.34 110.955 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.84 49.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 1.67 111.088 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.98 -23.7 61.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.029 2.486 . . . . 1.09 113.103 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.52 -57.28 13.39 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.417 -0.356 . . . . 2.62 110.436 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.82 -33.28 75.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 2.51 110.745 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.64 -53.9 51.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.282 0.563 . . . . 1.38 110.402 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.71 -28.56 66.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.574 -0.739 . . . . 1.41 111.345 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -64.36 -31.4 72.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 1.83 110.722 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.55 -41.32 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.74 109.662 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.86 -30.95 71.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.701 . . . . 1.41 111.656 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.3 40.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.69 0.281 . . . . 1.44 111.2 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 12.51 60.46 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.757 -0.735 . . . . 1.63 112.876 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 34.63 1.7 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.306 0.553 . . . . 3.56 111.822 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.5 52.74 5.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.125 -0.56 . . . . 1.63 113.847 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.47 123.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.724 -0.473 . . . . 1.47 109.724 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.5 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 62.3 t0 -73.34 113.13 10.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.859 0.361 . . . . 1.56 110.066 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -56.79 -38.0 71.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.487 -0.779 . . . . 1.93 111.494 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.53 -46.28 80.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.355 -0.384 . . . . 2.29 111.741 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 47.9 mmtm -64.64 -42.13 95.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 3.12 110.25 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 83.0 t80 -58.67 -56.9 16.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 2.28 110.866 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.73 -39.86 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.971 0.36 . . . . 1.64 111.971 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.3 m -63.13 -53.56 51.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.644 -0.253 . . . . 1.84 111.461 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.444 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -73.16 -22.88 60.41 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.748 0.277 . . . . 2.19 111.748 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 53.6 t80 -61.01 -30.98 70.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.12 0.486 . . . . 2.31 110.543 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -100.94 7.83 43.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.633 . . . . 1.91 111.316 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 26.9 m -86.27 155.87 20.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.015 0.436 . . . . 1.82 110.94 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.22 -19.6 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.042 -0.526 . . . . 1.65 110.766 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.92 -36.14 67.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.144 0.497 . . . . 1.39 110.971 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.7 mm -84.94 -38.32 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 1.85 109.683 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -57.86 -41.74 83.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 2.48 111.026 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.38 87.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.972 -0.632 . . . . 0.75 112.038 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.5 -32.91 54.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 2.14 110.04 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 80.3 mmm -62.88 -52.47 62.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.735 -0.666 . . . . 1.95 110.691 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -27.43 67.84 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.291 -0.413 . . . . 2.03 110.739 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 143' ' ' LYS . 7.2 tmtt? -70.35 -42.33 71.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.012 -0.366 . . . . 3.52 110.012 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.43 65.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.054 -0.521 . . . . 1.03 110.702 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -57.93 -48.43 79.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 2.16 111.365 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.59 -16.48 63.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.444 -0.343 . . . . 2.58 111.798 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.85 -37.74 15.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.715 0.293 . . . . 1.16 110.273 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.13 82.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 1.17 111.475 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -72.87 -20.46 61.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 3.03 111.458 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.67 23.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.832 0.348 . . . . 0.96 111.221 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -82.55 9.81 8.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 1.11 111.631 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 62.73 30.31 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.108 -0.497 . . . . 1.49 112.274 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.31 116.37 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.34 23.21 5.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.253 -0.43 . . . . 1.76 110.993 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.96 179.23 45.46 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.752 -0.737 . . . . 0.81 111.603 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.28 137.51 12.83 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.249 . . . . 1.3 110.408 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.01 169.05 71.22 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.253 -1.561 . . . . 0.73 112.229 -0.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.5 m -155.84 125.89 6.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 1.31 110.498 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.411 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 96.2 mtp -106.54 137.27 44.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.836 -0.62 . . . . 1.49 109.804 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.63 136.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.39 -0.368 . . . . 1.19 110.327 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -113.4 111.79 37.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.485 -0.325 . . . . 1.26 110.952 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 54.89 30.04 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.197 -0.911 . . . . 1.4 112.172 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.91 27.12 43.43 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.093 -0.503 . . . . 0.51 114.331 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.41 -39.03 2.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.651 0.725 . . . . 2.3 111.657 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.72 130.06 55.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.538 -0.301 . . . . 2.27 110.238 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -117.92 131.15 56.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.961 0.41 . . . . 2.19 110.209 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -147.94 160.52 42.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.106 -0.497 . . . . 0.72 109.761 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -154.36 179.03 9.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.138 -0.483 . . . . 1.35 110.43 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.07 -34.19 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.609 -0.723 . . . . 1.36 111.459 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.06 -46.29 59.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.862 -0.685 . . . . 0.73 112.398 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.9 m -67.29 -46.35 73.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.734 0.302 . . . . 1.68 110.903 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.47 66.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 1.13 111.011 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.18 -34.3 5.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.907 -0.663 . . . . 1.1 112.039 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.15 164.37 34.31 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.637 -0.585 . . . . 0.95 111.637 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.05 -36.04 90.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.016 2.477 . . . . 1.0 112.99 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -69.57 -38.2 77.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 2.52 109.975 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.53 -25.99 65.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.435 -0.802 . . . . 1.82 110.644 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.1 m -62.64 -44.54 96.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.067 -0.515 . . . . 1.21 110.575 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.45 -31.34 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 1.24 110.338 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.52 -44.09 95.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.693 -0.685 . . . . 2.73 110.026 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.5 -38.3 77.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.799 -0.637 . . . . 1.28 110.358 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.4 -48.21 81.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 1.12 111.117 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -58.19 -40.15 80.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.91 110.697 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -66.69 -45.17 79.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.751 -0.659 . . . . 2.65 110.839 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.93 -39.34 93.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.559 -0.292 . . . . 1.37 111.255 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 179' ' ' ALA . 84.2 mt -60.76 -45.06 98.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.432 . . . . 1.36 110.166 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.59 -40.72 84.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 2.17 110.138 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -55.75 -44.67 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.891 -0.595 . . . . 2.86 110.671 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.16 -39.81 68.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 1.64 111.14 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.474 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -64.01 -33.8 76.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 2.24 110.93 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.14 76.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 1.43 111.676 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.19 -6.63 53.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.253 -0.43 . . . . 1.52 111.414 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.45 27.64 2.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 1.84 110.935 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -96.05 78.32 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 6.86 110.578 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 pttt . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.529 1.143 . . . . 7.8 112.614 -179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.687 -0.565 . . . . 2.47 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.74 153.44 0.14 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.357 0.663 . . . . 2.13 110.727 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -151.53 18.44 0.72 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.097 0.475 . . . . 1.97 110.665 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -132.91 154.91 49.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 1.65 110.667 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 138.41 54.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.047 -0.524 . . . . 1.83 111.554 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.22 124.46 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.785 -0.45 . . . . 1.4 109.785 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.31 -11.5 60.04 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.928 -0.869 . . . . 1.14 110.928 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.94 -69.37 0.84 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.985 -0.376 . . . . 2.3 109.985 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -88.47 -38.23 15.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 1.55 111.178 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -141.67 159.59 41.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.082 -0.34 . . . . 1.33 110.082 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.44 136.3 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.856 0.36 . . . . 1.42 110.478 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -109.87 118.01 35.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.846 -0.428 . . . . 1.82 109.846 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 141.48 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 1.53 110.97 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -7.62 54.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 1.9 111.795 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -128.66 84.13 64.08 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.137 -0.483 . . . . 1.63 110.381 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.94 144.47 58.55 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.668 2.245 . . . . 1.12 112.952 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.06 126.05 29.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.722 -0.672 . . . . 1.37 109.966 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.48 141.13 34.35 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.347 2.032 . . . . 1.35 112.285 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.66 171.21 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 1.58 110.877 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -61.85 2.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.386 -0.37 . . . . 2.09 111.133 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -116.22 131.83 23.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.294 -0.261 . . . . 3.88 110.294 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.64 158.07 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.513 2.142 . . . . 1.66 112.545 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.36 -58.23 0.4 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.87 -0.681 . . . . 1.12 112.293 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -83.54 149.21 26.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.327 -0.249 . . . . 2.9 110.327 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.0 mm -91.5 126.66 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.045 -0.525 . . . . 1.22 110.722 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.78 125.5 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.554 -0.748 . . . . 2.69 110.49 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -124.93 92.59 2.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.472 -0.566 . . . . 1.19 109.472 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.5 t -90.88 125.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.832 -0.622 . . . . 1.36 110.988 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -109.13 116.01 31.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.558 -0.746 . . . . 2.43 109.748 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 4.3 mp -95.55 113.23 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.127 -0.488 . . . . 1.37 110.611 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -119.67 169.59 9.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.78 -0.645 . . . . 2.24 110.41 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.02 162.03 37.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.197 -0.456 . . . . 1.29 110.083 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -82.46 7.01 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.452 -0.34 . . . . 4.86 111.879 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.18 13.85 5.7 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.199 -1.0 . . . . 1.62 113.976 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 p -106.49 114.71 61.77 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 117.464 0.632 . . . . 1.12 110.261 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.12 -40.45 41.99 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.037 2.491 . . . . 1.16 113.831 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -67.11 -21.78 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.066 0.395 . . . . 1.81 112.066 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 81.5 m -66.28 -33.64 76.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.349 . . . . 1.32 110.604 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.46 -40.04 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.17 111.262 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.32 -12.94 60.38 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.965 0.358 . . . . 1.44 111.965 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -89.2 -23.05 22.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.6 -0.273 . . . . 0.81 111.31 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' O ' HG22 ' A' ' 48' ' ' VAL . 4.2 mt-10 -54.05 -58.02 15.4 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.353 0.501 . . . . 2.69 112.353 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.23 -14.76 40.17 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.108 1.872 . . . . 0.9 113.362 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 -30.27 15.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 1.29 111.309 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 HG12 ' HG ' ' A' ' 51' ' ' SER . 13.7 tt -95.0 -18.16 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.255 0.465 . . . . 1.48 112.255 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 44' ' ' GLU . 24.4 t -59.39 -54.43 56.14 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 111.871 0.322 . . . . 1.47 111.871 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 36.6 Cg_endo -65.47 -3.13 7.15 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.264 1.976 . . . . 0.95 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -102.6 -52.8 3.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 0.9 109.925 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HG ' HG12 ' A' ' 47' ' ' ILE . 12.9 m -64.95 -33.58 76.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 1.68 112.081 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.73 -5.26 47.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.663 0.268 . . . . 2.14 111.472 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 49' ' ' PRO . 3.1 mptp? -124.62 35.05 4.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 2.64 110.542 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -86.82 150.97 51.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.404 -0.362 . . . . 1.29 110.992 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.58 169.18 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.319 2.013 . . . . 1.09 111.951 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 14.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 1.57 112.19 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.69 5.72 11.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 1.65 110.597 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.4 t -129.69 122.09 54.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.514 . . . . 1.35 110.363 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -116.43 110.56 18.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.761 0.315 . . . . 1.69 110.353 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -74.39 138.04 43.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.511 . . . . 2.1 110.508 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.8 t -130.61 111.31 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.461 -0.336 . . . . 1.33 110.739 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -88.29 120.82 30.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.058 -0.719 . . . . 4.84 109.058 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 61.1 mt -135.45 130.5 19.05 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.153 0.502 . . . . 1.24 111.46 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.61 146.88 34.99 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.413 2.075 . . . . 0.7 111.781 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.43 90.91 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.295 0.569 . . . . 1.11 110.931 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.08 67.41 8.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.826 -0.625 . . . . 1.04 111.2 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.37 47.97 1.36 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 2.49 111.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.41 -155.52 36.2 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.375 -0.829 . . . . 1.39 113.371 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.63 -125.7 18.66 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.74 0.318 . . . . 1.35 113.403 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.6 tp -99.88 -5.14 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.414 0.626 . . . . 1.66 109.765 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -69.25 -48.24 62.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.7 . . . . 0.87 110.583 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -63.19 -34.27 77.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.251 -0.432 . . . . 2.57 111.03 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.17 -29.88 46.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.539 0.685 . . . . 1.49 109.715 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -93.36 24.23 4.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.407 -0.815 . . . . 1.5 110.595 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.98 -28.8 0.27 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.708 -0.758 . . . . 0.78 112.184 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.94 -33.64 67.2 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.838 0.351 . . . . 2.36 111.343 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.8 ttt -55.06 -38.57 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 1.99 111.259 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.73 -52.98 61.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 1.28 111.602 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.28 -32.67 73.42 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.432 -0.349 . . . . 1.36 111.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.7 m -64.66 -36.44 84.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.953 0.406 . . . . 1.23 110.563 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.62 -45.45 75.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 2.19 110.695 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.19 -36.47 79.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 2.19 111.561 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -72.25 -2.47 19.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.473 0.546 . . . . 1.91 112.473 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.2 mtm -91.03 -6.77 53.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.754 -0.379 . . . . 2.22 110.49 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.52 38.15 68.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.093 -0.575 . . . . 2.2 112.597 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.45 140.96 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 2.76 110.811 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.35 156.94 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.007 -0.542 . . . . 5.28 110.028 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.1 m80 58.66 40.57 23.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.46 0.648 . . . . 6.1 110.556 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.92 2.24 32.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.373 -0.83 . . . . 5.45 110.304 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t 66.79 79.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.83 . . . . 4.19 109.831 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -28.49 68.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.32 -0.854 . . . . 5.03 110.218 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.51 -29.32 67.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.693 -0.685 . . . . 2.88 111.349 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.55 -36.74 76.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.091 0.472 . . . . 2.25 110.372 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -70.67 -43.71 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 2.07 109.639 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -39.15 82.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.775 -0.648 . . . . 3.95 110.514 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.83 -47.26 85.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 2.61 110.822 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -65.19 -28.31 69.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 2.1 111.712 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -78.48 -42.34 26.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 111.99 0.367 . . . . 2.35 111.99 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -88.84 -38.32 14.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.446 0.906 . . . . 2.62 113.446 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -88.73 -53.42 4.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.015 -0.274 . . . . 3.06 111.634 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 35.9 mm-40 -72.18 -52.43 16.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.601 0.238 . . . . 2.59 110.898 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 56.89 69.01 0.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.678 -0.692 . . . . 2.81 110.701 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -90.04 9.01 29.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.052 -0.522 . . . . 2.69 111.005 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 tttt 65.41 85.56 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.575 -0.739 . . . . 3.02 111.366 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.9 mt -91.31 72.06 6.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.999 -0.546 . . . . 1.73 110.114 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.53 -44.84 6.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 1.34 110.992 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.56 147.17 33.15 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 1.67 111.299 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.52 -27.1 81.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 1.09 113.044 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 6.7 mt-10 -61.05 -48.15 83.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 2.62 110.769 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 2.51 110.524 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.5 mtt -60.93 -52.33 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.283 -0.871 . . . . 1.38 110.624 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.99 82.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.41 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 2.1 t70 -62.25 -48.47 79.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 1.83 110.819 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -69.46 -42.71 74.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 1.74 111.161 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 117' ' ' GLY . 52.9 mt -61.4 -33.56 73.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 1.41 111.25 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.36 7.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.448 -0.342 . . . . 1.44 111.263 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' LEU . . . -107.19 -3.58 35.77 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.128 -0.487 . . . . 1.63 112.02 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -130.19 19.34 5.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.752 0.311 . . . . 3.56 111.479 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.13 64.06 1.08 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.479 -0.867 . . . . 1.63 113.078 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -147.0 139.37 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.153 -0.684 . . . . 1.47 109.153 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.644 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 37.2 t70 -96.36 123.82 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.665 0.269 . . . . 1.56 110.475 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.56 -40.2 95.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 1.93 111.521 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 55.3 mm-40 -55.87 -54.88 39.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.569 -0.287 . . . . 2.29 110.919 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.644 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 35.8 mmtm -65.84 -38.34 88.62 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.555 -0.293 . . . . 3.12 110.644 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 87.2 t80 -59.32 -55.36 35.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.052 -0.522 . . . . 2.28 110.681 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.69 -32.86 74.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 1.64 111.483 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.5 m -60.16 -56.74 17.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.444 -0.344 . . . . 1.84 110.906 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -74.13 -23.8 59.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.565 -0.288 . . . . 2.19 111.462 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 38.2 t80 -61.3 -32.98 72.83 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.032 0.444 . . . . 2.31 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -105.28 24.84 11.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.029 -0.532 . . . . 1.91 111.106 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.1 m -105.77 156.61 18.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 1.82 110.789 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -68.71 -20.94 64.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 1.65 110.967 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.48 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.098 0.475 . . . . 1.39 110.612 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.82 -41.53 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.091 0.472 . . . . 1.85 109.806 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.93 -42.13 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.702 -0.681 . . . . 2.48 111.142 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.3 98.96 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.14 -0.552 . . . . 0.75 112.027 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.1 -35.47 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.029 0.442 . . . . 2.14 109.908 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.7 mmm -59.1 -51.61 69.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.375 -0.829 . . . . 1.95 110.964 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 2.5 pt-20 -70.86 -26.94 63.49 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.783 -0.367 . . . . 2.03 110.812 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.67 -47.78 84.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 3.52 110.318 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.21 39.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 1.03 110.845 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 139' ' ' GLU . 73.8 tttt -55.57 -53.65 53.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 2.16 111.603 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 35.5 pttt -73.23 -24.07 60.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.804 -0.358 . . . . 2.58 111.578 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 mt -76.38 -33.85 58.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.87 -0.332 . . . . 1.16 110.868 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.3 90.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.157 0.503 . . . . 1.17 110.842 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 17.4 ptp -80.26 -20.85 43.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.623 . . . . 3.03 110.39 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.92 -34.43 59.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.96 110.442 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -80.16 2.84 22.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.815 -0.63 . . . . 1.11 110.107 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.46 44.77 14.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.438 -0.801 . . . . 1.49 112.173 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.9 130.39 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.49 . . . . 1.26 109.864 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.89 20.29 5.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.008 0.373 . . . . 1.76 112.008 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.83 173.23 43.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.078 -1.058 . . . . 0.81 112.579 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.91 143.35 36.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.283 -0.265 . . . . 1.3 110.283 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.488 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -80.99 165.45 76.1 Favored 'Cis proline' 0 N--CA 1.461 -0.382 0 C-N-CA 123.015 -1.661 . . . . 0.73 112.387 -0.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -158.15 135.94 10.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.341 -0.39 . . . . 1.31 110.695 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 99.7 mtp -114.27 135.53 53.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.821 -0.437 . . . . 1.49 109.821 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.45 130.69 73.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 1.19 110.195 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.07 117.21 54.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 116.412 -0.358 . . . . 1.26 111.091 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.3 m-20 54.86 27.9 9.67 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.961 0.788 . . . . 1.4 112.276 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.48 29.89 54.52 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 116.176 -0.466 . . . . 0.51 113.286 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 159' ' ' ASN . 79.8 mttt -128.5 -37.88 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.864 0.332 . . . . 2.3 111.619 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.23 132.46 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 2.27 111.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -121.63 122.72 40.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.773 -0.649 . . . . 2.19 110.131 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.12 163.12 34.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.86 0.362 . . . . 0.72 110.281 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -151.6 175.29 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.012 -0.54 . . . . 1.35 110.013 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.81 -40.04 78.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 1.36 111.668 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.06 -49.82 55.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.03 -0.605 . . . . 0.73 112.64 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.6 m -65.09 -45.39 85.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.535 0.207 . . . . 1.68 111.18 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.6 84.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 1.13 110.874 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 29.63 6.22 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.543 -0.837 . . . . 1.1 112.412 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.28 156.86 7.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.616 -0.802 . . . . 0.95 112.622 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.01 -40.01 81.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.13 2.553 . . . . 1.0 111.971 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -63.3 -46.45 86.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 2.52 109.841 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.28 -35.21 76.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 1.82 110.367 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.5 m -60.5 -46.56 89.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 1.21 110.611 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.83 -40.61 91.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 1.24 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -64.59 -43.37 94.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 2.73 110.562 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 1.5 mm? -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 1.28 110.242 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.28 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 1.12 111.581 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.58 -42.74 97.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.917 0.389 . . . . 1.91 110.688 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -61.64 -44.8 96.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.953 -0.567 . . . . 2.65 110.683 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 178' ' ' LEU . 98.7 mt -65.52 -36.75 84.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 1.37 111.02 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.71 -46.86 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 1.36 110.002 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.68 -38.3 90.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 2.17 110.697 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -59.63 -45.38 92.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 2.86 110.892 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -76.54 -37.44 56.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 1.64 111.383 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.7 74.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.511 -0.313 . . . . 2.24 110.521 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -58.92 -31.21 68.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.146 -0.479 . . . . 1.43 112.11 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.46 68.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.161 0.505 . . . . 1.52 110.983 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.64 41.2 3.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.327 0.584 . . . . 1.84 110.0 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 6.3 tptm -90.02 60.57 4.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.645 -0.707 . . . . 6.86 110.472 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.027 -0.987 . . . . 7.8 112.184 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.151 -0.38 . . . . 2.47 112.151 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.53 100.66 0.05 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.263 0.625 . . . . 2.13 111.647 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.53 1.9 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 1.97 110.587 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -120.72 167.11 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.112 -0.495 . . . . 1.65 110.295 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -127.77 137.71 52.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 1.83 111.285 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 129.17 38.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 1.4 110.356 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.66 -16.27 61.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.916 -0.659 . . . . 1.14 111.675 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.24 -73.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.332 . . . . 2.3 110.102 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -87.39 -31.33 20.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -143.57 140.84 30.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.774 0.321 . . . . 1.33 110.548 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.95 132.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.224 -0.444 . . . . 1.42 110.124 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.33 126.84 35.69 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.486 -0.561 . . . . 1.82 109.486 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 mt -63.77 129.98 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.855 0.36 . . . . 1.53 110.749 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -19.23 65.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.477 0.656 . . . . 1.9 110.359 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -133.33 98.89 14.97 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.353 -0.84 . . . . 1.63 109.227 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.57 142.25 76.83 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.282 1.988 . . . . 1.12 112.506 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.08 124.03 35.25 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.921 -0.581 . . . . 1.37 110.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.5 144.76 50.99 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.416 2.077 . . . . 1.35 112.514 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.04 159.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 1.58 110.818 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -51.72 57.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.514 . . . . 2.09 111.417 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.79 101.33 29.92 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.122 -0.49 . . . . 3.88 110.722 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.88 71.88 4.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.013 2.475 . . . . 1.66 111.939 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.77 -57.59 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.885 -0.674 . . . . 1.12 111.694 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -102.37 167.48 9.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.989 -0.375 . . . . 2.9 109.989 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.36 121.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.485 -0.561 . . . . 1.22 109.485 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -101.29 119.09 38.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.151 -0.477 . . . . 2.69 111.081 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.32 112.1 38.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 1.19 109.926 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.29 137.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 1.36 111.627 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.25 139.57 53.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.742 -0.836 . . . . 2.43 108.742 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.4 mp -116.03 121.28 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 1.37 110.801 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 2.24 111.365 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.565 ' NE1' ' HA ' ' A' ' 71' ' ' TRP . 30.2 t90 -150.59 148.06 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 1.29 109.487 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -78.78 69.49 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.004 0.43 . . . . 4.86 110.208 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.67 35.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.607 -0.724 . . . . 1.62 112.16 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.6 115.48 13.57 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.991 0.424 . . . . 1.12 110.428 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.89 -34.01 18.79 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.495 2.13 . . . . 1.16 112.424 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -62.21 -33.07 73.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.608 -0.269 . . . . 1.81 111.437 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 18.1 m -65.19 -35.21 80.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 1.32 110.786 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.516 ' HB2' ' CE1' ' A' ' 99' ' ' HIS . 11.7 t80 -69.09 -25.2 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 3.17 111.083 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.34 -7.33 56.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.15 -0.477 . . . . 1.44 110.685 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CE2' HD13 ' A' ' 47' ' ' ILE . 2.7 t80 -99.03 -37.37 9.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.022 -0.536 . . . . 0.81 111.058 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 61.7 mm-40 -45.72 -54.74 14.74 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.142 0.793 . . . . 2.69 113.142 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 18.2 Cg_endo -59.92 -9.32 9.54 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.343 2.029 . . . . 0.9 113.657 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -35.5 5.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.627 0.251 . . . . 1.29 111.535 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 43' ' ' PHE . 15.5 tt -82.66 -33.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.045 0.387 . . . . 1.48 112.045 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.29 -58.63 14.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.568 -0.253 . . . . 1.47 111.666 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.58 -36.01 98.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.843 1.696 . . . . 0.95 111.798 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -65.59 -49.16 69.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.9 110.715 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.7 p -65.99 -29.54 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.988 0.366 . . . . 1.68 111.988 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -84.86 0.17 51.91 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.852 0.358 . . . . 2.14 111.211 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.64 18.93 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 2.64 110.522 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.81 148.07 84.64 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.514 . . . . 1.29 111.105 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.97 165.09 24.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 1.09 111.496 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.53 -10.24 59.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.726 0.298 . . . . 1.57 111.526 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.04 -6.19 57.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.12 0.486 . . . . 1.65 111.335 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.4 t -120.02 140.5 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 1.35 111.116 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -121.42 146.27 47.06 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.336 -0.616 . . . . 1.69 109.336 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -121.82 137.31 54.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.618 -0.265 . . . . 2.1 110.874 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.09 127.46 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 1.33 111.021 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -99.78 105.41 17.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.237 -0.653 . . . . 4.84 109.237 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 27.9 mt -111.26 146.8 35.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 1.24 111.192 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -87.96 145.21 6.4 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.608 2.205 . . . . 0.7 111.984 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.36 101.74 6.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.917 0.389 . . . . 1.11 110.549 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.41 96.57 8.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 1.04 110.056 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HD1' ' CE3' ' A' ' 71' ' ' TRP . 48.0 m-85 -114.37 38.07 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.588 0.588 . . . . 2.49 112.588 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.56 -54.26 4.04 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.14 0.816 . . . . 1.39 115.14 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 71' ' ' TRP . . . -68.64 -147.93 0.2 Allowed Glycine 0 C--O 1.225 -0.438 0 CA-C-N 117.195 0.497 . . . . 1.35 113.605 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.3 tp -67.71 9.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.771 0.796 . . . . 1.66 111.575 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.585 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 54.2 m95 -74.85 -50.11 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.427 -0.806 . . . . 0.87 110.528 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -68.22 -35.12 77.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 2.57 111.489 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.6 t -63.56 -27.17 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.343 0.592 . . . . 1.49 110.362 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -94.24 3.45 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.998 -0.547 . . . . 1.5 110.981 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.74 -28.59 3.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.452 -0.88 . . . . 0.78 111.837 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -59.81 -32.8 70.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.671 0.388 . . . . 2.36 111.007 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.1 ttm -59.35 -48.62 80.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.155 -0.475 . . . . 1.99 111.044 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.43 -45.51 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 1.28 110.964 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.43 -39.35 90.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.36 110.475 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.2 m -64.16 -44.28 92.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.854 -0.612 . . . . 1.23 110.401 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.24 -48.98 77.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 2.19 111.155 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.79 -39.67 92.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 2.19 111.255 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -21.04 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 1.91 111.151 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 74.7 mtp -91.75 -35.41 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.515 -0.311 . . . . 2.22 110.8 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.8 -46.65 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 2.2 112.045 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p 41.9 106.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.072 1.349 . . . . 2.76 114.08 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.01 131.69 41.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.37 -0.832 . . . . 5.28 110.618 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -65.1 -21.4 66.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.942 0.401 . . . . 6.1 110.477 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.35 -30.52 64.9 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.65 -0.704 . . . . 5.45 111.439 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.59 21.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 4.19 111.743 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.18 -19.88 65.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.081 0.401 . . . . 5.03 112.081 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.56 -30.96 10.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.821 0.343 . . . . 2.88 110.182 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.05 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 2.25 112.029 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.29 -41.9 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 2.07 111.145 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.25 -35.42 76.11 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.969 0.414 . . . . 3.95 110.561 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.91 -28.73 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 2.61 110.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -69.73 -17.28 63.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.959 -0.564 . . . . 2.1 110.655 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.4 mm -96.91 -33.0 4.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 2.35 110.489 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 41.3 m-70 -94.33 -80.02 0.41 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.841 0.682 . . . . 2.62 112.841 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -59.62 -51.97 67.54 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.323 0.49 . . . . 3.06 112.323 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.3 mm-40 -76.04 -48.99 18.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.442 -0.345 . . . . 2.59 111.153 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.3 t60 56.22 58.52 4.25 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.883 -0.784 . . . . 2.81 108.883 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -71.03 10.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.977 -1.01 . . . . 2.69 113.287 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 58.09 46.12 16.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.41 0.624 . . . . 3.02 110.486 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.99 78.46 7.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 1.73 110.606 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.8 -38.91 6.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.391 -0.368 . . . . 1.34 110.502 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 111' ' ' MET . 17.9 p -91.75 146.93 34.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 1.67 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.06 -34.05 91.49 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.806 2.337 . . . . 1.09 112.343 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.92 -46.21 82.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 2.62 110.991 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.02 -39.05 92.83 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.406 -0.59 . . . . 2.51 109.406 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 107' ' ' THR . 65.5 mtt -59.41 -54.22 49.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.505 -0.771 . . . . 1.38 110.204 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.07 -32.69 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 1.41 111.813 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 1.83 110.391 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 32.9 t80 -75.77 -46.65 29.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.74 110.331 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.3 mt -62.17 -24.95 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.822 -0.626 . . . . 1.41 111.629 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -59.78 -29.28 68.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 1.44 110.755 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.85 16.97 60.1 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.794 -0.717 . . . . 1.63 111.842 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -120.47 7.55 10.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.925 0.393 . . . . 3.56 110.498 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.16 12.34 54.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.737 -0.744 . . . . 1.63 112.161 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.1 t -106.25 128.47 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 1.47 110.396 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 6.1 t70 -78.69 131.1 36.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.385 . . . . 1.56 110.732 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -64.91 -36.52 84.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 1.93 111.549 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 48.5 mm-40 -63.44 -56.19 18.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 2.29 110.611 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -58.93 -39.92 83.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 3.12 111.036 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.436 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 85.6 t80 -61.16 -55.67 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 2.28 111.119 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.49 -29.6 70.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.543 -0.299 . . . . 1.64 111.645 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.4 t -70.61 -40.65 73.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.769 0.319 . . . . 1.84 110.558 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.5 m -79.41 -39.87 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.19 111.104 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -54.22 -50.62 66.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.305 -0.407 . . . . 2.31 110.697 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -95.3 65.48 2.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.602 0.715 . . . . 1.91 109.646 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.1 t -145.97 156.54 43.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 1.82 110.64 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -19.86 65.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 1.65 110.265 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.32 75.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 1.39 110.815 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.8 mm -91.98 -38.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.166 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.44 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 60.0 tttt -57.77 -40.33 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 2.48 110.819 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.19 -18.16 68.9 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.75 112.725 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.72 -25.59 19.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.309 0.576 . . . . 2.14 110.176 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 135' ' ' LYS . 67.4 mtp -67.4 -46.33 73.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.467 -0.788 . . . . 1.95 111.384 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.61 -33.92 74.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.664 -0.244 . . . . 2.03 111.65 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.63 -49.17 74.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.381 . . . . 3.52 110.938 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 1.03 111.42 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -59.14 -53.58 56.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 2.16 111.34 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.07 -27.77 66.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.531 -0.304 . . . . 2.58 111.42 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.7 mt -72.96 -41.32 64.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.127 -0.229 . . . . 1.16 110.99 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.04 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.922 0.391 . . . . 1.17 111.494 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.6 ptm -69.37 -30.39 68.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 3.03 111.357 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.38 65.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.806 0.336 . . . . 0.96 111.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -82.97 3.68 29.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 1.11 110.981 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 61.54 33.82 18.21 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.844 -0.616 . . . . 1.49 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.77 115.96 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.621 -0.511 . . . . 1.26 109.621 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.92 4.57 12.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.521 . . . . 1.76 112.063 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.31 35.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.387 -0.911 . . . . 0.81 112.409 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 m -138.58 134.02 17.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.068 -0.345 . . . . 1.3 110.068 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.8 179.91 26.16 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.643 -1.399 . . . . 0.73 112.195 -0.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.3 m -162.11 103.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.806 -0.442 . . . . 1.31 109.806 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 51.0 mtp -86.11 126.46 34.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.845 -0.616 . . . . 1.49 110.442 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.99 122.4 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 1.19 109.916 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.24 120.75 59.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.347 -0.388 . . . . 1.26 111.021 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 56.74 18.6 3.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.324 -0.853 . . . . 1.4 113.106 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 33.01 82.5 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.225 -0.512 . . . . 0.51 113.54 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -127.89 -38.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 2.3 111.356 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.4 138.82 51.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.742 0.306 . . . . 2.27 110.748 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -123.2 123.21 40.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.79 -0.641 . . . . 2.19 110.068 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.1 172.37 13.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.509 -0.314 . . . . 0.72 110.203 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -170.4 -176.22 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.024 -0.361 . . . . 1.35 110.024 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 43' ' ' PHE . 26.1 mt -57.96 -39.31 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 O-C-N 123.56 0.538 . . . . 1.36 111.482 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.15 -22.54 78.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.906 -0.664 . . . . 0.73 113.061 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -88.04 -49.25 7.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.84 0.352 . . . . 1.68 110.754 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.11 -35.52 69.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.215 -0.448 . . . . 1.13 111.433 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.87 44.18 2.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.613 -0.803 . . . . 1.1 112.564 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 135.77 148.51 5.61 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.688 -0.768 . . . . 0.95 112.266 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.0 -42.74 54.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.045 2.497 . . . . 1.0 112.482 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -65.69 -37.24 85.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 2.52 110.14 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.99 -32.42 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 1.82 110.384 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 m -65.57 -39.25 91.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 1.21 110.735 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.7 mt -63.12 -37.44 87.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.027 -0.533 . . . . 1.24 110.39 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.32 -42.0 96.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 2.73 110.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.07 -43.88 94.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.007 -0.542 . . . . 1.28 110.231 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.535 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.25 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 1.12 111.039 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.28 -36.23 79.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.91 111.271 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.79 -45.24 68.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.65 110.779 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.74 -31.27 72.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.379 -0.373 . . . . 1.37 111.344 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 179' ' ' ALA . 80.2 mt -60.97 -44.25 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 1.36 109.738 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.34 -32.81 66.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.739 -0.664 . . . . 2.17 110.307 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.9 -47.11 75.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.92 -0.582 . . . . 2.86 110.679 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -73.66 -31.2 63.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 1.64 111.439 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 5.3 tpm_? -64.05 -28.73 69.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 2.24 110.14 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.01 67.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.647 -0.706 . . . . 1.43 111.503 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.75 -42.53 84.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 1.52 110.942 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.21 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.17 -0.468 . . . . 1.84 110.241 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.63 41.37 12.29 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.476 -0.783 . . . . 6.86 110.972 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 C--O 1.245 0.858 0 CA-C-N 115.252 -0.886 . . . . 7.8 110.544 179.788 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.942 -0.463 . . . . 2.47 111.942 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 64.99 95.25 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.064 0.546 . . . . 2.13 111.478 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.79 -5.92 20.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.203 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -106.8 156.68 18.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.948 0.404 . . . . 1.65 111.343 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.42 133.32 56.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.961 -0.563 . . . . 1.83 110.797 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.18 124.41 24.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 1.4 110.499 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.06 -6.53 69.23 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.971 -0.633 . . . . 1.14 111.682 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -109.59 -68.25 0.93 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.729 0.3 . . . . 2.3 110.569 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -80.41 -29.98 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.55 111.254 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -152.46 161.46 42.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.729 -0.471 . . . . 1.33 109.729 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.68 131.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.79 0.328 . . . . 1.42 110.544 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -103.94 146.23 28.98 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.599 -0.519 . . . . 1.82 109.599 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -96.79 150.69 20.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.428 -0.351 . . . . 1.53 110.683 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.14 -43.22 71.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 1.9 110.887 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -103.66 102.52 30.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 1.63 110.258 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.85 154.76 23.23 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.428 2.085 . . . . 1.12 112.936 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.66 118.64 53.9 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 1.37 110.465 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.16 120.67 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.353 2.035 . . . . 1.35 112.431 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.12 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.494 . . . . 1.58 111.038 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -87.99 9.2 23.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 2.09 111.184 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -129.1 79.8 73.81 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 3.88 110.218 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.23 119.59 6.55 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.552 2.168 . . . . 1.66 111.645 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.62 -15.91 14.37 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.759 -0.734 . . . . 1.12 112.021 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.24 161.96 16.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.016 -0.364 . . . . 2.9 110.016 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.3 mm -103.07 116.3 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 1.22 110.561 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -97.75 113.99 25.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 2.69 110.823 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.83 101.19 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.02 -0.733 . . . . 1.19 109.02 178.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.1 t -91.59 119.64 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.536 . . . . 1.36 111.444 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' OE1' ' HB3' ' A' ' 62' ' ' ARG . 22.3 tt0 -102.16 115.28 30.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.412 -0.813 . . . . 2.43 108.971 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 3.6 mp -101.58 113.76 27.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 1.37 110.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -123.32 174.41 7.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.541 -0.754 . . . . 2.24 110.281 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.465 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 4.3 t90 -150.73 166.95 28.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.11 -0.496 . . . . 1.29 109.849 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -79.83 -1.42 38.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.392 -0.367 . . . . 4.86 111.111 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.05 7.74 19.0 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.515 -0.85 . . . . 1.62 114.082 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.0 p -104.06 110.05 63.42 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 117.723 0.761 . . . . 1.12 110.889 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.23 -30.68 24.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.345 2.03 . . . . 1.16 111.709 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -29.14 70.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.785 -0.643 . . . . 1.81 111.047 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 58.5 m -66.85 -41.97 86.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 1.32 111.17 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -67.71 -37.07 81.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.369 . . . . 3.17 111.163 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 -18.04 60.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.344 -0.389 . . . . 1.44 111.737 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.46 -25.82 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.481 -0.327 . . . . 0.81 111.408 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -50.06 -53.83 39.47 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.307 0.484 . . . . 2.69 112.307 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 36.8 Cg_endo -64.17 -4.07 7.16 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.379 2.053 . . . . 0.9 113.617 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 -35.89 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 1.29 111.339 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 tt -84.53 -28.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.124 0.416 . . . . 1.48 112.124 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.9 t -56.79 -56.31 34.22 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.557 0.577 . . . . 1.47 112.557 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.6 Cg_endo -55.82 -34.28 90.82 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.168 1.912 . . . . 0.95 112.63 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -73.81 -46.56 44.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.579 . . . . 0.9 110.975 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -64.63 -40.5 95.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 1.68 112.203 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.79 -8.95 57.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.196 -0.202 . . . . 2.14 111.371 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.8 15.36 18.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.638 0.256 . . . . 2.64 111.187 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.2 mt -71.37 145.37 90.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.633 0.254 . . . . 1.29 110.318 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.8 168.3 15.52 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.512 2.141 . . . . 1.09 112.055 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.54 53.77 0.89 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.221 0.534 . . . . 1.57 110.862 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 0.7 OUTLIER -150.05 -16.62 0.25 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.618 -0.719 . . . . 1.65 110.632 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.49 141.64 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 1.35 110.223 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -124.53 115.31 20.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.872 -0.418 . . . . 1.69 109.872 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' VAL . 24.4 t80 -74.82 116.13 15.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 2.1 110.704 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 53.2 t -121.25 114.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.153 -0.476 . . . . 1.33 110.273 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.457 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -110.93 133.75 53.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 4.84 110.137 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 74.4 mt -139.52 147.8 53.71 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.098 -0.501 . . . . 1.24 109.974 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 6.3 Cg_exo -78.25 153.45 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.388 2.059 . . . . 0.7 112.197 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.13 86.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.072 -0.513 . . . . 1.11 110.928 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.16 74.65 9.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.997 -0.547 . . . . 1.04 110.833 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -89.82 -1.36 57.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 2.49 110.7 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 108.63 177.7 21.77 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.833 -0.698 . . . . 1.39 111.743 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.6 -137.68 47.81 Favored Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.885 -0.674 . . . . 1.35 112.431 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -68.41 -18.41 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.807 0.337 . . . . 1.66 111.469 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.465 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 47.6 m95 -64.67 -46.03 84.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.87 110.258 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -32.28 70.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 2.57 110.549 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.68 -36.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.289 0.566 . . . . 1.49 110.059 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -91.53 33.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 1.5 110.617 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.35 -34.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.838 -0.696 . . . . 0.78 112.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -57.54 -32.98 67.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 2.36 111.466 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.551 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 13.7 ttt -54.51 -46.84 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.915 -0.584 . . . . 1.99 111.732 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.65 -41.33 97.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.24 0.459 . . . . 1.28 112.24 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.55 -21.86 61.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.531 -0.304 . . . . 1.36 111.797 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -84.6 -26.63 27.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.825 0.345 . . . . 1.23 111.582 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 77' ' ' MET . 92.7 mt -63.1 -62.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.994 0.738 . . . . 2.19 112.994 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.25 -9.58 53.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.901 0.704 . . . . 2.19 112.901 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -78.28 -4.1 46.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 1.91 110.596 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.2 ttm -87.9 0.34 55.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 2.22 110.378 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 49.13 7.73 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.831 -0.699 . . . . 2.2 111.931 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.79 152.43 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.742 0.306 . . . . 2.76 110.827 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.02 151.01 37.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.028 -0.533 . . . . 5.28 110.383 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 41.0 m80 55.85 42.47 28.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.136 0.494 . . . . 6.1 111.332 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.22 8.38 33.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 5.45 110.946 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.01 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.577 0.703 . . . . 4.19 110.128 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.85 -30.6 71.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.269 -0.878 . . . . 5.03 111.059 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.55 -37.76 70.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 2.88 111.861 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -34.1 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 2.25 110.762 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.53 -46.79 61.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.58 . . . . 2.07 110.275 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -35.83 81.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.973 -0.558 . . . . 3.95 111.175 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -65.03 -43.41 92.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 2.61 110.432 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.55 66.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.903 0.383 . . . . 2.1 111.311 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.6 mt -85.32 -36.87 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 2.35 111.702 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -100.13 -52.03 3.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.777 0.658 . . . . 2.62 112.777 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -66.19 -41.59 90.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 3.06 111.063 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.64 -51.85 4.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 2.59 111.176 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 64.97 58.97 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.059 -0.519 . . . . 2.81 110.212 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -79.4 25.16 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.839 -0.619 . . . . 2.69 112.437 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 46.22 66.39 0.97 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.199 0.6 . . . . 3.02 111.87 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.81 73.26 7.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 1.73 110.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.87 -43.0 5.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.056 -0.52 . . . . 1.34 110.733 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 140.31 37.29 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.959 -0.564 . . . . 1.67 110.326 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.05 -31.54 83.02 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.679 2.253 . . . . 1.09 111.862 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.76 -44.55 89.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.763 -0.653 . . . . 2.62 110.305 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -37.34 80.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.816 -0.629 . . . . 2.51 110.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.7 mtt -69.62 -55.09 11.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.235 -0.893 . . . . 1.38 110.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.87 85.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 1.41 112.657 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.53 -34.33 78.0 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.864 -0.334 . . . . 1.83 111.092 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.48 -41.24 61.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.783 -0.451 . . . . 1.74 109.783 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.62 -31.9 73.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.675 . . . . 1.41 111.143 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.29 -21.01 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.175 -0.466 . . . . 1.44 110.547 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.34 -1.59 90.13 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 116.03 -0.532 . . . . 1.63 112.863 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -125.47 2.34 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.228 0.514 . . . . 3.56 111.359 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.37 58.85 0.81 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.537 -0.84 . . . . 1.63 113.357 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.17 126.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 1.47 109.165 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.718 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 28.1 t0 -72.17 117.55 13.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 1.56 110.78 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -61.66 -32.08 72.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.245 -0.889 . . . . 1.93 110.818 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -66.87 -53.88 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.29 111.037 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.718 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 39.2 mmtm -61.94 -42.39 99.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 121.147 -0.221 . . . . 3.12 110.636 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 80.9 t80 -57.63 -56.24 24.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 2.28 111.162 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.56 -36.83 85.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.28 . . . . 1.64 111.254 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.63 -55.81 23.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.45 -0.341 . . . . 1.84 111.395 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 124' ' ' LYS . 14.6 t -73.01 -23.04 60.58 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.956 0.354 . . . . 2.19 111.956 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -63.97 -27.41 69.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 2.31 110.37 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -102.23 1.84 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.886 -0.597 . . . . 1.91 110.936 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 47.0 m -82.2 153.26 26.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 1.82 110.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.74 -24.21 66.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.864 -0.607 . . . . 1.65 110.977 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.32 -43.43 64.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.47 . . . . 1.39 111.649 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.1 mm -79.61 -38.91 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.01 0.433 . . . . 1.85 110.135 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.657 . . . . 2.48 111.136 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.66 95.17 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.123 -0.56 . . . . 0.75 112.548 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -75.6 -28.15 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 2.14 110.273 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.3 mmm -63.02 -53.28 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.765 -0.652 . . . . 1.95 110.593 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.1 -30.88 70.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.39 . . . . 2.03 110.528 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -62.44 -41.59 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.139 -0.482 . . . . 3.52 110.366 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.48 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.268 -0.424 . . . . 1.03 110.939 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.6 -49.12 78.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 2.16 110.995 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -66.02 -24.88 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 2.58 111.221 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.86 -36.43 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 1.16 110.54 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.92 -44.53 86.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 1.17 111.221 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 20.6 ptp -80.16 -14.8 58.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 3.03 110.737 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.79 -31.76 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.96 110.082 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -80.54 5.07 16.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.681 -0.69 . . . . 1.11 110.012 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.437 ' HG3' ' HB3' ' A' ' 15' ' ' LEU . 16.2 mm-40 58.58 35.03 24.32 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.148 -0.933 . . . . 1.49 111.995 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.37 126.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.158 -0.474 . . . . 1.26 109.726 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.14 35.34 4.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.916 0.389 . . . . 1.76 111.853 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 157.87 179.18 32.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.551 -0.833 . . . . 0.81 112.211 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.4 143.53 41.62 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.538 0.209 . . . . 1.3 110.6 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.558 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 84.6 Cg_endo -81.66 166.93 71.55 Favored 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 123.201 -1.583 . . . . 0.73 112.378 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -156.73 133.09 9.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.277 -0.42 . . . . 1.31 110.223 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.66 132.71 56.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.731 -0.47 . . . . 1.49 109.731 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.83 128.79 75.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.387 -0.37 . . . . 1.19 110.037 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.5 116.61 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 1.26 111.203 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 54.42 26.86 7.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.452 -0.795 . . . . 1.4 112.842 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.98 29.62 62.4 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.014 -0.539 . . . . 0.51 114.227 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -120.59 -56.11 1.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.306 0.574 . . . . 2.3 111.228 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.31 137.11 42.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.739 -0.664 . . . . 2.27 110.524 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -120.96 133.7 55.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.234 -0.439 . . . . 2.19 110.383 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.02 170.02 19.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 0.72 110.172 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.6 176.54 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.564 -0.532 . . . . 1.35 109.564 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.444 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 88.2 mt -56.15 -41.34 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 123.542 0.526 . . . . 1.36 111.174 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.28 -47.38 58.7 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.002 -0.618 . . . . 0.73 112.495 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.1 m -60.67 -43.54 97.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.025 0.44 . . . . 1.68 110.978 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.14 -38.5 72.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.5 . . . . 1.13 110.912 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 123.48 -32.12 4.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.734 -0.746 . . . . 1.1 112.258 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.33 171.53 41.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.062 -0.589 . . . . 0.95 112.055 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -54.71 -52.84 7.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.652 . . . . 1.0 112.315 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.08 -37.27 82.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.871 -0.604 . . . . 2.52 110.795 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' A' ' 177' ' ' LYS . 19.0 mm-40 -66.38 -29.73 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.593 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 166' ' ' ILE . 9.2 m -64.85 -38.68 91.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 1.21 109.923 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.99 -32.75 73.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 1.24 110.159 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.436 ' HZ1' ' CD ' ' A' ' 174' ' ' GLU . 96.4 mttt -61.97 -51.73 66.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 2.73 110.463 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -61.9 -42.22 98.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.28 110.682 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.86 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 1.12 111.039 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.51 -42.2 98.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.554 . . . . 1.91 110.691 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -62.57 -45.32 93.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 2.65 111.185 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.19 -31.11 72.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 1.37 111.062 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 179' ' ' ALA . 77.7 mt -61.36 -44.07 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.237 -0.653 . . . . 1.36 109.237 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.98 -41.21 91.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.52 -0.764 . . . . 2.17 110.389 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -56.97 -49.46 75.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 2.86 111.172 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -74.11 -40.24 62.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 1.64 111.585 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -62.8 -33.73 75.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.566 -0.288 . . . . 2.24 110.815 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.97 -33.14 75.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 1.43 111.73 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.87 -24.44 62.18 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.044 0.387 . . . . 1.52 112.044 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.75 37.21 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 1.84 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -86.22 65.91 9.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.173 -0.467 . . . . 6.86 110.478 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.101 -0.952 . . . . 7.8 110.646 -179.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.869 -0.492 . . . . 2.47 111.869 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.69 104.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.21 0.604 . . . . 2.13 111.319 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -128.77 6.52 5.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.335 0.588 . . . . 1.97 110.763 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -117.33 128.86 55.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.903 -0.589 . . . . 1.65 109.811 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 145.06 29.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.968 0.413 . . . . 1.83 112.019 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.52 131.84 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 1.4 110.116 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.63 -3.65 86.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.436 -0.887 . . . . 1.14 111.509 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG2' ' OE2' ' A' ' 11' ' ' GLU . 47.4 tttm -119.07 -52.0 2.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.43 -0.581 . . . . 2.3 109.43 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' OE2' ' HG2' ' A' ' 10' ' ' LYS . 4.3 mp0 -101.57 -48.4 4.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 1.55 110.635 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -130.02 159.41 36.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.165 -0.47 . . . . 1.33 110.49 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.31 122.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.289 -0.414 . . . . 1.42 110.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -112.31 124.09 51.72 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.339 -0.615 . . . . 1.82 109.339 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.34 145.86 24.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.986 0.422 . . . . 1.53 111.023 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -75.32 -11.48 60.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.95 -0.568 . . . . 1.9 111.183 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.81 77.67 22.21 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.474 -0.33 . . . . 1.63 110.752 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.4 156.23 62.13 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.215 1.943 . . . . 1.12 111.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.86 121.66 39.09 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.208 -0.451 . . . . 1.37 110.189 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.78 133.0 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.224 1.949 . . . . 1.35 111.786 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.96 153.51 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.127 -0.488 . . . . 1.58 111.052 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -25.55 59.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 2.09 111.539 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -142.76 126.09 9.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.533 -0.303 . . . . 3.88 110.787 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.22 -174.92 2.15 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.397 2.065 . . . . 1.66 111.574 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -87.36 0.61 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.343 -0.932 . . . . 1.12 111.652 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -81.6 141.13 34.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.935 -0.395 . . . . 2.9 109.935 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.3 mm -70.79 111.47 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.352 -0.61 . . . . 1.22 109.352 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.95 114.44 15.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.114 -0.494 . . . . 2.69 110.731 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.99 102.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 1.19 109.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.01 123.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.958 -0.565 . . . . 1.36 110.644 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -115.84 136.25 53.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.343 -0.614 . . . . 2.43 109.343 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.8 mp -115.52 130.69 56.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.923 0.392 . . . . 1.37 110.447 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -127.4 172.58 10.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 2.24 111.202 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -141.03 167.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.778 -0.646 . . . . 1.29 109.686 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -91.45 -13.11 32.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.802 0.297 . . . . 4.86 111.802 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.9 1.41 31.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.184 -1.008 . . . . 1.62 113.824 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 p -87.43 120.62 71.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.206 0.503 . . . . 1.12 110.776 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.66 -39.17 5.01 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.734 2.29 . . . . 1.16 112.88 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -62.96 -27.56 69.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.218 -0.446 . . . . 1.81 112.162 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.5 m -63.41 -40.08 96.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 1.32 110.961 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.515 ' OH ' ' HE3' ' A' ' 100' ' ' LYS . 10.8 t80 -68.18 -22.27 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 3.17 111.308 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.04 -7.15 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.034 0.445 . . . . 1.44 111.196 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -104.15 -21.61 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.81 111.241 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 14.2 mm-40 -50.98 -55.12 30.36 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.797 0.666 . . . . 2.69 112.797 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 37.0 Cg_endo -65.15 -2.32 5.6 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.199 1.933 . . . . 0.9 113.263 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.81 -36.01 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.293 . . . . 1.29 111.577 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 tp -84.08 -33.6 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.029 0.381 . . . . 1.48 112.029 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -55.52 45.0 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 112.191 0.441 . . . . 1.47 112.191 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.42 1.64 4.04 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.87 1.713 . . . . 0.95 113.003 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -107.81 -43.11 4.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.9 110.772 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -65.9 -32.08 73.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.982 0.42 . . . . 1.68 111.311 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.57 2.27 42.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 2.14 110.63 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -124.09 21.48 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.223 0.535 . . . . 2.64 110.02 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.83 137.35 40.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 1.29 110.433 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 57' ' ' ASP . 20.9 Cg_endo -62.69 165.17 16.5 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.792 2.328 . . . . 1.09 112.895 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.95 24.12 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.321 0.582 . . . . 1.57 111.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' PRO . 5.3 t0 -121.84 -0.48 9.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.581 0.705 . . . . 1.65 109.81 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 t -124.82 141.16 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.456 -0.793 . . . . 1.35 110.18 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -119.5 117.99 29.88 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.115 -0.698 . . . . 1.69 109.115 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -105.72 124.29 49.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.86 0.362 . . . . 2.1 111.445 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.2 t -130.88 125.04 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 1.33 109.843 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 11.5 ttt180 -107.3 119.69 40.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.708 -0.479 . . . . 4.84 109.708 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.7 mt -121.22 151.34 55.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 1.24 110.732 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.7 141.72 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.288 1.992 . . . . 0.7 111.97 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -78.47 94.3 4.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.969 0.414 . . . . 1.11 110.668 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.03 87.2 7.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.268 -0.423 . . . . 1.04 110.844 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.455 ' HB2' ' CG ' ' A' ' 71' ' ' TRP . 3.8 m-30 -84.16 -4.53 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 2.49 111.232 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.56 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.246 -0.978 . . . . 1.39 114.139 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.75 -131.37 0.44 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.009 -0.615 . . . . 1.35 113.835 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.64 -22.45 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.02 0.438 . . . . 1.66 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.562 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 37.8 m95 -57.66 -42.84 84.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.732 -0.667 . . . . 0.87 110.7 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -71.59 -46.46 59.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 2.57 111.259 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 t -60.57 -33.7 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 1.49 111.012 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -89.1 5.73 43.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.29 -0.414 . . . . 1.5 111.426 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 -27.08 2.81 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.823 -0.703 . . . . 0.78 111.73 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.11 -35.34 78.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.967 0.413 . . . . 2.36 110.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.443 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 2.0 ttm -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 1.99 110.764 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.39 -46.86 82.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 1.28 110.777 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 1.36 110.786 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -64.35 -43.51 94.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.945 -0.571 . . . . 1.23 110.758 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 77' ' ' MET . 90.8 mt -61.74 -47.9 83.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 2.19 110.905 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.94 -30.61 70.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 2.19 111.322 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m -87.15 -3.89 59.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 1.91 111.461 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.0 mtp -107.65 -3.45 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 2.22 111.41 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.47 0.77 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.604 -0.807 . . . . 2.2 112.06 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p 39.95 92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.474 1.11 . . . . 2.76 113.333 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.15 137.93 45.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.288 -0.869 . . . . 5.28 110.728 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 9.6 m-70 -65.57 -17.11 64.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 6.1 111.502 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.34 -34.44 76.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.768 0.318 . . . . 5.45 111.043 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.74 24.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.152 0.427 . . . . 4.19 112.152 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 88' ' ' HIS . 1.6 p80 -71.69 -20.02 61.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.87 0.322 . . . . 5.03 111.87 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 3.7 t-20 -100.2 -25.52 14.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.62 0.248 . . . . 2.88 110.631 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.41 -36.48 66.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.92 -0.582 . . . . 2.25 112.094 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.21 -41.67 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 2.07 111.162 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -72.34 -37.02 68.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 3.95 110.71 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 5.0 mm-40 -65.13 -36.28 83.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.102 0.477 . . . . 2.61 110.479 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.57 59.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 2.1 111.59 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.54 -43.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 111.819 0.303 . . . . 2.35 111.819 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.71 -50.37 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.643 0.609 . . . . 2.62 112.643 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HE3' ' OH ' ' A' ' 41' ' ' TYR . 85.4 mttt -72.42 -65.02 0.83 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 3.06 111.289 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.13 -45.21 50.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 2.59 111.383 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 t60 59.59 65.17 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 2.81 109.473 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -75.46 9.33 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.402 -0.817 . . . . 2.69 112.664 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp 58.98 41.01 21.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.478 0.656 . . . . 3.02 110.558 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.4 mt -77.99 76.24 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 1.73 110.475 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.06 -39.67 9.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.096 -0.502 . . . . 1.34 110.612 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 111' ' ' MET . 1.1 p -95.7 146.44 31.32 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 1.67 110.948 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.91 -37.59 93.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.06 2.507 . . . . 1.09 112.545 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.07 -45.33 93.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.234 -0.439 . . . . 2.62 110.065 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.35 -39.43 93.87 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 2.51 109.402 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 107' ' ' THR . 52.1 mtt -60.08 -56.69 18.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.576 -0.738 . . . . 1.38 110.204 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.445 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . . . -61.35 -30.09 70.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.809 -0.632 . . . . 1.41 111.33 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -35.3 78.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.883 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -90.88 -40.69 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.28 -0.418 . . . . 1.74 110.478 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 120' ' ' VAL . 83.1 mt -63.73 -24.14 67.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 1.41 111.685 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.67 -34.89 69.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 1.44 111.177 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.92 -12.1 84.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.812 -0.708 . . . . 1.63 112.214 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -97.09 -2.67 42.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 3.56 110.488 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.42 -17.39 26.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.756 -0.735 . . . . 1.63 112.799 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 115' ' ' LEU . 61.9 t -69.03 112.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.227 0.537 . . . . 1.47 110.534 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.528 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 14.8 t70 -68.52 128.7 37.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.477 -0.783 . . . . 1.56 110.927 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -67.15 -34.72 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 1.93 111.32 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 mm-40 -59.18 -57.06 14.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.788 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -64.24 -39.52 94.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 3.12 111.18 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 78.4 t80 -58.46 -57.36 13.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 2.28 111.853 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.41 -38.33 86.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 1.64 111.52 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.8 t -64.41 -46.56 82.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 1.84 111.345 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.5 m -76.31 -38.04 56.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.499 -0.319 . . . . 2.19 111.836 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -52.79 -50.49 63.49 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.87 0.367 . . . . 2.31 111.216 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.13 53.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 1.91 110.123 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -132.27 161.7 32.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 1.82 110.307 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -21.05 66.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.232 -0.44 . . . . 1.65 110.716 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.98 69.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.118 0.485 . . . . 1.39 111.021 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.74 -36.72 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.203 -0.453 . . . . 1.85 109.908 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -58.03 -37.82 75.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.968 -0.56 . . . . 2.48 110.977 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.88 -24.27 77.21 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.155 -0.545 . . . . 0.75 112.43 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -86.77 -29.82 22.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.101 0.476 . . . . 2.14 110.654 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.3 -46.87 84.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 1.95 111.615 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.398 -0.365 . . . . 2.03 111.309 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 95.6 mttt -68.33 -45.61 72.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.338 -0.392 . . . . 3.52 111.048 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.46 73.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.444 . . . . 1.03 111.255 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.24 -47.38 86.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 2.16 111.793 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.21 -28.51 68.14 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.061 -0.256 . . . . 2.58 111.324 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.1 mt -73.12 -39.15 65.98 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.08 -0.248 . . . . 1.16 110.756 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.56 93.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 1.17 111.14 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.1 ptm -75.68 -26.64 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 3.03 111.196 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.68 -39.83 56.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.678 0.275 . . . . 0.96 111.197 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.95 4.62 28.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 1.11 111.215 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 57.9 43.61 21.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.886 -0.597 . . . . 1.49 111.601 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.97 109.75 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.359 . . . . 1.26 110.066 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 3.32 11.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.075 -0.511 . . . . 1.76 111.565 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.96 175.23 25.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.922 -0.656 . . . . 0.81 111.88 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.69 132.65 9.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.689 0.281 . . . . 1.3 110.491 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.57 175.81 46.2 Favored 'Cis proline' 0 C--O 1.236 0.383 0 C-N-CA 123.212 -1.578 . . . . 0.73 112.294 0.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.2 m -159.48 118.4 2.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.908 0.385 . . . . 1.31 110.368 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 80.7 mtp -100.99 128.53 46.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.069 -0.514 . . . . 1.49 110.531 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -116.33 119.58 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 1.19 110.094 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.66 117.9 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 1.26 111.351 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.1 t30 59.55 15.79 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.935 -1.03 . . . . 1.4 112.485 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.54 13.89 63.85 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.204 -0.522 . . . . 0.51 113.642 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.42 -38.95 4.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.449 -0.442 . . . . 2.3 111.426 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.5 140.47 48.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.369 -0.378 . . . . 2.27 110.544 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -128.99 130.04 46.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.942 -0.572 . . . . 2.19 110.094 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -149.59 172.18 15.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.497 -0.32 . . . . 0.72 110.252 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.85 -178.26 6.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.98 -0.555 . . . . 1.35 109.521 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 53.0 mt -57.3 -41.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.472 0.482 . . . . 1.36 110.995 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.72 -45.8 72.96 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.083 -0.58 . . . . 0.73 112.604 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 m -61.75 -45.07 95.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.693 0.282 . . . . 1.68 110.698 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.97 68.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 1.13 111.268 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 118.96 -38.73 2.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.983 -0.627 . . . . 1.1 112.033 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.03 158.77 27.81 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.066 -0.588 . . . . 0.95 111.749 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.82 -44.71 42.36 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.138 2.559 . . . . 1.0 112.532 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.92 -32.38 71.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 2.52 110.212 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.35 -29.09 66.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.922 -0.581 . . . . 1.82 110.029 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.1 m -62.0 -37.55 85.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.689 . . . . 1.21 110.426 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.8 mt -65.54 -33.67 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 1.24 110.798 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.2 -47.4 79.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.209 0.528 . . . . 2.73 110.742 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.83 -43.12 99.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 1.28 110.568 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.41 -47.93 83.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 1.12 110.96 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.97 -47.46 84.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 1.91 111.218 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -62.22 -40.82 97.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.161 -0.472 . . . . 2.65 111.494 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.46 -28.77 68.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.58 0.229 . . . . 1.37 111.122 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 179' ' ' ALA . 58.7 mt -62.3 -43.66 98.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.842 -0.799 . . . . 1.36 108.842 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.52 -35.46 73.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.466 -0.788 . . . . 2.17 110.522 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -62.29 -46.38 89.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.531 -0.759 . . . . 2.86 110.627 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -76.78 -20.78 56.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.994 -0.548 . . . . 1.64 111.175 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 187' ' ' ARG . 6.4 tpm_? -65.66 -29.21 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.583 -0.525 . . . . 2.24 109.583 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.31 -13.26 60.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.641 . . . . 1.43 111.717 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.34 66.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.101 0.477 . . . . 1.52 110.395 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.68 -31.44 7.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.693 -0.685 . . . . 1.84 110.435 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 61.67 63.41 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.62 -0.718 . . . . 6.86 111.221 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.5 mptt . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.432 -0.804 . . . . 7.8 111.045 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.963 -0.455 . . . . 2.47 111.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.93 109.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.301 0.64 . . . . 2.13 110.538 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.48 2.07 3.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.998 -0.546 . . . . 1.97 111.801 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -129.53 175.81 8.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 1.65 111.004 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.69 123.59 37.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.154 -0.476 . . . . 1.83 110.727 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.05 18.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.029 -0.532 . . . . 1.4 110.206 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.39 -14.15 51.06 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.458 -0.657 . . . . 1.14 111.458 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -105.0 -80.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.48 -0.192 . . . . 2.3 110.48 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 168' ' ' SER . 14.4 mp0 -68.36 -39.96 81.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.55 110.986 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -135.45 144.96 46.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.484 -0.326 . . . . 1.33 110.345 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.69 126.86 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.824 0.345 . . . . 1.42 110.46 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -102.6 126.48 49.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 1.82 109.984 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.01 143.53 28.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.337 -0.392 . . . . 1.53 110.297 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 50.1 m -80.92 -8.32 59.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.447 -0.342 . . . . 1.9 111.277 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 83.28 8.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.462 -0.57 . . . . 1.63 109.462 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 16' ' ' SER . 4.5 Cg_exo -78.87 156.16 27.0 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.815 2.343 . . . . 1.12 113.053 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.09 132.64 22.61 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.396 -0.82 . . . . 1.37 109.752 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -64.88 146.89 88.91 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.336 2.024 . . . . 1.35 111.902 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.37 170.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.302 -0.408 . . . . 1.58 111.14 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.64 -36.84 12.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.299 -0.409 . . . . 2.09 110.946 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.448 ' NE2' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -131.7 105.08 14.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 3.88 110.941 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.21 106.2 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.781 2.321 . . . . 1.66 111.928 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.74 -45.21 0.63 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.12 -0.792 . . . . 1.12 111.12 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -105.02 140.13 38.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.221 -0.659 . . . . 2.9 109.221 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -74.77 121.18 25.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.752 0.31 . . . . 1.22 110.887 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HG3' ' NE2' ' A' ' 23' ' ' GLN . 6.0 mt-10 -87.32 99.54 12.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 2.69 110.162 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.81 106.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.631 . . . . 1.19 109.714 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.6 124.27 57.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.237 -0.438 . . . . 1.36 111.102 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.56 130.83 54.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.879 -0.785 . . . . 2.43 108.879 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -109.18 113.29 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.37 110.82 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -115.24 172.67 6.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.465 -0.789 . . . . 2.24 110.214 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.471 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 3.2 t90 -147.74 164.51 33.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.98 0.419 . . . . 1.29 110.341 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -79.25 -13.14 59.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 4.86 111.276 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.62 17.46 23.23 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.256 -0.974 . . . . 1.62 114.544 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.9 p -108.77 105.0 56.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 117.817 0.808 . . . . 1.12 110.366 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.72 -28.24 60.14 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.505 2.137 . . . . 1.16 112.905 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -22.24 63.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.446 -0.343 . . . . 1.81 111.193 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 64.6 m -70.32 -37.88 74.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 1.32 110.782 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -68.29 -38.26 81.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 3.17 110.886 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -12.87 61.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 1.44 111.31 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -92.71 -18.24 23.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.407 -0.36 . . . . 0.81 111.074 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -50.84 -60.19 6.0 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.465 0.542 . . . . 2.69 112.465 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 3.88 2.55 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.918 1.746 . . . . 0.9 113.157 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -108.97 -30.96 7.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.337 -0.392 . . . . 1.29 110.876 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.9 tt -94.05 -30.11 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.861 0.319 . . . . 1.48 111.861 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 47.6 t -54.55 -56.22 29.33 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.47 0.544 . . . . 1.47 112.47 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.1 Cg_endo -56.84 -32.18 91.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.106 1.87 . . . . 0.95 112.832 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.446 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 77.2 t90 -78.22 -48.36 15.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.28 -0.418 . . . . 0.9 110.71 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -64.36 -37.72 88.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.351 0.5 . . . . 1.68 112.351 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.64 -9.24 58.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.716 0.293 . . . . 2.14 111.281 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -118.47 34.7 5.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 2.64 110.787 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 50' ' ' TRP . 41.2 mt -95.33 147.92 33.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.917 -0.583 . . . . 1.29 111.121 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.62 172.91 10.7 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.48 2.12 . . . . 1.09 112.264 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 2.94 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 1.57 111.864 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.11 -5.19 41.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 1.65 111.045 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.01 128.38 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.097 0.475 . . . . 1.35 111.606 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -113.2 103.05 10.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.058 -0.719 . . . . 1.69 109.058 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -86.43 132.13 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.176 -0.465 . . . . 2.1 111.374 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.97 116.22 36.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.576 -0.738 . . . . 1.33 109.94 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -99.28 122.82 42.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.796 -0.446 . . . . 4.84 109.796 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 69.0 mt -138.09 151.61 70.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 1.24 111.209 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.8 150.44 11.22 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.578 2.186 . . . . 0.7 111.668 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.26 93.49 4.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 1.11 110.883 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mt -92.26 92.58 8.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.044 -0.525 . . . . 1.04 110.329 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -118.13 37.43 4.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.849 0.357 . . . . 2.49 111.723 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.01 -165.02 46.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.542 -0.837 . . . . 1.39 112.227 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.55 -122.72 16.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.659 -0.305 . . . . 1.35 112.67 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.08 -5.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 1.66 109.947 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.471 ' HA ' ' HE1' ' A' ' 34' ' ' TRP . 39.8 m95 -60.21 -49.39 77.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.675 -0.693 . . . . 0.87 110.622 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -66.86 -36.37 82.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 2.57 111.31 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.77 -38.59 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 1.49 109.901 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -89.48 43.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.531 -0.759 . . . . 1.5 110.073 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.22 -35.13 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.878 -0.677 . . . . 0.78 112.878 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.03 -33.76 62.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.851 0.358 . . . . 2.36 111.543 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.2 ttt -53.64 -39.28 64.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 1.99 111.49 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.61 -51.17 68.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 1.28 111.378 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.83 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 1.36 111.158 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -62.35 -39.91 94.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 1.23 110.681 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.36 -46.6 76.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 2.19 110.864 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -60.13 -39.85 87.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 2.19 111.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -62.86 -18.13 62.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.415 0.524 . . . . 1.91 112.415 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.0 -16.05 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.915 0.388 . . . . 2.22 110.482 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.25 82.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.848 -0.691 . . . . 2.2 113.197 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 m -82.66 144.04 10.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.785 0.326 . . . . 2.76 110.776 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.27 154.93 48.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.274 -0.421 . . . . 5.28 110.484 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.4 m80 56.06 41.45 29.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.004 -0.544 . . . . 6.1 111.524 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.74 2.35 41.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 5.45 110.147 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.5 t 68.92 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.315 -0.857 . . . . 4.19 110.246 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.81 -22.05 54.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 5.03 110.431 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.21 -35.31 75.12 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.671 -0.695 . . . . 2.88 111.546 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.76 71.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 2.25 111.19 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -43.41 81.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.052 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.32 -34.1 75.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 3.95 110.372 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.55 -42.65 86.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 2.61 110.833 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.63 -22.35 66.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.113 0.482 . . . . 2.1 111.387 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.1 -39.56 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.16 -0.473 . . . . 2.35 111.572 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -96.04 -53.71 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.278 0.844 . . . . 2.62 113.278 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -68.69 -51.46 41.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.73 0.3 . . . . 3.06 111.105 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -83.71 -43.28 15.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 2.59 111.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.5 60.01 2.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.216 0.531 . . . . 2.81 109.86 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -77.03 13.15 1.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.46 -0.791 . . . . 2.69 112.897 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 54.55 58.0 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.306 0.574 . . . . 3.02 110.505 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.22 84.81 4.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.138 0.494 . . . . 1.73 110.464 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.44 -41.93 2.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 1.34 110.572 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 141.25 42.49 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.908 -0.587 . . . . 1.67 110.743 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.26 -34.69 94.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.482 2.121 . . . . 1.09 111.237 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 29.1 mt-10 -63.76 -42.15 97.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.439 -0.801 . . . . 2.62 110.332 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -40.41 95.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.081 -0.509 . . . . 2.51 110.287 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.6 mtt -69.26 -55.77 9.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.165 -0.925 . . . . 1.38 111.091 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.28 88.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.41 112.706 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -62.33 -35.13 78.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 1.83 111.534 -179.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.36 -43.57 18.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 1.74 111.057 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.21 -35.36 75.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.297 -0.411 . . . . 1.41 111.555 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -61.5 -24.84 66.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 1.44 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -11.49 85.22 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.042 -0.599 . . . . 1.63 113.386 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -109.8 -15.67 14.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.575 0.688 . . . . 3.56 111.885 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.06 40.27 0.26 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.132 -1.032 . . . . 1.63 113.487 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 88.0 t -126.55 130.05 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.556 -0.535 . . . . 1.47 109.556 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.72 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 20.7 t0 -75.49 123.8 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 1.56 110.593 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -62.84 -34.09 76.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.283 -0.871 . . . . 1.93 111.058 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.21 -49.24 65.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.397 -0.365 . . . . 2.29 111.091 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.72 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 45.6 mmtm -62.03 -43.94 97.76 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 3.12 110.677 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 77.7 t80 -55.02 -59.97 4.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 2.28 111.276 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.45 -0.341 . . . . 1.64 111.863 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 t -62.08 -55.84 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.459 -0.337 . . . . 1.84 111.007 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.3 t -76.54 -20.18 57.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.796 -0.362 . . . . 2.19 111.859 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -62.69 -37.52 86.77 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.266 0.555 . . . . 2.31 110.115 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -103.0 32.82 3.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.505 -0.771 . . . . 1.91 110.328 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.5 m -108.6 153.85 22.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.04 0.448 . . . . 1.82 111.396 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -67.72 -24.75 65.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.704 -0.68 . . . . 1.65 110.62 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.34 -44.47 75.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 1.39 111.379 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.81 -37.09 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 1.85 110.094 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -58.03 -41.94 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 2.48 110.653 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.75 -25.63 71.82 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.18 -0.533 . . . . 0.75 112.672 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.33 -35.93 24.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 2.14 110.146 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mmm -61.08 -50.39 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.614 -0.721 . . . . 1.95 111.281 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -66.62 -36.59 82.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 2.03 110.985 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -63.19 -37.87 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 3.52 110.816 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.68 26.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 1.03 110.971 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.22 -46.32 88.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.214 -0.448 . . . . 2.16 111.837 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -65.71 -31.72 72.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 2.58 111.125 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.0 mt -77.06 -39.37 50.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.726 0.298 . . . . 1.16 110.437 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.49 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 1.17 111.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -71.63 -25.15 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 3.03 111.068 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.57 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.96 110.892 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -80.55 2.38 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 1.11 110.97 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 61.87 29.43 17.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.88 -0.6 . . . . 1.49 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.96 114.32 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.412 . . . . 1.26 110.313 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.66 27.54 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 1.76 111.042 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.32 170.18 42.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.866 -0.683 . . . . 0.81 112.177 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.58 143.16 28.52 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.575 0.226 . . . . 1.3 110.604 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.48 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -77.95 166.83 79.99 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.277 -1.551 . . . . 0.73 112.492 0.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.3 m -156.84 137.42 13.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.368 -0.378 . . . . 1.31 110.713 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.4 mtp -117.33 134.16 55.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 1.49 109.448 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -122.17 127.53 75.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.511 -0.313 . . . . 1.19 110.476 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.88 118.05 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.304 -0.407 . . . . 1.26 111.153 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 58.55 17.2 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.193 -0.912 . . . . 1.4 112.92 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.03 27.24 64.49 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.225 -0.512 . . . . 0.51 113.093 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 186' ' ' GLU . 51.5 mtpt -124.27 -32.86 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.985 0.421 . . . . 2.3 110.857 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -121.58 132.04 54.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 2.27 110.073 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -120.45 126.21 49.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.398 -0.365 . . . . 2.19 110.097 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -141.09 169.37 17.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.457 -0.338 . . . . 0.72 110.421 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -160.98 -177.46 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.144 -0.48 . . . . 1.35 109.764 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.2 -40.58 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 1.36 111.888 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.87 -45.55 63.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.795 -0.717 . . . . 0.73 112.501 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' GLU . 32.9 m -63.82 -47.51 80.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.726 0.298 . . . . 1.68 110.735 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 1.13 111.264 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 125.54 -38.54 2.25 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.985 -0.626 . . . . 1.1 111.697 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.17 170.66 41.61 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.414 -0.675 . . . . 0.95 111.414 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.55 -38.84 90.34 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.244 2.63 . . . . 1.0 112.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -68.47 -36.06 78.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.001 -0.545 . . . . 2.52 110.392 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 177' ' ' LYS . 23.6 mm-40 -72.98 -27.88 62.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 1.82 110.766 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.6 m -60.44 -41.0 93.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 1.21 110.741 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.88 -37.52 84.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 1.24 110.619 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 174' ' ' GLU . 82.4 mttt -63.41 -44.17 95.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.826 -0.625 . . . . 2.73 110.981 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.8 -40.66 88.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 1.28 110.483 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.19 74.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 1.12 110.757 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.98 87.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.617 -0.72 . . . . 1.91 111.005 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -62.6 -46.85 86.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.695 -0.684 . . . . 2.65 111.526 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 1.37 111.158 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.49 -47.41 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 1.36 109.898 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.72 -38.95 84.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.467 -0.788 . . . . 2.17 110.454 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -57.54 -45.33 85.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.787 -0.642 . . . . 2.86 111.176 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . 0.438 ' CD ' ' HZ2' ' A' ' 161' ' ' LYS . 39.0 mm-40 -78.72 -39.05 37.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.207 -0.451 . . . . 1.64 111.72 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.537 0.208 . . . . 2.24 111.079 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -75.5 -13.54 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.43 112.295 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.35 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 1.52 111.211 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.06 38.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.161 0.505 . . . . 1.84 110.141 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 17.3 tptm -86.16 54.21 3.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.441 . . . . 6.86 110.943 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.4 pttp . . . . . 0 C--O 1.248 0.985 0 O-C-N 124.352 1.033 . . . . 7.8 112.101 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.631 -0.588 . . . . 2.2000000000000002 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 65.1 168.74 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.279 0.632 . . . . 2.1299999999999999 111.28 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.77 9.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.213 -0.449 . . . . 1.97 111.321 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.64 159.14 40.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.901 0.381 . . . . 1.2 110.836 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 132.4 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.092 -0.504 . . . . 1.29 111.227 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.42 126.34 29.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 1.03 110.363 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.55 -21.74 41.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.769 -0.729 . . . . 1.1399999999999999 111.724 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -94.21 -57.94 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.28 -0.267 . . . . 1.8899999999999999 110.28 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -90.6 -50.67 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 1.55 110.321 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.14 147.04 52.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 1.03 110.027 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.51 131.86 60.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.795 0.331 . . . . 0.91000000000000003 110.449 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.29 132.57 40.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.65 -0.5 . . . . 1.8200000000000001 109.65 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 3.0 mt -82.02 133.61 35.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.459 -0.337 . . . . 1.04 110.702 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -39.12 93.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.187 0.518 . . . . 1.54 109.882 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -109.48 96.3 22.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.15 -0.685 . . . . 1.28 109.15 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.7 154.61 34.76 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.709 2.273 . . . . 0.90000000000000002 112.964 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.45 126.99 27.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.027 -0.533 . . . . 0.81000000000000005 110.224 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.33 144.58 18.28 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.624 2.216 . . . . 1.0900000000000001 112.692 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.16 165.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 1.05 110.508 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -56.3 11.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 1.6399999999999999 111.214 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -118.88 130.5 24.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.434 -0.348 . . . . 3.3300000000000001 110.396 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.68 179.93 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.671 2.248 . . . . 1.6599999999999999 112.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.77 -48.68 1.08 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.788 -0.72 . . . . 0.94999999999999996 112.587 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.19 152.87 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.581 0.229 . . . . 2.4700000000000002 110.4 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.9 mm -87.77 133.85 29.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.307 -0.406 . . . . 0.70999999999999996 110.473 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -88.8 125.72 35.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 2.6899999999999999 111.677 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.5 105.33 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.558 -0.904 . . . . 0.55000000000000004 108.558 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.53 133.93 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 0.69999999999999996 111.779 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -119.19 119.27 33.63 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.306 -0.998 . . . . 2.4300000000000002 108.306 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -94.84 93.7 7.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.571 . . . . 0.85999999999999999 111.03 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -93.72 168.69 10.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.138 -0.937 . . . . 1.3999999999999999 110.503 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 2.1 t90 -145.09 163.81 33.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 110.259 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -79.66 2.34 22.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 4.8099999999999996 111.197 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.49 15.88 6.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.299 -0.953 . . . . 1.6200000000000001 113.583 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 25.9 p -111.59 107.8 56.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.521 0.66 . . . . 0.93000000000000005 110.937 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.38 -31.08 43.78 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.16 . . . . 1.1000000000000001 111.957 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.16 70.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.62 -0.718 . . . . 1.47 111.126 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.88 -29.53 63.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.39 -40.28 70.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 2.6299999999999999 110.996 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.04 -9.7 58.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.052 0.453 . . . . 0.97999999999999998 111.327 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -89.59 -26.01 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 110.855 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.06 -58.15 12.42 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.889 0.7 . . . . 2.6899999999999999 112.889 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.36 2.87 2.01 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.231 1.954 . . . . 0.81000000000000005 113.549 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.44 HG22 HD11 ' A' ' 176' ' ' LEU . 0.6 OUTLIER -115.8 -33.4 5.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.809 0.337 . . . . 0.70999999999999996 111.352 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 tt -85.92 -29.81 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 111.835 0.309 . . . . 0.83999999999999997 111.835 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 42.3 t -56.41 -55.62 40.54 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.571 0.582 . . . . 0.94999999999999996 112.571 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 18.5 Cg_endo -58.38 -22.59 59.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.352 2.035 . . . . 0.94999999999999996 112.89 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.7 t90 -86.99 -47.73 8.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 110.501 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -65.25 -41.18 94.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 1.22 112.165 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -79.7 10.05 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 2.1400000000000001 111.704 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.43 6.91 6.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.04 0.448 . . . . 2.0899999999999999 110.181 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.55 147.15 86.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.772 -0.649 . . . . 0.81000000000000005 110.873 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 57' ' ' ASP . 57.7 Cg_endo -72.36 173.5 13.03 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.757 2.304 . . . . 0.98999999999999999 111.459 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 32.1 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 1.1399999999999999 111.516 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' HD2' ' A' ' 187' ' ' ARG . 4.6 t0 -125.04 -2.24 7.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.222 0.534 . . . . 1.6499999999999999 110.364 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 137.69 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.402 -0.817 . . . . 0.68000000000000005 109.769 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.91 121.52 26.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 1.27 110.861 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -93.07 135.23 34.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 1.3899999999999999 110.292 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.64 137.63 52.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.851 0.357 . . . . 0.69999999999999996 110.552 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 62' ' ' ARG . 47.6 mtt180 -96.44 102.92 14.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 4.2300000000000004 109.879 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 81.7 mt -125.04 129.95 24.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.484 0.183 . . . . 0.60999999999999999 110.635 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.4 Cg_endo -84.57 160.57 12.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.442 2.095 . . . . 0.48999999999999999 112.068 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.01 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.233 0.54 . . . . 0.45000000000000001 110.973 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 141' ' ' ALA . 20.6 mt -87.72 81.84 7.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 0.53000000000000003 110.965 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -112.66 46.15 1.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 1.71 111.209 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.35 -156.91 52.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 1.3899999999999999 112.112 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.08 -133.18 5.24 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 124.0 0.47 . . . . 1.24 113.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.61 -4.84 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.338 0.59 . . . . 1.1599999999999999 109.859 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 53.5 m95 -65.02 -53.93 38.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.246 -0.888 . . . . 0.78000000000000003 110.726 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.29 -30.15 71.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 1.99 111.111 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.03 -35.92 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.425 0.631 . . . . 0.89000000000000001 109.812 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -89.34 46.9 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.588 -0.733 . . . . 1.46 110.507 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.78 -31.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.263 -0.97 . . . . 0.66000000000000003 113.166 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.83 -35.09 61.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.342 . . . . 2.1200000000000001 111.53 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 ttt -54.3 -40.51 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.771 -0.65 . . . . 1.4299999999999999 111.52 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -48.96 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 1.0600000000000001 111.447 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.47 -32.06 72.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.419 . . . . 0.63 110.784 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.9 m -64.1 -42.75 96.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.727 -0.67 . . . . 0.68999999999999995 110.617 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.27 -42.58 83.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 1.6899999999999999 111.322 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.11 -28.36 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 2.1899999999999999 111.096 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 m -86.36 -5.82 59.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.779 0.323 . . . . 1.26 111.653 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mmm -79.07 -21.78 46.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.828 0.347 . . . . 1.7 110.678 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.94 28.36 21.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 2.2000000000000002 112.918 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 m -103.09 135.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.856 0.36 . . . . 2.3599999999999999 110.629 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.17 143.32 50.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.138 -0.483 . . . . 5.2800000000000002 110.083 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 38.3 m80 56.75 41.36 28.3 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.184 0.516 . . . . 5.2599999999999998 110.124 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -96.74 25.68 5.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.707 -0.679 . . . . 5.4500000000000002 111.035 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t 60.63 66.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.682 0.754 . . . . 3.7599999999999998 109.395 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -28.35 68.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.096 -0.956 . . . . 4.2599999999999998 111.569 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -66.38 -28.42 68.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 2.8799999999999999 111.568 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.17 -26.7 67.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.951 0.405 . . . . 1.71 111.117 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.78 -44.81 85.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.172 -0.467 . . . . 1.7 109.939 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -30.64 71.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.037 -0.528 . . . . 3.2999999999999998 110.549 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.31 -50.57 69.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 2.6099999999999999 110.651 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.5 -12.96 61.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 1.6699999999999999 111.737 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.14 -44.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.175 0.435 . . . . 1.9099999999999999 112.175 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -100.66 -25.0 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.682 0.993 . . . . 2.21 113.682 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -92.03 -46.78 7.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.046 0.451 . . . . 2.73 110.226 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.43 -52.27 4.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 2.5899999999999999 110.868 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 60.41 59.66 2.2 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.986 -0.552 . . . . 2.1600000000000001 110.24 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -83.49 40.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.997 -0.547 . . . . 2.2400000000000002 111.569 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 44.97 58.91 3.72 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.961 0.788 . . . . 2.6099999999999999 112.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.79 75.01 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.229 0.538 . . . . 1.24 109.717 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.01 -0.57 10.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.659 . . . . 0.95999999999999996 111.58 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.67 145.79 57.68 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.304 -0.407 . . . . 1.21 110.372 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.08 -33.23 72.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.18 2.587 . . . . 0.97999999999999998 113.644 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.94 -55.72 29.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 2.6200000000000001 110.77 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -59.53 -37.71 79.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 2.5099999999999998 110.913 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.4 mtt -63.01 -54.35 39.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.731 -0.668 . . . . 0.93999999999999995 110.803 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.2 93.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 111.476 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.87 -39.35 81.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.47 . . . . 1.8300000000000001 111.186 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.41 -44.91 23.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.904 -0.589 . . . . 1.52 110.812 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.77 -32.25 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.98999999999999999 112.132 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -18.8 59.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.515 -0.311 . . . . 1.25 111.751 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.76 1.22 78.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.788 -0.72 . . . . 1.6100000000000001 113.333 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -124.21 6.59 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.377 0.589 . . . . 2.9500000000000002 111.371 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.29 65.58 0.87 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.424 -0.893 . . . . 1.47 112.29 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.4 t -146.2 125.66 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 1.2 109.605 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.707 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 18.2 t0 -79.8 123.09 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 1.5600000000000001 110.333 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -60.57 -35.9 77.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.563 -0.744 . . . . 1.5700000000000001 111.252 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.61 -50.84 63.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 2.29 111.248 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.707 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 41.2 mmtm -60.32 -45.43 93.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.966 0.413 . . . . 2.6099999999999999 110.174 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 87.2 t80 -54.81 -59.25 4.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.387 -0.824 . . . . 1.4399999999999999 111.208 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.08 -32.54 74.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.992 0.367 . . . . 1.1299999999999999 111.992 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.9 t -59.32 -50.92 72.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.737 0.304 . . . . 1.46 111.343 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -84.03 -25.33 29.98 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.675 -0.41 . . . . 1.53 111.181 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 63.1 t80 -59.88 -43.81 94.55 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.991 0.424 . . . . 1.53 111.078 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -95.78 24.75 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.32 -0.4 . . . . 1.6100000000000001 111.314 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.3 m -108.99 162.62 14.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.922 0.391 . . . . 1.49 110.653 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -68.2 -23.24 64.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 1.3999999999999999 111.418 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.88 51.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.108 0.48 . . . . 0.92000000000000004 111.816 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.0 mm -82.5 -36.9 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.252 -0.431 . . . . 1.1899999999999999 110.484 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.15 -39.41 86.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 1.8999999999999999 110.878 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.76 81.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.75 111.717 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -79.71 -36.41 37.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 1.6699999999999999 110.046 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.3 mmm -61.16 -50.86 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 1.8500000000000001 111.141 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -33.35 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.641 0.258 . . . . 2.0299999999999998 110.599 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -60.94 -50.45 73.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 3.0800000000000001 110.612 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -72.67 -35.35 67.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.489 . . . . 0.34999999999999998 111.415 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -57.59 -50.63 72.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.363 -0.38 . . . . 1.6899999999999999 112.021 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -72.85 -18.92 61.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.543 -0.299 . . . . 2.1000000000000001 111.762 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.57 -39.78 15.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.56000000000000005 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.35 79.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.48999999999999999 111.609 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -71.95 -19.82 61.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 2.5699999999999998 111.201 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.36 29.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.42999999999999999 110.475 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -84.88 4.7 32.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.896 -0.593 . . . . 0.63 110.416 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.526 ' HG3' HD22 ' A' ' 15' ' ' LEU . 18.2 mm-40 62.09 30.76 17.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.708 -0.678 . . . . 1.4099999999999999 111.645 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.03 98.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.19 -0.459 . . . . 1.26 110.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.53 12.63 32.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.296 -0.411 . . . . 1.25 111.628 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.71 175.77 40.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.563 -0.827 . . . . 0.68999999999999995 112.294 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.65 134.93 18.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.062 -0.347 . . . . 0.64000000000000001 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.5 -175.91 17.67 Favored 'Cis proline' 0 C--O 1.235 0.348 0 C-N-CA 123.328 -1.53 . . . . 0.66000000000000003 112.641 -0.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -165.85 114.47 0.97 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.955 0.407 . . . . 0.56999999999999995 110.625 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.9 mtp -94.09 123.29 37.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.57 . . . . 0.92000000000000004 109.598 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.1 t -114.69 130.34 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.033 -0.531 . . . . 0.40000000000000002 109.618 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.23 117.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.58999999999999997 111.048 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.12 30.69 14.87 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.261 -0.882 . . . . 1.0800000000000001 112.188 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.34 32.39 29.76 Favored Glycine 0 CA--C 1.52 0.384 0 O-C-N 123.559 0.537 . . . . 0.48999999999999999 113.459 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 59.5 mtpt -130.03 -41.47 1.28 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 1.72 111.703 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -109.72 129.0 55.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 1.5 110.949 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HB2' HD21 ' A' ' 15' ' ' LEU . 8.7 ttp85 -119.06 128.57 54.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 1.6599999999999999 110.027 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -153.28 175.92 12.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.192 -0.458 . . . . 0.63 110.03 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.35 -177.24 3.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.643 -0.502 . . . . 1.3500000000000001 109.643 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.36 -43.9 78.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.651 0.594 . . . . 0.68999999999999995 111.81 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.52 -45.48 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.72999999999999998 112.943 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -64.71 -45.72 85.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 1.1499999999999999 111.021 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.28 83.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.325 -0.398 . . . . 0.71999999999999997 111.164 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.73 27.7 3.97 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.701 -0.762 . . . . 1.1000000000000001 112.796 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.13 154.81 6.25 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.101 -0.571 . . . . 0.72999999999999998 112.13 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.63 -40.07 87.44 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.176 2.584 . . . . 0.84999999999999998 112.351 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.09 -39.5 75.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.182 0.515 . . . . 2.52 110.019 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.31 -28.89 70.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.733 -0.667 . . . . 1.8200000000000001 110.196 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.837 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.44 HD11 HG22 ' A' ' 46' ' ' THR . 87.0 mt -68.48 -35.3 77.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.872 -0.604 . . . . 0.72999999999999998 109.942 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -61.92 -49.14 77.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 2.3399999999999999 110.449 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 178' ' ' LEU . 3.3 mm? -63.54 -42.35 98.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.553 -0.749 . . . . 0.69999999999999996 110.825 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.65 64.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.65000000000000002 111.529 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -40.28 93.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 1.9099999999999999 111.187 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -63.42 -46.55 85.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 1.8200000000000001 110.877 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.92 -30.09 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.345 -0.389 . . . . 0.75 111.59 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.91 -47.94 91.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.652 -0.499 . . . . 0.77000000000000002 109.652 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -27.91 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.6 -0.727 . . . . 2.1699999999999999 110.369 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -60.71 -49.33 77.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 2.4100000000000001 109.936 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -74.75 -37.69 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.755 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.54 ' HD2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 1.72 110.743 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.27 -21.93 64.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 1.1299999999999999 111.848 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.29 -7.55 57.34 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.347 0.594 . . . . 1.1699999999999999 110.796 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -152.16 56.08 0.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 1.8400000000000001 109.356 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -100.62 57.03 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.637 -0.711 . . . . 6.4299999999999997 110.448 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 59.9 pttt . . . . . 0 C--O 1.25 1.096 0 O-C-N 124.264 0.978 . . . . 7.3200000000000003 111.93 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.432 -0.667 . . . . 2.2000000000000002 111.432 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -124.1 122.98 39.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.86 0.362 . . . . 2.1299999999999999 111.167 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -93.29 5.51 51.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.787 0.803 . . . . 1.97 109.702 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -120.85 148.05 44.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.309 -0.859 . . . . 1.2 109.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.83 140.2 53.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.081 0.467 . . . . 1.29 111.655 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.75 130.41 40.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.918 -0.583 . . . . 1.03 109.942 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.39 0.62 67.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 1.1399999999999999 111.647 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -124.81 -59.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.688 -0.486 . . . . 1.8899999999999999 109.688 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -92.38 -50.45 5.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.403 0.621 . . . . 1.55 109.981 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -127.42 153.65 46.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.752 -0.658 . . . . 1.03 110.074 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -109.43 131.49 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.722 0.296 . . . . 0.91000000000000003 111.211 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.19 127.01 37.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.9 -0.778 . . . . 1.8200000000000001 108.9 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -74.52 134.22 42.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.467 -0.333 . . . . 1.04 111.259 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -41.88 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 1.54 110.275 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.32 94.78 14.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.747 -0.66 . . . . 1.28 109.818 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.12 146.16 69.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.418 2.079 . . . . 0.90000000000000002 112.649 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -98.46 117.38 64.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.21 -0.45 . . . . 0.81000000000000005 110.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.5 104.68 1.94 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.641 2.227 . . . . 1.0900000000000001 112.269 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.49 148.01 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.352 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -16.35 59.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.945 -0.57 . . . . 1.6399999999999999 111.576 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.3 102.03 46.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 3.3300000000000001 111.0 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.63 167.34 16.97 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.669 2.246 . . . . 1.6599999999999999 112.654 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.19 -70.78 0.75 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.897 -0.668 . . . . 0.94999999999999996 112.447 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -82.07 142.63 32.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.668 0.27 . . . . 2.4700000000000002 110.403 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.439 HG21 HG12 ' A' ' 183' ' ' ILE . 44.9 mm -71.96 121.3 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.129 -0.487 . . . . 0.70999999999999996 110.723 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 59' ' ' HIS . 3.8 tp10 -90.21 115.37 27.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.134 -0.485 . . . . 2.6899999999999999 110.712 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.77 109.64 29.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.156 -0.475 . . . . 0.55000000000000004 109.818 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.13 128.62 55.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.07 -0.514 . . . . 0.69999999999999996 111.333 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -107.18 134.18 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.612 -0.722 . . . . 2.4300000000000002 109.419 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.6 mp -113.62 119.31 37.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.787 0.327 . . . . 0.85999999999999999 110.439 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -120.42 165.03 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 110.887 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 15.6 t90 -147.31 -179.89 7.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.64 -0.709 . . . . 1.1599999999999999 109.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -87.65 -52.21 5.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.79 0.329 . . . . 4.8099999999999996 111.283 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.7 4.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.16 -0.543 . . . . 1.6200000000000001 113.596 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.8 p -146.36 98.9 4.24 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.267 0.556 . . . . 0.93000000000000005 110.169 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.84 -27.7 67.49 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.488 2.126 . . . . 1.1000000000000001 112.403 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -66.97 -22.9 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.47 111.197 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 m -76.23 -23.39 54.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.93999999999999995 110.33 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -80.51 -45.79 16.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.815 -0.629 . . . . 2.6299999999999999 110.655 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.03 -8.71 47.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.577 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 47' ' ' ILE . 2.2 t80 -97.52 -11.41 23.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.382 -0.372 . . . . 0.76000000000000001 111.184 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 10.9 tt0 -55.92 -56.12 33.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 119.497 -0.287 . . . . 2.6899999999999999 111.677 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 44' ' ' GLU . 65.1 Cg_endo -72.07 13.77 0.49 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.094 1.863 . . . . 0.81000000000000005 113.184 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 176' ' ' LEU . 0.2 OUTLIER -124.92 -42.42 2.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.709 0.29 . . . . 0.70999999999999996 111.306 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 43' ' ' PHE . 15.6 tt -83.28 -35.29 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 112.452 0.538 . . . . 0.83999999999999997 112.452 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 96.7 t -62.08 -55.85 36.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.269 0.47 . . . . 0.94999999999999996 112.269 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.7 Cg_endo -56.55 -41.95 70.61 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.882 1.721 . . . . 0.94999999999999996 111.952 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.24 -41.55 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.81999999999999995 110.871 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 t -62.05 -32.21 72.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 1.22 111.136 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -84.1 0.55 47.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.061 0.458 . . . . 2.1400000000000001 110.746 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.78 17.8 14.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.093 0.473 . . . . 2.0899999999999999 110.287 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.4 mt -74.24 147.12 85.22 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.81000000000000005 110.733 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -56.06 160.3 10.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 0.98999999999999999 112.501 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.4 26.09 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 1.1399999999999999 111.682 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.04 21.65 2.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.355 0.598 . . . . 1.6499999999999999 110.228 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.84 142.59 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.68000000000000005 109.487 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.4 ' HB3' ' OE1' ' A' ' 28' ' ' GLU . 20.8 t60 -118.11 131.49 56.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.432 -0.581 . . . . 1.27 109.432 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -116.26 127.03 54.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.744 0.306 . . . . 1.3899999999999999 110.587 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 t -128.24 129.51 69.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.69999999999999996 110.611 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -99.2 113.76 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.858 -0.793 . . . . 4.2300000000000004 108.858 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.3 mt -123.84 132.45 24.29 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 0.60999999999999999 111.115 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.34 145.15 52.99 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.443 2.096 . . . . 0.48999999999999999 111.579 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.83 80.21 4.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.152 0.501 . . . . 0.45000000000000001 110.997 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 72' ' ' ASN . 25.6 mt -79.68 79.05 6.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.53000000000000003 110.891 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.43 21.3 13.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.535 . . . . 1.71 111.217 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 89.77 176.66 45.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.755 -0.736 . . . . 1.3899999999999999 112.102 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.5 -135.63 51.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.737 . . . . 1.24 112.4 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.7 tp -76.03 -13.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 1.1599999999999999 110.763 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.509 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 43.1 m95 -65.91 -40.28 91.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.12 0.486 . . . . 0.78000000000000003 109.786 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' HD22 ' A' ' 66' ' ' LEU . 20.5 t-20 -71.41 -44.21 65.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 1.99 110.183 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.61 -48.83 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.89000000000000001 111.114 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -84.35 49.62 1.71 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 1.46 111.098 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.12 -33.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.377 -0.829 . . . . 0.66000000000000003 111.289 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -55.5 -34.56 64.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 2.1200000000000001 112.207 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.6 ttp -54.32 -42.86 70.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.747 0.308 . . . . 1.4299999999999999 111.499 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.45 -46.05 90.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 1.0600000000000001 110.674 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.27 -36.81 79.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 0.63 110.992 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.8 m -62.0 -45.78 92.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.68999999999999995 110.598 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HD13 ' A' ' 115' ' ' LEU . 81.8 mt -59.28 -38.24 79.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.098 0.475 . . . . 1.6899999999999999 110.633 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -41.29 75.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.856 -0.611 . . . . 2.1899999999999999 110.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -69.32 -13.89 62.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.26 111.19 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 81.3 mtp -88.1 -20.45 25.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.382 -0.372 . . . . 1.7 110.88 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.76 60.99 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.887 -0.673 . . . . 2.2000000000000002 111.827 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.65 165.1 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 2.3599999999999999 111.281 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.32 172.58 8.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.998 -0.547 . . . . 5.2800000000000002 110.349 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 74.52 115.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.023 0.827 . . . . 5.2599999999999998 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.56 54.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 5.4500000000000002 111.363 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.52 61.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.312 0.577 . . . . 3.7599999999999998 111.112 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -69.99 -12.7 61.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 4.2599999999999998 111.712 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 1.1 t30 -95.89 -35.82 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.573 0.225 . . . . 2.8799999999999999 110.934 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.24 71.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.144 -0.48 . . . . 1.71 111.828 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.38 -45.71 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 1.7 110.751 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 3.2999999999999998 110.746 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 39.7 mt-10 -65.43 -36.65 84.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.621 . . . . 2.6099999999999999 110.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.94 64.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.241 0.543 . . . . 1.6699999999999999 110.384 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.38 -50.62 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.588 -0.733 . . . . 1.9099999999999999 112.465 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -95.44 -48.98 5.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.546 0.943 . . . . 2.21 113.546 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 77.7 mttt -68.52 -56.01 9.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.144 -0.222 . . . . 2.73 111.451 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.62 -47.19 73.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.626 -0.509 . . . . 2.5899999999999999 109.626 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 57.36 58.29 3.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.839 -0.618 . . . . 2.1600000000000001 111.464 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -92.66 33.77 1.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.659 -0.246 . . . . 2.2400000000000002 111.261 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt 68.85 -68.69 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.649 0.593 . . . . 2.6099999999999999 111.139 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt 53.48 59.84 4.09 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.122 0.569 . . . . 1.24 111.301 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.77 -57.69 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.909 0.385 . . . . 0.95999999999999996 111.174 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.6 145.04 50.1 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.275 -0.42 . . . . 1.21 111.125 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.97 -36.65 96.18 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.7 2.267 . . . . 0.97999999999999998 112.099 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.82 -33.3 74.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.1 -0.5 . . . . 2.6200000000000001 110.372 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.56 -40.34 80.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.5099999999999998 109.52 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.93 -53.71 46.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.447 -0.797 . . . . 0.93999999999999995 109.854 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -59.74 -31.01 69.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.161 -0.927 . . . . 0.95999999999999996 111.927 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.69 -40.96 89.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.374 . . . . 1.8300000000000001 111.432 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.1 -40.77 19.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.52 110.669 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 HD21 ' A' ' 81' ' ' LEU . 70.8 mt -65.73 -23.31 66.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.57 . . . . 0.98999999999999999 111.568 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -56.62 -34.45 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.25 111.574 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.6 -4.28 73.41 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.773 -0.727 . . . . 1.6100000000000001 112.21 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -98.04 22.29 9.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.856 0.36 . . . . 2.9500000000000002 111.094 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.16 18.66 71.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 1.47 112.137 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 59.8 t -109.73 128.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.593 0.235 . . . . 1.2 110.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.5 122.64 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.93 0.395 . . . . 1.5600000000000001 110.476 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -60.02 -37.3 79.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.521 -0.763 . . . . 1.5700000000000001 111.058 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.91 -54.55 29.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.434 -0.348 . . . . 2.29 110.716 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -55.5 -39.16 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.32 -0.4 . . . . 2.6099999999999999 110.957 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.515 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 75.5 t80 -62.13 -54.64 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 1.4399999999999999 110.745 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.6 -37.59 86.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.1299999999999999 111.388 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 m -65.3 -45.65 83.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 1.46 111.032 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.5 m -71.98 -32.89 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 1.53 111.037 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.4 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.335 0.588 . . . . 1.53 110.282 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -115.92 34.0 5.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.785 . . . . 1.6100000000000001 109.704 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.8 t -115.92 145.02 43.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.458 -0.792 . . . . 1.49 110.682 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.11 -20.53 66.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.021 -0.536 . . . . 1.3999999999999999 110.626 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.83 78.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.92000000000000004 110.667 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -31.33 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 1.1899999999999999 110.287 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -65.45 -36.17 83.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.8999999999999999 110.533 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.88 -28.44 68.49 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.75 112.35 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -91.43 -35.53 14.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.138 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 ttm -62.12 -47.07 86.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 1.8500000000000001 111.311 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.44 -36.71 84.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.689 -0.232 . . . . 2.0299999999999998 110.929 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.8 tmtp? -65.52 -43.68 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.347 -0.388 . . . . 3.0800000000000001 110.011 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.38 75.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.245 -0.434 . . . . 0.34999999999999998 111.158 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -62.93 -48.71 77.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.6899999999999999 111.112 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -66.88 -23.93 66.06 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.988 -0.285 . . . . 2.1000000000000001 111.203 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.4 mt -75.82 -51.12 13.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.926 -0.398 . . . . 0.56000000000000005 109.926 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.48999999999999999 111.65 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.5 mtm -69.7 -24.98 63.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 2.5699999999999998 111.389 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.64 -17.58 35.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.42999999999999999 111.33 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 150' ' ' VAL . 21.7 m-30 -83.64 -3.56 57.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.109 -0.496 . . . . 0.63 111.024 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 56.51 32.92 21.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.968 -0.56 . . . . 1.4099999999999999 111.391 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 148' ' ' TYR . 59.1 t -76.42 123.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 1.26 110.745 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 13.94 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.195 0.522 . . . . 1.25 111.061 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.45 171.67 37.49 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.701 -0.761 . . . . 0.68999999999999995 111.951 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.15 144.59 35.29 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.625 0.25 . . . . 0.64000000000000001 110.736 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.12 173.09 57.16 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.175 -1.594 . . . . 0.66000000000000003 112.045 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.4 m -157.68 138.51 13.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 110.787 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.0 mtp -115.53 136.7 52.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.145 -0.687 . . . . 0.92000000000000004 109.145 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.68 127.6 71.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.68 0.276 . . . . 0.40000000000000002 110.559 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.66 120.9 54.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 0.58999999999999997 110.478 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.5 m120 51.26 20.61 0.95 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.987 0.804 . . . . 1.0800000000000001 113.082 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.0 27.56 70.61 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.921 -0.657 . . . . 0.48999999999999999 112.726 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -123.39 -38.34 2.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.826 0.313 . . . . 1.72 110.995 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -114.75 130.9 56.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.998 0.427 . . . . 1.5 111.63 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.7 ttp85 -119.32 134.17 55.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.366 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.43 171.68 19.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.63 110.352 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.58 -176.9 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.425 -0.352 . . . . 1.3500000000000001 110.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.43 -48.47 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 0.68999999999999995 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.92 -39.84 89.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.268 -0.491 . . . . 0.72999999999999998 112.495 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.7 t -65.4 -39.39 92.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 1.1499999999999999 110.843 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -44.03 21.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.834 0.349 . . . . 0.71999999999999997 111.354 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 137.8 -43.34 1.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.996 -0.621 . . . . 1.1000000000000001 111.826 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.5 170.14 34.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.568 -0.613 . . . . 0.72999999999999998 111.568 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.74 -42.52 67.8 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.165 2.577 . . . . 0.84999999999999998 113.126 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.48 -28.94 64.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 2.52 110.299 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.42 -32.99 70.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.8200000000000001 109.71 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.6 m -61.26 -45.17 95.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.62 109.944 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.443 HD11 HG22 ' A' ' 46' ' ' THR . 65.0 mt -63.73 -39.65 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.72999999999999998 110.23 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -62.29 -47.06 85.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.96 -0.564 . . . . 2.3399999999999999 110.268 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.34 -40.77 98.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.69999999999999996 110.436 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.312 -0.404 . . . . 0.65000000000000002 110.982 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.86 -40.41 84.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 1.9099999999999999 110.373 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -67.05 -46.64 73.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.636 -0.711 . . . . 1.8200000000000001 111.099 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.93 -41.45 99.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.571 -0.286 . . . . 0.75 110.966 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.439 HG12 HG21 ' A' ' 27' ' ' ILE . 82.1 mt -58.12 -39.19 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.77000000000000002 109.758 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -41.44 67.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.698 -0.683 . . . . 2.1699999999999999 110.756 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -62.91 -48.54 78.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 2.4100000000000001 111.469 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.45 -23.95 62.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 1.6399999999999999 111.365 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.3 OUTLIER -74.32 -7.9 54.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 1.72 110.818 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.43 -24.34 67.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.943 0.401 . . . . 1.1299999999999999 110.538 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.06 0.55 39.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 1.1699999999999999 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.407 ' HB3' ' HE ' ' A' ' 187' ' ' ARG . . . -127.78 -4.08 5.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.533 -0.303 . . . . 1.8400000000000001 111.388 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.5 tptt 64.03 44.03 4.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.815 -0.63 . . . . 6.4299999999999997 110.958 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 52.0 mttp . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.505 -0.77 . . . . 7.3200000000000003 111.701 179.618 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.827 -0.509 . . . . 2.2000000000000002 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.27 152.03 20.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 2.1299999999999999 110.317 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -112.62 -15.91 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 1.97 111.319 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -114.56 159.2 20.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.989 0.423 . . . . 1.2 111.181 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 132.5 55.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.134 -0.484 . . . . 1.29 111.416 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.97 132.24 48.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.03 110.446 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.46 -12.77 67.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.895 -0.669 . . . . 1.1399999999999999 112.055 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -114.48 -49.58 2.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.922 0.392 . . . . 1.8899999999999999 110.064 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -100.75 -47.68 4.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 1.55 111.021 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.68 159.36 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 1.03 110.095 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.28 124.12 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.484 -0.325 . . . . 0.91000000000000003 110.55 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -101.4 114.3 28.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.083 -0.508 . . . . 1.8200000000000001 109.912 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 136.42 49.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.435 -0.348 . . . . 1.04 110.25 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -73.03 -14.56 61.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.146 -0.479 . . . . 1.54 110.793 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -119.92 86.13 35.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.198 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.79 168.53 24.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.583 2.189 . . . . 0.90000000000000002 112.457 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.6 115.15 58.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.81000000000000005 110.041 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.13 115.27 4.07 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.351 2.034 . . . . 1.0900000000000001 112.396 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.51 159.23 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 1.05 111.216 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -50.81 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 1.6399999999999999 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.34 124.7 19.38 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.515 -0.311 . . . . 3.3300000000000001 110.255 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.51 142.41 16.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.577 2.184 . . . . 1.6599999999999999 112.399 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.56 -78.08 0.22 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.94999999999999996 111.807 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -79.14 156.07 28.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.784 0.326 . . . . 2.4700000000000002 110.369 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 183' ' ' ILE . 30.6 mm -94.45 123.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.846 -0.427 . . . . 0.70999999999999996 109.846 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -103.45 117.9 35.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 2.6899999999999999 110.636 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -105.49 113.9 43.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.137 -0.483 . . . . 0.55000000000000004 109.974 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.16 131.12 50.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.995 -0.548 . . . . 0.69999999999999996 111.223 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -111.18 131.14 55.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 2.4300000000000002 109.678 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.47 110.81 22.41 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.85999999999999999 110.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -110.03 160.2 16.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.943 -0.571 . . . . 1.3999999999999999 111.048 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.415 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 9.2 t90 -143.57 -178.87 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.69 . . . . 1.1599999999999999 109.789 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.09 -40.31 10.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.767 0.318 . . . . 4.8099999999999996 111.334 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.29 40.24 3.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.994 -0.622 . . . . 1.6200000000000001 113.264 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 p -129.81 99.48 20.35 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.066 0.46 . . . . 0.93000000000000005 110.082 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.75 -28.34 59.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.465 2.11 . . . . 1.1000000000000001 112.254 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -66.22 -25.54 66.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.965 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 54.1 m -69.63 -34.28 73.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.429 . . . . 0.93999999999999995 110.133 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.88 -39.04 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 2.6299999999999999 110.433 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.99 -16.66 63.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.97999999999999998 111.379 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.97 -12.53 21.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.288 . . . . 0.76000000000000001 111.215 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 3.7 tt0 -52.36 -54.95 36.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.619 0.599 . . . . 2.6899999999999999 112.619 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 38.2 Cg_endo -65.8 -2.78 7.02 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.478 2.119 . . . . 0.81000000000000005 113.774 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.51 HG22 HD11 ' A' ' 176' ' ' LEU . 0.9 OUTLIER -114.5 -40.01 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.058 0.392 . . . . 0.70999999999999996 112.058 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -75.71 -36.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.83999999999999997 112.329 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.59 -58.89 16.04 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.56 0.578 . . . . 0.94999999999999996 112.56 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.38 -28.8 88.53 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.954 1.769 . . . . 0.94999999999999996 112.451 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -73.81 -48.02 34.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.81999999999999995 110.685 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.3 -33.97 77.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 1.22 111.308 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -78.2 0.33 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.091 -0.504 . . . . 2.1400000000000001 111.099 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -130.78 41.39 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 2.0899999999999999 110.456 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 mt -93.77 148.89 36.16 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.736 -0.665 . . . . 0.81000000000000005 110.438 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 9.9 Cg_endo -52.37 156.64 7.89 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.951 2.434 . . . . 0.98999999999999999 112.383 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.85 56.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 1.1399999999999999 112.898 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -106.25 15.38 26.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.24 0.543 . . . . 1.6499999999999999 111.694 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 55' ' ' PRO . 66.0 t -127.62 139.22 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.68000000000000005 109.617 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -118.68 152.93 35.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.626 0.251 . . . . 1.27 110.589 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.81 129.07 41.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 1.3899999999999999 110.242 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.3 t -131.11 129.38 63.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.883 0.373 . . . . 0.69999999999999996 110.932 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -97.06 118.89 34.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.374 -0.602 . . . . 4.2300000000000004 109.374 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.3 mt -123.78 127.45 25.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.729 0.299 . . . . 0.60999999999999999 110.437 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.66 146.12 78.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.347 2.032 . . . . 0.48999999999999999 111.671 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.607 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.13 73.98 2.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.992 0.425 . . . . 0.45000000000000001 110.733 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.7 mt -76.21 76.55 3.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.814 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -104.32 32.96 3.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 1.71 110.993 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 166.77 35.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.901 -0.666 . . . . 1.3899999999999999 112.885 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 -138.08 47.7 Favored Glycine 0 C--O 1.235 0.162 0 C-N-CA 121.264 -0.493 . . . . 1.24 112.779 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 tp -68.22 -16.97 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.79 0.329 . . . . 1.1599999999999999 111.141 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.607 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 56.5 m95 -66.75 -33.52 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.78000000000000003 109.688 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.03 -42.75 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.538 -0.755 . . . . 1.99 110.238 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.82 -51.06 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.89000000000000001 110.944 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -82.68 61.7 5.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.213 0.53 . . . . 1.46 111.101 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.36 -33.7 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.66000000000000003 111.534 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.69 -32.09 65.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.647 0.379 . . . . 2.1200000000000001 111.932 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 31.9 ttp -54.96 -39.98 69.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.343 -0.389 . . . . 1.4299999999999999 111.49 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -65.34 -44.54 87.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.0600000000000001 111.388 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.92 -37.51 78.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.337 -0.392 . . . . 0.63 111.243 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.5 m -59.8 -36.58 77.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 111.158 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 77' ' ' MET . 89.4 mt -62.38 -47.47 84.03 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.908 0.385 . . . . 1.6899999999999999 110.777 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -68.58 -33.15 73.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 2.1899999999999999 110.261 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -66.68 -32.49 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 1.26 110.653 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.4 mtp -73.58 -34.45 65.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.388 -0.369 . . . . 1.7 110.928 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.71 56.42 4.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.593 -0.813 . . . . 2.2000000000000002 111.435 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.79 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.803 0.335 . . . . 2.3599999999999999 110.903 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 88' ' ' HIS . 7.9 tt0 -109.16 171.03 7.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.413 -0.358 . . . . 5.2800000000000002 110.452 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 1.0 OUTLIER 75.0 124.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.85 0.719 . . . . 5.2599999999999998 111.458 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -82.68 68.49 9.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.4500000000000002 110.39 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 94' ' ' VAL . 4.8 m -100.15 47.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 3.7599999999999998 111.072 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.96 -11.19 58.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 4.2599999999999998 111.858 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 2.0 t30 -90.29 -53.74 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.466 -0.334 . . . . 2.8799999999999999 110.658 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.97 -35.46 46.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.55 0.574 . . . . 1.71 112.55 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 90' ' ' VAL . 96.2 t -58.42 -49.94 80.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.389 . . . . 1.7 110.974 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -66.38 -35.27 79.92 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.283 -0.417 . . . . 3.2999999999999998 110.488 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 31.0 mt-10 -63.47 -39.82 95.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 2.6099999999999999 110.654 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -68.53 -27.46 66.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.247 0.546 . . . . 1.6699999999999999 110.67 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.24 -49.94 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 1.9099999999999999 112.09 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -99.15 -52.48 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.401 0.889 . . . . 2.21 113.401 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 75.8 mttt -61.68 -54.01 48.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 2.73 111.337 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 29.8 mm-40 -69.64 -50.7 41.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.587 -0.523 . . . . 2.5899999999999999 109.587 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 60.35 57.3 2.91 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.573 -0.739 . . . . 2.1600000000000001 111.324 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -91.57 32.33 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.519 -0.31 . . . . 2.2400000000000002 110.988 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 69.3 -73.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.506 0.722 . . . . 2.6099999999999999 111.288 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.05 54.74 7.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.021 0.438 . . . . 1.24 110.644 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.73 -3.06 36.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.245 -0.434 . . . . 0.95999999999999996 111.503 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 p -137.48 146.14 52.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.385 -0.371 . . . . 1.21 110.763 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.76 -35.54 93.63 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.743 2.296 . . . . 0.97999999999999998 111.822 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -63.24 -42.32 99.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 110.088 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -67.26 -41.42 85.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 2.5099999999999998 109.914 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtt -63.8 -52.96 57.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.596 -0.729 . . . . 0.93999999999999995 110.581 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.568 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -60.3 -39.27 86.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.43 -0.804 . . . . 0.95999999999999996 112.319 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.47 -42.98 97.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.07 0.462 . . . . 1.8300000000000001 110.443 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -71.59 -48.25 49.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 1.52 110.915 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.15 -24.3 67.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.202 -0.454 . . . . 0.98999999999999999 112.112 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -58.41 -35.86 72.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 1.25 110.859 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.11 10.69 73.24 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.859 -0.686 . . . . 1.6100000000000001 112.114 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -114.01 6.15 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.885 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.42 1.92 55.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 1.47 113.014 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.9 t -97.35 128.48 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.172 -0.306 . . . . 1.2 110.172 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -70.43 119.21 14.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 1.5600000000000001 110.61 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.568 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 37.1 ttpt -61.98 -38.46 88.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.602 -0.726 . . . . 1.5700000000000001 111.446 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.19 -58.14 9.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.299 -0.41 . . . . 2.29 110.974 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -59.19 -35.37 73.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.429 -0.35 . . . . 2.6099999999999999 111.384 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -61.42 -54.22 46.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 1.4399999999999999 110.668 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.02 -35.11 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.1299999999999999 110.817 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -67.14 -49.78 63.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.466 . . . . 1.46 110.755 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.1 m -65.49 -33.49 76.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 1.53 111.038 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -61.74 -33.94 74.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.108 0.48 . . . . 1.53 110.364 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -99.15 18.93 16.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 1.6100000000000001 110.765 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.2 m -104.29 156.81 17.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 1.49 111.31 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' CE2' ' HD3' ' A' ' 135' ' ' LYS . 12.0 t80 -73.97 -24.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 1.3999999999999999 110.184 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.72 -37.7 68.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.92000000000000004 110.776 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -28.72 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.802 -0.635 . . . . 1.1899999999999999 110.491 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HD3' ' CE2' ' A' ' 132' ' ' PHE . 53.2 tttp -63.44 -37.15 86.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 1.8999999999999999 110.873 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.44 91.22 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.75 112.079 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -78.21 -35.53 48.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 1.6699999999999999 110.19 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.7 ttm -59.74 -52.29 66.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.363 -0.835 . . . . 1.8500000000000001 111.686 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -68.53 -32.55 72.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.549 -0.296 . . . . 2.0299999999999998 111.186 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -63.18 -44.92 94.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 3.0800000000000001 110.85 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.72 -37.09 65.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.379 -0.373 . . . . 0.34999999999999998 110.947 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -59.19 -51.0 71.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.059 -0.518 . . . . 1.6899999999999999 111.802 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -63.66 -35.54 80.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.029 -0.268 . . . . 2.1000000000000001 111.309 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.94 -49.28 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.124 -0.324 . . . . 0.56000000000000005 110.124 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.29 84.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.48999999999999999 110.969 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 74.9 mmm -67.08 -39.36 86.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 2.5699999999999998 111.141 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.88 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.357 -0.383 . . . . 0.42999999999999999 111.851 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 150' ' ' VAL . 20.8 m-30 -82.29 -6.17 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.63 111.018 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 58.93 27.55 16.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.061 -0.518 . . . . 1.4099999999999999 111.648 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 148' ' ' TYR . 94.3 t -67.45 119.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 1.26 110.732 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.91 39.83 3.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.876 -0.602 . . . . 1.25 111.116 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.22 166.53 30.99 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.594 -0.812 . . . . 0.68999999999999995 112.424 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.63 144.79 37.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.495 0.188 . . . . 0.64000000000000001 110.6 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.8 Cg_endo -80.98 163.39 80.05 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 123.25 -1.563 . . . . 0.66000000000000003 112.236 -0.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -157.0 139.38 14.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.279 -0.419 . . . . 0.56999999999999995 110.434 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -116.69 138.11 51.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.6 -0.518 . . . . 0.92000000000000004 109.6 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.1 130.92 74.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.728 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.4 t -102.73 112.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.58999999999999997 110.707 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 53.8 13.81 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.322 0.86 . . . . 1.0800000000000001 113.322 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.36 16.0 78.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.61 -0.805 . . . . 0.48999999999999999 112.117 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -104.79 -44.11 4.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.72 110.576 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -119.14 138.1 53.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.319 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.42 117.1 26.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 1.6599999999999999 109.425 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -135.14 161.01 36.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.883 0.373 . . . . 0.63 110.899 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.69 178.12 10.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 1.3500000000000001 109.701 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.02 -37.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 111.765 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.79 94.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.031 -0.604 . . . . 0.72999999999999998 112.665 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -72.87 -45.73 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.84 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.66 76.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.989 -0.551 . . . . 0.71999999999999997 111.503 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.65 16.65 38.7 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.737 -0.744 . . . . 1.1000000000000001 112.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.06 153.49 6.93 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.995 -0.621 . . . . 0.72999999999999998 112.321 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.06 -46.21 27.08 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.759 2.306 . . . . 0.84999999999999998 112.579 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.49 -37.25 86.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.417 0.627 . . . . 2.52 109.418 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.66 -36.12 81.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 1.8200000000000001 109.977 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 17.2 m -60.15 -44.93 94.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.179 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 46' ' ' THR . 50.9 mt -64.01 -38.14 90.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.351 . . . . 0.72999999999999998 111.002 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -69.16 -34.76 75.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.488 . . . . 2.3399999999999999 110.479 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 1.3 mm? -67.13 -37.27 83.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.602 -0.518 . . . . 0.69999999999999996 109.602 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -59.08 -52.73 64.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.722 -0.672 . . . . 0.65000000000000002 110.832 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -57.97 -38.83 76.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.051 -0.522 . . . . 1.9099999999999999 110.623 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -62.51 -47.15 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.524 -0.762 . . . . 1.8200000000000001 110.938 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 178' ' ' LEU . 88.3 mt -65.33 -45.12 85.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.48 -0.327 . . . . 0.75 110.536 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 90.9 mt -58.38 -41.29 81.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.77000000000000002 110.449 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.67 -47.58 80.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 2.1699999999999999 110.769 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -62.19 -47.6 83.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 2.4100000000000001 111.413 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.8 -27.54 66.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 1.6399999999999999 111.138 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.555 ' CG ' ' HA ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -65.4 -18.1 65.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 1.72 111.483 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.76 68.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 1.1299999999999999 111.443 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.59 -22.08 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.411 . . . . 1.1699999999999999 111.251 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.09 9.13 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.8400000000000001 110.8 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 191' ' ' LYS . 24.5 tptt 62.69 35.56 13.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.434 -0.803 . . . . 6.4299999999999997 111.418 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.555 ' HA ' ' CG ' ' A' ' 187' ' ' ARG . 54.5 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.442 -0.799 . . . . 7.3200000000000003 111.92 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.678 -0.569 . . . . 2.2000000000000002 111.678 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 59.75 59.51 2.49 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.556 0.693 . . . . 2.1299999999999999 110.455 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.52 -13.73 57.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.844 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -98.57 138.67 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.665 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m -95.69 128.88 42.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.393 . . . . 1.29 110.82 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.49 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 1.03 110.436 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.31 -39.62 2.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.836 -0.697 . . . . 1.1399999999999999 111.658 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -93.49 -51.96 4.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.603 0.24 . . . . 1.8899999999999999 110.437 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.93 -63.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 1.55 110.724 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -120.23 155.56 32.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.107 -0.497 . . . . 1.03 110.308 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -103.31 126.79 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.91000000000000003 110.683 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.38 124.19 46.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.886 -0.783 . . . . 1.8200000000000001 108.886 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -82.53 127.15 33.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.773 0.321 . . . . 1.04 110.875 -179.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -68.56 -19.37 64.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 1.54 110.203 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 86.74 9.33 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.579 -0.737 . . . . 1.28 109.047 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.13 141.13 62.21 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.455 2.104 . . . . 0.90000000000000002 112.988 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 t -100.43 128.96 28.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.81000000000000005 110.137 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.0 143.47 72.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.377 2.051 . . . . 1.0900000000000001 112.85 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.53 173.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.691 . . . . 1.05 110.52 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -76.99 -40.99 44.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.821 0.344 . . . . 1.6399999999999999 111.018 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.55 113.9 16.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 3.3300000000000001 110.948 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.18 100.62 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.457 2.104 . . . . 1.6599999999999999 112.13 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.84 -48.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.51 -0.636 . . . . 0.94999999999999996 111.51 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -100.81 155.69 17.78 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.662 -0.496 . . . . 2.4700000000000002 109.662 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -79.22 113.32 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.70999999999999996 110.401 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.81 114.33 26.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 2.6899999999999999 110.458 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.15 126.09 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.985 -0.552 . . . . 0.55000000000000004 110.05 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.51 126.72 55.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 111.297 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -102.42 123.5 46.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.75 -0.659 . . . . 2.4300000000000002 109.86 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.39 120.49 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.186 -0.301 . . . . 0.85999999999999999 110.186 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -132.62 171.03 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 1.3999999999999999 111.404 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -138.98 172.18 13.23 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.545 -0.752 . . . . 1.1599999999999999 109.526 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -94.28 -12.85 27.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 4.8099999999999996 111.564 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.19 29.29 7.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.512 -0.851 . . . . 1.6200000000000001 113.135 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.4 p -112.98 107.93 53.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.841 0.353 . . . . 0.93000000000000005 110.471 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.99 -28.83 28.52 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.303 2.002 . . . . 1.1000000000000001 111.464 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -23.41 67.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.313 -0.858 . . . . 1.47 110.842 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.77 -41.1 68.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.93999999999999995 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.63 -28.2 68.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.978 0.418 . . . . 2.6299999999999999 111.077 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.08 25.23 2.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.367 0.603 . . . . 0.97999999999999998 109.881 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -145.47 -35.88 0.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.76000000000000001 110.941 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 mt-10 -48.51 -56.54 14.12 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.022 0.749 . . . . 2.6899999999999999 113.022 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.54 -11.14 18.72 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.908 1.738 . . . . 0.81000000000000005 113.157 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -100.68 -37.08 8.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.747 0.308 . . . . 0.70999999999999996 111.284 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.7 tt -81.21 -34.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.203 0.446 . . . . 0.83999999999999997 112.203 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' GLU . 75.1 t -53.24 -56.59 22.63 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.433 -0.318 . . . . 0.94999999999999996 111.483 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 12.3 Cg_endo -57.88 -31.49 92.68 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.117 1.878 . . . . 0.94999999999999996 111.879 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -63.76 -47.57 80.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.81999999999999995 109.888 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -27.84 65.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 1.22 111.139 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -76.0 -18.28 59.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 2.1400000000000001 110.776 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -114.55 24.67 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.577 0.227 . . . . 2.0899999999999999 111.348 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.21 144.05 70.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.655 -0.248 . . . . 0.81000000000000005 110.816 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.04 -179.99 3.93 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.549 2.166 . . . . 0.98999999999999999 112.272 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.1 9.78 7.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 1.1399999999999999 111.888 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.62 10.19 19.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 1.6499999999999999 111.134 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.74 139.15 52.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.862 0.363 . . . . 0.68000000000000005 110.826 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -113.72 137.19 51.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -117.69 117.63 29.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 1.3899999999999999 111.542 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG12 ' HG ' ' A' ' 63' ' ' LEU . 80.3 t -111.65 129.5 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.064 -0.517 . . . . 0.69999999999999996 110.158 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 118.18 36.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.678 -0.49 . . . . 4.2300000000000004 109.678 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 61' ' ' VAL . 61.7 mt -129.31 139.99 37.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.87 0.366 . . . . 0.60999999999999999 111.277 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.41 149.69 21.75 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.518 2.145 . . . . 0.48999999999999999 112.019 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -75.48 94.09 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 110.266 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.84 84.06 4.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.53000000000000003 111.25 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -106.62 6.88 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.609 . . . . 1.71 110.563 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.82 -169.58 32.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 1.3899999999999999 111.89 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.26 -123.37 31.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.143 -0.551 . . . . 1.24 113.177 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.57 -8.09 10.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.249 0.547 . . . . 1.1599999999999999 111.09 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 18.8 m95 -67.92 -54.7 16.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.849 -0.614 . . . . 0.78000000000000003 110.029 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.32 -38.41 74.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.296 -0.866 . . . . 1.99 111.599 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.68 -37.9 55.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.062 -0.517 . . . . 0.89000000000000001 111.334 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -86.61 -14.07 43.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.213 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.84 -32.2 54.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.686 -0.768 . . . . 0.66000000000000003 111.657 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.94 -39.77 90.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.594 -0.303 . . . . 2.1200000000000001 110.806 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.41 -50.39 65.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.009 -0.541 . . . . 1.4299999999999999 111.506 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.86 -45.51 92.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 111.082 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.91 -40.46 96.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.63 111.203 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -60.35 -35.41 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 0.68999999999999995 111.529 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.63 -51.34 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.414 -0.357 . . . . 1.6899999999999999 110.75 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -71.21 -28.1 63.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 111.844 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 m -77.46 -3.87 42.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.9 0.333 . . . . 1.26 111.9 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.9 ttm -82.88 -9.44 59.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 1.7 110.358 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.83 64.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.069 -0.586 . . . . 2.2000000000000002 112.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.8 m -98.18 158.56 3.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.61 0.243 . . . . 2.3599999999999999 110.43 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -122.07 -69.5 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.779 -0.452 . . . . 5.2800000000000002 109.779 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.6 t60 68.32 150.67 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.513 0.673 . . . . 5.2599999999999998 111.638 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -106.91 -164.46 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.443 -0.577 . . . . 5.4500000000000002 109.443 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.2 m 37.6 59.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.37 1.068 . . . . 3.7599999999999998 112.941 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -78.78 44.77 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 4.2599999999999998 110.691 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.666 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 64.7 m-80 -80.8 -43.7 19.67 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.827 -0.624 . . . . 2.8799999999999999 110.603 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.31 -23.73 62.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.821 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.83 -54.04 34.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.491 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 92' ' ' ASN . 23.0 p90 -78.15 -13.0 60.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.674 -0.41 . . . . 3.2999999999999998 111.516 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 32.6 mm-40 -62.76 -43.48 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 2.6099999999999999 110.377 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.07 15.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 1.6699999999999999 110.941 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.1 mt -109.84 -46.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.59 -0.732 . . . . 1.9099999999999999 110.788 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -99.25 -42.39 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.165 0.432 . . . . 2.21 112.165 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -80.88 -70.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 2.73 110.562 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.97 68.68 6.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.953 -0.567 . . . . 2.5899999999999999 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -56.28 95.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 2.1600000000000001 111.714 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -90.97 4.86 50.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 111.163 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 74.58 -56.81 0.63 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.504 0.721 . . . . 2.6099999999999999 110.407 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.7 mt 59.93 44.6 13.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.54 . . . . 1.24 111.446 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.85 -23.77 22.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.269 0.557 . . . . 0.95999999999999996 110.134 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.84 138.23 19.47 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.58 -0.736 . . . . 1.21 110.541 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.51 -37.31 95.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.89 2.393 . . . . 0.97999999999999998 112.384 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -61.76 -34.35 75.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 2.6200000000000001 110.742 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -69.83 -45.53 67.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.502 . . . . 2.5099999999999998 110.392 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 62.6 mtm -65.2 -43.77 90.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.93999999999999995 110.714 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.721 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -67.29 -38.43 85.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.788 -0.642 . . . . 0.95999999999999996 111.434 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.94 -48.21 82.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 1.8300000000000001 111.59 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -64.09 -49.13 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 1.52 111.211 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.25 -30.63 71.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.07 0.396 . . . . 0.98999999999999999 112.07 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.57 -36.77 72.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 1.25 111.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.4 6.1 82.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.579 -0.82 . . . . 1.6100000000000001 112.511 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -107.83 1.64 22.97 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.718 -0.283 . . . . 2.9500000000000002 111.362 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.67 21.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.513 -0.851 . . . . 1.47 112.864 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 21.3 t -93.67 144.02 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.109 -0.33 . . . . 1.2 110.109 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 24.7 t0 -84.02 124.07 30.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.701 0.286 . . . . 1.5600000000000001 110.576 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.721 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 32.9 ttpt -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 1.5700000000000001 111.049 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 73.2 mt-10 -64.88 -65.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.171 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.631 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -56.6 -34.6 67.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.762 -0.654 . . . . 2.6099999999999999 111.741 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -62.5 -56.9 13.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.756 -0.202 . . . . 1.4399999999999999 111.088 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.15 -38.47 89.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.887 0.329 . . . . 1.1299999999999999 111.887 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -64.0 -47.79 78.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.71 0.29 . . . . 1.46 110.621 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.6 m -68.93 -35.98 77.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 1.53 111.068 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -57.33 -32.57 66.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.555 . . . . 1.53 110.627 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -99.36 13.76 32.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.869 -0.605 . . . . 1.6100000000000001 111.432 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -97.63 163.71 12.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 1.49 111.29 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -18.23 61.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.813 -0.63 . . . . 1.3999999999999999 111.082 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.41 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 111.611 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.86 -41.85 39.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.099 -0.5 . . . . 1.1899999999999999 110.216 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -56.46 -45.11 81.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 1.8999999999999999 111.558 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.83 89.63 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.021 -0.609 . . . . 0.75 113.052 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.66 -37.69 35.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 1.6699999999999999 110.182 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 mmm -58.27 -50.93 71.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 1.8500000000000001 111.059 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -67.79 -24.62 65.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.073 -0.512 . . . . 2.0299999999999998 111.756 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 87.0 tttt -79.02 -44.02 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 3.0800000000000001 111.088 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.69 65.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.34999999999999998 110.792 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.32 -48.41 79.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.47 -0.786 . . . . 1.6899999999999999 111.758 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -69.5 -37.7 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.535 -0.302 . . . . 2.1000000000000001 111.305 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.73 -40.81 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 0.56000000000000005 111.08 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.54 87.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.025 0.441 . . . . 0.48999999999999999 110.777 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 38.5 mmt -68.47 -34.91 76.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.813 -0.63 . . . . 2.5699999999999998 110.472 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.69 71.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.84 -0.618 . . . . 0.42999999999999999 111.206 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.419 ' HB3' HG21 ' A' ' 157' ' ' VAL . 25.0 m-85 -76.54 4.62 8.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.173 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 59.44 30.41 20.09 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.71 -0.677 . . . . 1.4099999999999999 112.448 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.85 113.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 1.26 109.657 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.32 -11.05 14.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.856 0.317 . . . . 1.25 111.856 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.88 179.29 32.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.57 -0.824 . . . . 0.68999999999999995 111.958 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.67 141.43 38.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.614 0.245 . . . . 0.64000000000000001 111.266 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.79 173.83 52.09 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.953 -1.686 . . . . 0.66000000000000003 111.967 -0.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -156.28 135.56 12.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.376 -0.374 . . . . 0.56999999999999995 110.127 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -117.19 133.14 56.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.627 -0.508 . . . . 0.92000000000000004 109.627 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 148' ' ' TYR . 9.6 t -121.36 128.12 75.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.40000000000000002 110.311 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.2 t -109.04 115.78 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.352 -0.386 . . . . 0.58999999999999997 111.286 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.25 21.24 3.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.337 -0.847 . . . . 1.0800000000000001 113.04 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.48 26.52 64.52 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.094 -0.574 . . . . 0.48999999999999999 113.214 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.513 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 39.9 mttp -118.07 -40.73 2.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.871 0.367 . . . . 1.72 111.168 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -121.38 138.75 54.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.256 -0.429 . . . . 1.5 111.03 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -120.87 131.94 54.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.743 -0.662 . . . . 1.6599999999999999 109.282 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.61 168.14 22.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.978 0.418 . . . . 0.63 110.65 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.08 179.41 7.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 1.3500000000000001 109.515 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.41 -35.42 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.269 0.356 . . . . 0.68999999999999995 111.324 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.4 89.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.008 -0.615 . . . . 0.72999999999999998 112.25 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.6 m -74.01 -42.69 59.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.608 0.242 . . . . 1.1499999999999999 111.544 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.09 -43.19 58.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.849 0.314 . . . . 0.71999999999999997 111.849 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.1 -51.3 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.039 -0.601 . . . . 1.1000000000000001 111.888 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.14 164.45 25.57 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.182 -0.532 . . . . 0.72999999999999998 111.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.29 -49.99 14.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.47 2.78 . . . . 0.84999999999999998 112.423 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.98 -37.48 87.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 2.52 110.442 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -66.35 -28.32 68.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.657 . . . . 1.8200000000000001 110.167 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.9 m -65.47 -44.08 88.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.62 109.536 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.8 mt -68.66 -32.3 72.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.881 -0.599 . . . . 0.72999999999999998 109.998 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -62.27 -39.48 93.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 2.3399999999999999 109.903 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.66 -42.54 86.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.684 -0.689 . . . . 0.69999999999999996 109.718 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.95 83.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.662 -0.699 . . . . 0.65000000000000002 111.067 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.24 72.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.028 -0.533 . . . . 1.9099999999999999 110.924 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -71.86 -44.73 63.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 1.8200000000000001 110.6 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.48 -29.45 70.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.75 111.229 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 53.2 mt -59.21 -47.08 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.792 -0.447 . . . . 0.77000000000000002 109.792 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -74.51 -34.16 62.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 2.1699999999999999 110.19 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -54.55 -44.33 72.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 2.4100000000000001 111.054 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.87 -29.94 23.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.377 . . . . 1.6399999999999999 111.412 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -72.19 -23.54 61.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.617 -0.265 . . . . 1.72 111.016 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.71 -20.74 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.511 -0.313 . . . . 1.1299999999999999 111.47 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 1.1699999999999999 110.77 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.32 22.68 5.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.092 0.557 . . . . 1.8400000000000001 112.01 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.77 51.81 10.4 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.283 0.564 . . . . 6.4299999999999997 110.811 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.404 ' H ' ' HG3' ' A' ' 192' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.454 -0.784 . . . . 7.3200000000000003 110.413 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.925 -0.47 . . . . 2.2000000000000002 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 62.35 75.21 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.021 0.529 . . . . 2.1299999999999999 111.292 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -118.59 21.6 12.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.294 0.569 . . . . 1.97 110.386 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -134.41 155.62 49.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 1.2 109.537 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 134.93 54.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.191 0.52 . . . . 1.29 111.683 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.1 23.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 1.03 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.63 -23.28 35.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.88 -0.676 . . . . 1.1399999999999999 111.776 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -93.73 -75.81 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.193 -0.299 . . . . 1.8899999999999999 110.193 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -75.28 -44.06 47.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.568 -0.287 . . . . 1.55 111.576 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -133.46 151.12 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.59 0.233 . . . . 1.03 110.45 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.38 121.05 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.961 0.41 . . . . 0.91000000000000003 110.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -87.42 131.18 34.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.116 -0.493 . . . . 1.8200000000000001 109.836 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.22 128.37 35.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.398 -0.364 . . . . 1.04 110.577 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -69.23 -26.52 64.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 1.54 110.147 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 m -114.61 97.55 47.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.634 -0.712 . . . . 1.28 109.365 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.24 151.63 15.83 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.837 2.358 . . . . 0.90000000000000002 113.133 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 t -115.1 121.84 34.42 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.81000000000000005 110.215 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.31 122.69 8.56 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.273 1.982 . . . . 1.0900000000000001 111.774 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.38 158.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.12 -0.491 . . . . 1.05 111.898 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.14 -11.08 57.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 110.999 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.82 96.25 43.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.447 -0.342 . . . . 3.3300000000000001 111.154 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.64 149.36 12.76 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.703 2.268 . . . . 1.6599999999999999 112.019 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.07 -26.3 7.87 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.816 -0.707 . . . . 0.94999999999999996 112.972 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 137.68 44.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.687 -0.486 . . . . 2.4700000000000002 109.687 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.16 119.66 24.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.464 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -85.95 121.21 28.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.592 -0.731 . . . . 2.6899999999999999 110.973 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -127.45 94.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.648 -0.871 . . . . 0.55000000000000004 108.648 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 32.5 t -99.85 129.55 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.054 -0.521 . . . . 0.69999999999999996 111.319 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.9 OUTLIER -111.26 116.7 31.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.576 -0.898 . . . . 2.4300000000000002 108.576 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.8 mp -101.37 110.34 22.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.488 . . . . 0.85999999999999999 110.463 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -114.52 175.39 5.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.3999999999999999 110.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -151.6 171.0 18.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 1.1599999999999999 110.234 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -80.83 -20.45 42.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.064 0.459 . . . . 4.8099999999999996 110.593 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.23 19.33 43.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.683 -0.77 . . . . 1.6200000000000001 114.312 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.2 p -109.23 106.17 58.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 117.716 0.758 . . . . 0.93000000000000005 110.238 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.44 -37.34 30.64 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.392 2.061 . . . . 1.1000000000000001 113.015 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -24.93 66.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.396 -0.366 . . . . 1.47 111.948 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 54.7 m -67.99 -36.43 79.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.947 0.403 . . . . 0.93999999999999995 110.629 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.66 -33.0 74.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 2.6299999999999999 110.862 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.08 3.15 47.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 0.97999999999999998 111.346 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.92 -27.49 12.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.76000000000000001 110.579 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 13.6 mm-40 -49.18 -56.48 15.65 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 112.743 0.646 . . . . 2.6899999999999999 112.743 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' GLU . 41.8 Cg_endo -66.38 -1.69 5.98 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.997 1.798 . . . . 0.81000000000000005 113.695 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 m -109.52 -39.95 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.317 . . . . 0.70999999999999996 111.855 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 tt -82.92 -31.1 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.548 0.573 . . . . 0.83999999999999997 112.548 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 55.6 t -58.67 -54.14 59.25 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.107 0.41 . . . . 0.94999999999999996 112.107 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 38.6 Cg_endo -67.29 -2.79 8.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.04 1.827 . . . . 0.94999999999999996 112.771 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -101.72 -46.95 4.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.81999999999999995 110.076 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -63.88 -32.3 73.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.22 111.978 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.31 -6.61 55.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.788 0.328 . . . . 2.1400000000000001 111.215 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.21 7.37 23.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.983 0.421 . . . . 2.0899999999999999 110.518 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.96 145.34 69.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.13 -0.486 . . . . 0.81000000000000005 111.079 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.8 168.77 19.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.197 . . . . 0.98999999999999999 111.721 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.41 27.91 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.0 0.428 . . . . 1.1399999999999999 111.835 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 27.9 t70 -112.54 -11.16 13.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.547 0.689 . . . . 1.6499999999999999 109.922 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.12 138.69 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.324 -0.853 . . . . 0.68000000000000005 110.794 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -116.55 92.43 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.591 -0.522 . . . . 1.27 109.591 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.32 128.55 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.814 -0.63 . . . . 1.3899999999999999 110.686 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 78.7 t -132.62 131.54 59.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 109.738 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -114.23 124.44 52.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.679 -0.489 . . . . 4.2300000000000004 109.679 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 95.2 mt -126.98 151.63 74.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.281 -0.418 . . . . 0.60999999999999999 110.539 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.34 156.52 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.631 2.221 . . . . 0.48999999999999999 111.922 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.73 79.43 3.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.45000000000000001 110.567 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.0 78.6 9.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 0.53000000000000003 111.254 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -102.95 26.32 8.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 1.71 110.943 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 84.11 -173.66 50.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.799 -0.715 . . . . 1.3899999999999999 111.777 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.98 -135.37 39.54 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.174 -0.536 . . . . 1.24 112.755 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.8 tp -78.04 -16.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 1.1599999999999999 110.807 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 40.3 m95 -62.98 -46.16 88.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.78000000000000003 110.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -34.94 75.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.703 -0.68 . . . . 1.99 110.956 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.57 -41.61 88.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.365 0.602 . . . . 0.89000000000000001 109.759 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -86.41 51.31 2.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.704 -0.68 . . . . 1.46 110.34 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.64 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.679 -0.691 . . . . 0.66000000000000003 112.412 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -56.16 -37.98 70.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 111.215 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.3 ttt -55.49 -38.07 68.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.038 -0.528 . . . . 1.4299999999999999 111.499 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.42 -52.5 63.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 111.285 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.74 -25.31 68.13 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.63 111.561 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.5 m -67.14 -38.89 86.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.433 . . . . 0.68999999999999995 110.716 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 115' ' ' LEU . 77.6 mt -72.96 -40.93 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 1.6899999999999999 111.006 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.515 . . . . 2.1899999999999999 111.214 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -92.69 12.86 21.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.392 0.516 . . . . 1.26 112.392 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.1 ttm -93.65 -17.95 22.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.054 0.454 . . . . 1.7 110.668 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.51 65.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.951 -0.642 . . . . 2.2000000000000002 112.504 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.61 149.44 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 2.3599999999999999 111.037 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 156.34 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.441 -0.577 . . . . 5.2800000000000002 109.441 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.7 m80 57.58 41.86 25.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.251 0.548 . . . . 5.2599999999999998 110.279 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -104.44 15.5 28.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 5.4500000000000002 110.574 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.1 t 66.05 69.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.631 0.729 . . . . 3.7599999999999998 109.256 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -22.08 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.344 -0.844 . . . . 4.2599999999999998 111.029 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -69.23 -23.07 63.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 2.8799999999999999 111.02 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.78 69.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.939 0.399 . . . . 1.71 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.83 -38.12 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 1.7 109.767 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.56 -33.6 75.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.887 -0.597 . . . . 3.2999999999999998 110.247 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 5.4 mm-40 -65.98 -46.58 77.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 2.6099999999999999 111.043 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.7 -23.49 65.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 1.6699999999999999 111.553 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.6 mt -88.82 -47.21 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.334 -0.394 . . . . 1.9099999999999999 112.058 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -86.45 -52.82 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.362 0.875 . . . . 2.21 113.362 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 1.3 mmmm -75.9 -57.54 3.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.628 0.232 . . . . 2.73 111.628 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.9 mm-40 -68.81 -58.57 3.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.533 -0.303 . . . . 2.5899999999999999 110.707 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.8 t60 59.29 57.74 3.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 2.1600000000000001 109.594 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -81.36 22.33 0.69 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.555 -0.748 . . . . 2.2400000000000002 112.023 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 55.41 78.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.321 0.581 . . . . 2.6099999999999999 110.375 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.3 mt -96.92 77.36 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.029 -0.532 . . . . 1.24 110.049 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.91 -54.45 2.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.95999999999999996 110.955 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.84 49.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 1.21 111.088 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.98 -23.7 61.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.029 2.486 . . . . 0.97999999999999998 113.103 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.52 -57.28 13.39 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.417 -0.356 . . . . 2.6200000000000001 110.436 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.82 -33.28 75.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 2.5099999999999998 110.745 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.64 -53.9 51.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.282 0.563 . . . . 0.93999999999999995 110.402 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -68.71 -28.56 66.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.95999999999999996 111.345 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -64.36 -31.4 72.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 1.8300000000000001 110.722 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.55 -41.32 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.662 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 81' ' ' LEU . 97.2 mt -64.86 -30.95 71.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.701 . . . . 0.98999999999999999 111.656 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.3 40.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.69 0.281 . . . . 1.25 111.2 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 12.51 60.46 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.757 -0.735 . . . . 1.6100000000000001 112.876 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 34.63 1.7 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.306 0.553 . . . . 2.9500000000000002 111.822 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.5 52.74 5.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.125 -0.56 . . . . 1.47 113.847 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.47 123.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.724 -0.473 . . . . 1.2 109.724 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 62.3 t0 -73.34 113.13 10.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.859 0.361 . . . . 1.5600000000000001 110.066 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 30.1 ttmt -56.79 -38.0 71.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.487 -0.779 . . . . 1.5700000000000001 111.494 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.53 -46.28 80.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.355 -0.384 . . . . 2.29 111.741 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 47.9 mmtm -64.64 -42.13 95.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 2.6099999999999999 110.25 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.437 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 83.0 t80 -58.67 -56.9 16.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 1.4399999999999999 110.866 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.73 -39.86 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.971 0.36 . . . . 1.1299999999999999 111.971 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.3 m -63.13 -53.56 51.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.644 -0.253 . . . . 1.46 111.461 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.459 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -73.16 -22.88 60.41 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.748 0.277 . . . . 1.53 111.748 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 53.6 t80 -61.01 -30.98 70.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.12 0.486 . . . . 1.53 110.543 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -100.94 7.83 43.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.633 . . . . 1.6100000000000001 111.316 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 26.9 m -86.27 155.87 20.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.015 0.436 . . . . 1.49 110.94 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.22 -19.6 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.042 -0.526 . . . . 1.3999999999999999 110.766 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.92 -36.14 67.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.144 0.497 . . . . 0.92000000000000004 110.971 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.7 mm -84.94 -38.32 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 1.1899999999999999 109.683 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -57.86 -41.74 83.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 1.8999999999999999 111.026 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.38 87.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.972 -0.632 . . . . 0.75 112.038 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.5 -32.91 54.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 1.6699999999999999 110.04 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 80.3 mmm -62.88 -52.47 62.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.735 -0.666 . . . . 1.8500000000000001 110.691 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -27.43 67.84 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.291 -0.413 . . . . 2.0299999999999998 110.739 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 143' ' ' LYS . 7.2 tmtt? -70.35 -42.33 71.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.012 -0.366 . . . . 3.0800000000000001 110.012 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.43 65.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.054 -0.521 . . . . 0.34999999999999998 110.702 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -57.93 -48.43 79.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 1.6899999999999999 111.365 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.59 -16.48 63.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.444 -0.343 . . . . 2.1000000000000001 111.798 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.85 -37.74 15.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.715 0.293 . . . . 0.56000000000000005 110.273 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.13 82.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.48999999999999999 111.475 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -72.87 -20.46 61.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 2.5699999999999998 111.458 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.67 23.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.832 0.348 . . . . 0.42999999999999999 111.221 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -82.55 9.81 8.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.63 111.631 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 62.73 30.31 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.108 -0.497 . . . . 1.4099999999999999 112.274 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.31 116.37 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.34 23.21 5.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.253 -0.43 . . . . 1.25 110.993 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.96 179.23 45.46 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.752 -0.737 . . . . 0.68999999999999995 111.603 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.28 137.51 12.83 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.249 . . . . 0.64000000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.01 169.05 71.22 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.253 -1.561 . . . . 0.66000000000000003 112.229 -0.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.5 m -155.84 125.89 6.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.498 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.446 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 96.2 mtp -106.54 137.27 44.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.836 -0.62 . . . . 0.92000000000000004 109.804 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.63 136.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.327 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -113.4 111.79 37.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.485 -0.325 . . . . 0.58999999999999997 110.952 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 54.89 30.04 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.197 -0.911 . . . . 1.0800000000000001 112.172 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.91 27.12 43.43 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 114.331 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.41 -39.03 2.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.651 0.725 . . . . 1.72 111.657 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.72 130.06 55.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.538 -0.301 . . . . 1.5 110.238 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -117.92 131.15 56.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.961 0.41 . . . . 1.6599999999999999 110.209 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -147.94 160.52 42.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.106 -0.497 . . . . 0.63 109.761 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -154.36 179.03 9.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.138 -0.483 . . . . 1.3500000000000001 110.43 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.07 -34.19 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.609 -0.723 . . . . 0.68999999999999995 111.459 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.06 -46.29 59.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.862 -0.685 . . . . 0.72999999999999998 112.398 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.9 m -67.29 -46.35 73.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.734 0.302 . . . . 1.1499999999999999 110.903 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.47 66.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.71999999999999997 111.011 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.18 -34.3 5.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.907 -0.663 . . . . 1.1000000000000001 112.039 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.15 164.37 34.31 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.637 -0.585 . . . . 0.72999999999999998 111.637 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.05 -36.04 90.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.016 2.477 . . . . 0.84999999999999998 112.99 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -69.57 -38.2 77.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 2.52 109.975 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.53 -25.99 65.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.644 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.1 m -62.64 -44.54 96.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.62 110.575 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.45 -31.34 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.72999999999999998 110.338 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.52 -44.09 95.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.693 -0.685 . . . . 2.3399999999999999 110.026 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.5 -38.3 77.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 110.358 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.4 -48.21 81.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.65000000000000002 111.117 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -58.19 -40.15 80.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.9099999999999999 110.697 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -66.69 -45.17 79.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.751 -0.659 . . . . 1.8200000000000001 110.839 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.93 -39.34 93.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.559 -0.292 . . . . 0.75 111.255 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 179' ' ' ALA . 84.2 mt -60.76 -45.06 98.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.432 . . . . 0.77000000000000002 110.166 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.59 -40.72 84.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 2.1699999999999999 110.138 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -55.75 -44.67 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.891 -0.595 . . . . 2.4100000000000001 110.671 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.16 -39.81 68.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 1.6399999999999999 111.14 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.478 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -64.01 -33.8 76.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.72 110.93 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.14 76.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 1.1299999999999999 111.676 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.19 -6.63 53.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.253 -0.43 . . . . 1.1699999999999999 111.414 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.45 27.64 2.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 1.8400000000000001 110.935 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -96.05 78.32 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 6.4299999999999997 110.578 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 pttt . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.529 1.143 . . . . 7.3200000000000003 112.614 -179.737 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.687 -0.565 . . . . 2.2000000000000002 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.74 153.44 0.14 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.357 0.663 . . . . 2.1299999999999999 110.727 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -151.53 18.44 0.72 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.097 0.475 . . . . 1.97 110.665 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -132.91 154.91 49.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 1.2 110.667 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 138.41 54.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.047 -0.524 . . . . 1.29 111.554 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.22 124.46 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.785 -0.45 . . . . 1.03 109.785 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.31 -11.5 60.04 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.928 -0.869 . . . . 1.1399999999999999 110.928 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.94 -69.37 0.84 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.985 -0.376 . . . . 1.8899999999999999 109.985 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -88.47 -38.23 15.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 1.55 111.178 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -141.67 159.59 41.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.082 -0.34 . . . . 1.03 110.082 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.44 136.3 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.856 0.36 . . . . 0.91000000000000003 110.478 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -109.87 118.01 35.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.846 -0.428 . . . . 1.8200000000000001 109.846 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 141.48 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 1.04 110.97 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -7.62 54.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 1.54 111.795 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -128.66 84.13 64.08 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.137 -0.483 . . . . 1.28 110.381 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.94 144.47 58.55 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.668 2.245 . . . . 0.90000000000000002 112.952 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.06 126.05 29.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.722 -0.672 . . . . 0.81000000000000005 109.966 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.48 141.13 34.35 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.347 2.032 . . . . 1.0900000000000001 112.285 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.66 171.21 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 1.05 110.877 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -61.85 2.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.386 -0.37 . . . . 1.6399999999999999 111.133 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -116.22 131.83 23.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.294 -0.261 . . . . 3.3300000000000001 110.294 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.64 158.07 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.513 2.142 . . . . 1.6599999999999999 112.545 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.36 -58.23 0.4 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.87 -0.681 . . . . 0.94999999999999996 112.293 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -83.54 149.21 26.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.327 -0.249 . . . . 2.4700000000000002 110.327 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.0 mm -91.5 126.66 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.045 -0.525 . . . . 0.70999999999999996 110.722 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.78 125.5 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.554 -0.748 . . . . 2.6899999999999999 110.49 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -124.93 92.59 2.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.472 -0.566 . . . . 0.55000000000000004 109.472 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.5 t -90.88 125.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.832 -0.622 . . . . 0.69999999999999996 110.988 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -109.13 116.01 31.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.558 -0.746 . . . . 2.4300000000000002 109.748 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 4.3 mp -95.55 113.23 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.127 -0.488 . . . . 0.85999999999999999 110.611 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -119.67 169.59 9.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.78 -0.645 . . . . 1.3999999999999999 110.41 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.02 162.03 37.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.083 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -82.46 7.01 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.452 -0.34 . . . . 4.8099999999999996 111.879 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.18 13.85 5.7 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.199 -1.0 . . . . 1.6200000000000001 113.976 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 p -106.49 114.71 61.77 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 117.464 0.632 . . . . 0.93000000000000005 110.261 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.12 -40.45 41.99 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.037 2.491 . . . . 1.1000000000000001 113.831 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -67.11 -21.78 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.066 0.395 . . . . 1.47 112.066 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 81.5 m -66.28 -33.64 76.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.349 . . . . 0.93999999999999995 110.604 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.46 -40.04 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 2.6299999999999999 111.262 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.32 -12.94 60.38 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.965 0.358 . . . . 0.97999999999999998 111.965 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -89.2 -23.05 22.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.6 -0.273 . . . . 0.76000000000000001 111.31 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.2 mt-10 -54.05 -58.02 15.4 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.353 0.501 . . . . 2.6899999999999999 112.353 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.23 -14.76 40.17 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.108 1.872 . . . . 0.81000000000000005 113.362 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 -30.27 15.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.70999999999999996 111.309 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' HG ' ' A' ' 51' ' ' SER . 13.7 tt -95.0 -18.16 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.255 0.465 . . . . 0.83999999999999997 112.255 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' GLU . 24.4 t -59.39 -54.43 56.14 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 111.871 0.322 . . . . 0.94999999999999996 111.871 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 36.6 Cg_endo -65.47 -3.13 7.15 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.264 1.976 . . . . 0.94999999999999996 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -102.6 -52.8 3.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 0.81999999999999995 109.925 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.401 ' HG ' HG12 ' A' ' 47' ' ' ILE . 12.9 m -64.95 -33.58 76.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 1.22 112.081 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.73 -5.26 47.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.663 0.268 . . . . 2.1400000000000001 111.472 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 49' ' ' PRO . 3.1 mptp? -124.62 35.05 4.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 2.0899999999999999 110.542 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -86.82 150.97 51.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.404 -0.362 . . . . 0.81000000000000005 110.992 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.58 169.18 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.319 2.013 . . . . 0.98999999999999999 111.951 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 14.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 1.1399999999999999 112.19 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.69 5.72 11.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 1.6499999999999999 110.597 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.4 t -129.69 122.09 54.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.514 . . . . 0.68000000000000005 110.363 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -116.43 110.56 18.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.761 0.315 . . . . 1.27 110.353 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -74.39 138.04 43.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.511 . . . . 1.3899999999999999 110.508 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG12 ' HG ' ' A' ' 63' ' ' LEU . 27.8 t -130.61 111.31 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 110.739 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -88.29 120.82 30.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.058 -0.719 . . . . 4.2300000000000004 109.058 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 61.1 mt -135.45 130.5 19.05 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.153 0.502 . . . . 0.60999999999999999 111.46 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.61 146.88 34.99 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.413 2.075 . . . . 0.48999999999999999 111.781 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.43 90.91 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.295 0.569 . . . . 0.45000000000000001 110.931 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.08 67.41 8.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.826 -0.625 . . . . 0.53000000000000003 111.2 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.37 47.97 1.36 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 1.71 111.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.41 -155.52 36.2 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.375 -0.829 . . . . 1.3899999999999999 113.371 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.63 -125.7 18.66 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.74 0.318 . . . . 1.24 113.403 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.6 tp -99.88 -5.14 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.414 0.626 . . . . 1.1599999999999999 109.765 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -69.25 -48.24 62.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.7 . . . . 0.78000000000000003 110.583 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -34.27 77.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.251 -0.432 . . . . 1.99 111.03 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.17 -29.88 46.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.539 0.685 . . . . 0.89000000000000001 109.715 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -93.36 24.23 4.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.407 -0.815 . . . . 1.46 110.595 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.98 -28.8 0.27 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.708 -0.758 . . . . 0.66000000000000003 112.184 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.94 -33.64 67.2 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.838 0.351 . . . . 2.1200000000000001 111.343 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.8 ttt -55.06 -38.57 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 1.4299999999999999 111.259 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.73 -52.98 61.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 1.0600000000000001 111.602 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.28 -32.67 73.42 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.432 -0.349 . . . . 0.63 111.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.7 m -64.66 -36.44 84.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.953 0.406 . . . . 0.68999999999999995 110.563 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.62 -45.45 75.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 1.6899999999999999 110.695 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.19 -36.47 79.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 2.1899999999999999 111.561 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -72.25 -2.47 19.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.473 0.546 . . . . 1.26 112.473 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.2 mtm -91.03 -6.77 53.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.754 -0.379 . . . . 1.7 110.49 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.52 38.15 68.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.093 -0.575 . . . . 2.2000000000000002 112.597 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.45 140.96 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 2.3599999999999999 110.811 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.35 156.94 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.007 -0.542 . . . . 5.2800000000000002 110.028 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.1 m80 58.66 40.57 23.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.46 0.648 . . . . 5.2599999999999998 110.556 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.92 2.24 32.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.373 -0.83 . . . . 5.4500000000000002 110.304 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t 66.79 79.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.83 . . . . 3.7599999999999998 109.831 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -28.49 68.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.32 -0.854 . . . . 4.2599999999999998 110.218 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.51 -29.32 67.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.693 -0.685 . . . . 2.8799999999999999 111.349 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.55 -36.74 76.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.091 0.472 . . . . 1.71 110.372 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -70.67 -43.71 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 1.7 109.639 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -39.15 82.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.775 -0.648 . . . . 3.2999999999999998 110.514 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.83 -47.26 85.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 2.6099999999999999 110.822 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -65.19 -28.31 69.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 1.6699999999999999 111.712 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -78.48 -42.34 26.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 111.99 0.367 . . . . 1.9099999999999999 111.99 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -88.84 -38.32 14.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.446 0.906 . . . . 2.21 113.446 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -88.73 -53.42 4.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.015 -0.274 . . . . 2.73 111.634 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 35.9 mm-40 -72.18 -52.43 16.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.601 0.238 . . . . 2.5899999999999999 110.898 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 56.89 69.01 0.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.678 -0.692 . . . . 2.1600000000000001 110.701 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -90.04 9.01 29.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.052 -0.522 . . . . 2.2400000000000002 111.005 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 tttt 65.41 85.56 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.575 -0.739 . . . . 2.6099999999999999 111.366 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.9 mt -91.31 72.06 6.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.999 -0.546 . . . . 1.24 110.114 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.53 -44.84 6.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 0.95999999999999996 110.992 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.56 147.17 33.15 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 1.21 111.299 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.52 -27.1 81.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 0.97999999999999998 113.044 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 6.7 mt-10 -61.05 -48.15 83.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 2.6200000000000001 110.769 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 2.5099999999999998 110.524 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.5 mtt -60.93 -52.33 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.283 -0.871 . . . . 0.93999999999999995 110.624 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.99 82.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.95999999999999996 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 2.1 t70 -62.25 -48.47 79.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 1.8300000000000001 110.819 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -69.46 -42.71 74.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 1.52 111.161 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.4 -33.56 73.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 0.98999999999999999 111.25 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.36 7.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.448 -0.342 . . . . 1.25 111.263 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.19 -3.58 35.77 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.128 -0.487 . . . . 1.6100000000000001 112.02 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -130.19 19.34 5.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.752 0.311 . . . . 2.9500000000000002 111.479 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.13 64.06 1.08 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.479 -0.867 . . . . 1.47 113.078 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -147.0 139.37 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.153 -0.684 . . . . 1.2 109.153 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.648 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 37.2 t70 -96.36 123.82 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.665 0.269 . . . . 1.5600000000000001 110.475 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.56 -40.2 95.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 1.5700000000000001 111.521 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 55.3 mm-40 -55.87 -54.88 39.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.569 -0.287 . . . . 2.29 110.919 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.648 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 35.8 mmtm -65.84 -38.34 88.62 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.555 -0.293 . . . . 2.6099999999999999 110.644 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 87.2 t80 -59.32 -55.36 35.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.052 -0.522 . . . . 1.4399999999999999 110.681 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.69 -32.86 74.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 1.1299999999999999 111.483 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.5 m -60.16 -56.74 17.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.444 -0.344 . . . . 1.46 110.906 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -74.13 -23.8 59.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.565 -0.288 . . . . 1.53 111.462 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 38.2 t80 -61.3 -32.98 72.83 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.032 0.444 . . . . 1.53 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -105.28 24.84 11.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.029 -0.532 . . . . 1.6100000000000001 111.106 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.1 m -105.77 156.61 18.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 1.49 110.789 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -68.71 -20.94 64.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 1.3999999999999999 110.967 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.48 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.098 0.475 . . . . 0.92000000000000004 110.612 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.82 -41.53 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.091 0.472 . . . . 1.1899999999999999 109.806 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.93 -42.13 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.702 -0.681 . . . . 1.8999999999999999 111.142 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.3 98.96 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.14 -0.552 . . . . 0.75 112.027 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.1 -35.47 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.029 0.442 . . . . 1.6699999999999999 109.908 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.7 mmm -59.1 -51.61 69.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.375 -0.829 . . . . 1.8500000000000001 110.964 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 2.5 pt-20 -70.86 -26.94 63.49 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.783 -0.367 . . . . 2.0299999999999998 110.812 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.67 -47.78 84.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 3.0800000000000001 110.318 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.21 39.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.34999999999999998 110.845 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 139' ' ' GLU . 73.8 tttt -55.57 -53.65 53.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 1.6899999999999999 111.603 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 35.5 pttt -73.23 -24.07 60.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.804 -0.358 . . . . 2.1000000000000001 111.578 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 mt -76.38 -33.85 58.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.87 -0.332 . . . . 0.56000000000000005 110.868 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.3 90.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.157 0.503 . . . . 0.48999999999999999 110.842 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 17.4 ptp -80.26 -20.85 43.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.623 . . . . 2.5699999999999998 110.39 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.92 -34.43 59.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.42999999999999999 110.442 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -80.16 2.84 22.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.815 -0.63 . . . . 0.63 110.107 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.46 44.77 14.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.438 -0.801 . . . . 1.4099999999999999 112.173 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.9 130.39 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.49 . . . . 1.26 109.864 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.89 20.29 5.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.008 0.373 . . . . 1.25 112.008 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.83 173.23 43.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.078 -1.058 . . . . 0.68999999999999995 112.579 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.91 143.35 36.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.283 -0.265 . . . . 0.64000000000000001 110.283 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -80.99 165.45 76.1 Favored 'Cis proline' 0 N--CA 1.461 -0.382 0 C-N-CA 123.015 -1.661 . . . . 0.66000000000000003 112.387 -0.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -158.15 135.94 10.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.341 -0.39 . . . . 0.56999999999999995 110.695 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 99.7 mtp -114.27 135.53 53.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.821 -0.437 . . . . 0.92000000000000004 109.821 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.45 130.69 73.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 110.195 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.07 117.21 54.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 116.412 -0.358 . . . . 0.58999999999999997 111.091 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.3 m-20 54.86 27.9 9.67 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.961 0.788 . . . . 1.0800000000000001 112.276 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.48 29.89 54.52 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 113.286 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 159' ' ' ASN . 79.8 mttt -128.5 -37.88 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.864 0.332 . . . . 1.72 111.619 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.23 132.46 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 1.5 111.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -121.63 122.72 40.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.773 -0.649 . . . . 1.6599999999999999 110.131 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.12 163.12 34.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.86 0.362 . . . . 0.63 110.281 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -151.6 175.29 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.012 -0.54 . . . . 1.3500000000000001 110.013 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.81 -40.04 78.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.68999999999999995 111.668 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.06 -49.82 55.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.03 -0.605 . . . . 0.72999999999999998 112.64 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.6 m -65.09 -45.39 85.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.535 0.207 . . . . 1.1499999999999999 111.18 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.6 84.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.71999999999999997 110.874 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 29.63 6.22 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.543 -0.837 . . . . 1.1000000000000001 112.412 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.28 156.86 7.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.616 -0.802 . . . . 0.72999999999999998 112.622 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.01 -40.01 81.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.13 2.553 . . . . 0.84999999999999998 111.971 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -63.3 -46.45 86.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 2.52 109.841 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.28 -35.21 76.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 1.8200000000000001 110.367 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.5 m -60.5 -46.56 89.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.62 110.611 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.83 -40.61 91.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.72999999999999998 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -64.59 -43.37 94.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 2.3399999999999999 110.562 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 1.5 mm? -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.69999999999999996 110.242 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.28 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.65000000000000002 111.581 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.58 -42.74 97.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.688 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -61.64 -44.8 96.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 110.683 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 178' ' ' LEU . 98.7 mt -65.52 -36.75 84.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.75 111.02 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.71 -46.86 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.77000000000000002 110.002 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.68 -38.3 90.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 110.697 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -59.63 -45.38 92.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 2.4100000000000001 110.892 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -76.54 -37.44 56.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 1.6399999999999999 111.383 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.7 74.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.511 -0.313 . . . . 1.72 110.521 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -58.92 -31.21 68.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.146 -0.479 . . . . 1.1299999999999999 112.11 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.46 68.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.161 0.505 . . . . 1.1699999999999999 110.983 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.64 41.2 3.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.327 0.584 . . . . 1.8400000000000001 110.0 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 6.3 tptm -90.02 60.57 4.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.645 -0.707 . . . . 6.4299999999999997 110.472 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.027 -0.987 . . . . 7.3200000000000003 112.184 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.151 -0.38 . . . . 2.2000000000000002 112.151 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.53 100.66 0.05 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.263 0.625 . . . . 2.1299999999999999 111.647 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.53 1.9 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 1.97 110.587 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -120.72 167.11 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.112 -0.495 . . . . 1.2 110.295 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -127.77 137.71 52.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 1.29 111.285 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 129.17 38.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 1.03 110.356 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.66 -16.27 61.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.916 -0.659 . . . . 1.1399999999999999 111.675 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.24 -73.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.332 . . . . 1.8899999999999999 110.102 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -87.39 -31.33 20.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -143.57 140.84 30.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.774 0.321 . . . . 1.03 110.548 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.95 132.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.124 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.33 126.84 35.69 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.486 -0.561 . . . . 1.8200000000000001 109.486 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 163' ' ' ARG . 53.2 mt -63.77 129.98 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.855 0.36 . . . . 1.04 110.749 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -19.23 65.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.477 0.656 . . . . 1.54 110.359 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -133.33 98.89 14.97 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.353 -0.84 . . . . 1.28 109.227 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.57 142.25 76.83 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 112.506 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.08 124.03 35.25 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.5 144.76 50.99 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.416 2.077 . . . . 1.0900000000000001 112.514 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.04 159.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 1.05 110.818 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -51.72 57.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.514 . . . . 1.6399999999999999 111.417 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.79 101.33 29.92 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.122 -0.49 . . . . 3.3300000000000001 110.722 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.88 71.88 4.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.013 2.475 . . . . 1.6599999999999999 111.939 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.77 -57.59 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.885 -0.674 . . . . 0.94999999999999996 111.694 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -102.37 167.48 9.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.989 -0.375 . . . . 2.4700000000000002 109.989 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.458 HG13 HG23 ' A' ' 183' ' ' ILE . 39.1 mm -85.36 121.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.485 -0.561 . . . . 0.70999999999999996 109.485 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -101.29 119.09 38.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.151 -0.477 . . . . 2.6899999999999999 111.081 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.32 112.1 38.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 109.926 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.29 137.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.69999999999999996 111.627 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.25 139.57 53.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.742 -0.836 . . . . 2.4300000000000002 108.742 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.4 mp -116.03 121.28 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.85999999999999999 110.801 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 1.3999999999999999 111.365 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.578 ' NE1' ' HA ' ' A' ' 71' ' ' TRP . 30.2 t90 -150.59 148.06 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 1.1599999999999999 109.487 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -78.78 69.49 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.004 0.43 . . . . 4.8099999999999996 110.208 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.67 35.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.607 -0.724 . . . . 1.6200000000000001 112.16 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.6 115.48 13.57 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.991 0.424 . . . . 0.93000000000000005 110.428 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.89 -34.01 18.79 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.495 2.13 . . . . 1.1000000000000001 112.424 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -62.21 -33.07 73.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.608 -0.269 . . . . 1.47 111.437 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 18.1 m -65.19 -35.21 80.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.93999999999999995 110.786 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -69.09 -25.2 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 2.6299999999999999 111.083 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.34 -7.33 56.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 110.685 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.7 t80 -99.03 -37.37 9.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.022 -0.536 . . . . 0.76000000000000001 111.058 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 61.7 mm-40 -45.72 -54.74 14.74 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.142 0.793 . . . . 2.6899999999999999 113.142 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 18.2 Cg_endo -59.92 -9.32 9.54 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.343 2.029 . . . . 0.81000000000000005 113.657 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -35.5 5.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.627 0.251 . . . . 0.70999999999999996 111.535 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 44' ' ' GLU . 15.5 tt -82.66 -33.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.045 0.387 . . . . 0.83999999999999997 112.045 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.29 -58.63 14.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.568 -0.253 . . . . 0.94999999999999996 111.666 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.58 -36.01 98.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.843 1.696 . . . . 0.94999999999999996 111.798 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -65.59 -49.16 69.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.81999999999999995 110.715 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.7 p -65.99 -29.54 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.988 0.366 . . . . 1.22 111.988 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -84.86 0.17 51.91 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.852 0.358 . . . . 2.1400000000000001 111.211 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.64 18.93 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 2.0899999999999999 110.522 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.81 148.07 84.64 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.514 . . . . 0.81000000000000005 111.105 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HG2' HG23 ' A' ' 58' ' ' VAL . 28.3 Cg_endo -65.97 165.09 24.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.98999999999999999 111.496 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.53 -10.24 59.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.726 0.298 . . . . 1.1399999999999999 111.526 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.04 -6.19 57.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.12 0.486 . . . . 1.6499999999999999 111.335 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 55' ' ' PRO . 64.4 t -120.02 140.5 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.68000000000000005 111.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -121.42 146.27 47.06 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.336 -0.616 . . . . 1.27 109.336 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -121.82 137.31 54.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.618 -0.265 . . . . 1.3899999999999999 110.874 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.09 127.46 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 0.69999999999999996 111.021 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -99.78 105.41 17.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.237 -0.653 . . . . 4.2300000000000004 109.237 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 27.9 mt -111.26 146.8 35.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.60999999999999999 111.192 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -87.96 145.21 6.4 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.608 2.205 . . . . 0.48999999999999999 111.984 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.6 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.36 101.74 6.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 110.549 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.41 96.57 8.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.53000000000000003 110.056 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' H ' ' HB2' ' A' ' 71' ' ' TRP . 48.0 m-85 -114.37 38.07 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.588 0.588 . . . . 1.71 112.588 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.56 -54.26 4.04 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.14 0.816 . . . . 1.3899999999999999 115.14 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 71' ' ' TRP . . . -68.64 -147.93 0.2 Allowed Glycine 0 C--O 1.225 -0.438 0 CA-C-N 117.195 0.497 . . . . 1.24 113.605 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.3 tp -67.71 9.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.771 0.796 . . . . 1.1599999999999999 111.575 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.6 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 54.2 m95 -74.85 -50.11 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.427 -0.806 . . . . 0.78000000000000003 110.528 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -68.22 -35.12 77.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 1.99 111.489 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.6 t -63.56 -27.17 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.343 0.592 . . . . 0.89000000000000001 110.362 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -94.24 3.45 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.981 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.74 -28.59 3.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.452 -0.88 . . . . 0.66000000000000003 111.837 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -59.81 -32.8 70.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.671 0.388 . . . . 2.1200000000000001 111.007 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.1 ttm -59.35 -48.62 80.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.155 -0.475 . . . . 1.4299999999999999 111.044 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.43 -45.51 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 1.0600000000000001 110.964 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.43 -39.35 90.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.63 110.475 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 128' ' ' THR . 32.2 m -64.16 -44.28 92.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.854 -0.612 . . . . 0.68999999999999995 110.401 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 115' ' ' LEU . 77.9 mt -62.24 -48.98 77.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 1.6899999999999999 111.155 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.79 -39.67 92.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 2.1899999999999999 111.255 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -21.04 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 1.26 111.151 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 74.7 mtp -91.75 -35.41 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.515 -0.311 . . . . 1.7 110.8 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.8 -46.65 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 2.2000000000000002 112.045 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p 41.9 106.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.072 1.349 . . . . 2.3599999999999999 114.08 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.01 131.69 41.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.37 -0.832 . . . . 5.2800000000000002 110.618 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -65.1 -21.4 66.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.942 0.401 . . . . 5.2599999999999998 110.477 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.35 -30.52 64.9 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.65 -0.704 . . . . 5.4500000000000002 111.439 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.59 21.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 3.7599999999999998 111.743 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.18 -19.88 65.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.081 0.401 . . . . 4.2599999999999998 112.081 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.56 -30.96 10.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.821 0.343 . . . . 2.8799999999999999 110.182 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.05 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 1.71 112.029 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.29 -41.9 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.145 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.25 -35.42 76.11 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.969 0.414 . . . . 3.2999999999999998 110.561 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.91 -28.73 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 2.6099999999999999 110.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -69.73 -17.28 63.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 110.655 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.4 mm -96.91 -33.0 4.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 1.9099999999999999 110.489 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -94.33 -80.02 0.41 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.841 0.682 . . . . 2.21 112.841 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -59.62 -51.97 67.54 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.323 0.49 . . . . 2.73 112.323 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.3 mm-40 -76.04 -48.99 18.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 111.153 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.3 t60 56.22 58.52 4.25 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.883 -0.784 . . . . 2.1600000000000001 108.883 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -71.03 10.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.977 -1.01 . . . . 2.2400000000000002 113.287 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 58.09 46.12 16.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.41 0.624 . . . . 2.6099999999999999 110.486 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.99 78.46 7.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 1.24 110.606 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.8 -38.91 6.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.391 -0.368 . . . . 0.95999999999999996 110.502 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 111' ' ' MET . 17.9 p -91.75 146.93 34.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 1.21 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.06 -34.05 91.49 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.806 2.337 . . . . 0.97999999999999998 112.343 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.92 -46.21 82.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 110.991 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.02 -39.05 92.83 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.406 -0.59 . . . . 2.5099999999999998 109.406 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 107' ' ' THR . 65.5 mtt -59.41 -54.22 49.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.505 -0.771 . . . . 0.93999999999999995 110.204 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.47 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -62.07 -32.69 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.95999999999999996 111.813 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 1.8300000000000001 110.391 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 32.9 t80 -75.77 -46.65 29.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.52 110.331 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 81' ' ' LEU . 82.3 mt -62.17 -24.95 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.822 -0.626 . . . . 0.98999999999999999 111.629 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -59.78 -29.28 68.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 1.25 110.755 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.85 16.97 60.1 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.794 -0.717 . . . . 1.6100000000000001 111.842 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -120.47 7.55 10.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.925 0.393 . . . . 2.9500000000000002 110.498 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.16 12.34 54.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.737 -0.744 . . . . 1.47 112.161 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.1 t -106.25 128.47 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 1.2 110.396 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 6.1 t70 -78.69 131.1 36.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.385 . . . . 1.5600000000000001 110.732 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 37.0 ttmt -64.91 -36.52 84.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 1.5700000000000001 111.549 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 48.5 mm-40 -63.44 -56.19 18.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 2.29 110.611 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -58.93 -39.92 83.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 2.6099999999999999 111.036 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 85.6 t80 -61.16 -55.67 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 1.4399999999999999 111.119 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.49 -29.6 70.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.543 -0.299 . . . . 1.1299999999999999 111.645 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.4 t -70.61 -40.65 73.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.769 0.319 . . . . 1.46 110.558 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HB ' HG23 ' A' ' 80' ' ' THR . 11.5 m -79.41 -39.87 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.104 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -54.22 -50.62 66.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.305 -0.407 . . . . 1.53 110.697 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -95.3 65.48 2.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.602 0.715 . . . . 1.6100000000000001 109.646 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.1 t -145.97 156.54 43.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 1.49 110.64 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -19.86 65.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 1.3999999999999999 110.265 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.32 75.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.92000000000000004 110.815 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.8 mm -91.98 -38.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.104 -0.498 . . . . 1.1899999999999999 110.166 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.447 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 60.0 tttt -57.77 -40.33 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 1.8999999999999999 110.819 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.19 -18.16 68.9 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.75 112.725 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.72 -25.59 19.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.309 0.576 . . . . 1.6699999999999999 110.176 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 135' ' ' LYS . 67.4 mtp -67.4 -46.33 73.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.467 -0.788 . . . . 1.8500000000000001 111.384 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.61 -33.92 74.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.664 -0.244 . . . . 2.0299999999999998 111.65 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.63 -49.17 74.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.381 . . . . 3.0800000000000001 110.938 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.34999999999999998 111.42 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -59.14 -53.58 56.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 1.6899999999999999 111.34 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.07 -27.77 66.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.531 -0.304 . . . . 2.1000000000000001 111.42 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 144' ' ' LEU . 40.7 mt -72.96 -41.32 64.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.127 -0.229 . . . . 0.56000000000000005 110.99 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.04 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.922 0.391 . . . . 0.48999999999999999 111.494 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.6 ptm -69.37 -30.39 68.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 2.5699999999999998 111.357 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.38 65.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.806 0.336 . . . . 0.42999999999999999 111.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.413 ' HB2' HG23 ' A' ' 150' ' ' VAL . 20.1 m-85 -82.97 3.68 29.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.981 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 61.54 33.82 18.21 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.844 -0.616 . . . . 1.4099999999999999 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 148' ' ' TYR . 74.0 t -69.77 115.96 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.621 -0.511 . . . . 1.26 109.621 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.92 4.57 12.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.521 . . . . 1.25 112.063 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.31 35.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.387 -0.911 . . . . 0.68999999999999995 112.409 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 m -138.58 134.02 17.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.068 -0.345 . . . . 0.64000000000000001 110.068 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.8 179.91 26.16 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.643 -1.399 . . . . 0.66000000000000003 112.195 -0.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.3 m -162.11 103.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.806 -0.442 . . . . 0.56999999999999995 109.806 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 51.0 mtp -86.11 126.46 34.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.845 -0.616 . . . . 0.92000000000000004 110.442 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.99 122.4 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 0.40000000000000002 109.916 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.24 120.75 59.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.347 -0.388 . . . . 0.58999999999999997 111.021 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 56.74 18.6 3.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.324 -0.853 . . . . 1.0800000000000001 113.106 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 33.01 82.5 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.225 -0.512 . . . . 0.48999999999999999 113.54 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -127.89 -38.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.72 111.356 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.4 138.82 51.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.742 0.306 . . . . 1.5 110.748 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.403 ' HB2' HD21 ' A' ' 15' ' ' LEU . 21.5 ttp180 -123.2 123.21 40.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 110.068 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.1 172.37 13.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.509 -0.314 . . . . 0.63 110.203 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -170.4 -176.22 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.024 -0.361 . . . . 1.3500000000000001 110.024 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 43' ' ' PHE . 26.1 mt -57.96 -39.31 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 O-C-N 123.56 0.538 . . . . 0.68999999999999995 111.482 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.15 -22.54 78.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.906 -0.664 . . . . 0.72999999999999998 113.061 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -88.04 -49.25 7.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.84 0.352 . . . . 1.1499999999999999 110.754 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.11 -35.52 69.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.215 -0.448 . . . . 0.71999999999999997 111.433 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.87 44.18 2.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.613 -0.803 . . . . 1.1000000000000001 112.564 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 135.77 148.51 5.61 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.688 -0.768 . . . . 0.72999999999999998 112.266 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.0 -42.74 54.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.045 2.497 . . . . 0.84999999999999998 112.482 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -65.69 -37.24 85.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 2.52 110.14 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.99 -32.42 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 1.8200000000000001 110.384 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 m -65.57 -39.25 91.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.62 110.735 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.7 mt -63.12 -37.44 87.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.027 -0.533 . . . . 0.72999999999999998 110.39 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.32 -42.0 96.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 2.3399999999999999 110.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.07 -43.88 94.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.007 -0.542 . . . . 0.69999999999999996 110.231 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.25 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.65000000000000002 111.039 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.28 -36.23 79.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.9099999999999999 111.271 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.79 -45.24 68.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.8200000000000001 110.779 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.74 -31.27 72.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.344 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 179' ' ' ALA . 80.2 mt -60.97 -44.25 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 0.77000000000000002 109.738 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.34 -32.81 66.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.739 -0.664 . . . . 2.1699999999999999 110.307 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.9 -47.11 75.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.92 -0.582 . . . . 2.4100000000000001 110.679 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -73.66 -31.2 63.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 1.6399999999999999 111.439 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 5.3 tpm_? -64.05 -28.73 69.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 1.72 110.14 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.01 67.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.647 -0.706 . . . . 1.1299999999999999 111.503 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.75 -42.53 84.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 1.1699999999999999 110.942 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.21 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.17 -0.468 . . . . 1.8400000000000001 110.241 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.63 41.37 12.29 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.476 -0.783 . . . . 6.4299999999999997 110.972 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 C--O 1.245 0.858 0 CA-C-N 115.252 -0.886 . . . . 7.3200000000000003 110.544 179.788 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.942 -0.463 . . . . 2.2000000000000002 111.942 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 64.99 95.25 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.064 0.546 . . . . 2.1299999999999999 111.478 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.79 -5.92 20.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.203 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -106.8 156.68 18.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.948 0.404 . . . . 1.2 111.343 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.42 133.32 56.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.797 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.18 124.41 24.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 1.03 110.499 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.06 -6.53 69.23 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.971 -0.633 . . . . 1.1399999999999999 111.682 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -109.59 -68.25 0.93 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.729 0.3 . . . . 1.8899999999999999 110.569 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -80.41 -29.98 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.55 111.254 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -152.46 161.46 42.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.729 -0.471 . . . . 1.03 109.729 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.68 131.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.79 0.328 . . . . 0.91000000000000003 110.544 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -103.94 146.23 28.98 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.599 -0.519 . . . . 1.8200000000000001 109.599 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -96.79 150.69 20.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.428 -0.351 . . . . 1.04 110.683 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.14 -43.22 71.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 1.54 110.887 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -103.66 102.52 30.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 1.28 110.258 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.85 154.76 23.23 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.428 2.085 . . . . 0.90000000000000002 112.936 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.66 118.64 53.9 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.81000000000000005 110.465 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.16 120.67 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.353 2.035 . . . . 1.0900000000000001 112.431 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.12 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.494 . . . . 1.05 111.038 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -87.99 9.2 23.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 1.6399999999999999 111.184 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -129.1 79.8 73.81 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 3.3300000000000001 110.218 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.23 119.59 6.55 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.552 2.168 . . . . 1.6599999999999999 111.645 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.62 -15.91 14.37 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.759 -0.734 . . . . 0.94999999999999996 112.021 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.24 161.96 16.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.016 -0.364 . . . . 2.4700000000000002 110.016 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.3 mm -103.07 116.3 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.70999999999999996 110.561 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -97.75 113.99 25.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 2.6899999999999999 110.823 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -110.83 101.19 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.02 -0.733 . . . . 0.55000000000000004 109.02 178.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.1 t -91.59 119.64 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.536 . . . . 0.69999999999999996 111.444 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 62' ' ' ARG . 22.3 tt0 -102.16 115.28 30.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.412 -0.813 . . . . 2.4300000000000002 108.971 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 3.6 mp -101.58 113.76 27.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.85999999999999999 110.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 34.9 p90 -123.32 174.41 7.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.541 -0.754 . . . . 1.3999999999999999 110.281 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 4.3 t90 -150.73 166.95 28.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.11 -0.496 . . . . 1.1599999999999999 109.849 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -79.83 -1.42 38.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.392 -0.367 . . . . 4.8099999999999996 111.111 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.05 7.74 19.0 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.515 -0.85 . . . . 1.6200000000000001 114.082 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.0 p -104.06 110.05 63.42 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 117.723 0.761 . . . . 0.93000000000000005 110.889 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.23 -30.68 24.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.345 2.03 . . . . 1.1000000000000001 111.709 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -29.14 70.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.785 -0.643 . . . . 1.47 111.047 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 58.5 m -66.85 -41.97 86.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.93999999999999995 111.17 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -67.71 -37.07 81.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.369 . . . . 2.6299999999999999 111.163 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 -18.04 60.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.344 -0.389 . . . . 0.97999999999999998 111.737 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.46 -25.82 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.481 -0.327 . . . . 0.76000000000000001 111.408 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -50.06 -53.83 39.47 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.307 0.484 . . . . 2.6899999999999999 112.307 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 36.8 Cg_endo -64.17 -4.07 7.16 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.379 2.053 . . . . 0.81000000000000005 113.617 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 -35.89 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 0.70999999999999996 111.339 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 tt -84.53 -28.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.124 0.416 . . . . 0.83999999999999997 112.124 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.9 t -56.79 -56.31 34.22 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.557 0.577 . . . . 0.94999999999999996 112.557 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.6 Cg_endo -55.82 -34.28 90.82 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.168 1.912 . . . . 0.94999999999999996 112.63 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -73.81 -46.56 44.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.579 . . . . 0.81999999999999995 110.975 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -64.63 -40.5 95.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 1.22 112.203 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.79 -8.95 57.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.196 -0.202 . . . . 2.1400000000000001 111.371 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.8 15.36 18.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.638 0.256 . . . . 2.0899999999999999 111.187 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.2 mt -71.37 145.37 90.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.633 0.254 . . . . 0.81000000000000005 110.318 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.8 168.3 15.52 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.512 2.141 . . . . 0.98999999999999999 112.055 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.54 53.77 0.89 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.221 0.534 . . . . 1.1399999999999999 110.862 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 0.7 OUTLIER -150.05 -16.62 0.25 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.618 -0.719 . . . . 1.6499999999999999 110.632 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.49 141.64 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.68000000000000005 110.223 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -124.53 115.31 20.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.872 -0.418 . . . . 1.27 109.872 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.484 ' HA ' HG23 ' A' ' 29' ' ' VAL . 24.4 t80 -74.82 116.13 15.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 1.3899999999999999 110.704 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 53.2 t -121.25 114.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.153 -0.476 . . . . 0.69999999999999996 110.273 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -110.93 133.75 53.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 4.2300000000000004 110.137 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 74.4 mt -139.52 147.8 53.71 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.098 -0.501 . . . . 0.60999999999999999 109.974 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 6.3 Cg_exo -78.25 153.45 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.388 2.059 . . . . 0.48999999999999999 112.197 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.13 86.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.072 -0.513 . . . . 0.45000000000000001 110.928 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.16 74.65 9.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.997 -0.547 . . . . 0.53000000000000003 110.833 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -89.82 -1.36 57.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 1.71 110.7 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 108.63 177.7 21.77 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.833 -0.698 . . . . 1.3899999999999999 111.743 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.6 -137.68 47.81 Favored Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.885 -0.674 . . . . 1.24 112.431 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -68.41 -18.41 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.807 0.337 . . . . 1.1599999999999999 111.469 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 47.6 m95 -64.67 -46.03 84.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.78000000000000003 110.258 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -32.28 70.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 1.99 110.549 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.68 -36.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.289 0.566 . . . . 0.89000000000000001 110.059 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -91.53 33.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 1.46 110.617 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.35 -34.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.838 -0.696 . . . . 0.66000000000000003 112.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -57.54 -32.98 67.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 2.1200000000000001 111.466 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.56 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 13.7 ttt -54.51 -46.84 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.732 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.65 -41.33 97.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.24 0.459 . . . . 1.0600000000000001 112.24 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.55 -21.86 61.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.531 -0.304 . . . . 0.63 111.797 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -84.6 -26.63 27.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.825 0.345 . . . . 0.68999999999999995 111.582 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 77' ' ' MET . 92.7 mt -63.1 -62.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.994 0.738 . . . . 1.6899999999999999 112.994 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.25 -9.58 53.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.901 0.704 . . . . 2.1899999999999999 112.901 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -78.28 -4.1 46.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 1.26 110.596 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.2 ttm -87.9 0.34 55.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 1.7 110.378 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 49.13 7.73 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.831 -0.699 . . . . 2.2000000000000002 111.931 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.79 152.43 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.742 0.306 . . . . 2.3599999999999999 110.827 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.02 151.01 37.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.028 -0.533 . . . . 5.2800000000000002 110.383 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 41.0 m80 55.85 42.47 28.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.136 0.494 . . . . 5.2599999999999998 111.332 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.22 8.38 33.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 5.4500000000000002 110.946 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.01 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.577 0.703 . . . . 3.7599999999999998 110.128 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.85 -30.6 71.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.269 -0.878 . . . . 4.2599999999999998 111.059 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.55 -37.76 70.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 2.8799999999999999 111.861 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -34.1 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 1.71 110.762 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.53 -46.79 61.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.58 . . . . 1.7 110.275 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -35.83 81.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.973 -0.558 . . . . 3.2999999999999998 111.175 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -65.03 -43.41 92.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 2.6099999999999999 110.432 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.55 66.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 111.311 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.6 mt -85.32 -36.87 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 1.9099999999999999 111.702 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -100.13 -52.03 3.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.777 0.658 . . . . 2.21 112.777 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -66.19 -41.59 90.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 2.73 111.063 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.64 -51.85 4.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 2.5899999999999999 111.176 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 64.97 58.97 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.059 -0.519 . . . . 2.1600000000000001 110.212 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -79.4 25.16 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.839 -0.619 . . . . 2.2400000000000002 112.437 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 46.22 66.39 0.97 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.199 0.6 . . . . 2.6099999999999999 111.87 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.81 73.26 7.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 1.24 110.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.87 -43.0 5.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.056 -0.52 . . . . 0.95999999999999996 110.733 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 140.31 37.29 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.959 -0.564 . . . . 1.21 110.326 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.05 -31.54 83.02 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.679 2.253 . . . . 0.97999999999999998 111.862 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.76 -44.55 89.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.763 -0.653 . . . . 2.6200000000000001 110.305 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -37.34 80.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.816 -0.629 . . . . 2.5099999999999998 110.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.7 mtt -69.62 -55.09 11.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.235 -0.893 . . . . 0.93999999999999995 110.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -57.47 -44.87 85.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.95999999999999996 112.657 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.53 -34.33 78.0 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.864 -0.334 . . . . 1.8300000000000001 111.092 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.48 -41.24 61.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.783 -0.451 . . . . 1.52 109.783 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.62 -31.9 73.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.675 . . . . 0.98999999999999999 111.143 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.29 -21.01 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.175 -0.466 . . . . 1.25 110.547 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.34 -1.59 90.13 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 112.863 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -125.47 2.34 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.228 0.514 . . . . 2.9500000000000002 111.359 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.37 58.85 0.81 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.537 -0.84 . . . . 1.47 113.357 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.17 126.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 1.2 109.165 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.724 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 28.1 t0 -72.17 117.55 13.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 1.5600000000000001 110.78 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.541 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 27.7 ttmt -61.66 -32.08 72.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.245 -0.889 . . . . 1.5700000000000001 110.818 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -66.87 -53.88 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.29 111.037 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.724 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 39.2 mmtm -61.94 -42.39 99.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 121.147 -0.221 . . . . 2.6099999999999999 110.636 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 80.9 t80 -57.63 -56.24 24.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 1.4399999999999999 111.162 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.56 -36.83 85.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.28 . . . . 1.1299999999999999 111.254 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.63 -55.81 23.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.45 -0.341 . . . . 1.46 111.395 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 124' ' ' LYS . 14.6 t -73.01 -23.04 60.58 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.956 0.354 . . . . 1.53 111.956 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -63.97 -27.41 69.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 1.53 110.37 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -102.23 1.84 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.886 -0.597 . . . . 1.6100000000000001 110.936 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 47.0 m -82.2 153.26 26.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 1.49 110.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.74 -24.21 66.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.864 -0.607 . . . . 1.3999999999999999 110.977 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.32 -43.43 64.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.47 . . . . 0.92000000000000004 111.649 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.1 mm -79.61 -38.91 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.01 0.433 . . . . 1.1899999999999999 110.135 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.657 . . . . 1.8999999999999999 111.136 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.66 95.17 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.123 -0.56 . . . . 0.75 112.548 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -75.6 -28.15 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 1.6699999999999999 110.273 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.3 mmm -63.02 -53.28 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.765 -0.652 . . . . 1.8500000000000001 110.593 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.1 -30.88 70.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.39 . . . . 2.0299999999999998 110.528 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -62.44 -41.59 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.139 -0.482 . . . . 3.0800000000000001 110.366 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.48 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.268 -0.424 . . . . 0.34999999999999998 110.939 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.6 -49.12 78.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.6899999999999999 110.995 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -66.02 -24.88 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 2.1000000000000001 111.221 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.86 -36.43 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.56000000000000005 110.54 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.92 -44.53 86.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 111.221 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 20.6 ptp -80.16 -14.8 58.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 2.5699999999999998 110.737 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.79 -31.76 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.42999999999999999 110.082 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.514 ' HB3' HG21 ' A' ' 157' ' ' VAL . 18.0 m-85 -80.54 5.07 16.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.681 -0.69 . . . . 0.63 110.012 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.467 ' HG3' ' HB3' ' A' ' 15' ' ' LEU . 16.2 mm-40 58.58 35.03 24.32 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.148 -0.933 . . . . 1.4099999999999999 111.995 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.37 126.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.158 -0.474 . . . . 1.26 109.726 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.14 35.34 4.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.916 0.389 . . . . 1.25 111.853 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 157.87 179.18 32.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.551 -0.833 . . . . 0.68999999999999995 112.211 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.4 143.53 41.62 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.538 0.209 . . . . 0.64000000000000001 110.6 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.549 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 84.6 Cg_endo -81.66 166.93 71.55 Favored 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 123.201 -1.583 . . . . 0.66000000000000003 112.378 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -156.73 133.09 9.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 110.223 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.66 132.71 56.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.731 -0.47 . . . . 0.92000000000000004 109.731 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 148' ' ' TYR . 24.8 t -122.83 128.79 75.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.387 -0.37 . . . . 0.40000000000000002 110.037 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 29' ' ' VAL . 68.9 t -106.5 116.61 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.58999999999999997 111.203 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 54.42 26.86 7.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.452 -0.795 . . . . 1.0800000000000001 112.842 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.98 29.62 62.4 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.014 -0.539 . . . . 0.48999999999999999 114.227 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -120.59 -56.11 1.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.306 0.574 . . . . 1.72 111.228 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.31 137.11 42.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.739 -0.664 . . . . 1.5 110.524 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -120.96 133.7 55.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.234 -0.439 . . . . 1.6599999999999999 110.383 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' HE1' HG23 ' A' ' 158' ' ' VAL . 25.9 p90 -149.02 170.02 19.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.172 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.6 176.54 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.564 -0.532 . . . . 1.3500000000000001 109.564 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.453 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 88.2 mt -56.15 -41.34 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 123.542 0.526 . . . . 0.68999999999999995 111.174 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.28 -47.38 58.7 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.002 -0.618 . . . . 0.72999999999999998 112.495 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.1 m -60.67 -43.54 97.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 110.978 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.14 -38.5 72.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.5 . . . . 0.71999999999999997 110.912 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 123.48 -32.12 4.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.734 -0.746 . . . . 1.1000000000000001 112.258 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.33 171.53 41.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.062 -0.589 . . . . 0.72999999999999998 112.055 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -54.71 -52.84 7.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.652 . . . . 0.84999999999999998 112.315 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.08 -37.27 82.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.871 -0.604 . . . . 2.52 110.795 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.38 -29.73 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 1.8200000000000001 110.593 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 166' ' ' ILE . 9.2 m -64.85 -38.68 91.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 0.62 109.923 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.99 -32.75 73.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.72999999999999998 110.159 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -61.97 -51.73 66.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 2.3399999999999999 110.463 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -61.9 -42.22 98.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 0.69999999999999996 110.682 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.86 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.65000000000000002 111.039 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.51 -42.2 98.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.554 . . . . 1.9099999999999999 110.691 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -62.57 -45.32 93.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 1.8200000000000001 111.185 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.19 -31.11 72.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 0.75 111.062 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 179' ' ' ALA . 77.7 mt -61.36 -44.07 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.237 -0.653 . . . . 0.77000000000000002 109.237 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.98 -41.21 91.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.52 -0.764 . . . . 2.1699999999999999 110.389 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -56.97 -49.46 75.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 2.4100000000000001 111.172 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -74.11 -40.24 62.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 1.6399999999999999 111.585 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -62.8 -33.73 75.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.566 -0.288 . . . . 1.72 110.815 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -65.97 -33.14 75.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 1.1299999999999999 111.73 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.87 -24.44 62.18 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.044 0.387 . . . . 1.1699999999999999 112.044 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.75 37.21 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 1.8400000000000001 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 19.6 tptm -86.22 65.91 9.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.173 -0.467 . . . . 6.4299999999999997 110.478 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.101 -0.952 . . . . 7.3200000000000003 110.646 -179.694 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.869 -0.492 . . . . 2.2000000000000002 111.869 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.69 104.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.21 0.604 . . . . 2.1299999999999999 111.319 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -128.77 6.52 5.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.335 0.588 . . . . 1.97 110.763 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -117.33 128.86 55.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.903 -0.589 . . . . 1.2 109.811 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 145.06 29.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.968 0.413 . . . . 1.29 112.019 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.52 131.84 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 1.03 110.116 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.63 -3.65 86.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.436 -0.887 . . . . 1.1399999999999999 111.509 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG2' ' OE2' ' A' ' 11' ' ' GLU . 47.4 tttm -119.07 -52.0 2.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.43 -0.581 . . . . 1.8899999999999999 109.43 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' OE2' ' HG2' ' A' ' 10' ' ' LYS . 4.3 mp0 -101.57 -48.4 4.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 1.55 110.635 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -130.02 159.41 36.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.165 -0.47 . . . . 1.03 110.49 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.31 122.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.289 -0.414 . . . . 0.91000000000000003 110.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -112.31 124.09 51.72 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.339 -0.615 . . . . 1.8200000000000001 109.339 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -92.34 145.86 24.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.986 0.422 . . . . 1.04 111.023 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -75.32 -11.48 60.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.95 -0.568 . . . . 1.54 111.183 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.81 77.67 22.21 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.474 -0.33 . . . . 1.28 110.752 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.4 156.23 62.13 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.215 1.943 . . . . 0.90000000000000002 111.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.86 121.66 39.09 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.208 -0.451 . . . . 0.81000000000000005 110.189 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.78 133.0 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.224 1.949 . . . . 1.0900000000000001 111.786 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.96 153.51 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.052 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -25.55 59.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 1.6399999999999999 111.539 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -142.76 126.09 9.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.533 -0.303 . . . . 3.3300000000000001 110.787 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.22 -174.92 2.15 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.397 2.065 . . . . 1.6599999999999999 111.574 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -87.36 0.61 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.343 -0.932 . . . . 0.94999999999999996 111.652 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -81.6 141.13 34.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.935 -0.395 . . . . 2.4700000000000002 109.935 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.498 HG13 HG23 ' A' ' 183' ' ' ILE . 48.3 mm -70.79 111.47 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.352 -0.61 . . . . 0.70999999999999996 109.352 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.95 114.44 15.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.731 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.99 102.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.55000000000000004 109.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.01 123.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.958 -0.565 . . . . 0.69999999999999996 110.644 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -115.84 136.25 53.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.343 -0.614 . . . . 2.4300000000000002 109.343 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.8 mp -115.52 130.69 56.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.923 0.392 . . . . 0.85999999999999999 110.447 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -127.4 172.58 10.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 1.3999999999999999 111.202 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -141.03 167.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.686 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -91.45 -13.11 32.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.802 0.297 . . . . 4.8099999999999996 111.802 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.9 1.41 31.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.184 -1.008 . . . . 1.6200000000000001 113.824 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 p -87.43 120.62 71.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.206 0.503 . . . . 0.93000000000000005 110.776 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.66 -39.17 5.01 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.734 2.29 . . . . 1.1000000000000001 112.88 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -62.96 -27.56 69.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.218 -0.446 . . . . 1.47 112.162 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.5 m -63.41 -40.08 96.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 0.93999999999999995 110.961 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' OH ' ' HE3' ' A' ' 100' ' ' LYS . 10.8 t80 -68.18 -22.27 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 2.6299999999999999 111.308 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.04 -7.15 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.034 0.445 . . . . 0.97999999999999998 111.196 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 166' ' ' ILE . 9.1 t80 -104.15 -21.61 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.76000000000000001 111.241 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 14.2 mm-40 -50.98 -55.12 30.36 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.797 0.666 . . . . 2.6899999999999999 112.797 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 37.0 Cg_endo -65.15 -2.32 5.6 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.199 1.933 . . . . 0.81000000000000005 113.263 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.42 HG22 HD11 ' A' ' 176' ' ' LEU . 0.2 OUTLIER -110.81 -36.01 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.293 . . . . 0.70999999999999996 111.577 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 tp -84.08 -33.6 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.029 0.381 . . . . 0.83999999999999997 112.029 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -55.52 45.0 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 112.191 0.441 . . . . 0.94999999999999996 112.191 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.42 1.64 4.04 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.87 1.713 . . . . 0.94999999999999996 113.003 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -107.81 -43.11 4.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.81999999999999995 110.772 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -65.9 -32.08 73.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.982 0.42 . . . . 1.22 111.311 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.57 2.27 42.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 2.1400000000000001 110.63 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -124.09 21.48 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.223 0.535 . . . . 2.0899999999999999 110.02 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.83 137.35 40.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.81000000000000005 110.433 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 57' ' ' ASP . 20.9 Cg_endo -62.69 165.17 16.5 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.792 2.328 . . . . 0.98999999999999999 112.895 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.95 24.12 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.321 0.582 . . . . 1.1399999999999999 111.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 55' ' ' PRO . 5.3 t0 -121.84 -0.48 9.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.581 0.705 . . . . 1.6499999999999999 109.81 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 t -124.82 141.16 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.456 -0.793 . . . . 0.68000000000000005 110.18 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -119.5 117.99 29.88 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.115 -0.698 . . . . 1.27 109.115 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -105.72 124.29 49.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.86 0.362 . . . . 1.3899999999999999 111.445 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.2 t -130.88 125.04 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 0.69999999999999996 109.843 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 11.5 ttt180 -107.3 119.69 40.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.708 -0.479 . . . . 4.2300000000000004 109.708 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.7 mt -121.22 151.34 55.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.60999999999999999 110.732 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.7 141.72 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.288 1.992 . . . . 0.48999999999999999 111.97 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -78.47 94.3 4.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.969 0.414 . . . . 0.45000000000000001 110.668 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 72' ' ' ASN . 21.7 mt -84.03 87.2 7.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.268 -0.423 . . . . 0.53000000000000003 110.844 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' HB2' ' CG ' ' A' ' 71' ' ' TRP . 3.8 m-30 -84.16 -4.53 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 1.71 111.232 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.56 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.246 -0.978 . . . . 1.3899999999999999 114.139 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.75 -131.37 0.44 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.009 -0.615 . . . . 1.24 113.835 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.64 -22.45 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.02 0.438 . . . . 1.1599999999999999 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.573 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 37.8 m95 -57.66 -42.84 84.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.732 -0.667 . . . . 0.78000000000000003 110.7 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 66' ' ' LEU . 7.4 t30 -71.59 -46.46 59.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 1.99 111.259 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 t -60.57 -33.7 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.89000000000000001 111.012 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -89.1 5.73 43.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.426 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 -27.08 2.81 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.823 -0.703 . . . . 0.66000000000000003 111.73 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.11 -35.34 78.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.967 0.413 . . . . 2.1200000000000001 110.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 2.0 ttm -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 110.764 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.39 -46.86 82.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 1.0600000000000001 110.777 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.63 110.786 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -64.35 -43.51 94.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.945 -0.571 . . . . 0.68999999999999995 110.758 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 77' ' ' MET . 90.8 mt -61.74 -47.9 83.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 1.6899999999999999 110.905 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.94 -30.61 70.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 2.1899999999999999 111.322 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m -87.15 -3.89 59.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 1.26 111.461 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.0 mtp -107.65 -3.45 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 1.7 111.41 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.47 0.77 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.604 -0.807 . . . . 2.2000000000000002 112.06 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.5 p 39.95 92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.474 1.11 . . . . 2.3599999999999999 113.333 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.15 137.93 45.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.288 -0.869 . . . . 5.2800000000000002 110.728 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 9.6 m-70 -65.57 -17.11 64.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 5.2599999999999998 111.502 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.34 -34.44 76.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.768 0.318 . . . . 5.4500000000000002 111.043 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.74 24.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.152 0.427 . . . . 3.7599999999999998 112.152 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 88' ' ' HIS . 5.8 p-80 -71.69 -20.02 61.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.87 0.322 . . . . 4.2599999999999998 111.87 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 65.2 t30 -100.2 -25.52 14.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.62 0.248 . . . . 2.8799999999999999 110.631 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.41 -36.48 66.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.92 -0.582 . . . . 1.71 112.094 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.21 -41.67 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.162 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -72.34 -37.02 68.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 3.2999999999999998 110.71 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 5.0 mm-40 -65.13 -36.28 83.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.102 0.477 . . . . 2.6099999999999999 110.479 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.57 59.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 1.6699999999999999 111.59 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.54 -43.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 111.819 0.303 . . . . 1.9099999999999999 111.819 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.71 -50.37 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.643 0.609 . . . . 2.21 112.643 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HE3' ' OH ' ' A' ' 41' ' ' TYR . 85.4 mttt -72.42 -65.02 0.83 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 2.73 111.289 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.13 -45.21 50.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 2.5899999999999999 111.383 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 t60 59.59 65.17 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 2.1600000000000001 109.473 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -75.46 9.33 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.402 -0.817 . . . . 2.2400000000000002 112.664 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp 58.98 41.01 21.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.478 0.656 . . . . 2.6099999999999999 110.558 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.4 mt -77.99 76.24 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 1.24 110.475 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.06 -39.67 9.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 110.612 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 111' ' ' MET . 1.1 p -95.7 146.44 31.32 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 1.21 110.948 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' SD ' ' A' ' 111' ' ' MET . 9.6 Cg_endo -54.91 -37.59 93.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.06 2.507 . . . . 0.97999999999999998 112.545 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -62.07 -45.33 93.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.234 -0.439 . . . . 2.6200000000000001 110.065 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.35 -39.43 93.87 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 2.5099999999999998 109.402 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 107' ' ' THR . 52.1 mtt -60.08 -56.69 18.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.93999999999999995 110.204 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . . . -61.35 -30.09 70.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 111.33 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -35.3 78.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 1.8300000000000001 110.883 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -90.88 -40.69 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.28 -0.418 . . . . 1.52 110.478 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 120' ' ' VAL . 83.1 mt -63.73 -24.14 67.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.98999999999999999 111.685 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.67 -34.89 69.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 1.25 111.177 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.92 -12.1 84.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.812 -0.708 . . . . 1.6100000000000001 112.214 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -97.09 -2.67 42.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 2.9500000000000002 110.488 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.42 -17.39 26.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.756 -0.735 . . . . 1.47 112.799 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 115' ' ' LEU . 61.9 t -69.03 112.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.227 0.537 . . . . 1.2 110.534 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 14.8 t70 -68.52 128.7 37.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.477 -0.783 . . . . 1.5600000000000001 110.927 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -67.15 -34.72 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 1.5700000000000001 111.32 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 mm-40 -59.18 -57.06 14.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.788 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -64.24 -39.52 94.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 2.6099999999999999 111.18 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 78.4 t80 -58.46 -57.36 13.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 1.4399999999999999 111.853 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.41 -38.33 86.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 1.1299999999999999 111.52 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.8 t -64.41 -46.56 82.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 1.46 111.345 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.5 m -76.31 -38.04 56.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.499 -0.319 . . . . 1.53 111.836 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -52.79 -50.49 63.49 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.87 0.367 . . . . 1.53 111.216 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.13 53.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 1.6100000000000001 110.123 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -132.27 161.7 32.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 1.49 110.307 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -21.05 66.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.232 -0.44 . . . . 1.3999999999999999 110.716 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.98 69.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.118 0.485 . . . . 0.92000000000000004 111.021 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.74 -36.72 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.203 -0.453 . . . . 1.1899999999999999 109.908 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -58.03 -37.82 75.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.968 -0.56 . . . . 1.8999999999999999 110.977 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.88 -24.27 77.21 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.155 -0.545 . . . . 0.75 112.43 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -86.77 -29.82 22.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.101 0.476 . . . . 1.6699999999999999 110.654 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.3 -46.87 84.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 1.8500000000000001 111.615 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.398 -0.365 . . . . 2.0299999999999998 111.309 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 95.6 mttt -68.33 -45.61 72.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.338 -0.392 . . . . 3.0800000000000001 111.048 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.46 73.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.444 . . . . 0.34999999999999998 111.255 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.24 -47.38 86.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 1.6899999999999999 111.793 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.21 -28.51 68.14 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.061 -0.256 . . . . 2.1000000000000001 111.324 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.1 mt -73.12 -39.15 65.98 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.08 -0.248 . . . . 0.56000000000000005 110.756 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.56 93.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.48999999999999999 111.14 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.1 ptm -75.68 -26.64 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 2.5699999999999998 111.196 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.68 -39.83 56.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.678 0.275 . . . . 0.42999999999999999 111.197 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.95 4.62 28.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.63 111.215 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 57.9 43.61 21.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.886 -0.597 . . . . 1.4099999999999999 111.601 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.97 109.75 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.359 . . . . 1.26 110.066 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 3.32 11.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.075 -0.511 . . . . 1.25 111.565 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.96 175.23 25.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.922 -0.656 . . . . 0.68999999999999995 111.88 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.69 132.65 9.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.689 0.281 . . . . 0.64000000000000001 110.491 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.57 175.81 46.2 Favored 'Cis proline' 0 C--O 1.236 0.383 0 C-N-CA 123.212 -1.578 . . . . 0.66000000000000003 112.294 0.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.2 m -159.48 118.4 2.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.908 0.385 . . . . 0.56999999999999995 110.368 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 80.7 mtp -100.99 128.53 46.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.069 -0.514 . . . . 0.92000000000000004 110.531 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -116.33 119.58 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.40000000000000002 110.094 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.66 117.9 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.58999999999999997 111.351 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.1 t30 59.55 15.79 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.935 -1.03 . . . . 1.0800000000000001 112.485 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.54 13.89 63.85 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.204 -0.522 . . . . 0.48999999999999999 113.642 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.42 -38.95 4.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.449 -0.442 . . . . 1.72 111.426 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.5 140.47 48.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.369 -0.378 . . . . 1.5 110.544 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -128.99 130.04 46.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.942 -0.572 . . . . 1.6599999999999999 110.094 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -149.59 172.18 15.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.497 -0.32 . . . . 0.63 110.252 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.85 -178.26 6.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.98 -0.555 . . . . 1.3500000000000001 109.521 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 43' ' ' PHE . 53.0 mt -57.3 -41.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.472 0.482 . . . . 0.68999999999999995 110.995 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.72 -45.8 72.96 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.083 -0.58 . . . . 0.72999999999999998 112.604 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 m -61.75 -45.07 95.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.693 0.282 . . . . 1.1499999999999999 110.698 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.97 68.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.71999999999999997 111.268 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 118.96 -38.73 2.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.983 -0.627 . . . . 1.1000000000000001 112.033 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.03 158.77 27.81 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.066 -0.588 . . . . 0.72999999999999998 111.749 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.82 -44.71 42.36 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.138 2.559 . . . . 0.84999999999999998 112.532 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.92 -32.38 71.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 2.52 110.212 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.35 -29.09 66.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.922 -0.581 . . . . 1.8200000000000001 110.029 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.1 m -62.0 -37.55 85.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.689 . . . . 0.62 110.426 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD11 HG22 ' A' ' 46' ' ' THR . 77.8 mt -65.54 -33.67 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 0.72999999999999998 110.798 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.2 -47.4 79.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.209 0.528 . . . . 2.3399999999999999 110.742 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 178' ' ' LEU . 3.4 mm? -61.83 -43.12 99.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.69999999999999996 110.568 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.41 -47.93 83.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.65000000000000002 110.96 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.97 -47.46 84.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 1.9099999999999999 111.218 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -62.22 -40.82 97.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.161 -0.472 . . . . 1.8200000000000001 111.494 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.46 -28.77 68.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.58 0.229 . . . . 0.75 111.122 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 27' ' ' ILE . 58.7 mt -62.3 -43.66 98.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.842 -0.799 . . . . 0.77000000000000002 108.842 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.52 -35.46 73.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.466 -0.788 . . . . 2.1699999999999999 110.522 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -62.29 -46.38 89.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.531 -0.759 . . . . 2.4100000000000001 110.627 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -76.78 -20.78 56.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.994 -0.548 . . . . 1.6399999999999999 111.175 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 187' ' ' ARG . 6.4 tpm_? -65.66 -29.21 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.583 -0.525 . . . . 1.72 109.583 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.31 -13.26 60.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.641 . . . . 1.1299999999999999 111.717 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.34 66.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.101 0.477 . . . . 1.1699999999999999 110.395 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.68 -31.44 7.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.693 -0.685 . . . . 1.8400000000000001 110.435 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 61.67 63.41 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.62 -0.718 . . . . 6.4299999999999997 111.221 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.5 mptt . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.432 -0.804 . . . . 7.3200000000000003 111.045 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.963 -0.455 . . . . 2.2000000000000002 111.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.93 109.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.301 0.64 . . . . 2.1299999999999999 110.538 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.48 2.07 3.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.998 -0.546 . . . . 1.97 111.801 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -129.53 175.81 8.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 1.2 111.004 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.69 123.59 37.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.154 -0.476 . . . . 1.29 110.727 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.05 18.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.029 -0.532 . . . . 1.03 110.206 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.39 -14.15 51.06 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.458 -0.657 . . . . 1.1399999999999999 111.458 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -105.0 -80.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.48 -0.192 . . . . 1.8899999999999999 110.48 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' SER . 14.4 mp0 -68.36 -39.96 81.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.55 110.986 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -135.45 144.96 46.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.484 -0.326 . . . . 1.03 110.345 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.69 126.86 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.824 0.345 . . . . 0.91000000000000003 110.46 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -102.6 126.48 49.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 109.984 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.01 143.53 28.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.337 -0.392 . . . . 1.04 110.297 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 50.1 m -80.92 -8.32 59.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.447 -0.342 . . . . 1.54 111.277 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 83.28 8.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.462 -0.57 . . . . 1.28 109.462 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 16' ' ' SER . 4.5 Cg_exo -78.87 156.16 27.0 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.815 2.343 . . . . 0.90000000000000002 113.053 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.09 132.64 22.61 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.396 -0.82 . . . . 0.81000000000000005 109.752 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -64.88 146.89 88.91 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.336 2.024 . . . . 1.0900000000000001 111.902 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.37 170.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.302 -0.408 . . . . 1.05 111.14 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.64 -36.84 12.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.299 -0.409 . . . . 1.6399999999999999 110.946 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' NE2' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -131.7 105.08 14.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 3.3300000000000001 110.941 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 13.8 Cg_exo -70.21 106.2 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.781 2.321 . . . . 1.6599999999999999 111.928 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.74 -45.21 0.63 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.12 -0.792 . . . . 0.94999999999999996 111.12 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -105.02 140.13 38.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.221 -0.659 . . . . 2.4700000000000002 109.221 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -74.77 121.18 25.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.752 0.31 . . . . 0.70999999999999996 110.887 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' NE2' ' A' ' 23' ' ' GLN . 6.0 mt-10 -87.32 99.54 12.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 2.6899999999999999 110.162 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.81 106.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.631 . . . . 0.55000000000000004 109.714 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.6 124.27 57.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.237 -0.438 . . . . 0.69999999999999996 111.102 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.56 130.83 54.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.879 -0.785 . . . . 2.4300000000000002 108.879 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -109.18 113.29 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 0.85999999999999999 110.82 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -115.24 172.67 6.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.465 -0.789 . . . . 1.3999999999999999 110.214 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 3.2 t90 -147.74 164.51 33.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.98 0.419 . . . . 1.1599999999999999 110.341 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -79.25 -13.14 59.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 4.8099999999999996 111.276 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.62 17.46 23.23 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.256 -0.974 . . . . 1.6200000000000001 114.544 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.9 p -108.77 105.0 56.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 117.817 0.808 . . . . 0.93000000000000005 110.366 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.72 -28.24 60.14 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.505 2.137 . . . . 1.1000000000000001 112.905 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -22.24 63.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.446 -0.343 . . . . 1.47 111.193 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 64.6 m -70.32 -37.88 74.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 0.93999999999999995 110.782 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -68.29 -38.26 81.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 2.6299999999999999 110.886 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -12.87 61.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.97999999999999998 111.31 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -92.71 -18.24 23.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.407 -0.36 . . . . 0.76000000000000001 111.074 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -50.84 -60.19 6.0 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.465 0.542 . . . . 2.6899999999999999 112.465 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 3.88 2.55 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.918 1.746 . . . . 0.81000000000000005 113.157 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -108.97 -30.96 7.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.337 -0.392 . . . . 0.70999999999999996 110.876 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.9 tt -94.05 -30.11 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.861 0.319 . . . . 0.83999999999999997 111.861 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 47.6 t -54.55 -56.22 29.33 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.47 0.544 . . . . 0.94999999999999996 112.47 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.1 Cg_endo -56.84 -32.18 91.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.106 1.87 . . . . 0.94999999999999996 112.832 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.454 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 77.2 t90 -78.22 -48.36 15.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.28 -0.418 . . . . 0.81999999999999995 110.71 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -64.36 -37.72 88.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.351 0.5 . . . . 1.22 112.351 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.64 -9.24 58.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.716 0.293 . . . . 2.1400000000000001 111.281 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -118.47 34.7 5.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 2.0899999999999999 110.787 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 50' ' ' TRP . 41.2 mt -95.33 147.92 33.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.917 -0.583 . . . . 0.81000000000000005 111.121 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.62 172.91 10.7 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.48 2.12 . . . . 0.98999999999999999 112.264 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 2.94 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 1.1399999999999999 111.864 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.11 -5.19 41.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 1.6499999999999999 111.045 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.01 128.38 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.097 0.475 . . . . 0.68000000000000005 111.606 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -113.2 103.05 10.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.058 -0.719 . . . . 1.27 109.058 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -86.43 132.13 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.176 -0.465 . . . . 1.3899999999999999 111.374 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.97 116.22 36.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.576 -0.738 . . . . 0.69999999999999996 109.94 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -99.28 122.82 42.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.796 -0.446 . . . . 4.2300000000000004 109.796 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 69.0 mt -138.09 151.61 70.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 0.60999999999999999 111.209 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.8 150.44 11.22 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.578 2.186 . . . . 0.48999999999999999 111.668 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.26 93.49 4.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.45000000000000001 110.883 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mt -92.26 92.58 8.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.044 -0.525 . . . . 0.53000000000000003 110.329 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -118.13 37.43 4.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.849 0.357 . . . . 1.71 111.723 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.01 -165.02 46.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.542 -0.837 . . . . 1.3899999999999999 112.227 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.55 -122.72 16.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.659 -0.305 . . . . 1.24 112.67 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.08 -5.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 1.1599999999999999 109.947 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' ' 34' ' ' TRP . 39.8 m95 -60.21 -49.39 77.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.675 -0.693 . . . . 0.78000000000000003 110.622 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -66.86 -36.37 82.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 1.99 111.31 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.77 -38.59 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.89000000000000001 109.901 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -89.48 43.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.531 -0.759 . . . . 1.46 110.073 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.22 -35.13 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.878 -0.677 . . . . 0.66000000000000003 112.878 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.03 -33.76 62.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.851 0.358 . . . . 2.1200000000000001 111.543 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.2 ttt -53.64 -39.28 64.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 1.4299999999999999 111.49 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.61 -51.17 68.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 111.378 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.83 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.63 111.158 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' THR . 25.5 m -62.35 -39.91 94.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.68999999999999995 110.681 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.36 -46.6 76.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 1.6899999999999999 110.864 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -60.13 -39.85 87.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 2.1899999999999999 111.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -62.86 -18.13 62.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.415 0.524 . . . . 1.26 112.415 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.0 -16.05 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.915 0.388 . . . . 1.7 110.482 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.25 82.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.848 -0.691 . . . . 2.2000000000000002 113.197 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 m -82.66 144.04 10.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 110.776 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.27 154.93 48.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.274 -0.421 . . . . 5.2800000000000002 110.484 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.4 m80 56.06 41.45 29.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.004 -0.544 . . . . 5.2599999999999998 111.524 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.74 2.35 41.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 5.4500000000000002 110.147 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.5 t 68.92 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.315 -0.857 . . . . 3.7599999999999998 110.246 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.81 -22.05 54.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 4.2599999999999998 110.431 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.21 -35.31 75.12 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.671 -0.695 . . . . 2.8799999999999999 111.546 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.76 71.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 1.71 111.19 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -43.41 81.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 1.7 110.052 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.32 -34.1 75.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 3.2999999999999998 110.372 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.55 -42.65 86.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 2.6099999999999999 110.833 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.63 -22.35 66.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.113 0.482 . . . . 1.6699999999999999 111.387 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 72.0 mt -88.1 -39.56 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.16 -0.473 . . . . 1.9099999999999999 111.572 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -96.04 -53.71 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.278 0.844 . . . . 2.21 113.278 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -68.69 -51.46 41.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.73 0.3 . . . . 2.73 111.105 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -83.71 -43.28 15.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 2.5899999999999999 111.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 1.7 t-80 60.5 60.01 2.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.216 0.531 . . . . 2.1600000000000001 109.86 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -77.03 13.15 1.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.46 -0.791 . . . . 2.2400000000000002 112.897 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 54.55 58.0 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.306 0.574 . . . . 2.6099999999999999 110.505 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.22 84.81 4.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.138 0.494 . . . . 1.24 110.464 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.44 -41.93 2.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.95999999999999996 110.572 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 141.25 42.49 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.908 -0.587 . . . . 1.21 110.743 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.26 -34.69 94.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.482 2.121 . . . . 0.97999999999999998 111.237 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 29.1 mt-10 -63.76 -42.15 97.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.439 -0.801 . . . . 2.6200000000000001 110.332 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -40.41 95.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.081 -0.509 . . . . 2.5099999999999998 110.287 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.6 mtt -69.26 -55.77 9.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.165 -0.925 . . . . 0.93999999999999995 111.091 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.603 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -58.66 -42.28 88.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 0.95999999999999996 112.706 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -62.33 -35.13 78.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 1.8300000000000001 111.534 -179.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.36 -43.57 18.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.057 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.21 -35.36 75.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.297 -0.411 . . . . 0.98999999999999999 111.555 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -61.5 -24.84 66.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 1.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -11.49 85.22 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.042 -0.599 . . . . 1.6100000000000001 113.386 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -109.8 -15.67 14.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.575 0.688 . . . . 2.9500000000000002 111.885 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.06 40.27 0.26 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.132 -1.032 . . . . 1.47 113.487 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 88.0 t -126.55 130.05 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.556 -0.535 . . . . 1.2 109.556 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.729 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 20.7 t0 -75.49 123.8 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 1.5600000000000001 110.593 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.603 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 23.4 ttmt -62.84 -34.09 76.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.283 -0.871 . . . . 1.5700000000000001 111.058 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.21 -49.24 65.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.397 -0.365 . . . . 2.29 111.091 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.729 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 45.6 mmtm -62.03 -43.94 97.76 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 2.6099999999999999 110.677 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 77.7 t80 -55.02 -59.97 4.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 1.4399999999999999 111.276 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.45 -0.341 . . . . 1.1299999999999999 111.863 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 t -62.08 -55.84 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.459 -0.337 . . . . 1.46 111.007 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 80' ' ' THR . 7.3 t -76.54 -20.18 57.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.796 -0.362 . . . . 1.53 111.859 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -62.69 -37.52 86.77 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.266 0.555 . . . . 1.53 110.115 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -103.0 32.82 3.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.505 -0.771 . . . . 1.6100000000000001 110.328 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.5 m -108.6 153.85 22.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.04 0.448 . . . . 1.49 111.396 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -67.72 -24.75 65.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.704 -0.68 . . . . 1.3999999999999999 110.62 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.34 -44.47 75.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 111.379 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.81 -37.09 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 110.094 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -58.03 -41.94 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 1.8999999999999999 110.653 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.75 -25.63 71.82 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.18 -0.533 . . . . 0.75 112.672 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.33 -35.93 24.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 1.6699999999999999 110.146 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mmm -61.08 -50.39 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.614 -0.721 . . . . 1.8500000000000001 111.281 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -66.62 -36.59 82.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 2.0299999999999998 110.985 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -63.19 -37.87 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 3.0800000000000001 110.816 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.68 26.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.34999999999999998 110.971 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.22 -46.32 88.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.214 -0.448 . . . . 1.6899999999999999 111.837 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -65.71 -31.72 72.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 2.1000000000000001 111.125 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.0 mt -77.06 -39.37 50.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.726 0.298 . . . . 0.56000000000000005 110.437 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.49 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.48999999999999999 111.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -71.63 -25.15 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 2.5699999999999998 111.068 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.57 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.42999999999999999 110.892 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -80.55 2.38 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.63 110.97 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 61.87 29.43 17.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.96 114.32 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.412 . . . . 1.26 110.313 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.66 27.54 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 1.25 111.042 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.32 170.18 42.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.866 -0.683 . . . . 0.68999999999999995 112.177 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.58 143.16 28.52 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.575 0.226 . . . . 0.64000000000000001 110.604 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.465 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -77.95 166.83 79.99 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.277 -1.551 . . . . 0.66000000000000003 112.492 0.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.3 m -156.84 137.42 13.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.368 -0.378 . . . . 0.56999999999999995 110.713 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.4 mtp -117.33 134.16 55.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 0.92000000000000004 109.448 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -122.17 127.53 75.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.511 -0.313 . . . . 0.40000000000000002 110.476 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.88 118.05 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.304 -0.407 . . . . 0.58999999999999997 111.153 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 58.55 17.2 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.193 -0.912 . . . . 1.0800000000000001 112.92 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.03 27.24 64.49 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.225 -0.512 . . . . 0.48999999999999999 113.093 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -124.27 -32.86 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.985 0.421 . . . . 1.72 110.857 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -121.58 132.04 54.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 1.5 110.073 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -120.45 126.21 49.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 110.097 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -141.09 169.37 17.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.457 -0.338 . . . . 0.63 110.421 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -160.98 -177.46 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.144 -0.48 . . . . 1.3500000000000001 109.764 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.2 -40.58 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.68999999999999995 111.888 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.87 -45.55 63.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.795 -0.717 . . . . 0.72999999999999998 112.501 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' GLU . 32.9 m -63.82 -47.51 80.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.726 0.298 . . . . 1.1499999999999999 110.735 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.71999999999999997 111.264 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 125.54 -38.54 2.25 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.985 -0.626 . . . . 1.1000000000000001 111.697 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.17 170.66 41.61 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.414 -0.675 . . . . 0.72999999999999998 111.414 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.55 -38.84 90.34 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.244 2.63 . . . . 0.84999999999999998 112.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -68.47 -36.06 78.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.001 -0.545 . . . . 2.52 110.392 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -72.98 -27.88 62.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 1.8200000000000001 110.766 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.6 m -60.44 -41.0 93.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 0.62 110.741 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.88 -37.52 84.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.72999999999999998 110.619 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -63.41 -44.17 95.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.826 -0.625 . . . . 2.3399999999999999 110.981 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.8 -40.66 88.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.69999999999999996 110.483 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.19 74.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 110.757 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.98 87.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.617 -0.72 . . . . 1.9099999999999999 111.005 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -62.6 -46.85 86.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.695 -0.684 . . . . 1.8200000000000001 111.526 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 0.75 111.158 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.49 -47.41 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.77000000000000002 109.898 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.72 -38.95 84.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.467 -0.788 . . . . 2.1699999999999999 110.454 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -57.54 -45.33 85.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 111.176 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -78.72 -39.05 37.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.207 -0.451 . . . . 1.6399999999999999 111.72 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.537 0.208 . . . . 1.72 111.079 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -75.5 -13.54 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1299999999999999 112.295 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.35 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 1.1699999999999999 111.211 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.06 38.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.161 0.505 . . . . 1.8400000000000001 110.141 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 17.3 tptm -86.16 54.21 3.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.441 . . . . 6.4299999999999997 110.943 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.4 pttp . . . . . 0 C--O 1.248 0.985 0 O-C-N 124.352 1.033 . . . . 7.3200000000000003 112.101 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.631 -0.588 . . . . 2.2000000000000002 111.631 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 65.1 168.74 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.279 0.632 . . . . 2.1299999999999999 111.28 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -165.77 9.58 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.213 -0.449 . . . . 1.97 111.321 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.64 159.14 40.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.901 0.381 . . . . 1.2 110.836 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 132.4 54.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.092 -0.504 . . . . 1.29 111.227 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.42 126.34 29.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.02 -0.536 . . . . 1.03 110.363 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.55 -21.74 41.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.769 -0.729 . . . . 1.1399999999999999 111.724 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -94.21 -57.94 2.37 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.28 -0.267 . . . . 1.8899999999999999 110.28 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -90.6 -50.67 5.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.988 0.423 . . . . 1.55 110.321 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -131.14 147.04 52.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.864 -0.607 . . . . 1.03 110.027 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.7 t -110.51 131.86 60.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.795 0.331 . . . . 0.91000000000000003 110.449 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.29 132.57 40.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.65 -0.5 . . . . 1.8200000000000001 109.65 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 3.0 mt -82.02 133.61 35.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.459 -0.337 . . . . 1.04 110.702 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -39.12 93.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.187 0.518 . . . . 1.54 109.882 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -109.48 96.3 22.27 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.15 -0.685 . . . . 1.28 109.15 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.7 154.61 34.76 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.709 2.273 . . . . 0.90000000000000002 112.964 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.3 t -112.45 126.99 27.44 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.027 -0.533 . . . . 0.81000000000000005 110.224 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.33 144.58 18.28 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.624 2.216 . . . . 1.0900000000000001 112.692 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.16 165.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 1.05 110.508 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -56.3 11.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 1.6399999999999999 111.214 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -118.88 130.5 24.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.434 -0.348 . . . . 3.3300000000000001 110.396 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -80.68 179.93 5.66 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.671 2.248 . . . . 1.6599999999999999 112.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.77 -48.68 1.08 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.788 -0.72 . . . . 0.94999999999999996 112.587 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.19 152.87 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.581 0.229 . . . . 2.4700000000000002 110.4 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.9 mm -87.77 133.85 29.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.307 -0.406 . . . . 0.70999999999999996 110.473 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -88.8 125.72 35.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 2.6899999999999999 111.677 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.5 105.33 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.558 -0.904 . . . . 0.55000000000000004 108.558 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.53 133.93 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.437 -0.347 . . . . 0.69999999999999996 111.779 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -119.19 119.27 33.63 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.306 -0.998 . . . . 2.4300000000000002 108.306 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -94.84 93.7 7.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.571 . . . . 0.85999999999999999 111.03 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -93.72 168.69 10.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.138 -0.937 . . . . 1.3999999999999999 110.503 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 2.1 t90 -145.09 163.81 33.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.098 -0.501 . . . . 1.1599999999999999 110.259 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -79.66 2.34 22.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 4.8099999999999996 111.197 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.49 15.88 6.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.299 -0.953 . . . . 1.6200000000000001 113.583 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 25.9 p -111.59 107.8 56.56 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 117.521 0.66 . . . . 0.93000000000000005 110.937 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -66.38 -31.08 43.78 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.16 . . . . 1.1000000000000001 111.957 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -30.16 70.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.62 -0.718 . . . . 1.47 111.126 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.88 -29.53 63.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.347 -0.388 . . . . 0.93999999999999995 111.182 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -71.39 -40.28 70.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.84 0.352 . . . . 2.6299999999999999 110.996 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.04 -9.7 58.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.052 0.453 . . . . 0.97999999999999998 111.327 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -89.59 -26.01 21.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.097 -0.501 . . . . 0.76000000000000001 110.855 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.06 -58.15 12.42 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.889 0.7 . . . . 2.6899999999999999 112.889 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.36 2.87 2.01 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.231 1.954 . . . . 0.81000000000000005 113.549 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.44 HG22 HD11 ' A' ' 176' ' ' LEU . 0.6 OUTLIER -115.8 -33.4 5.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.809 0.337 . . . . 0.70999999999999996 111.352 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 tt -85.92 -29.81 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 111.835 0.309 . . . . 0.83999999999999997 111.835 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 42.3 t -56.41 -55.62 40.54 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.571 0.582 . . . . 0.94999999999999996 112.571 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 18.5 Cg_endo -58.38 -22.59 59.13 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.352 2.035 . . . . 0.94999999999999996 112.89 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.7 t90 -86.99 -47.73 8.71 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.988 0.423 . . . . 0.81999999999999995 110.501 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.7 m -65.25 -41.18 94.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 1.22 112.165 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -79.7 10.05 4.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.706 0.289 . . . . 2.1400000000000001 111.704 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.43 6.91 6.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.04 0.448 . . . . 2.0899999999999999 110.181 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.55 147.15 86.88 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.772 -0.649 . . . . 0.81000000000000005 110.873 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 57' ' ' ASP . 57.7 Cg_endo -72.36 173.5 13.03 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.757 2.304 . . . . 0.98999999999999999 111.459 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.58 32.1 0.13 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 1.1399999999999999 111.516 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' HD2' ' A' ' 187' ' ' ARG . 4.6 t0 -125.04 -2.24 7.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.222 0.534 . . . . 1.6499999999999999 110.364 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.2 137.69 55.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.402 -0.817 . . . . 0.68000000000000005 109.769 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.91 121.52 26.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.873 0.368 . . . . 1.27 110.861 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -93.07 135.23 34.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 1.3899999999999999 110.292 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.64 137.63 52.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.851 0.357 . . . . 0.69999999999999996 110.552 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 62' ' ' ARG . 47.6 mtt180 -96.44 102.92 14.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.182 -0.463 . . . . 4.2300000000000004 109.879 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 81.7 mt -125.04 129.95 24.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.484 0.183 . . . . 0.60999999999999999 110.635 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.4 Cg_endo -84.57 160.57 12.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.442 2.095 . . . . 0.48999999999999999 112.068 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 83.01 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.233 0.54 . . . . 0.45000000000000001 110.973 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' A' ' 141' ' ' ALA . 20.6 mt -87.72 81.84 7.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.874 -0.603 . . . . 0.53000000000000003 110.965 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -112.66 46.15 1.23 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 1.71 111.209 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.35 -156.91 52.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.725 -0.75 . . . . 1.3899999999999999 112.112 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.08 -133.18 5.24 Favored Glycine 0 C--N 1.333 0.382 0 O-C-N 124.0 0.47 . . . . 1.24 113.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.61 -4.84 10.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.338 0.59 . . . . 1.1599999999999999 109.859 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 53.5 m95 -65.02 -53.93 38.22 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.246 -0.888 . . . . 0.78000000000000003 110.726 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -64.29 -30.15 71.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.94 -0.573 . . . . 1.99 111.111 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.03 -35.92 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.425 0.631 . . . . 0.89000000000000001 109.812 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -89.34 46.9 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.588 -0.733 . . . . 1.46 110.507 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.78 -31.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.263 -0.97 . . . . 0.66000000000000003 113.166 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.83 -35.09 61.06 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.342 . . . . 2.1200000000000001 111.53 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 8.7 ttt -54.3 -40.51 67.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.771 -0.65 . . . . 1.4299999999999999 111.52 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -48.96 72.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 1.0600000000000001 111.447 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.47 -32.06 72.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.979 0.419 . . . . 0.63 110.784 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.9 m -64.1 -42.75 96.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.727 -0.67 . . . . 0.68999999999999995 110.617 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.27 -42.58 83.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 1.6899999999999999 111.322 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -62.11 -28.36 69.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.972 0.415 . . . . 2.1899999999999999 111.096 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.3 m -86.36 -5.82 59.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.779 0.323 . . . . 1.26 111.653 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 16.6 mmm -79.07 -21.78 46.26 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.828 0.347 . . . . 1.7 110.678 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.94 28.36 21.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 2.2000000000000002 112.918 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 m -103.09 135.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.856 0.36 . . . . 2.3599999999999999 110.629 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.17 143.32 50.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.138 -0.483 . . . . 5.2800000000000002 110.083 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 38.3 m80 56.75 41.36 28.3 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.184 0.516 . . . . 5.2599999999999998 110.124 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -96.74 25.68 5.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.707 -0.679 . . . . 5.4500000000000002 111.035 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t 60.63 66.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.682 0.754 . . . . 3.7599999999999998 109.395 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -28.35 68.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.096 -0.956 . . . . 4.2599999999999998 111.569 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -66.38 -28.42 68.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 2.8799999999999999 111.568 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.17 -26.7 67.88 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.951 0.405 . . . . 1.71 111.117 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.6 t -67.78 -44.81 85.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.172 -0.467 . . . . 1.7 109.939 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -30.64 71.66 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.037 -0.528 . . . . 3.2999999999999998 110.549 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.31 -50.57 69.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 2.6099999999999999 110.651 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.5 -12.96 61.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 1.6699999999999999 111.737 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -95.14 -44.17 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.175 0.435 . . . . 1.9099999999999999 112.175 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -100.66 -25.0 14.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.682 0.993 . . . . 2.21 113.682 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -92.03 -46.78 7.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.046 0.451 . . . . 2.73 110.226 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.43 -52.27 4.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.895 -0.593 . . . . 2.5899999999999999 110.868 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 60.41 59.66 2.2 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.986 -0.552 . . . . 2.1600000000000001 110.24 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -83.49 40.36 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.997 -0.547 . . . . 2.2400000000000002 111.569 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttt 44.97 58.91 3.72 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.961 0.788 . . . . 2.6099999999999999 112.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.79 75.01 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.229 0.538 . . . . 1.24 109.717 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.01 -0.57 10.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.659 . . . . 0.95999999999999996 111.58 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.67 145.79 57.68 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.304 -0.407 . . . . 1.21 110.372 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.08 -33.23 72.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.18 2.587 . . . . 0.97999999999999998 113.644 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.94 -55.72 29.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 2.6200000000000001 110.77 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -59.53 -37.71 79.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.013 -0.539 . . . . 2.5099999999999998 110.913 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.4 mtt -63.01 -54.35 39.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.731 -0.668 . . . . 0.93999999999999995 110.803 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.2 93.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.95999999999999996 111.476 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.87 -39.35 81.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.086 0.47 . . . . 1.8300000000000001 111.186 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.41 -44.91 23.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.904 -0.589 . . . . 1.52 110.812 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.2 mt -61.77 -32.25 72.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.98999999999999999 112.132 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -18.8 59.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.515 -0.311 . . . . 1.25 111.751 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.76 1.22 78.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.788 -0.72 . . . . 1.6100000000000001 113.333 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -124.21 6.59 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.377 0.589 . . . . 2.9500000000000002 111.371 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.29 65.58 0.87 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.424 -0.893 . . . . 1.47 112.29 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.4 t -146.2 125.66 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.605 -0.517 . . . . 1.2 109.605 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.707 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 18.2 t0 -79.8 123.09 27.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 1.5600000000000001 110.333 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -60.57 -35.9 77.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.563 -0.744 . . . . 1.5700000000000001 111.252 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.61 -50.84 63.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 2.29 111.248 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.707 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 41.2 mmtm -60.32 -45.43 93.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.966 0.413 . . . . 2.6099999999999999 110.174 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 87.2 t80 -54.81 -59.25 4.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.387 -0.824 . . . . 1.4399999999999999 111.208 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.08 -32.54 74.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.992 0.367 . . . . 1.1299999999999999 111.992 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.9 t -59.32 -50.92 72.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.737 0.304 . . . . 1.46 111.343 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -84.03 -25.33 29.98 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.675 -0.41 . . . . 1.53 111.181 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 63.1 t80 -59.88 -43.81 94.55 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.991 0.424 . . . . 1.53 111.078 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -95.78 24.75 5.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.32 -0.4 . . . . 1.6100000000000001 111.314 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 10.3 m -108.99 162.62 14.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.922 0.391 . . . . 1.49 110.653 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -68.2 -23.24 64.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 1.3999999999999999 111.418 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.88 51.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.108 0.48 . . . . 0.92000000000000004 111.816 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.0 mm -82.5 -36.9 13.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.252 -0.431 . . . . 1.1899999999999999 110.484 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.15 -39.41 86.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 1.8999999999999999 110.878 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.0 -32.76 81.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.75 111.717 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -79.71 -36.41 37.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.164 0.507 . . . . 1.6699999999999999 110.046 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.3 mmm -61.16 -50.86 71.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 1.8500000000000001 111.141 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -33.35 75.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.641 0.258 . . . . 2.0299999999999998 110.599 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -60.94 -50.45 73.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 3.0800000000000001 110.612 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -72.67 -35.35 67.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.123 -0.489 . . . . 0.34999999999999998 111.415 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -57.59 -50.63 72.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.363 -0.38 . . . . 1.6899999999999999 112.021 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -72.85 -18.92 61.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.543 -0.299 . . . . 2.1000000000000001 111.762 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.57 -39.78 15.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.56000000000000005 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.36 -48.35 79.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.928 -0.578 . . . . 0.48999999999999999 111.609 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -71.95 -19.82 61.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.29 -0.414 . . . . 2.5699999999999998 111.201 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.79 -21.36 29.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.42999999999999999 110.475 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -84.88 4.7 32.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.896 -0.593 . . . . 0.63 110.416 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.526 ' HG3' HD22 ' A' ' 15' ' ' LEU . 18.2 mm-40 62.09 30.76 17.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.708 -0.678 . . . . 1.4099999999999999 111.645 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.03 98.88 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.19 -0.459 . . . . 1.26 110.509 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.53 12.63 32.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.296 -0.411 . . . . 1.25 111.628 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.71 175.77 40.64 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.563 -0.827 . . . . 0.68999999999999995 112.294 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.65 134.93 18.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.062 -0.347 . . . . 0.64000000000000001 110.062 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.5 -175.91 17.67 Favored 'Cis proline' 0 C--O 1.235 0.348 0 C-N-CA 123.328 -1.53 . . . . 0.66000000000000003 112.641 -0.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.4 m -165.85 114.47 0.97 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.955 0.407 . . . . 0.56999999999999995 110.625 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.9 mtp -94.09 123.29 37.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.947 -0.57 . . . . 0.92000000000000004 109.598 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.1 t -114.69 130.34 69.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.033 -0.531 . . . . 0.40000000000000002 109.618 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.23 117.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.58999999999999997 111.048 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.12 30.69 14.87 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.261 -0.882 . . . . 1.0800000000000001 112.188 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 51.34 32.39 29.76 Favored Glycine 0 CA--C 1.52 0.384 0 O-C-N 123.559 0.537 . . . . 0.48999999999999999 113.459 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 59.5 mtpt -130.03 -41.47 1.28 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 1.72 111.703 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -109.72 129.0 55.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 1.5 110.949 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HB2' HD21 ' A' ' 15' ' ' LEU . 8.7 ttp85 -119.06 128.57 54.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 1.6599999999999999 110.027 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -153.28 175.92 12.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.192 -0.458 . . . . 0.63 110.03 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.35 -177.24 3.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.643 -0.502 . . . . 1.3500000000000001 109.643 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.36 -43.9 78.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.651 0.594 . . . . 0.68999999999999995 111.81 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.52 -45.48 67.42 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.72999999999999998 112.943 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.7 m -64.71 -45.72 85.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.927 0.394 . . . . 1.1499999999999999 111.021 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -67.52 -42.28 83.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.325 -0.398 . . . . 0.71999999999999997 111.164 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 111.73 27.7 3.97 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.701 -0.762 . . . . 1.1000000000000001 112.796 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.13 154.81 6.25 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.101 -0.571 . . . . 0.72999999999999998 112.13 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.63 -40.07 87.44 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.176 2.584 . . . . 0.84999999999999998 112.351 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.09 -39.5 75.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.182 0.515 . . . . 2.52 110.019 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.31 -28.89 70.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.733 -0.667 . . . . 1.8200000000000001 110.196 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.0 m -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.837 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.44 HD11 HG22 ' A' ' 46' ' ' THR . 87.0 mt -68.48 -35.3 77.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.872 -0.604 . . . . 0.72999999999999998 109.942 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -61.92 -49.14 77.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 2.3399999999999999 110.449 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 178' ' ' LEU . 3.3 mm? -63.54 -42.35 98.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.553 -0.749 . . . . 0.69999999999999996 110.825 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.98 -52.65 64.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.65000000000000002 111.529 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -40.28 93.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.107 -0.497 . . . . 1.9099999999999999 111.187 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -63.42 -46.55 85.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.012 -0.54 . . . . 1.8200000000000001 110.877 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.9 mt -66.92 -30.09 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.345 -0.389 . . . . 0.75 111.59 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 63.1 mt -60.91 -47.94 91.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.652 -0.499 . . . . 0.77000000000000002 109.652 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -27.91 64.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.6 -0.727 . . . . 2.1699999999999999 110.369 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -60.71 -49.33 77.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.009 -0.541 . . . . 2.4100000000000001 109.936 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -74.75 -37.69 62.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.781 -0.645 . . . . 1.6399999999999999 110.755 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.54 ' HD2' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.465 . . . . 1.72 110.743 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.27 -21.93 64.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 1.1299999999999999 111.848 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.29 -7.55 57.34 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.347 0.594 . . . . 1.1699999999999999 110.796 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -152.16 56.08 0.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.373 -0.831 . . . . 1.8400000000000001 109.356 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -100.62 57.03 0.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.637 -0.711 . . . . 6.4299999999999997 110.448 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 59.9 pttt . . . . . 0 C--O 1.25 1.096 0 O-C-N 124.264 0.978 . . . . 7.3200000000000003 111.93 -179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.432 -0.667 . . . . 2.2000000000000002 111.432 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -124.1 122.98 39.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.86 0.362 . . . . 2.1299999999999999 111.167 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -93.29 5.51 51.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.787 0.803 . . . . 1.97 109.702 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -120.85 148.05 44.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.309 -0.859 . . . . 1.2 109.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.83 140.2 53.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.081 0.467 . . . . 1.29 111.655 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.75 130.41 40.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.918 -0.583 . . . . 1.03 109.942 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.39 0.62 67.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 1.1399999999999999 111.647 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -124.81 -59.11 1.45 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.688 -0.486 . . . . 1.8899999999999999 109.688 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -92.38 -50.45 5.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.403 0.621 . . . . 1.55 109.981 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -127.42 153.65 46.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.752 -0.658 . . . . 1.03 110.074 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -109.43 131.49 60.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.722 0.296 . . . . 0.91000000000000003 111.211 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -92.19 127.01 37.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.9 -0.778 . . . . 1.8200000000000001 108.9 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -74.52 134.22 42.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.467 -0.333 . . . . 1.04 111.259 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -41.88 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.025 -0.534 . . . . 1.54 110.275 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.32 94.78 14.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.747 -0.66 . . . . 1.28 109.818 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.12 146.16 69.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.418 2.079 . . . . 0.90000000000000002 112.649 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -98.46 117.38 64.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.21 -0.45 . . . . 0.81000000000000005 110.695 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.5 104.68 1.94 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.641 2.227 . . . . 1.0900000000000001 112.269 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.49 148.01 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.352 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -16.35 59.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.945 -0.57 . . . . 1.6399999999999999 111.576 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.3 102.03 46.17 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.846 0.355 . . . . 3.3300000000000001 111.0 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.63 167.34 16.97 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.669 2.246 . . . . 1.6599999999999999 112.654 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.19 -70.78 0.75 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.897 -0.668 . . . . 0.94999999999999996 112.447 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -82.07 142.63 32.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.668 0.27 . . . . 2.4700000000000002 110.403 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 159' ' ' ASN . 44.9 mm -71.96 121.3 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.129 -0.487 . . . . 0.70999999999999996 110.723 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 59' ' ' HIS . 3.8 tp10 -90.21 115.37 27.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.134 -0.485 . . . . 2.6899999999999999 110.712 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.77 109.64 29.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.156 -0.475 . . . . 0.55000000000000004 109.818 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.13 128.62 55.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.07 -0.514 . . . . 0.69999999999999996 111.333 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -107.18 134.18 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.612 -0.722 . . . . 2.4300000000000002 109.419 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.6 mp -113.62 119.31 37.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.787 0.327 . . . . 0.85999999999999999 110.439 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -120.42 165.03 15.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.939 -0.573 . . . . 1.3999999999999999 110.887 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 15.6 t90 -147.31 -179.89 7.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.64 -0.709 . . . . 1.1599999999999999 109.565 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -87.65 -52.21 5.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.79 0.329 . . . . 4.8099999999999996 111.283 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.7 4.91 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.16 -0.543 . . . . 1.6200000000000001 113.596 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.8 p -146.36 98.9 4.24 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.267 0.556 . . . . 0.93000000000000005 110.169 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.84 -27.7 67.49 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.488 2.126 . . . . 1.1000000000000001 112.403 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -66.97 -22.9 65.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.47 111.197 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 m -76.23 -23.39 54.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.264 0.554 . . . . 0.93999999999999995 110.33 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -80.51 -45.79 16.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.815 -0.629 . . . . 2.6299999999999999 110.655 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.03 -8.71 47.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.97999999999999998 111.577 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' O ' HG22 ' A' ' 47' ' ' ILE . 2.2 t80 -97.52 -11.41 23.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.382 -0.372 . . . . 0.76000000000000001 111.184 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 10.9 tt0 -55.92 -56.12 33.84 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 119.497 -0.287 . . . . 2.6899999999999999 111.677 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 44' ' ' GLU . 65.1 Cg_endo -72.07 13.77 0.49 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.094 1.863 . . . . 0.81000000000000005 113.184 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.443 HG22 HD11 ' A' ' 176' ' ' LEU . 0.2 OUTLIER -124.92 -42.42 2.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.709 0.29 . . . . 0.70999999999999996 111.306 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 43' ' ' PHE . 15.6 tt -83.28 -35.29 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 112.452 0.538 . . . . 0.83999999999999997 112.452 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 96.7 t -62.08 -55.85 36.97 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.269 0.47 . . . . 0.94999999999999996 112.269 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.7 Cg_endo -56.55 -41.95 70.61 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.882 1.721 . . . . 0.94999999999999996 111.952 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.24 -41.55 94.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.877 -0.601 . . . . 0.81999999999999995 110.871 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.3 t -62.05 -32.21 72.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 1.22 111.136 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -84.1 0.55 47.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.061 0.458 . . . . 2.1400000000000001 110.746 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.78 17.8 14.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.093 0.473 . . . . 2.0899999999999999 110.287 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.4 mt -74.24 147.12 85.22 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.81000000000000005 110.733 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -56.06 160.3 10.65 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.822 2.348 . . . . 0.98999999999999999 112.501 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.4 26.09 0.17 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.136 -0.484 . . . . 1.1399999999999999 111.682 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.04 21.65 2.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.355 0.598 . . . . 1.6499999999999999 110.228 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.84 142.59 43.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.68000000000000005 109.487 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.4 ' HB3' ' OE1' ' A' ' 28' ' ' GLU . 20.8 t60 -118.11 131.49 56.42 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.432 -0.581 . . . . 1.27 109.432 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -116.26 127.03 54.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.744 0.306 . . . . 1.3899999999999999 110.587 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 t -128.24 129.51 69.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.69999999999999996 110.611 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -99.2 113.76 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.858 -0.793 . . . . 4.2300000000000004 108.858 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.3 mt -123.84 132.45 24.29 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 0.60999999999999999 111.115 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.34 145.15 52.99 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.443 2.096 . . . . 0.48999999999999999 111.579 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.83 80.21 4.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.152 0.501 . . . . 0.45000000000000001 110.997 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 72' ' ' ASN . 25.6 mt -79.68 79.05 6.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.53000000000000003 110.891 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.43 21.3 13.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.022 -0.535 . . . . 1.71 111.217 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 89.77 176.66 45.46 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.755 -0.736 . . . . 1.3899999999999999 112.102 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.5 -135.63 51.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.737 . . . . 1.24 112.4 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.7 tp -76.03 -13.26 14.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 1.1599999999999999 110.763 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.509 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 43.1 m95 -65.91 -40.28 91.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.12 0.486 . . . . 0.78000000000000003 109.786 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' HD22 ' A' ' 66' ' ' LEU . 20.5 t-20 -71.41 -44.21 65.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.682 -0.69 . . . . 1.99 110.183 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.9 t -62.61 -48.83 86.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.396 -0.82 . . . . 0.89000000000000001 111.114 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -84.35 49.62 1.71 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 1.46 111.098 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.12 -33.44 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.377 -0.829 . . . . 0.66000000000000003 111.289 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.496 HE22 HD12 ' A' ' 134' ' ' ILE . 3.3 mm100 -55.5 -34.56 64.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.207 0.447 . . . . 2.1200000000000001 112.207 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.6 ttp -54.32 -42.86 70.63 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.747 0.308 . . . . 1.4299999999999999 111.499 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.45 -46.05 90.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 1.0600000000000001 110.674 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.5 mt -68.27 -36.81 79.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.941 -0.572 . . . . 0.63 110.992 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.8 m -62.0 -45.78 92.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.68999999999999995 110.598 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HD13 ' A' ' 115' ' ' LEU . 81.8 mt -59.28 -38.24 79.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.098 0.475 . . . . 1.6899999999999999 110.633 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.65 -41.29 75.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.856 -0.611 . . . . 2.1899999999999999 110.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -69.32 -13.89 62.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.26 111.19 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 81.3 mtp -88.1 -20.45 25.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.382 -0.372 . . . . 1.7 110.88 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.84 50.76 60.99 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.887 -0.673 . . . . 2.2000000000000002 111.827 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -74.65 165.1 3.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.919 0.39 . . . . 2.3599999999999999 111.281 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.32 172.58 8.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.998 -0.547 . . . . 5.2800000000000002 110.349 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 74.52 115.54 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 124.023 0.827 . . . . 5.2599999999999998 110.954 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.56 54.69 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 5.4500000000000002 111.363 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.52 61.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.312 0.577 . . . . 3.7599999999999998 111.112 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -69.99 -12.7 61.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 4.2599999999999998 111.712 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 1.1 t30 -95.89 -35.82 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.573 0.225 . . . . 2.8799999999999999 110.934 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.24 71.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.144 -0.48 . . . . 1.71 111.828 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.38 -45.71 95.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 1.7 110.751 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.071 -0.513 . . . . 3.2999999999999998 110.746 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 39.7 mt-10 -65.43 -36.65 84.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.621 . . . . 2.6099999999999999 110.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.94 64.51 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.241 0.543 . . . . 1.6699999999999999 110.384 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.9 mt -81.38 -50.62 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.588 -0.733 . . . . 1.9099999999999999 112.465 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -95.44 -48.98 5.62 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.546 0.943 . . . . 2.21 113.546 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 77.7 mttt -68.52 -56.01 9.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.144 -0.222 . . . . 2.73 111.451 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.62 -47.19 73.41 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.626 -0.509 . . . . 2.5899999999999999 109.626 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 57.36 58.29 3.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.839 -0.618 . . . . 2.1600000000000001 111.464 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -92.66 33.77 1.11 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.659 -0.246 . . . . 2.2400000000000002 111.261 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt 68.85 -68.69 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.649 0.593 . . . . 2.6099999999999999 111.139 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt 53.48 59.84 4.09 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.122 0.569 . . . . 1.24 111.301 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.77 -57.69 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.909 0.385 . . . . 0.95999999999999996 111.174 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.6 145.04 50.1 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.275 -0.42 . . . . 1.21 111.125 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.97 -36.65 96.18 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.7 2.267 . . . . 0.97999999999999998 112.099 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.82 -33.3 74.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.1 -0.5 . . . . 2.6200000000000001 110.372 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.56 -40.34 80.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 2.5099999999999998 109.52 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.9 mtt -63.93 -53.71 46.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.447 -0.797 . . . . 0.93999999999999995 109.854 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.418 ' HB2' ' CD1' ' A' ' 125' ' ' PHE . . . -59.74 -31.01 69.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.161 -0.927 . . . . 0.95999999999999996 111.927 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.69 -40.96 89.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.374 . . . . 1.8300000000000001 111.432 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -83.1 -40.77 19.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.975 -0.557 . . . . 1.52 110.669 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 HD21 ' A' ' 81' ' ' LEU . 70.8 mt -65.73 -23.31 66.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.945 -0.57 . . . . 0.98999999999999999 111.568 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -56.62 -34.45 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 1.25 111.574 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -89.6 -4.28 73.41 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.773 -0.727 . . . . 1.6100000000000001 112.21 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -98.04 22.29 9.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.856 0.36 . . . . 2.9500000000000002 111.094 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.16 18.66 71.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.815 -0.707 . . . . 1.47 112.137 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 59.8 t -109.73 128.14 66.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.593 0.235 . . . . 1.2 110.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.5 122.64 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.93 0.395 . . . . 1.5600000000000001 110.476 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -60.02 -37.3 79.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.521 -0.763 . . . . 1.5700000000000001 111.058 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.91 -54.55 29.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.434 -0.348 . . . . 2.29 110.716 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -55.5 -39.16 70.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.32 -0.4 . . . . 2.6099999999999999 110.957 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.515 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 75.5 t80 -62.13 -54.64 38.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 1.4399999999999999 110.745 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.6 -37.59 86.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.1299999999999999 111.388 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.5 m -65.3 -45.65 83.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.419 . . . . 1.46 111.032 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.5 m -71.98 -32.89 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.856 0.36 . . . . 1.53 111.037 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.4 -26.52 68.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.335 0.588 . . . . 1.53 110.282 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -115.92 34.0 5.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.785 . . . . 1.6100000000000001 109.704 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.8 t -115.92 145.02 43.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.458 -0.792 . . . . 1.49 110.682 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -64.11 -20.53 66.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.021 -0.536 . . . . 1.3999999999999999 110.626 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.83 78.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 0.92000000000000004 110.667 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.496 HD12 HE22 ' A' ' 76' ' ' GLN . 0.4 OUTLIER -75.72 -31.33 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.161 -0.472 . . . . 1.1899999999999999 110.287 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -65.45 -36.17 83.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 1.8999999999999999 110.533 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -60.88 -28.44 68.49 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.948 -0.569 . . . . 0.75 112.35 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -91.43 -35.53 14.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.837 0.351 . . . . 1.6699999999999999 110.138 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.0 ttm -62.12 -47.07 86.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 1.8500000000000001 111.311 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.44 -36.71 84.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.689 -0.232 . . . . 2.0299999999999998 110.929 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 3.8 tmtp? -65.52 -43.68 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.347 -0.388 . . . . 3.0800000000000001 110.011 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.38 75.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.245 -0.434 . . . . 0.34999999999999998 111.158 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -62.93 -48.71 77.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.6899999999999999 111.112 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -66.88 -23.93 66.06 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.988 -0.285 . . . . 2.1000000000000001 111.203 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.4 mt -75.82 -51.12 13.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.926 -0.398 . . . . 0.56000000000000005 109.926 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.48999999999999999 111.65 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 53.5 mtm -69.7 -24.98 63.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.172 -0.467 . . . . 2.5699999999999998 111.389 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -85.64 -17.58 35.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.861 0.362 . . . . 0.42999999999999999 111.33 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 150' ' ' VAL . 21.7 m-30 -83.64 -3.56 57.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.109 -0.496 . . . . 0.63 111.024 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 56.51 32.92 21.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.968 -0.56 . . . . 1.4099999999999999 111.391 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 148' ' ' TYR . 59.1 t -76.42 123.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.011 -0.54 . . . . 1.26 110.745 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 13.94 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.195 0.522 . . . . 1.25 111.061 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.45 171.67 37.49 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.701 -0.761 . . . . 0.68999999999999995 111.951 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.15 144.59 35.29 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.625 0.25 . . . . 0.64000000000000001 110.736 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.12 173.09 57.16 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.175 -1.594 . . . . 0.66000000000000003 112.045 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.4 m -157.68 138.51 13.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.72 0.295 . . . . 0.56999999999999995 110.787 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.0 mtp -115.53 136.7 52.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.145 -0.687 . . . . 0.92000000000000004 109.145 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.68 127.6 71.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.68 0.276 . . . . 0.40000000000000002 110.559 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.66 120.9 54.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.291 -0.413 . . . . 0.58999999999999997 110.478 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.462 HD21 HG23 ' A' ' 27' ' ' ILE . 61.3 m-80 51.26 20.61 0.95 Allowed 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.987 0.804 . . . . 1.0800000000000001 113.082 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.0 27.56 70.61 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.921 -0.657 . . . . 0.48999999999999999 112.726 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -123.39 -38.34 2.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.826 0.313 . . . . 1.72 110.995 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -114.75 130.9 56.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.998 0.427 . . . . 1.5 111.63 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 44.7 ttp85 -119.32 134.17 55.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.668 -0.696 . . . . 1.6599999999999999 110.366 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -158.43 171.68 19.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.63 110.352 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.58 -176.9 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.425 -0.352 . . . . 1.3500000000000001 110.312 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 89.0 mt -58.43 -48.47 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.35 -0.386 . . . . 0.68999999999999995 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.92 -39.84 89.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.268 -0.491 . . . . 0.72999999999999998 112.495 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.7 t -65.4 -39.39 92.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 1.1499999999999999 110.843 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -44.03 21.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.834 0.349 . . . . 0.71999999999999997 111.354 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 137.8 -43.34 1.21 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.996 -0.621 . . . . 1.1000000000000001 111.826 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.5 170.14 34.53 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.568 -0.613 . . . . 0.72999999999999998 111.568 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.74 -42.52 67.8 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.165 2.577 . . . . 0.84999999999999998 113.126 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.48 -28.94 64.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 2.52 110.299 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.42 -32.99 70.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 1.8200000000000001 109.71 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.6 m -61.26 -45.17 95.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.62 109.944 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.443 HD11 HG22 ' A' ' 46' ' ' THR . 65.0 mt -63.73 -39.65 94.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.72999999999999998 110.23 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.7 ttmm -62.29 -47.06 85.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.96 -0.564 . . . . 2.3399999999999999 110.268 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -63.34 -40.77 98.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.69999999999999996 110.436 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.312 -0.404 . . . . 0.65000000000000002 110.982 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.86 -40.41 84.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 1.9099999999999999 110.373 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -67.05 -46.64 73.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.636 -0.711 . . . . 1.8200000000000001 111.099 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.93 -41.45 99.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.571 -0.286 . . . . 0.75 110.966 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.439 HG12 HG21 ' A' ' 27' ' ' ILE . 82.1 mt -58.12 -39.19 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.77000000000000002 109.758 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -41.44 67.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.698 -0.683 . . . . 2.1699999999999999 110.756 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -62.91 -48.54 78.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 2.4100000000000001 111.469 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -70.45 -23.95 62.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.862 0.363 . . . . 1.6399999999999999 111.365 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.3 OUTLIER -74.32 -7.9 54.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.57 -0.286 . . . . 1.72 110.818 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.43 -24.34 67.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.943 0.401 . . . . 1.1299999999999999 110.538 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.06 0.55 39.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.888 -0.597 . . . . 1.1699999999999999 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.407 ' HB3' ' HE ' ' A' ' 187' ' ' ARG . . . -127.78 -4.08 5.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.533 -0.303 . . . . 1.8400000000000001 111.388 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 35.5 tptt 64.03 44.03 4.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.815 -0.63 . . . . 6.4299999999999997 110.958 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 52.0 mttp . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.505 -0.77 . . . . 7.3200000000000003 111.701 179.618 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.949 0 N-CA-C 111.827 -0.509 . . . . 2.2000000000000002 111.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.27 152.03 20.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.791 0.329 . . . . 2.1299999999999999 110.317 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -112.62 -15.91 12.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 1.97 111.319 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -114.56 159.2 20.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.989 0.423 . . . . 1.2 111.181 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.09 132.5 55.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.134 -0.484 . . . . 1.29 111.416 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.97 132.24 48.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.03 110.446 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.46 -12.77 67.28 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.895 -0.669 . . . . 1.1399999999999999 112.055 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -114.48 -49.58 2.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.922 0.392 . . . . 1.8899999999999999 110.064 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -100.75 -47.68 4.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 1.55 111.021 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.68 159.36 37.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.215 -0.448 . . . . 1.03 110.095 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.28 124.12 71.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.484 -0.325 . . . . 0.91000000000000003 110.55 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -101.4 114.3 28.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.083 -0.508 . . . . 1.8200000000000001 109.912 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 136.42 49.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.435 -0.348 . . . . 1.04 110.25 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -73.03 -14.56 61.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.146 -0.479 . . . . 1.54 110.793 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.1 m -119.92 86.13 35.78 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.21 -0.45 . . . . 1.28 110.198 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -74.79 168.53 24.62 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.583 2.189 . . . . 0.90000000000000002 112.457 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.6 115.15 58.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 0.81000000000000005 110.041 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.13 115.27 4.07 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.351 2.034 . . . . 1.0900000000000001 112.396 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m -67.51 159.23 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.773 -0.649 . . . . 1.05 111.216 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -61.3 -50.81 71.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 1.6399999999999999 111.188 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -132.34 124.7 19.38 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.515 -0.311 . . . . 3.3300000000000001 110.255 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.51 142.41 16.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.577 2.184 . . . . 1.6599999999999999 112.399 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.56 -78.08 0.22 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.823 -0.703 . . . . 0.94999999999999996 111.807 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -79.14 156.07 28.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.784 0.326 . . . . 2.4700000000000002 110.369 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 183' ' ' ILE . 30.6 mm -94.45 123.0 46.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.846 -0.427 . . . . 0.70999999999999996 109.846 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -103.45 117.9 35.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.94 0.4 . . . . 2.6899999999999999 110.636 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -105.49 113.9 43.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.137 -0.483 . . . . 0.55000000000000004 109.974 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -102.16 131.12 50.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.995 -0.548 . . . . 0.69999999999999996 111.223 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -111.18 131.14 55.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.76 -0.654 . . . . 2.4300000000000002 109.678 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.47 110.81 22.41 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.85999999999999999 110.231 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -110.03 160.2 16.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.943 -0.571 . . . . 1.3999999999999999 111.048 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.415 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 9.2 t90 -143.57 -178.87 6.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.69 . . . . 1.1599999999999999 109.789 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -93.09 -40.31 10.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.767 0.318 . . . . 4.8099999999999996 111.334 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.29 40.24 3.03 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.994 -0.622 . . . . 1.6200000000000001 113.264 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.3 p -129.81 99.48 20.35 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 121.066 0.46 . . . . 0.93000000000000005 110.082 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.75 -28.34 59.83 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.465 2.11 . . . . 1.1000000000000001 112.254 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -66.22 -25.54 66.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.965 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 54.1 m -69.63 -34.28 73.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.429 . . . . 0.93999999999999995 110.133 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -76.88 -39.04 52.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.56 . . . . 2.6299999999999999 110.433 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.99 -16.66 63.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.166 -0.47 . . . . 0.97999999999999998 111.379 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.97 -12.53 21.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.565 -0.288 . . . . 0.76000000000000001 111.215 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 3.7 tt0 -52.36 -54.95 36.36 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.619 0.599 . . . . 2.6899999999999999 112.619 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 38.2 Cg_endo -65.8 -2.78 7.02 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.478 2.119 . . . . 0.81000000000000005 113.774 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.51 HG22 HD11 ' A' ' 176' ' ' LEU . 0.9 OUTLIER -114.5 -40.01 3.69 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.058 0.392 . . . . 0.70999999999999996 112.058 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 tt -75.71 -36.71 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.83999999999999997 112.329 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.59 -58.89 16.04 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.56 0.578 . . . . 0.94999999999999996 112.56 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.38 -28.8 88.53 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.954 1.769 . . . . 0.94999999999999996 112.451 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -73.81 -48.02 34.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.951 -0.568 . . . . 0.81999999999999995 110.685 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -65.3 -33.97 77.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 1.22 111.308 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -78.2 0.33 25.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.091 -0.504 . . . . 2.1400000000000001 111.099 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -130.78 41.39 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.235 0.541 . . . . 2.0899999999999999 110.456 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 mt -93.77 148.89 36.16 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.736 -0.665 . . . . 0.81000000000000005 110.438 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HG2' ' CG2' ' A' ' 58' ' ' VAL . 9.9 Cg_endo -52.37 156.64 7.89 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.951 2.434 . . . . 0.98999999999999999 112.383 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.7 -11.85 56.0 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.898 0.703 . . . . 1.1399999999999999 112.898 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -106.25 15.38 26.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.24 0.543 . . . . 1.6499999999999999 111.694 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 55' ' ' PRO . 66.0 t -127.62 139.22 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.906 -0.588 . . . . 0.68000000000000005 109.617 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -118.68 152.93 35.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.626 0.251 . . . . 1.27 110.589 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.81 129.07 41.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 1.3899999999999999 110.242 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.3 t -131.11 129.38 63.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.883 0.373 . . . . 0.69999999999999996 110.932 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -97.06 118.89 34.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.374 -0.602 . . . . 4.2300000000000004 109.374 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.3 mt -123.78 127.45 25.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.729 0.299 . . . . 0.60999999999999999 110.437 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.66 146.12 78.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.347 2.032 . . . . 0.48999999999999999 111.671 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.607 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.13 73.98 2.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.992 0.425 . . . . 0.45000000000000001 110.733 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.7 mt -76.21 76.55 3.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.814 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -104.32 32.96 3.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 1.71 110.993 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 166.77 35.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.901 -0.666 . . . . 1.3899999999999999 112.885 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 -138.08 47.7 Favored Glycine 0 C--O 1.235 0.162 0 C-N-CA 121.264 -0.493 . . . . 1.24 112.779 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.9 tp -68.22 -16.97 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.79 0.329 . . . . 1.1599999999999999 111.141 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.607 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 56.5 m95 -66.75 -33.52 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.368 0.604 . . . . 0.78000000000000003 109.688 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.03 -42.75 31.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.538 -0.755 . . . . 1.99 110.238 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.82 -51.06 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.89000000000000001 110.944 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -82.68 61.7 5.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.213 0.53 . . . . 1.46 111.101 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.36 -33.7 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.372 -0.831 . . . . 0.66000000000000003 111.534 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.437 HE22 HD12 ' A' ' 134' ' ' ILE . 2.3 mm100 -56.69 -32.09 65.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 122.647 0.379 . . . . 2.1200000000000001 111.932 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 31.9 ttp -54.96 -39.98 69.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.343 -0.389 . . . . 1.4299999999999999 111.49 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -65.34 -44.54 87.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.0600000000000001 111.388 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.92 -37.51 78.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.337 -0.392 . . . . 0.63 111.243 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.5 m -59.8 -36.58 77.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.68999999999999995 111.158 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 77' ' ' MET . 89.4 mt -62.38 -47.47 84.03 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.908 0.385 . . . . 1.6899999999999999 110.777 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -68.58 -33.15 73.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 2.1899999999999999 110.261 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 t -66.68 -32.49 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 1.26 110.653 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.4 mtp -73.58 -34.45 65.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.388 -0.369 . . . . 1.7 110.928 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.71 56.42 4.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.593 -0.813 . . . . 2.2000000000000002 111.435 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.79 -179.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.803 0.335 . . . . 2.3599999999999999 110.903 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 88' ' ' HIS . 7.9 tt0 -109.16 171.03 7.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.413 -0.358 . . . . 5.2800000000000002 110.452 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 1.0 OUTLIER 75.0 124.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.85 0.719 . . . . 5.2599999999999998 111.458 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -82.68 68.49 9.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.572 -0.74 . . . . 5.4500000000000002 110.39 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 94' ' ' VAL . 4.8 m -100.15 47.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 3.7599999999999998 111.072 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.96 -11.19 58.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 4.2599999999999998 111.858 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.524 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 2.0 t30 -90.29 -53.74 4.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.466 -0.334 . . . . 2.8799999999999999 110.658 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.97 -35.46 46.3 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.55 0.574 . . . . 1.71 112.55 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 90' ' ' VAL . 96.2 t -58.42 -49.94 80.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.389 . . . . 1.7 110.974 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -66.38 -35.27 79.92 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.283 -0.417 . . . . 3.2999999999999998 110.488 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 31.0 mt-10 -63.47 -39.82 95.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.625 . . . . 2.6099999999999999 110.654 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -68.53 -27.46 66.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.247 0.546 . . . . 1.6699999999999999 110.67 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.24 -49.94 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 1.9099999999999999 112.09 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -99.15 -52.48 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.401 0.889 . . . . 2.21 113.401 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 75.8 mttt -61.68 -54.01 48.41 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 2.73 111.337 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 29.8 mm-40 -69.64 -50.7 41.71 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.587 -0.523 . . . . 2.5899999999999999 109.587 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 60.35 57.3 2.91 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.573 -0.739 . . . . 2.1600000000000001 111.324 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -91.57 32.33 1.09 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.519 -0.31 . . . . 2.2400000000000002 110.988 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 69.3 -73.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.506 0.722 . . . . 2.6099999999999999 111.288 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.5 mt 56.05 54.74 7.57 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.021 0.438 . . . . 1.24 110.644 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -98.73 -3.06 36.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.245 -0.434 . . . . 0.95999999999999996 111.503 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 p -137.48 146.14 52.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.385 -0.371 . . . . 1.21 110.763 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.76 -35.54 93.63 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.743 2.296 . . . . 0.97999999999999998 111.822 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -63.24 -42.32 99.19 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.944 -0.571 . . . . 2.6200000000000001 110.088 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -67.26 -41.42 85.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.687 -0.688 . . . . 2.5099999999999998 109.914 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtt -63.8 -52.96 57.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.596 -0.729 . . . . 0.93999999999999995 110.581 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.568 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -60.3 -39.27 86.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.43 -0.804 . . . . 0.95999999999999996 112.319 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -60.47 -42.98 97.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.07 0.462 . . . . 1.8300000000000001 110.443 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -71.59 -48.25 49.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.062 -0.517 . . . . 1.52 110.915 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.15 -24.3 67.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.202 -0.454 . . . . 0.98999999999999999 112.112 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -58.41 -35.86 72.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 1.25 110.859 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.11 10.69 73.24 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.859 -0.686 . . . . 1.6100000000000001 112.114 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -114.01 6.15 16.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.885 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.42 1.92 55.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 1.47 113.014 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.9 t -97.35 128.48 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.172 -0.306 . . . . 1.2 110.172 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -70.43 119.21 14.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 1.5600000000000001 110.61 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.568 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 37.1 ttpt -61.98 -38.46 88.65 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.602 -0.726 . . . . 1.5700000000000001 111.446 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.19 -58.14 9.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.299 -0.41 . . . . 2.29 110.974 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -59.19 -35.37 73.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.429 -0.35 . . . . 2.6099999999999999 111.384 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -61.42 -54.22 46.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.769 0.319 . . . . 1.4399999999999999 110.668 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.02 -35.11 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 1.1299999999999999 110.817 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.3 m -67.14 -49.78 63.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.466 . . . . 1.46 110.755 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.1 m -65.49 -33.49 76.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.759 0.314 . . . . 1.53 111.038 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -61.74 -33.94 74.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.108 0.48 . . . . 1.53 110.364 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -99.15 18.93 16.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 1.6100000000000001 110.765 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 57.2 m -104.29 156.81 17.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 1.49 111.31 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' CE2' ' HD3' ' A' ' 135' ' ' LYS . 12.0 t80 -73.97 -24.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 1.3999999999999999 110.184 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.72 -37.7 68.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.817 -0.629 . . . . 0.92000000000000004 110.776 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.437 HD12 HE22 ' A' ' 76' ' ' GLN . 0.4 OUTLIER -79.01 -28.72 13.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.802 -0.635 . . . . 1.1899999999999999 110.491 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HD3' ' CE2' ' A' ' 132' ' ' PHE . 53.2 tttp -63.44 -37.15 86.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 1.8999999999999999 110.873 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.44 91.22 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.75 112.079 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -78.21 -35.53 48.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 1.6699999999999999 110.19 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 30.7 ttm -59.74 -52.29 66.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.363 -0.835 . . . . 1.8500000000000001 111.686 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -68.53 -32.55 72.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.549 -0.296 . . . . 2.0299999999999998 111.186 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.7 tmtp? -63.18 -44.92 94.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 3.0800000000000001 110.85 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.72 -37.09 65.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.379 -0.373 . . . . 0.34999999999999998 110.947 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -59.19 -51.0 71.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.059 -0.518 . . . . 1.6899999999999999 111.802 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -63.66 -35.54 80.87 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.029 -0.268 . . . . 2.1000000000000001 111.309 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.9 mt -63.94 -49.28 73.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.124 -0.324 . . . . 0.56000000000000005 110.124 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.29 84.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.102 -0.499 . . . . 0.48999999999999999 110.969 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 74.9 mmm -67.08 -39.36 86.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.979 -0.555 . . . . 2.5699999999999998 111.141 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.09 -21.88 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.357 -0.383 . . . . 0.42999999999999999 111.851 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 150' ' ' VAL . 20.8 m-30 -82.29 -6.17 59.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.63 111.018 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 58.93 27.55 16.39 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.061 -0.518 . . . . 1.4099999999999999 111.648 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 148' ' ' TYR . 94.3 t -67.45 119.46 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 1.26 110.732 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.91 39.83 3.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.876 -0.602 . . . . 1.25 111.116 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 172.22 166.53 30.99 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.594 -0.812 . . . . 0.68999999999999995 112.424 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.63 144.79 37.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.495 0.188 . . . . 0.64000000000000001 110.6 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.451 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 89.8 Cg_endo -80.98 163.39 80.05 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 123.25 -1.563 . . . . 0.66000000000000003 112.236 -0.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 18.1 m -157.0 139.38 14.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.279 -0.419 . . . . 0.56999999999999995 110.434 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 89.8 mtp -116.69 138.11 51.7 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.6 -0.518 . . . . 0.92000000000000004 109.6 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.3 t -123.1 130.92 74.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.728 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.4 t -102.73 112.28 35.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.58999999999999997 110.707 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 53.8 13.81 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.322 0.86 . . . . 1.0800000000000001 113.322 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 73.36 16.0 78.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.61 -0.805 . . . . 0.48999999999999999 112.117 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -104.79 -44.11 4.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.72 110.576 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -119.14 138.1 53.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.036 -0.529 . . . . 1.5 111.319 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.42 117.1 26.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 1.6599999999999999 109.425 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -135.14 161.01 36.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.883 0.373 . . . . 0.63 110.899 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.69 178.12 10.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.962 -0.563 . . . . 1.3500000000000001 109.701 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 72.0 mt -58.02 -37.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 111.765 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.79 94.56 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.031 -0.604 . . . . 0.72999999999999998 112.665 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.6 m -72.87 -45.73 56.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 1.1499999999999999 110.84 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.66 76.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.989 -0.551 . . . . 0.71999999999999997 111.503 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.65 16.65 38.7 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.737 -0.744 . . . . 1.1000000000000001 112.553 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 160.06 153.49 6.93 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.995 -0.621 . . . . 0.72999999999999998 112.321 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.06 -46.21 27.08 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.759 2.306 . . . . 0.84999999999999998 112.579 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.49 -37.25 86.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.417 0.627 . . . . 2.52 109.418 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.66 -36.12 81.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.352 -0.84 . . . . 1.8200000000000001 109.977 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 17.2 m -60.15 -44.93 94.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.559 -0.746 . . . . 0.62 111.179 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.51 HD11 HG22 ' A' ' 46' ' ' THR . 50.9 mt -64.01 -38.14 90.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.351 . . . . 0.72999999999999998 111.002 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -69.16 -34.76 75.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.488 . . . . 2.3399999999999999 110.479 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 1.3 mm? -67.13 -37.27 83.54 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.602 -0.518 . . . . 0.69999999999999996 109.602 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -59.08 -52.73 64.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.722 -0.672 . . . . 0.65000000000000002 110.832 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -57.97 -38.83 76.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.051 -0.522 . . . . 1.9099999999999999 110.623 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -62.51 -47.15 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.524 -0.762 . . . . 1.8200000000000001 110.938 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 178' ' ' LEU . 88.3 mt -65.33 -45.12 85.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.48 -0.327 . . . . 0.75 110.536 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 90.9 mt -58.38 -41.29 81.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.77000000000000002 110.449 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.67 -47.58 80.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 2.1699999999999999 110.769 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -62.19 -47.6 83.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 2.4100000000000001 111.413 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.8 -27.54 66.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 1.6399999999999999 111.138 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.555 ' CG ' ' HA ' ' A' ' 192' ' ' LYS . 0.0 OUTLIER -65.4 -18.1 65.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 1.72 111.483 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.11 -27.76 68.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 1.1299999999999999 111.443 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.59 -22.08 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.962 0.411 . . . . 1.1699999999999999 111.251 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -108.09 9.13 28.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.8400000000000001 110.8 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' HA ' ' A' ' 191' ' ' LYS . 24.5 tptt 62.69 35.56 13.99 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.434 -0.803 . . . . 6.4299999999999997 111.418 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.555 ' HA ' ' CG ' ' A' ' 187' ' ' ARG . 54.5 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.442 -0.799 . . . . 7.3200000000000003 111.92 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.678 -0.569 . . . . 2.2000000000000002 111.678 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 59.75 59.51 2.49 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.556 0.693 . . . . 2.1299999999999999 110.455 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -81.52 -13.73 57.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.178 -0.919 . . . . 1.97 110.844 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -98.57 138.67 35.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 1.2 110.665 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.3 m -95.69 128.88 42.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.393 . . . . 1.29 110.82 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.49 56.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 1.03 110.436 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.31 -39.62 2.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.836 -0.697 . . . . 1.1399999999999999 111.658 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -93.49 -51.96 4.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.603 0.24 . . . . 1.8899999999999999 110.437 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -83.93 -63.67 1.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.067 0.461 . . . . 1.55 110.724 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -120.23 155.56 32.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.107 -0.497 . . . . 1.03 110.308 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -103.31 126.79 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.417 -0.356 . . . . 0.91000000000000003 110.683 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.38 124.19 46.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.886 -0.783 . . . . 1.8200000000000001 108.886 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -82.53 127.15 33.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.773 0.321 . . . . 1.04 110.875 -179.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.8 m -68.56 -19.37 64.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.114 -0.494 . . . . 1.54 110.203 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 86.74 9.33 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.579 -0.737 . . . . 1.28 109.047 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.13 141.13 62.21 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.455 2.104 . . . . 0.90000000000000002 112.988 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 t -100.43 128.96 28.96 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.811 -0.631 . . . . 0.81000000000000005 110.137 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.0 143.47 72.52 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.377 2.051 . . . . 1.0900000000000001 112.85 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 m -90.53 173.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.691 . . . . 1.05 110.52 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 m -76.99 -40.99 44.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.821 0.344 . . . . 1.6399999999999999 111.018 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -130.55 113.9 16.8 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 3.3300000000000001 110.948 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.18 100.62 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.457 2.104 . . . . 1.6599999999999999 112.13 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.84 -48.91 0.29 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.51 -0.636 . . . . 0.94999999999999996 111.51 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -100.81 155.69 17.78 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.662 -0.496 . . . . 2.4700000000000002 109.662 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 mm -79.22 113.32 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.70999999999999996 110.401 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.81 114.33 26.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.253 -0.431 . . . . 2.6899999999999999 110.458 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.3 t -106.15 126.09 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.985 -0.552 . . . . 0.55000000000000004 110.05 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.51 126.72 55.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.194 -0.457 . . . . 0.69999999999999996 111.297 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -102.42 123.5 46.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.75 -0.659 . . . . 2.4300000000000002 109.86 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.39 120.49 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.186 -0.301 . . . . 0.85999999999999999 110.186 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -132.62 171.03 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 1.3999999999999999 111.404 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -138.98 172.18 13.23 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.545 -0.752 . . . . 1.1599999999999999 109.526 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -94.28 -12.85 27.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 4.8099999999999996 111.564 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.19 29.29 7.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.512 -0.851 . . . . 1.6200000000000001 113.135 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.4 p -112.98 107.93 53.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.841 0.353 . . . . 0.93000000000000005 110.471 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.99 -28.83 28.52 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.303 2.002 . . . . 1.1000000000000001 111.464 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -23.41 67.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.313 -0.858 . . . . 1.47 110.842 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.77 -41.1 68.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.04 -0.527 . . . . 0.93999999999999995 110.789 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.63 -28.2 68.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.978 0.418 . . . . 2.6299999999999999 111.077 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.08 25.23 2.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.367 0.603 . . . . 0.97999999999999998 109.881 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -145.47 -35.88 0.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.546 -0.752 . . . . 0.76000000000000001 110.941 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 48' ' ' VAL . 9.9 mt-10 -48.51 -56.54 14.12 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 113.022 0.749 . . . . 2.6899999999999999 113.022 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.54 -11.14 18.72 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.908 1.738 . . . . 0.81000000000000005 113.157 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 m -100.68 -37.08 8.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.747 0.308 . . . . 0.70999999999999996 111.284 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.7 tt -81.21 -34.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.203 0.446 . . . . 0.83999999999999997 112.203 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' GLU . 75.1 t -53.24 -56.59 22.63 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.433 -0.318 . . . . 0.94999999999999996 111.483 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 12.3 Cg_endo -57.88 -31.49 92.68 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.117 1.878 . . . . 0.94999999999999996 111.879 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -63.76 -47.57 80.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.965 -0.561 . . . . 0.81999999999999995 109.888 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -27.84 65.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 1.22 111.139 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -76.0 -18.28 59.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 2.1400000000000001 110.776 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -114.55 24.67 11.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.577 0.227 . . . . 2.0899999999999999 111.348 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.21 144.05 70.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.655 -0.248 . . . . 0.81000000000000005 110.816 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.04 -179.99 3.93 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.549 2.166 . . . . 0.98999999999999999 112.272 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.1 9.78 7.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.828 -0.624 . . . . 1.1399999999999999 111.888 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.62 10.19 19.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.085 0.469 . . . . 1.6499999999999999 111.134 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -128.74 139.15 52.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.862 0.363 . . . . 0.68000000000000005 110.826 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -113.72 137.19 51.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -117.69 117.63 29.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.9 0.381 . . . . 1.3899999999999999 111.542 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG12 ' HG ' ' A' ' 63' ' ' LEU . 80.3 t -111.65 129.5 66.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.064 -0.517 . . . . 0.69999999999999996 110.158 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 118.18 36.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.678 -0.49 . . . . 4.2300000000000004 109.678 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 61' ' ' VAL . 61.7 mt -129.31 139.99 37.31 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.87 0.366 . . . . 0.60999999999999999 111.277 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.41 149.69 21.75 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.518 2.145 . . . . 0.48999999999999999 112.019 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -75.48 94.09 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 110.266 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.84 84.06 4.5 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.924 -0.58 . . . . 0.53000000000000003 111.25 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -106.62 6.88 30.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.609 . . . . 1.71 110.563 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.82 -169.58 32.62 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 1.3899999999999999 111.89 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.26 -123.37 31.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.143 -0.551 . . . . 1.24 113.177 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.57 -8.09 10.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.249 0.547 . . . . 1.1599999999999999 111.09 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 18.8 m95 -67.92 -54.7 16.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.849 -0.614 . . . . 0.78000000000000003 110.029 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.32 -38.41 74.03 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.296 -0.866 . . . . 1.99 111.599 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.4 t -56.68 -37.9 55.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.062 -0.517 . . . . 0.89000000000000001 111.334 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -86.61 -14.07 43.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.213 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.84 -32.2 54.11 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.686 -0.768 . . . . 0.66000000000000003 111.657 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.94 -39.77 90.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.594 -0.303 . . . . 2.1200000000000001 110.806 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.41 -50.39 65.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.009 -0.541 . . . . 1.4299999999999999 111.506 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -62.86 -45.51 92.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 111.082 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.91 -40.46 96.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.63 111.203 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.9 m -60.35 -35.41 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.712 0.291 . . . . 0.68999999999999995 111.529 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.63 -51.34 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.414 -0.357 . . . . 1.6899999999999999 110.75 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -71.21 -28.1 63.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.175 -0.466 . . . . 2.1899999999999999 111.844 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 m -77.46 -3.87 42.58 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.9 0.333 . . . . 1.26 111.9 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 21.9 ttm -82.88 -9.44 59.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.46 . . . . 1.7 110.358 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.62 -9.83 64.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.069 -0.586 . . . . 2.2000000000000002 112.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.8 m -98.18 158.56 3.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.61 0.243 . . . . 2.3599999999999999 110.43 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -122.07 -69.5 0.83 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.779 -0.452 . . . . 5.2800000000000002 109.779 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.6 t60 68.32 150.67 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.513 0.673 . . . . 5.2599999999999998 111.638 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -106.91 -164.46 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.443 -0.577 . . . . 5.4500000000000002 109.443 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.2 m 37.6 59.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.37 1.068 . . . . 3.7599999999999998 112.941 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -78.78 44.77 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 4.2599999999999998 110.691 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.666 ' HA ' ' CE2' ' A' ' 95' ' ' PHE . 64.7 m-80 -80.8 -43.7 19.67 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.827 -0.624 . . . . 2.8799999999999999 110.603 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.31 -23.73 62.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.821 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.83 -54.04 34.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.491 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 92' ' ' ASN . 23.0 p90 -78.15 -13.0 60.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.674 -0.41 . . . . 3.2999999999999998 111.516 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 32.6 mm-40 -62.76 -43.48 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.992 0.425 . . . . 2.6099999999999999 110.377 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -86.16 10.07 15.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.362 0.601 . . . . 1.6699999999999999 110.941 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 63.1 mt -109.84 -46.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.59 -0.732 . . . . 1.9099999999999999 110.788 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -99.25 -42.39 7.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.165 0.432 . . . . 2.21 112.165 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -80.88 -70.01 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.037 0.446 . . . . 2.73 110.562 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -90.97 68.68 6.24 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.953 -0.567 . . . . 2.5899999999999999 109.504 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -56.28 95.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 2.1600000000000001 111.714 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -90.97 4.86 50.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 2.2400000000000002 111.163 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 74.58 -56.81 0.63 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.504 0.721 . . . . 2.6099999999999999 110.407 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.7 mt 59.93 44.6 13.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.011 -0.54 . . . . 1.24 111.446 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.85 -23.77 22.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.269 0.557 . . . . 0.95999999999999996 110.134 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.84 138.23 19.47 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.58 -0.736 . . . . 1.21 110.541 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.51 -37.31 95.23 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.89 2.393 . . . . 0.97999999999999998 112.384 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -61.76 -34.35 75.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 2.6200000000000001 110.742 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -69.83 -45.53 67.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.153 0.502 . . . . 2.5099999999999998 110.392 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 62.6 mtm -65.2 -43.77 90.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.93999999999999995 110.714 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.721 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -67.29 -38.43 85.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.788 -0.642 . . . . 0.95999999999999996 111.434 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.94 -48.21 82.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 1.8300000000000001 111.59 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -64.09 -49.13 73.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 1.52 111.211 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -65.25 -30.63 71.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.07 0.396 . . . . 0.98999999999999999 112.07 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.57 -36.77 72.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 1.25 111.01 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.4 6.1 82.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.579 -0.82 . . . . 1.6100000000000001 112.511 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -107.83 1.64 22.97 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.718 -0.283 . . . . 2.9500000000000002 111.362 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.92 -7.67 21.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.513 -0.851 . . . . 1.47 112.864 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 21.3 t -93.67 144.02 10.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.109 -0.33 . . . . 1.2 110.109 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 24.7 t0 -84.02 124.07 30.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.701 0.286 . . . . 1.5600000000000001 110.576 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.721 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 32.9 ttpt -60.03 -33.27 71.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 1.5700000000000001 111.049 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 73.2 mt-10 -64.88 -65.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.171 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.631 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -56.6 -34.6 67.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.762 -0.654 . . . . 2.6099999999999999 111.741 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -62.5 -56.9 13.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.756 -0.202 . . . . 1.4399999999999999 111.088 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.15 -38.47 89.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.887 0.329 . . . . 1.1299999999999999 111.887 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.8 m -64.0 -47.79 78.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.71 0.29 . . . . 1.46 110.621 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.6 m -68.93 -35.98 77.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.381 -0.372 . . . . 1.53 111.068 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -57.33 -32.57 66.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.555 . . . . 1.53 110.627 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -99.36 13.76 32.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.869 -0.605 . . . . 1.6100000000000001 111.432 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.9 m -97.63 163.71 12.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 1.49 111.29 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -18.23 61.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.813 -0.63 . . . . 1.3999999999999999 111.082 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.93 -37.41 68.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 111.611 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.86 -41.85 39.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.099 -0.5 . . . . 1.1899999999999999 110.216 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -56.46 -45.11 81.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.727 -0.67 . . . . 1.8999999999999999 111.558 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.93 -36.83 89.63 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.021 -0.609 . . . . 0.75 113.052 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -79.66 -37.69 35.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 1.6699999999999999 110.182 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 54.7 mmm -58.27 -50.93 71.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.644 . . . . 1.8500000000000001 111.059 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -67.79 -24.62 65.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.073 -0.512 . . . . 2.0299999999999998 111.756 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 87.0 tttt -79.02 -44.02 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 3.0800000000000001 111.088 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.69 65.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.885 0.374 . . . . 0.34999999999999998 110.792 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -57.32 -48.41 79.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.47 -0.786 . . . . 1.6899999999999999 111.758 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -69.5 -37.7 77.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.535 -0.302 . . . . 2.1000000000000001 111.305 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.7 mt -65.73 -40.81 92.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.511 -0.313 . . . . 0.56000000000000005 111.08 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.54 87.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.025 0.441 . . . . 0.48999999999999999 110.777 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 38.5 mmt -68.47 -34.91 76.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.813 -0.63 . . . . 2.5699999999999998 110.472 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.69 71.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.84 -0.618 . . . . 0.42999999999999999 111.206 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.419 ' HB3' HG21 ' A' ' 157' ' ' VAL . 25.0 m-85 -76.54 4.62 8.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.173 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 59.44 30.41 20.09 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.71 -0.677 . . . . 1.4099999999999999 112.448 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.85 113.33 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 1.26 109.657 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.32 -11.05 14.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.856 0.317 . . . . 1.25 111.856 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.88 179.29 32.79 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.57 -0.824 . . . . 0.68999999999999995 111.958 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.67 141.43 38.72 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 120.614 0.245 . . . . 0.64000000000000001 111.266 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.79 173.83 52.09 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.953 -1.686 . . . . 0.66000000000000003 111.967 -0.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -156.28 135.56 12.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.376 -0.374 . . . . 0.56999999999999995 110.127 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 98.5 mtp -117.19 133.14 56.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.627 -0.508 . . . . 0.92000000000000004 109.627 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 148' ' ' TYR . 9.6 t -121.36 128.12 75.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.409 -0.36 . . . . 0.40000000000000002 110.311 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.2 t -109.04 115.78 50.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.352 -0.386 . . . . 0.58999999999999997 111.286 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.25 21.24 3.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.337 -0.847 . . . . 1.0800000000000001 113.04 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.48 26.52 64.52 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.094 -0.574 . . . . 0.48999999999999999 113.214 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.513 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 39.9 mttp -118.07 -40.73 2.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.871 0.367 . . . . 1.72 111.168 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -121.38 138.75 54.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.256 -0.429 . . . . 1.5 111.03 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 62.8 ttp85 -120.87 131.94 54.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.743 -0.662 . . . . 1.6599999999999999 109.282 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -147.61 168.14 22.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.978 0.418 . . . . 0.63 110.65 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.08 179.41 7.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.787 -0.642 . . . . 1.3500000000000001 109.515 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 mt -62.41 -35.42 69.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 123.269 0.356 . . . . 0.68999999999999995 111.324 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.93 -40.4 89.09 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.008 -0.615 . . . . 0.72999999999999998 112.25 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.6 m -74.01 -42.69 59.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.608 0.242 . . . . 1.1499999999999999 111.544 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.09 -43.19 58.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.849 0.314 . . . . 0.71999999999999997 111.849 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 126.1 -51.3 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.039 -0.601 . . . . 1.1000000000000001 111.888 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.14 164.45 25.57 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.182 -0.532 . . . . 0.72999999999999998 111.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.29 -49.99 14.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.47 2.78 . . . . 0.84999999999999998 112.423 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -63.98 -37.48 87.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.004 0.431 . . . . 2.52 110.442 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -66.35 -28.32 68.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.657 . . . . 1.8200000000000001 110.167 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.9 m -65.47 -44.08 88.28 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.536 -0.542 . . . . 0.62 109.536 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.8 mt -68.66 -32.3 72.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.881 -0.599 . . . . 0.72999999999999998 109.998 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -62.27 -39.48 93.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.746 -0.661 . . . . 2.3399999999999999 109.903 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.66 -42.54 86.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.684 -0.689 . . . . 0.69999999999999996 109.718 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.95 83.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.662 -0.699 . . . . 0.65000000000000002 111.067 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -40.24 72.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.028 -0.533 . . . . 1.9099999999999999 110.924 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -71.86 -44.73 63.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 1.8200000000000001 110.6 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.48 -29.45 70.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.75 111.229 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 187' ' ' ARG . 53.2 mt -59.21 -47.08 91.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.792 -0.447 . . . . 0.77000000000000002 109.792 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -74.51 -34.16 62.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 2.1699999999999999 110.19 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -54.55 -44.33 72.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 2.4100000000000001 111.054 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -85.87 -29.94 23.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.377 . . . . 1.6399999999999999 111.412 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -72.19 -23.54 61.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.617 -0.265 . . . . 1.72 111.016 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.71 -20.74 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.511 -0.313 . . . . 1.1299999999999999 111.47 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.314 -0.403 . . . . 1.1699999999999999 110.77 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 55.32 22.68 5.02 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.092 0.557 . . . . 1.8400000000000001 112.01 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.77 51.81 10.4 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.283 0.564 . . . . 6.4299999999999997 110.811 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.404 ' H ' ' HG3' ' A' ' 192' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.454 -0.784 . . . . 7.3200000000000003 110.413 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.925 -0.47 . . . . 2.2000000000000002 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 62.35 75.21 0.41 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.021 0.529 . . . . 2.1299999999999999 111.292 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -118.59 21.6 12.48 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.294 0.569 . . . . 1.97 110.386 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -134.41 155.62 49.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.91 -0.586 . . . . 1.2 109.537 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.76 134.93 54.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.191 0.52 . . . . 1.29 111.683 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.04 124.1 23.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 1.03 110.389 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.63 -23.28 35.51 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.88 -0.676 . . . . 1.1399999999999999 111.776 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -93.73 -75.81 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.193 -0.299 . . . . 1.8899999999999999 110.193 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -75.28 -44.06 47.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.568 -0.287 . . . . 1.55 111.576 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -133.46 151.12 51.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.59 0.233 . . . . 1.03 110.45 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.2 t -109.38 121.05 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.961 0.41 . . . . 0.91000000000000003 110.522 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -87.42 131.18 34.4 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.116 -0.493 . . . . 1.8200000000000001 109.836 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.22 128.37 35.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.398 -0.364 . . . . 1.04 110.577 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 m -69.23 -26.52 64.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 1.54 110.147 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 m -114.61 97.55 47.03 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.634 -0.712 . . . . 1.28 109.365 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.24 151.63 15.83 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.837 2.358 . . . . 0.90000000000000002 113.133 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.2 t -115.1 121.84 34.42 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.992 -0.549 . . . . 0.81000000000000005 110.215 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -72.31 122.69 8.56 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.273 1.982 . . . . 1.0900000000000001 111.774 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.38 158.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.12 -0.491 . . . . 1.05 111.898 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.14 -11.08 57.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.834 -0.621 . . . . 1.6399999999999999 110.999 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.82 96.25 43.83 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.447 -0.342 . . . . 3.3300000000000001 111.154 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.64 149.36 12.76 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.703 2.268 . . . . 1.6599999999999999 112.019 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.07 -26.3 7.87 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.816 -0.707 . . . . 0.94999999999999996 112.972 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 137.68 44.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.687 -0.486 . . . . 2.4700000000000002 109.687 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.16 119.66 24.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 110.464 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -85.95 121.21 28.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.592 -0.731 . . . . 2.6899999999999999 110.973 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -127.45 94.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.648 -0.871 . . . . 0.55000000000000004 108.648 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 32.5 t -99.85 129.55 50.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.054 -0.521 . . . . 0.69999999999999996 111.319 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 156' ' ' MET . 0.9 OUTLIER -111.26 116.7 31.47 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.576 -0.898 . . . . 2.4300000000000002 108.576 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 2.8 mp -101.37 110.34 22.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.488 . . . . 0.85999999999999999 110.463 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -114.52 175.39 5.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.3999999999999999 110.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -151.6 171.0 18.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 1.1599999999999999 110.234 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -80.83 -20.45 42.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.064 0.459 . . . . 4.8099999999999996 110.593 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.23 19.33 43.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.683 -0.77 . . . . 1.6200000000000001 114.312 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 99' ' ' HIS . 27.2 p -109.23 106.17 58.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 117.716 0.758 . . . . 0.93000000000000005 110.238 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.44 -37.34 30.64 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.392 2.061 . . . . 1.1000000000000001 113.015 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -24.93 66.77 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.396 -0.366 . . . . 1.47 111.948 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 54.7 m -67.99 -36.43 79.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.947 0.403 . . . . 0.93999999999999995 110.629 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.66 -33.0 74.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.95 0.405 . . . . 2.6299999999999999 110.862 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.08 3.15 47.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 0.97999999999999998 111.346 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -102.92 -27.49 12.61 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.76000000000000001 110.579 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 13.6 mm-40 -49.18 -56.48 15.65 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 112.743 0.646 . . . . 2.6899999999999999 112.743 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' A' ' 44' ' ' GLU . 41.8 Cg_endo -66.38 -1.69 5.98 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.997 1.798 . . . . 0.81000000000000005 113.695 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 m -109.52 -39.95 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.317 . . . . 0.70999999999999996 111.855 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 tt -82.92 -31.1 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.548 0.573 . . . . 0.83999999999999997 112.548 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 55.6 t -58.67 -54.14 59.25 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.107 0.41 . . . . 0.94999999999999996 112.107 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 38.6 Cg_endo -67.29 -2.79 8.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.04 1.827 . . . . 0.94999999999999996 112.771 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -101.72 -46.95 4.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.913 0.387 . . . . 0.81999999999999995 110.076 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 m -63.88 -32.3 73.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.901 -0.591 . . . . 1.22 111.978 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -78.31 -6.61 55.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.788 0.328 . . . . 2.1400000000000001 111.215 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.21 7.37 23.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.983 0.421 . . . . 2.0899999999999999 110.518 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.9 mt -77.96 145.34 69.68 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.13 -0.486 . . . . 0.81000000000000005 111.079 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.8 168.77 19.28 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.595 2.197 . . . . 0.98999999999999999 111.721 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.41 27.91 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.0 0.428 . . . . 1.1399999999999999 111.835 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 27.9 t70 -112.54 -11.16 13.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.547 0.689 . . . . 1.6499999999999999 109.922 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.1 t -110.12 138.69 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.324 -0.853 . . . . 0.68000000000000005 110.794 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -116.55 92.43 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.591 -0.522 . . . . 1.27 109.591 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -71.32 128.55 36.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.814 -0.63 . . . . 1.3899999999999999 110.686 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 78.7 t -132.62 131.54 59.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.052 -0.522 . . . . 0.69999999999999996 109.738 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -114.23 124.44 52.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.679 -0.489 . . . . 4.2300000000000004 109.679 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 95.2 mt -126.98 151.63 74.38 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.281 -0.418 . . . . 0.60999999999999999 110.539 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.34 156.52 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.631 2.221 . . . . 0.48999999999999999 111.922 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -76.73 79.43 3.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.199 0.523 . . . . 0.45000000000000001 110.567 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.0 78.6 9.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 0.53000000000000003 111.254 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -102.95 26.32 8.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 1.71 110.943 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 84.11 -173.66 50.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.799 -0.715 . . . . 1.3899999999999999 111.777 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.98 -135.37 39.54 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.174 -0.536 . . . . 1.24 112.755 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.8 tp -78.04 -16.54 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 1.1599999999999999 110.807 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.51 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 40.3 m95 -62.98 -46.16 88.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.699 -0.682 . . . . 0.78000000000000003 110.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -34.94 75.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.703 -0.68 . . . . 1.99 110.956 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.57 -41.61 88.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.365 0.602 . . . . 0.89000000000000001 109.759 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -86.41 51.31 2.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.704 -0.68 . . . . 1.46 110.34 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.64 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.679 -0.691 . . . . 0.66000000000000003 112.412 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -56.16 -37.98 70.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.778 0.323 . . . . 2.1200000000000001 111.215 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.3 ttt -55.49 -38.07 68.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.038 -0.528 . . . . 1.4299999999999999 111.499 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.42 -52.5 63.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 1.0600000000000001 111.285 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.8 mt -63.74 -25.31 68.13 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.63 111.561 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.5 m -67.14 -38.89 86.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.433 . . . . 0.68999999999999995 110.716 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 115' ' ' LEU . 77.6 mt -72.96 -40.93 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 1.6899999999999999 111.006 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -59.92 -31.53 69.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.515 . . . . 2.1899999999999999 111.214 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m -92.69 12.86 21.89 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.392 0.516 . . . . 1.26 112.392 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 51.1 ttm -93.65 -17.95 22.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.054 0.454 . . . . 1.7 110.668 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.51 65.74 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.951 -0.642 . . . . 2.2000000000000002 112.504 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.61 149.44 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.872 0.368 . . . . 2.3599999999999999 111.037 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.48 156.34 35.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.441 -0.577 . . . . 5.2800000000000002 109.441 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.7 m80 57.58 41.86 25.04 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.251 0.548 . . . . 5.2599999999999998 110.279 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -104.44 15.5 28.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.575 -0.739 . . . . 5.4500000000000002 110.574 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.1 t 66.05 69.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.631 0.729 . . . . 3.7599999999999998 109.256 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -22.08 65.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.344 -0.844 . . . . 4.2599999999999998 111.029 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -69.23 -23.07 63.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 2.8799999999999999 111.02 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.78 69.42 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.939 0.399 . . . . 1.71 110.699 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.83 -38.12 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.017 -0.538 . . . . 1.7 109.767 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -63.56 -33.6 75.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.887 -0.597 . . . . 3.2999999999999998 110.247 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 5.4 mm-40 -65.98 -46.58 77.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 2.6099999999999999 111.043 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -67.7 -23.49 65.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.811 -0.631 . . . . 1.6699999999999999 111.553 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.6 mt -88.82 -47.21 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.334 -0.394 . . . . 1.9099999999999999 112.058 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.417 ' HE1' ' O ' ' A' ' 37' ' ' CYS . 56.8 m-70 -86.45 -52.82 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.362 0.875 . . . . 2.21 113.362 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.49 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 1.3 mmmm -75.9 -57.54 3.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.628 0.232 . . . . 2.73 111.628 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.9 mm-40 -68.81 -58.57 3.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.533 -0.303 . . . . 2.5899999999999999 110.707 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 59.29 57.74 3.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.95 -0.568 . . . . 2.1600000000000001 109.594 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -81.36 22.33 0.69 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.555 -0.748 . . . . 2.2400000000000002 112.023 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 55.41 78.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.321 0.581 . . . . 2.6099999999999999 110.375 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.3 mt -96.92 77.36 2.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.029 -0.532 . . . . 1.24 110.049 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.91 -54.45 2.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.95999999999999996 110.955 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.47 145.84 49.03 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.464 . . . . 1.21 111.088 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.98 -23.7 61.43 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.029 2.486 . . . . 0.97999999999999998 113.103 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.52 -57.28 13.39 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.417 -0.356 . . . . 2.6200000000000001 110.436 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -64.82 -33.28 75.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 2.5099999999999998 110.745 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.64 -53.9 51.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.282 0.563 . . . . 0.93999999999999995 110.402 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -68.71 -28.56 66.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.574 -0.739 . . . . 0.95999999999999996 111.345 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -64.36 -31.4 72.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 1.8300000000000001 110.722 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.55 -41.32 19.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.662 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD13 HD21 ' A' ' 81' ' ' LEU . 97.2 mt -64.86 -30.95 71.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.701 . . . . 0.98999999999999999 111.656 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.34 -12.3 40.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.69 0.281 . . . . 1.25 111.2 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 12.51 60.46 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.757 -0.735 . . . . 1.6100000000000001 112.876 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.23 34.63 1.7 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.306 0.553 . . . . 2.9500000000000002 111.822 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.5 52.74 5.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.125 -0.56 . . . . 1.47 113.847 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.9 t -139.47 123.47 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.724 -0.473 . . . . 1.2 109.724 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 62.3 t0 -73.34 113.13 10.08 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.859 0.361 . . . . 1.5600000000000001 110.066 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 30.1 ttmt -56.79 -38.0 71.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.487 -0.779 . . . . 1.5700000000000001 111.494 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -65.53 -46.28 80.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.355 -0.384 . . . . 2.29 111.741 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 47.9 mmtm -64.64 -42.13 95.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 2.6099999999999999 110.25 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.437 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 83.0 t80 -58.67 -56.9 16.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 1.4399999999999999 110.866 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -60.73 -39.86 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.971 0.36 . . . . 1.1299999999999999 111.971 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 60.3 m -63.13 -53.56 51.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.644 -0.253 . . . . 1.46 111.461 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.459 ' HA ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -73.16 -22.88 60.41 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.748 0.277 . . . . 1.53 111.748 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 53.6 t80 -61.01 -30.98 70.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.12 0.486 . . . . 1.53 110.543 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -100.94 7.83 43.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.633 . . . . 1.6100000000000001 111.316 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 26.9 m -86.27 155.87 20.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.015 0.436 . . . . 1.49 110.94 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -69.22 -19.6 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.042 -0.526 . . . . 1.3999999999999999 110.766 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.92 -36.14 67.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.144 0.497 . . . . 0.92000000000000004 110.971 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.7 mm -84.94 -38.32 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.987 -0.551 . . . . 1.1899999999999999 109.683 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -57.86 -41.74 83.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.799 -0.637 . . . . 1.8999999999999999 111.026 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.38 87.77 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.972 -0.632 . . . . 0.75 112.038 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.5 -32.91 54.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 1.6699999999999999 110.04 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 80.3 mmm -62.88 -52.47 62.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.735 -0.666 . . . . 1.8500000000000001 110.691 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -27.43 67.84 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.291 -0.413 . . . . 2.0299999999999998 110.739 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 143' ' ' LYS . 7.2 tmtt? -70.35 -42.33 71.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.012 -0.366 . . . . 3.0800000000000001 110.012 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.43 65.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.054 -0.521 . . . . 0.34999999999999998 110.702 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -57.93 -48.43 79.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 1.6899999999999999 111.365 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -68.59 -16.48 63.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.444 -0.343 . . . . 2.1000000000000001 111.798 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.85 -37.74 15.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.715 0.293 . . . . 0.56000000000000005 110.273 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.21 -48.13 82.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.48999999999999999 111.475 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -72.87 -20.46 61.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 2.5699999999999998 111.458 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.67 23.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.832 0.348 . . . . 0.42999999999999999 111.221 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -82.55 9.81 8.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.63 111.631 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 62.73 30.31 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.108 -0.497 . . . . 1.4099999999999999 112.274 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.31 116.37 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.818 -0.438 . . . . 1.26 109.818 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.34 23.21 5.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.253 -0.43 . . . . 1.25 110.993 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -173.96 179.23 45.46 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.752 -0.737 . . . . 0.68999999999999995 111.603 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.28 137.51 12.83 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.624 0.249 . . . . 0.64000000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.01 169.05 71.22 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.253 -1.561 . . . . 0.66000000000000003 112.229 -0.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.5 m -155.84 125.89 6.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.56999999999999995 110.498 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.446 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 96.2 mtp -106.54 137.27 44.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.836 -0.62 . . . . 0.92000000000000004 109.804 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.63 136.8 58.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.327 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.9 t -113.4 111.79 37.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.485 -0.325 . . . . 0.58999999999999997 110.952 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 54.89 30.04 13.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.197 -0.911 . . . . 1.0800000000000001 112.172 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.91 27.12 43.43 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 114.331 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.41 -39.03 2.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.651 0.725 . . . . 1.72 111.657 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.72 130.06 55.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.538 -0.301 . . . . 1.5 110.238 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -117.92 131.15 56.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.961 0.41 . . . . 1.6599999999999999 110.209 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -147.94 160.52 42.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.106 -0.497 . . . . 0.63 109.761 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -154.36 179.03 9.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.138 -0.483 . . . . 1.3500000000000001 110.43 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.07 -34.19 67.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.609 -0.723 . . . . 0.68999999999999995 111.459 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -69.06 -46.29 59.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.862 -0.685 . . . . 0.72999999999999998 112.398 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.9 m -67.29 -46.35 73.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.734 0.302 . . . . 1.1499999999999999 110.903 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.47 66.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.71999999999999997 111.011 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.18 -34.3 5.79 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.907 -0.663 . . . . 1.1000000000000001 112.039 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.15 164.37 34.31 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.637 -0.585 . . . . 0.72999999999999998 111.637 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.05 -36.04 90.78 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.016 2.477 . . . . 0.84999999999999998 112.99 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -69.57 -38.2 77.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.244 0.545 . . . . 2.52 109.975 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.53 -25.99 65.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.644 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 4.1 m -62.64 -44.54 96.02 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.067 -0.515 . . . . 0.62 110.575 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.45 -31.34 71.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.72999999999999998 110.338 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.52 -44.09 95.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.693 -0.685 . . . . 2.3399999999999999 110.026 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.5 -38.3 77.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.799 -0.637 . . . . 0.69999999999999996 110.358 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.4 -48.21 81.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.65000000000000002 111.117 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -58.19 -40.15 80.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 1.9099999999999999 110.697 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -66.69 -45.17 79.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.751 -0.659 . . . . 1.8200000000000001 110.839 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.93 -39.34 93.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.559 -0.292 . . . . 0.75 111.255 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 179' ' ' ALA . 84.2 mt -60.76 -45.06 98.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.008 0.432 . . . . 0.77000000000000002 110.166 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.59 -40.72 84.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.723 -0.671 . . . . 2.1699999999999999 110.138 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -55.75 -44.67 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.891 -0.595 . . . . 2.4100000000000001 110.671 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.16 -39.81 68.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.963 -0.562 . . . . 1.6399999999999999 111.14 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.478 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -64.01 -33.8 76.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.72 110.93 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.14 76.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 1.1299999999999999 111.676 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.19 -6.63 53.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.253 -0.43 . . . . 1.1699999999999999 111.414 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.45 27.64 2.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.905 0.383 . . . . 1.8400000000000001 110.935 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -96.05 78.32 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 6.4299999999999997 110.578 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 32.3 pttt . . . . . 0 C--O 1.248 1.017 0 O-C-N 124.529 1.143 . . . . 7.3200000000000003 112.614 -179.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.687 -0.565 . . . . 2.2000000000000002 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.74 153.44 0.14 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.357 0.663 . . . . 2.1299999999999999 110.727 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -151.53 18.44 0.72 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.097 0.475 . . . . 1.97 110.665 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -132.91 154.91 49.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 1.2 110.667 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.14 138.41 54.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.047 -0.524 . . . . 1.29 111.554 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.22 124.46 27.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.785 -0.45 . . . . 1.03 109.785 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.31 -11.5 60.04 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.928 -0.869 . . . . 1.1399999999999999 110.928 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.94 -69.37 0.84 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.985 -0.376 . . . . 1.8899999999999999 109.985 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -88.47 -38.23 15.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 1.55 111.178 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -141.67 159.59 41.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.082 -0.34 . . . . 1.03 110.082 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.44 136.3 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.856 0.36 . . . . 0.91000000000000003 110.478 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -109.87 118.01 35.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.846 -0.428 . . . . 1.8200000000000001 109.846 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 141.48 55.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 1.04 110.97 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -7.62 54.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 1.54 111.795 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -128.66 84.13 64.08 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.137 -0.483 . . . . 1.28 110.381 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.94 144.47 58.55 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.668 2.245 . . . . 0.90000000000000002 112.952 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.06 126.05 29.14 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.722 -0.672 . . . . 0.81000000000000005 109.966 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -72.48 141.13 34.35 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.347 2.032 . . . . 1.0900000000000001 112.285 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.4 m -76.66 171.21 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 1.05 110.877 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -61.85 2.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.386 -0.37 . . . . 1.6399999999999999 111.133 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -116.22 131.83 23.59 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.294 -0.261 . . . . 3.3300000000000001 110.294 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.64 158.07 43.81 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.513 2.142 . . . . 1.6599999999999999 112.545 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.36 -58.23 0.4 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.87 -0.681 . . . . 0.94999999999999996 112.293 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -83.54 149.21 26.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.327 -0.249 . . . . 2.4700000000000002 110.327 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.0 mm -91.5 126.66 44.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.045 -0.525 . . . . 0.70999999999999996 110.722 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -89.78 125.5 35.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.554 -0.748 . . . . 2.6899999999999999 110.49 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -124.93 92.59 2.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.472 -0.566 . . . . 0.55000000000000004 109.472 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.5 t -90.88 125.34 43.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.832 -0.622 . . . . 0.69999999999999996 110.988 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -109.13 116.01 31.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.558 -0.746 . . . . 2.4300000000000002 109.748 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 4.3 mp -95.55 113.23 24.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.127 -0.488 . . . . 0.85999999999999999 110.611 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -119.67 169.59 9.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.78 -0.645 . . . . 1.3999999999999999 110.41 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -145.02 162.03 37.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.083 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -82.46 7.01 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.452 -0.34 . . . . 4.8099999999999996 111.879 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.18 13.85 5.7 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.199 -1.0 . . . . 1.6200000000000001 113.976 -178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 5.2 p -106.49 114.71 61.77 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 117.464 0.632 . . . . 0.93000000000000005 110.261 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.12 -40.45 41.99 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.037 2.491 . . . . 1.1000000000000001 113.831 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -67.11 -21.78 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.066 0.395 . . . . 1.47 112.066 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 81.5 m -66.28 -33.64 76.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.349 . . . . 0.93999999999999995 110.604 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.46 -40.04 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 2.6299999999999999 111.262 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.32 -12.94 60.38 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.965 0.358 . . . . 0.97999999999999998 111.965 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -89.2 -23.05 22.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.6 -0.273 . . . . 0.76000000000000001 111.31 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 48' ' ' VAL . 4.2 mt-10 -54.05 -58.02 15.4 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 112.353 0.501 . . . . 2.6899999999999999 112.353 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.23 -14.76 40.17 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.108 1.872 . . . . 0.81000000000000005 113.362 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.31 -30.27 15.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.70999999999999996 111.309 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG12 ' HG ' ' A' ' 51' ' ' SER . 13.7 tt -95.0 -18.16 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.255 0.465 . . . . 0.83999999999999997 112.255 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 44' ' ' GLU . 24.4 t -59.39 -54.43 56.14 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 111.871 0.322 . . . . 0.94999999999999996 111.871 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 36.6 Cg_endo -65.47 -3.13 7.15 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.264 1.976 . . . . 0.94999999999999996 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -102.6 -52.8 3.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.127 -0.488 . . . . 0.81999999999999995 109.925 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.401 ' HG ' HG12 ' A' ' 47' ' ' ILE . 12.9 m -64.95 -33.58 76.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 1.22 112.081 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.73 -5.26 47.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.663 0.268 . . . . 2.1400000000000001 111.472 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 49' ' ' PRO . 3.1 mptp? -124.62 35.05 4.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.947 0.403 . . . . 2.0899999999999999 110.542 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -86.82 150.97 51.64 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.404 -0.362 . . . . 0.81000000000000005 110.992 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.58 169.18 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.319 2.013 . . . . 0.98999999999999999 111.951 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.77 14.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 1.1399999999999999 112.19 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.69 5.72 11.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.949 0.404 . . . . 1.6499999999999999 110.597 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.4 t -129.69 122.09 54.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.514 . . . . 0.68000000000000005 110.363 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -116.43 110.56 18.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.761 0.315 . . . . 1.27 110.353 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -74.39 138.04 43.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.075 -0.511 . . . . 1.3899999999999999 110.508 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.406 HG12 ' HG ' ' A' ' 63' ' ' LEU . 27.8 t -130.61 111.31 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 110.739 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -88.29 120.82 30.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.058 -0.719 . . . . 4.2300000000000004 109.058 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 61.1 mt -135.45 130.5 19.05 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.153 0.502 . . . . 0.60999999999999999 111.46 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.61 146.88 34.99 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.413 2.075 . . . . 0.48999999999999999 111.781 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.43 90.91 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.295 0.569 . . . . 0.45000000000000001 110.931 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.2 mt -89.08 67.41 8.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.826 -0.625 . . . . 0.53000000000000003 111.2 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -92.37 47.97 1.36 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.123 0.487 . . . . 1.71 111.095 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.41 -155.52 36.2 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.375 -0.829 . . . . 1.3899999999999999 113.371 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.63 -125.7 18.66 Favored Glycine 0 C--N 1.336 0.535 0 O-C-N 123.74 0.318 . . . . 1.24 113.403 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.6 tp -99.88 -5.14 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.414 0.626 . . . . 1.1599999999999999 109.765 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -69.25 -48.24 62.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.659 -0.7 . . . . 0.78000000000000003 110.583 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -63.19 -34.27 77.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.251 -0.432 . . . . 1.99 111.03 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.7 t -68.17 -29.88 46.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.539 0.685 . . . . 0.89000000000000001 109.715 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -93.36 24.23 4.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.407 -0.815 . . . . 1.46 110.595 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.98 -28.8 0.27 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.708 -0.758 . . . . 0.66000000000000003 112.184 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -56.94 -33.64 67.2 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.838 0.351 . . . . 2.1200000000000001 111.343 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.8 ttt -55.06 -38.57 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.868 -0.606 . . . . 1.4299999999999999 111.259 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.73 -52.98 61.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.163 -0.471 . . . . 1.0600000000000001 111.602 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -62.28 -32.67 73.42 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.432 -0.349 . . . . 0.63 111.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.7 m -64.66 -36.44 84.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.953 0.406 . . . . 0.68999999999999995 110.563 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.62 -45.45 75.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 1.6899999999999999 110.695 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.19 -36.47 79.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.95 -0.568 . . . . 2.1899999999999999 111.561 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -72.25 -2.47 19.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.473 0.546 . . . . 1.26 112.473 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 13.2 mtm -91.03 -6.77 53.45 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.754 -0.379 . . . . 1.7 110.49 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.52 38.15 68.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.093 -0.575 . . . . 2.2000000000000002 112.597 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.45 140.96 28.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.787 0.327 . . . . 2.3599999999999999 110.811 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.35 156.94 44.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.007 -0.542 . . . . 5.2800000000000002 110.028 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.1 m80 58.66 40.57 23.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.46 0.648 . . . . 5.2599999999999998 110.556 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.92 2.24 32.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.373 -0.83 . . . . 5.4500000000000002 110.304 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 45.4 t 66.79 79.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.83 . . . . 3.7599999999999998 109.831 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -28.49 68.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.32 -0.854 . . . . 4.2599999999999998 110.218 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -59.51 -29.32 67.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.693 -0.685 . . . . 2.8799999999999999 111.349 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.55 -36.74 76.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.091 0.472 . . . . 1.71 110.372 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -70.67 -43.71 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 1.7 109.639 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -39.15 82.29 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.775 -0.648 . . . . 3.2999999999999998 110.514 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.83 -47.26 85.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 2.6099999999999999 110.822 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 101' ' ' GLU . . . -65.19 -28.31 69.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.393 -0.367 . . . . 1.6699999999999999 111.712 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -78.48 -42.34 26.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 111.99 0.367 . . . . 1.9099999999999999 111.99 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -88.84 -38.32 14.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.446 0.906 . . . . 2.21 113.446 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -88.73 -53.42 4.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.015 -0.274 . . . . 2.73 111.634 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 97' ' ' ALA . 35.9 mm-40 -72.18 -52.43 16.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.601 0.238 . . . . 2.5899999999999999 110.898 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 56.89 69.01 0.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.678 -0.692 . . . . 2.1600000000000001 110.701 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -90.04 9.01 29.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.052 -0.522 . . . . 2.2400000000000002 111.005 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 tttt 65.41 85.56 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.575 -0.739 . . . . 2.6099999999999999 111.366 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.9 mt -91.31 72.06 6.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.999 -0.546 . . . . 1.24 110.114 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.53 -44.84 6.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.237 -0.438 . . . . 0.95999999999999996 110.992 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.56 147.17 33.15 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 1.21 111.299 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.52 -27.1 81.18 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 0.97999999999999998 113.044 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 6.7 mt-10 -61.05 -48.15 83.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.324 -0.398 . . . . 2.6200000000000001 110.769 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.25 -42.3 90.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 2.5099999999999998 110.524 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 53.5 mtt -60.93 -52.33 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.283 -0.871 . . . . 0.93999999999999995 110.624 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.96 -35.99 82.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.95999999999999996 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 2.1 t70 -62.25 -48.47 79.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.519 . . . . 1.8300000000000001 110.819 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -69.46 -42.71 74.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 1.52 111.161 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.4 -33.56 73.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 0.98999999999999999 111.25 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.36 7.13 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.448 -0.342 . . . . 1.25 111.263 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.19 -3.58 35.77 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 116.128 -0.487 . . . . 1.6100000000000001 112.02 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -130.19 19.34 5.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.752 0.311 . . . . 2.9500000000000002 111.479 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.13 64.06 1.08 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.479 -0.867 . . . . 1.47 113.078 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.4 t -147.0 139.37 19.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.153 -0.684 . . . . 1.2 109.153 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.648 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 37.2 t70 -96.36 123.82 40.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.665 0.269 . . . . 1.5600000000000001 110.475 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -64.56 -40.2 95.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.13 -0.486 . . . . 1.5700000000000001 111.521 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 55.3 mm-40 -55.87 -54.88 39.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.569 -0.287 . . . . 2.29 110.919 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.648 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 35.8 mmtm -65.84 -38.34 88.62 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.555 -0.293 . . . . 2.6099999999999999 110.644 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 87.2 t80 -59.32 -55.36 35.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.052 -0.522 . . . . 1.4399999999999999 110.681 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.69 -32.86 74.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 1.1299999999999999 111.483 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.5 m -60.16 -56.74 17.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.444 -0.344 . . . . 1.46 110.906 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.3 t -74.13 -23.8 59.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.565 -0.288 . . . . 1.53 111.462 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 38.2 t80 -61.3 -32.98 72.83 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.032 0.444 . . . . 1.53 110.73 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -105.28 24.84 11.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.029 -0.532 . . . . 1.6100000000000001 111.106 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 62.1 m -105.77 156.61 18.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.122 -0.49 . . . . 1.49 110.789 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -68.71 -20.94 64.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 1.3999999999999999 110.967 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.48 67.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.098 0.475 . . . . 0.92000000000000004 110.612 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.82 -41.53 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.091 0.472 . . . . 1.1899999999999999 109.806 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.93 -42.13 79.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.702 -0.681 . . . . 1.8999999999999999 111.142 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.58 -40.3 98.96 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.14 -0.552 . . . . 0.75 112.027 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.1 -35.47 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.029 0.442 . . . . 1.6699999999999999 109.908 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.7 mmm -59.1 -51.61 69.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.375 -0.829 . . . . 1.8500000000000001 110.964 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 2.5 pt-20 -70.86 -26.94 63.49 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.783 -0.367 . . . . 2.0299999999999998 110.812 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.67 -47.78 84.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.322 -0.399 . . . . 3.0800000000000001 110.318 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.21 39.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.104 -0.498 . . . . 0.34999999999999998 110.845 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 139' ' ' GLU . 73.8 tttt -55.57 -53.65 53.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 1.6899999999999999 111.603 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 139' ' ' GLU . 35.5 pttt -73.23 -24.07 60.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.804 -0.358 . . . . 2.1000000000000001 111.578 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 mt -76.38 -33.85 58.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.87 -0.332 . . . . 0.56000000000000005 110.868 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.3 90.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.157 0.503 . . . . 0.48999999999999999 110.842 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 17.4 ptp -80.26 -20.85 43.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.828 -0.623 . . . . 2.5699999999999998 110.39 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.92 -34.43 59.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.42999999999999999 110.442 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -80.16 2.84 22.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.815 -0.63 . . . . 0.63 110.107 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 59.46 44.77 14.49 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.438 -0.801 . . . . 1.4099999999999999 112.173 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.9 130.39 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.49 . . . . 1.26 109.864 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.89 20.29 5.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.008 0.373 . . . . 1.25 112.008 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.83 173.23 43.39 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.078 -1.058 . . . . 0.68999999999999995 112.579 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.91 143.35 36.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.283 -0.265 . . . . 0.64000000000000001 110.283 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -80.99 165.45 76.1 Favored 'Cis proline' 0 N--CA 1.461 -0.382 0 C-N-CA 123.015 -1.661 . . . . 0.66000000000000003 112.387 -0.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -158.15 135.94 10.53 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.341 -0.39 . . . . 0.56999999999999995 110.695 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 99.7 mtp -114.27 135.53 53.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.821 -0.437 . . . . 0.92000000000000004 109.821 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.45 130.69 73.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.40000000000000002 110.195 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.07 117.21 54.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 116.412 -0.358 . . . . 0.58999999999999997 111.091 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 161' ' ' LYS . 2.3 m-20 54.86 27.9 9.67 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.961 0.788 . . . . 1.0800000000000001 112.276 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.48 29.89 54.52 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 113.286 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 159' ' ' ASN . 79.8 mttt -128.5 -37.88 1.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.864 0.332 . . . . 1.72 111.619 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.23 132.46 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.686 0.279 . . . . 1.5 111.2 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 25.7 ttp85 -121.63 122.72 40.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.773 -0.649 . . . . 1.6599999999999999 110.131 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -144.12 163.12 34.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.86 0.362 . . . . 0.63 110.281 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -151.6 175.29 12.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.012 -0.54 . . . . 1.3500000000000001 110.013 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.81 -40.04 78.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.68999999999999995 111.668 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -66.06 -49.82 55.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.03 -0.605 . . . . 0.72999999999999998 112.64 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 5.6 m -65.09 -45.39 85.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.535 0.207 . . . . 1.1499999999999999 111.18 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.74 -36.6 84.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.76 0.314 . . . . 0.71999999999999997 110.874 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.46 29.63 6.22 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.543 -0.837 . . . . 1.1000000000000001 112.412 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.28 156.86 7.42 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.616 -0.802 . . . . 0.72999999999999998 112.622 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.01 -40.01 81.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.13 2.553 . . . . 0.84999999999999998 111.971 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -63.3 -46.45 86.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 2.52 109.841 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.28 -35.21 76.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 1.8200000000000001 110.367 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.5 m -60.5 -46.56 89.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.951 -0.568 . . . . 0.62 110.611 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 62.1 mt -65.83 -40.61 91.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.72999999999999998 110.68 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -64.59 -43.37 94.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 2.3399999999999999 110.562 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 182' ' ' LEU . 1.5 mm? -61.12 -41.21 96.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.69999999999999996 110.242 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.28 81.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.818 -0.628 . . . . 0.65000000000000002 111.581 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.58 -42.74 97.3 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.917 0.389 . . . . 1.9099999999999999 110.688 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -61.64 -44.8 96.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 110.683 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 178' ' ' LEU . 98.7 mt -65.52 -36.75 84.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.75 111.02 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 72.3 mt -59.71 -46.86 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.386 . . . . 0.77000000000000002 110.002 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.68 -38.3 90.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 2.1699999999999999 110.697 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -59.63 -45.38 92.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.023 -0.535 . . . . 2.4100000000000001 110.892 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -76.54 -37.44 56.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 1.6399999999999999 111.383 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.7 74.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.511 -0.313 . . . . 1.72 110.521 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -58.92 -31.21 68.44 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.146 -0.479 . . . . 1.1299999999999999 112.11 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.0 -25.46 68.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.161 0.505 . . . . 1.1699999999999999 110.983 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -127.64 41.2 3.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.327 0.584 . . . . 1.8400000000000001 110.0 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 6.3 tptm -90.02 60.57 4.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.645 -0.707 . . . . 6.4299999999999997 110.472 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.027 -0.987 . . . . 7.3200000000000003 112.184 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.151 -0.38 . . . . 2.2000000000000002 112.151 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.53 100.66 0.05 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.263 0.625 . . . . 2.1299999999999999 111.647 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.53 1.9 41.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.741 . . . . 1.97 110.587 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -120.72 167.11 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.112 -0.495 . . . . 1.2 110.295 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -127.77 137.71 52.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.766 0.317 . . . . 1.29 111.285 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 129.17 38.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 1.03 110.356 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.66 -16.27 61.15 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.916 -0.659 . . . . 1.1399999999999999 111.675 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.24 -73.41 0.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.102 -0.332 . . . . 1.8899999999999999 110.102 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -87.39 -31.33 20.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.073 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -143.57 140.84 30.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.774 0.321 . . . . 1.03 110.548 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.4 t -102.95 132.65 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.224 -0.444 . . . . 0.91000000000000003 110.124 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.33 126.84 35.69 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.486 -0.561 . . . . 1.8200000000000001 109.486 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 163' ' ' ARG . 53.2 mt -63.77 129.98 42.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.855 0.36 . . . . 1.04 110.749 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -19.23 65.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.477 0.656 . . . . 1.54 110.359 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -133.33 98.89 14.97 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.353 -0.84 . . . . 1.28 109.227 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.57 142.25 76.83 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 112.506 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.08 124.03 35.25 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.921 -0.581 . . . . 0.81000000000000005 110.508 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.5 144.76 50.99 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.416 2.077 . . . . 1.0900000000000001 112.514 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.04 159.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 1.05 110.818 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -51.72 57.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.514 . . . . 1.6399999999999999 111.417 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -125.79 101.33 29.92 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.122 -0.49 . . . . 3.3300000000000001 110.722 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.88 71.88 4.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.013 2.475 . . . . 1.6599999999999999 111.939 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.77 -57.59 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.885 -0.674 . . . . 0.94999999999999996 111.694 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -102.37 167.48 9.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.989 -0.375 . . . . 2.4700000000000002 109.989 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.458 HG13 HG23 ' A' ' 183' ' ' ILE . 39.1 mm -85.36 121.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.485 -0.561 . . . . 0.70999999999999996 109.485 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -101.29 119.09 38.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.151 -0.477 . . . . 2.6899999999999999 111.081 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.32 112.1 38.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.853 -0.612 . . . . 0.55000000000000004 109.926 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.29 137.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.229 -0.441 . . . . 0.69999999999999996 111.627 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.25 139.57 53.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.742 -0.836 . . . . 2.4300000000000002 108.742 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.4 mp -116.03 121.28 41.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.85999999999999999 110.801 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -121.12 167.58 12.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.893 -0.594 . . . . 1.3999999999999999 111.365 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.578 ' NE1' ' HA ' ' A' ' 71' ' ' TRP . 30.2 t90 -150.59 148.06 28.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 1.1599999999999999 109.487 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -78.78 69.49 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.004 0.43 . . . . 4.8099999999999996 110.208 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.67 35.29 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.607 -0.724 . . . . 1.6200000000000001 112.16 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.6 115.48 13.57 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.991 0.424 . . . . 0.93000000000000005 110.428 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.89 -34.01 18.79 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.495 2.13 . . . . 1.1000000000000001 112.424 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -62.21 -33.07 73.86 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.608 -0.269 . . . . 1.47 111.437 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 18.1 m -65.19 -35.21 80.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.984 0.421 . . . . 0.93999999999999995 110.786 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 99' ' ' HIS . 11.7 t80 -69.09 -25.2 64.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 2.6299999999999999 111.083 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.34 -7.33 56.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.15 -0.477 . . . . 0.97999999999999998 110.685 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 166' ' ' ILE . 2.7 t80 -99.03 -37.37 9.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.022 -0.536 . . . . 0.76000000000000001 111.058 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 61.7 mm-40 -45.72 -54.74 14.74 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.142 0.793 . . . . 2.6899999999999999 113.142 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 18.2 Cg_endo -59.92 -9.32 9.54 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.343 2.029 . . . . 0.81000000000000005 113.657 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -35.5 5.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.627 0.251 . . . . 0.70999999999999996 111.535 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 44' ' ' GLU . 15.5 tt -82.66 -33.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.045 0.387 . . . . 0.83999999999999997 112.045 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.29 -58.63 14.15 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 119.568 -0.253 . . . . 0.94999999999999996 111.666 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.58 -36.01 98.69 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.843 1.696 . . . . 0.94999999999999996 111.798 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -65.59 -49.16 69.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.81999999999999995 110.715 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.7 p -65.99 -29.54 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.988 0.366 . . . . 1.22 111.988 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -84.86 0.17 51.91 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.852 0.358 . . . . 2.1400000000000001 111.211 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -125.64 18.93 8.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 2.0899999999999999 110.522 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.5 mt -74.81 148.07 84.64 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.07 -0.514 . . . . 0.81000000000000005 111.105 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HG2' HG23 ' A' ' 58' ' ' VAL . 28.3 Cg_endo -65.97 165.09 24.94 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.98999999999999999 111.496 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.53 -10.24 59.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.726 0.298 . . . . 1.1399999999999999 111.526 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.04 -6.19 57.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.12 0.486 . . . . 1.6499999999999999 111.335 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG23 ' HG2' ' A' ' 55' ' ' PRO . 64.4 t -120.02 140.5 43.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.298 -0.41 . . . . 0.68000000000000005 111.116 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -121.42 146.27 47.06 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.336 -0.616 . . . . 1.27 109.336 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -121.82 137.31 54.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.618 -0.265 . . . . 1.3899999999999999 110.874 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.8 t -127.09 127.46 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 0.69999999999999996 111.021 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -99.78 105.41 17.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.237 -0.653 . . . . 4.2300000000000004 109.237 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 27.9 mt -111.26 146.8 35.32 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.60999999999999999 111.192 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -87.96 145.21 6.4 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.608 2.205 . . . . 0.48999999999999999 111.984 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.6 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.36 101.74 6.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 110.549 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.41 96.57 8.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.307 -0.406 . . . . 0.53000000000000003 110.056 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' H ' ' HB2' ' A' ' 71' ' ' TRP . 48.0 m-85 -114.37 38.07 3.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.588 0.588 . . . . 1.71 112.588 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.56 -54.26 4.04 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 115.14 0.816 . . . . 1.3899999999999999 115.14 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 71' ' ' TRP . . . -68.64 -147.93 0.2 Allowed Glycine 0 C--O 1.225 -0.438 0 CA-C-N 117.195 0.497 . . . . 1.24 113.605 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.3 tp -67.71 9.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.771 0.796 . . . . 1.1599999999999999 111.575 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.6 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 54.2 m95 -74.85 -50.11 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.427 -0.806 . . . . 0.78000000000000003 110.528 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -68.22 -35.12 77.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.495 -0.32 . . . . 1.99 111.489 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.6 t -63.56 -27.17 42.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.343 0.592 . . . . 0.89000000000000001 110.362 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -94.24 3.45 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.981 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.74 -28.59 3.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.452 -0.88 . . . . 0.66000000000000003 111.837 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -59.81 -32.8 70.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.671 0.388 . . . . 2.1200000000000001 111.007 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.1 ttm -59.35 -48.62 80.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.155 -0.475 . . . . 1.4299999999999999 111.044 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -59.43 -45.51 91.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 1.0600000000000001 110.964 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.43 -39.35 90.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.63 110.475 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 HG23 ' HB ' ' A' ' 128' ' ' THR . 32.2 m -64.16 -44.28 92.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.854 -0.612 . . . . 0.68999999999999995 110.401 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD21 HD13 ' A' ' 115' ' ' LEU . 77.9 mt -62.24 -48.98 77.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.015 -0.539 . . . . 1.6899999999999999 111.155 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.79 -39.67 92.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 2.1899999999999999 111.255 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -21.04 64.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 1.26 111.151 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' A' ' 125' ' ' PHE . 74.7 mtp -91.75 -35.41 14.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.515 -0.311 . . . . 1.7 110.8 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.8 -46.65 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.975 -0.631 . . . . 2.2000000000000002 112.045 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p 41.9 106.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.072 1.349 . . . . 2.3599999999999999 114.08 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.01 131.69 41.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.37 -0.832 . . . . 5.2800000000000002 110.618 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -65.1 -21.4 66.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.942 0.401 . . . . 5.2599999999999998 110.477 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.35 -30.52 64.9 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.65 -0.704 . . . . 5.4500000000000002 111.439 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.59 21.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 3.7599999999999998 111.743 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.18 -19.88 65.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.081 0.401 . . . . 4.2599999999999998 112.081 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.56 -30.96 10.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.821 0.343 . . . . 2.8799999999999999 110.182 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.96 -39.05 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.758 -0.656 . . . . 1.71 112.029 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.29 -41.9 94.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 1.7 111.145 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.25 -35.42 76.11 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.969 0.414 . . . . 3.2999999999999998 110.561 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -68.91 -28.73 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 2.6099999999999999 110.453 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 101' ' ' GLU . . . -69.73 -17.28 63.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.959 -0.564 . . . . 1.6699999999999999 110.655 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.4 mm -96.91 -33.0 4.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 1.9099999999999999 110.489 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 41.3 m-70 -94.33 -80.02 0.41 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.841 0.682 . . . . 2.21 112.841 -178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -59.62 -51.97 67.54 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.323 0.49 . . . . 2.73 112.323 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 5.3 mm-40 -76.04 -48.99 18.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.442 -0.345 . . . . 2.5899999999999999 111.153 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.3 t60 56.22 58.52 4.25 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.883 -0.784 . . . . 2.1600000000000001 108.883 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -71.03 10.79 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.977 -1.01 . . . . 2.2400000000000002 113.287 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp 58.09 46.12 16.66 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.41 0.624 . . . . 2.6099999999999999 110.486 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.99 78.46 7.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 1.24 110.606 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -105.8 -38.91 6.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.391 -0.368 . . . . 0.95999999999999996 110.502 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HG3' ' A' ' 111' ' ' MET . 17.9 p -91.75 146.93 34.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 1.21 110.636 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.06 -34.05 91.49 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.806 2.337 . . . . 0.97999999999999998 112.343 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.92 -46.21 82.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 2.6200000000000001 110.991 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -65.02 -39.05 92.83 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.406 -0.59 . . . . 2.5099999999999998 109.406 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 107' ' ' THR . 65.5 mtt -59.41 -54.22 49.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.505 -0.771 . . . . 0.93999999999999995 110.204 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.47 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -62.07 -32.69 73.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.501 -0.772 . . . . 0.95999999999999996 111.813 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.24 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.015 0.436 . . . . 1.8300000000000001 110.391 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 97' ' ' ALA . 32.9 t80 -75.77 -46.65 29.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.52 110.331 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.4 HD13 HD21 ' A' ' 81' ' ' LEU . 82.3 mt -62.17 -24.95 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.822 -0.626 . . . . 0.98999999999999999 111.629 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -59.78 -29.28 68.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.876 0.37 . . . . 1.25 110.755 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.85 16.97 60.1 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.794 -0.717 . . . . 1.6100000000000001 111.842 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -120.47 7.55 10.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.925 0.393 . . . . 2.9500000000000002 110.498 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.16 12.34 54.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.737 -0.744 . . . . 1.47 112.161 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 61.1 t -106.25 128.47 60.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.659 0.266 . . . . 1.2 110.396 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 6.1 t70 -78.69 131.1 36.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.354 -0.385 . . . . 1.5600000000000001 110.732 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.47 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 37.0 ttmt -64.91 -36.52 84.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 1.5700000000000001 111.549 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 48.5 mm-40 -63.44 -56.19 18.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.816 0.341 . . . . 2.29 110.611 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.8 mmtt -58.93 -39.92 83.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.851 -0.613 . . . . 2.6099999999999999 111.036 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.445 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 85.6 t80 -61.16 -55.67 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.434 -0.348 . . . . 1.4399999999999999 111.119 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.49 -29.6 70.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.543 -0.299 . . . . 1.1299999999999999 111.645 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.4 t -70.61 -40.65 73.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.769 0.319 . . . . 1.46 110.558 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HB ' HG23 ' A' ' 80' ' ' THR . 11.5 m -79.41 -39.87 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.104 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -54.22 -50.62 66.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.305 -0.407 . . . . 1.53 110.697 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -95.3 65.48 2.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.602 0.715 . . . . 1.6100000000000001 109.646 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.1 t -145.97 156.54 43.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.533 -0.758 . . . . 1.49 110.64 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -19.86 65.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 1.3999999999999999 110.265 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.32 75.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.92000000000000004 110.815 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.8 mm -91.98 -38.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.104 -0.498 . . . . 1.1899999999999999 110.166 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.447 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 60.0 tttt -57.77 -40.33 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 1.8999999999999999 110.819 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.19 -18.16 68.9 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.75 112.725 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -91.72 -25.59 19.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.309 0.576 . . . . 1.6699999999999999 110.176 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 135' ' ' LYS . 67.4 mtp -67.4 -46.33 73.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.467 -0.788 . . . . 1.8500000000000001 111.384 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.61 -33.92 74.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.664 -0.244 . . . . 2.0299999999999998 111.65 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -63.63 -49.17 74.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.361 -0.381 . . . . 3.0800000000000001 110.938 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.34999999999999998 111.42 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -59.14 -53.58 56.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 1.6899999999999999 111.34 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.07 -27.77 66.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.531 -0.304 . . . . 2.1000000000000001 111.42 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 144' ' ' LEU . 40.7 mt -72.96 -41.32 64.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.127 -0.229 . . . . 0.56000000000000005 110.99 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.58 -50.04 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.922 0.391 . . . . 0.48999999999999999 111.494 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 21.6 ptm -69.37 -30.39 68.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.292 -0.413 . . . . 2.5699999999999998 111.357 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.38 65.96 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.806 0.336 . . . . 0.42999999999999999 111.271 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.413 ' HB2' HG23 ' A' ' 150' ' ' VAL . 20.1 m-85 -82.97 3.68 29.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.981 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 61.54 33.82 18.21 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.844 -0.616 . . . . 1.4099999999999999 110.933 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.413 HG23 ' HB2' ' A' ' 148' ' ' TYR . 74.0 t -69.77 115.96 9.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.621 -0.511 . . . . 1.26 109.621 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.92 4.57 12.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.053 -0.521 . . . . 1.25 112.063 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.31 35.15 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.387 -0.911 . . . . 0.68999999999999995 112.409 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.9 m -138.58 134.02 17.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.068 -0.345 . . . . 0.64000000000000001 110.068 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -81.8 179.91 26.16 Favored 'Cis proline' 0 C--O 1.234 0.296 0 C-N-CA 123.643 -1.399 . . . . 0.66000000000000003 112.195 -0.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 29.3 m -162.11 103.94 1.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.806 -0.442 . . . . 0.56999999999999995 109.806 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 51.0 mtp -86.11 126.46 34.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.845 -0.616 . . . . 0.92000000000000004 110.442 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.4 t -120.99 122.4 67.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 0.40000000000000002 109.916 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.3 t -107.24 120.75 59.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.347 -0.388 . . . . 0.58999999999999997 111.021 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 56.74 18.6 3.83 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.324 -0.853 . . . . 1.0800000000000001 113.106 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 33.01 82.5 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.225 -0.512 . . . . 0.48999999999999999 113.54 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -127.89 -38.15 1.87 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.354 . . . . 1.72 111.356 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -116.4 138.82 51.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.742 0.306 . . . . 1.5 110.748 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.403 ' HB2' HD21 ' A' ' 15' ' ' LEU . 21.5 ttp180 -123.2 123.21 40.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 110.068 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.1 172.37 13.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.509 -0.314 . . . . 0.63 110.203 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -170.4 -176.22 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.024 -0.361 . . . . 1.3500000000000001 110.024 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 43' ' ' PHE . 26.1 mt -57.96 -39.31 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 O-C-N 123.56 0.538 . . . . 0.68999999999999995 111.482 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -71.15 -22.54 78.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.906 -0.664 . . . . 0.72999999999999998 113.061 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -88.04 -49.25 7.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.84 0.352 . . . . 1.1499999999999999 110.754 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.11 -35.52 69.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.215 -0.448 . . . . 0.71999999999999997 111.433 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.87 44.18 2.92 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.613 -0.803 . . . . 1.1000000000000001 112.564 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 135.77 148.51 5.61 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.688 -0.768 . . . . 0.72999999999999998 112.266 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.0 -42.74 54.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.045 2.497 . . . . 0.84999999999999998 112.482 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -65.69 -37.24 85.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 2.52 110.14 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -68.99 -32.42 71.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 1.8200000000000001 110.384 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 m -65.57 -39.25 91.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.893 -0.594 . . . . 0.62 110.735 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.7 mt -63.12 -37.44 87.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.027 -0.533 . . . . 0.72999999999999998 110.39 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.32 -42.0 96.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.726 -0.67 . . . . 2.3399999999999999 110.568 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -64.07 -43.88 94.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.007 -0.542 . . . . 0.69999999999999996 110.231 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.25 -50.59 73.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.912 -0.586 . . . . 0.65000000000000002 111.039 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.28 -36.23 79.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.9099999999999999 111.271 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -69.79 -45.24 68.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.8200000000000001 110.779 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.5 mt -62.74 -31.27 72.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.344 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 179' ' ' ALA . 80.2 mt -60.97 -44.25 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.738 -0.467 . . . . 0.77000000000000002 109.738 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.34 -32.81 66.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.739 -0.664 . . . . 2.1699999999999999 110.307 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -65.9 -47.11 75.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.92 -0.582 . . . . 2.4100000000000001 110.679 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -73.66 -31.2 63.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.268 -0.424 . . . . 1.6399999999999999 111.439 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 187' ' ' ARG . 5.3 tpm_? -64.05 -28.73 69.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.859 0.361 . . . . 1.72 110.14 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.01 67.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.647 -0.706 . . . . 1.1299999999999999 111.503 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.75 -42.53 84.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 1.1699999999999999 110.942 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.21 17.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.17 -0.468 . . . . 1.8400000000000001 110.241 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.63 41.37 12.29 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.476 -0.783 . . . . 6.4299999999999997 110.972 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 C--O 1.245 0.858 0 CA-C-N 115.252 -0.886 . . . . 7.3200000000000003 110.544 179.788 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.942 -0.463 . . . . 2.2000000000000002 111.942 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 64.99 95.25 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.064 0.546 . . . . 2.1299999999999999 111.478 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.79 -5.92 20.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.203 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -106.8 156.68 18.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.948 0.404 . . . . 1.2 111.343 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.42 133.32 56.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.961 -0.563 . . . . 1.29 110.797 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.18 124.41 24.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 1.03 110.499 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.06 -6.53 69.23 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.971 -0.633 . . . . 1.1399999999999999 111.682 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -109.59 -68.25 0.93 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.729 0.3 . . . . 1.8899999999999999 110.569 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -80.41 -29.98 37.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 1.55 111.254 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -152.46 161.46 42.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.729 -0.471 . . . . 1.03 109.729 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.68 131.76 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.79 0.328 . . . . 0.91000000000000003 110.544 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -103.94 146.23 28.98 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.599 -0.519 . . . . 1.8200000000000001 109.599 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -96.79 150.69 20.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.428 -0.351 . . . . 1.04 110.683 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.14 -43.22 71.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 1.54 110.887 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.5 m -103.66 102.52 30.9 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.224 -0.443 . . . . 1.28 110.258 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.85 154.76 23.23 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.428 2.085 . . . . 0.90000000000000002 112.936 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.66 118.64 53.9 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.763 -0.653 . . . . 0.81000000000000005 110.465 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.16 120.67 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.353 2.035 . . . . 1.0900000000000001 112.431 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.12 153.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.494 . . . . 1.05 111.038 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.8 m -87.99 9.2 23.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.018 0.437 . . . . 1.6399999999999999 111.184 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -129.1 79.8 73.81 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 3.3300000000000001 110.218 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.23 119.59 6.55 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.552 2.168 . . . . 1.6599999999999999 111.645 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.62 -15.91 14.37 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.759 -0.734 . . . . 0.94999999999999996 112.021 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.24 161.96 16.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.016 -0.364 . . . . 2.4700000000000002 110.016 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.3 mm -103.07 116.3 46.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.785 0.326 . . . . 0.70999999999999996 110.561 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -97.75 113.99 25.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 2.6899999999999999 110.823 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -110.83 101.19 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.02 -0.733 . . . . 0.55000000000000004 109.02 178.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.1 t -91.59 119.64 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.022 -0.536 . . . . 0.69999999999999996 111.444 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 62' ' ' ARG . 22.3 tt0 -102.16 115.28 30.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.412 -0.813 . . . . 2.4300000000000002 108.971 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 3.6 mp -101.58 113.76 27.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.169 0.509 . . . . 0.85999999999999999 110.255 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' PRO . 34.9 p90 -123.32 174.41 7.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.541 -0.754 . . . . 1.3999999999999999 110.281 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 71' ' ' TRP . 4.3 t90 -150.73 166.95 28.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.11 -0.496 . . . . 1.1599999999999999 109.849 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-30 -79.83 -1.42 38.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.392 -0.367 . . . . 4.8099999999999996 111.111 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.05 7.74 19.0 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.515 -0.85 . . . . 1.6200000000000001 114.082 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.0 p -104.06 110.05 63.42 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 117.723 0.761 . . . . 0.93000000000000005 110.889 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.23 -30.68 24.36 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.345 2.03 . . . . 1.1000000000000001 111.709 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -29.14 70.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.785 -0.643 . . . . 1.47 111.047 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 58.5 m -66.85 -41.97 86.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.386 . . . . 0.93999999999999995 111.17 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -67.71 -37.07 81.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.874 0.369 . . . . 2.6299999999999999 111.163 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.42 -18.04 60.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.344 -0.389 . . . . 0.97999999999999998 111.737 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.46 -25.82 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.481 -0.327 . . . . 0.76000000000000001 111.408 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.4 OUTLIER -50.06 -53.83 39.47 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.307 0.484 . . . . 2.6899999999999999 112.307 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 36.8 Cg_endo -64.17 -4.07 7.16 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.379 2.053 . . . . 0.81000000000000005 113.617 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 -35.89 6.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.92 0.39 . . . . 0.70999999999999996 111.339 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.1 tt -84.53 -28.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 112.124 0.416 . . . . 0.83999999999999997 112.124 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 30.9 t -56.79 -56.31 34.22 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.557 0.577 . . . . 0.94999999999999996 112.557 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 48' ' ' VAL . 11.6 Cg_endo -55.82 -34.28 90.82 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.168 1.912 . . . . 0.94999999999999996 112.63 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -73.81 -46.56 44.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.925 -0.579 . . . . 0.81999999999999995 110.975 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -64.63 -40.5 95.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.206 -0.452 . . . . 1.22 112.203 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -71.79 -8.95 57.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.196 -0.202 . . . . 2.1400000000000001 111.371 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -113.8 15.36 18.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.638 0.256 . . . . 2.0899999999999999 111.187 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.2 mt -71.37 145.37 90.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.633 0.254 . . . . 0.81000000000000005 110.318 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.8 168.3 15.52 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.512 2.141 . . . . 0.98999999999999999 112.055 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.54 53.77 0.89 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.221 0.534 . . . . 1.1399999999999999 110.862 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 187' ' ' ARG . 0.7 OUTLIER -150.05 -16.62 0.25 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.618 -0.719 . . . . 1.6499999999999999 110.632 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.49 141.64 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.68000000000000005 110.223 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -124.53 115.31 20.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.872 -0.418 . . . . 1.27 109.872 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.484 ' HA ' HG23 ' A' ' 29' ' ' VAL . 24.4 t80 -74.82 116.13 15.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 1.3899999999999999 110.704 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 30' ' ' VAL . 53.2 t -121.25 114.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.153 -0.476 . . . . 0.69999999999999996 110.273 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -110.93 133.75 53.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.137 -0.32 . . . . 4.2300000000000004 110.137 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 74.4 mt -139.52 147.8 53.71 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.098 -0.501 . . . . 0.60999999999999999 109.974 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 6.3 Cg_exo -78.25 153.45 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.388 2.059 . . . . 0.48999999999999999 112.197 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -74.13 86.01 1.87 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.072 -0.513 . . . . 0.45000000000000001 110.928 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.16 74.65 9.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.997 -0.547 . . . . 0.53000000000000003 110.833 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -89.82 -1.36 57.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.162 -0.472 . . . . 1.71 110.7 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 71' ' ' TRP . . . 108.63 177.7 21.77 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.833 -0.698 . . . . 1.3899999999999999 111.743 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.6 -137.68 47.81 Favored Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.885 -0.674 . . . . 1.24 112.431 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.8 tp -68.41 -18.41 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.807 0.337 . . . . 1.1599999999999999 111.469 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 34' ' ' TRP . 47.6 m95 -64.67 -46.03 84.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.78000000000000003 110.258 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -32.28 70.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.829 -0.623 . . . . 1.99 110.549 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.68 -36.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.289 0.566 . . . . 0.89000000000000001 110.059 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -91.53 33.7 1.0 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 1.46 110.617 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.35 -34.97 0.1 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.838 -0.696 . . . . 0.66000000000000003 112.351 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -57.54 -32.98 67.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 2.1200000000000001 111.466 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.56 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 13.7 ttt -54.51 -46.84 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.732 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.65 -41.33 97.37 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.24 0.459 . . . . 1.0600000000000001 112.24 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.55 -21.86 61.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.531 -0.304 . . . . 0.63 111.797 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -84.6 -26.63 27.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.825 0.345 . . . . 0.68999999999999995 111.582 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 77' ' ' MET . 92.7 mt -63.1 -62.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.994 0.738 . . . . 1.6899999999999999 112.994 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -69.25 -9.58 53.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.901 0.704 . . . . 2.1899999999999999 112.901 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 m -78.28 -4.1 46.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 1.26 110.596 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 32.2 ttm -87.9 0.34 55.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.928 -0.578 . . . . 1.7 110.378 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.14 49.13 7.73 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.831 -0.699 . . . . 2.2000000000000002 111.931 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -127.79 152.43 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.742 0.306 . . . . 2.3599999999999999 110.827 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.02 151.01 37.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.028 -0.533 . . . . 5.2800000000000002 110.383 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 41.0 m80 55.85 42.47 28.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.136 0.494 . . . . 5.2599999999999998 111.332 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.22 8.38 33.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 5.4500000000000002 110.946 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.01 77.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.577 0.703 . . . . 3.7599999999999998 110.128 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.85 -30.6 71.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.269 -0.878 . . . . 4.2599999999999998 111.059 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -56.55 -37.76 70.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.884 -0.598 . . . . 2.8799999999999999 111.861 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -34.1 69.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 1.71 110.762 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.53 -46.79 61.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.923 -0.58 . . . . 1.7 110.275 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -35.83 81.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.973 -0.558 . . . . 3.2999999999999998 111.175 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -65.03 -43.41 92.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 2.6099999999999999 110.432 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.55 66.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 111.311 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.6 mt -85.32 -36.87 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 1.9099999999999999 111.702 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -100.13 -52.03 3.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.777 0.658 . . . . 2.21 112.777 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -66.19 -41.59 90.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.656 0.265 . . . . 2.73 111.063 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.64 -51.85 4.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.458 -0.337 . . . . 2.5899999999999999 111.176 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 64.97 58.97 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.059 -0.519 . . . . 2.1600000000000001 110.212 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -79.4 25.16 0.32 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.839 -0.619 . . . . 2.2400000000000002 112.437 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 46.22 66.39 0.97 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.199 0.6 . . . . 2.6099999999999999 111.87 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.8 mt -80.81 73.26 7.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 1.24 110.316 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -103.87 -43.0 5.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.056 -0.52 . . . . 0.95999999999999996 110.733 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.95 140.31 37.29 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.959 -0.564 . . . . 1.21 110.326 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.05 -31.54 83.02 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.679 2.253 . . . . 0.97999999999999998 111.862 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.76 -44.55 89.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.763 -0.653 . . . . 2.6200000000000001 110.305 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -37.34 80.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.816 -0.629 . . . . 2.5099999999999998 110.035 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.7 mtt -69.62 -55.09 11.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.235 -0.893 . . . . 0.93999999999999995 110.424 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -57.47 -44.87 85.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.509 -0.769 . . . . 0.95999999999999996 112.657 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.53 -34.33 78.0 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.864 -0.334 . . . . 1.8300000000000001 111.092 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -74.48 -41.24 61.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.783 -0.451 . . . . 1.52 109.783 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.62 -31.9 73.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.716 -0.675 . . . . 0.98999999999999999 111.143 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.29 -21.01 64.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.175 -0.466 . . . . 1.25 110.547 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.34 -1.59 90.13 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 112.863 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -125.47 2.34 7.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.228 0.514 . . . . 2.9500000000000002 111.359 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.37 58.85 0.81 Allowed Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.537 -0.84 . . . . 1.47 113.357 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -135.17 126.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.165 -0.68 . . . . 1.2 109.165 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.724 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 28.1 t0 -72.17 117.55 13.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 1.5600000000000001 110.78 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.541 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 27.7 ttmt -61.66 -32.08 72.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.245 -0.889 . . . . 1.5700000000000001 110.818 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -66.87 -53.88 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 2.29 111.037 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.724 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 39.2 mmtm -61.94 -42.39 99.05 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 121.147 -0.221 . . . . 2.6099999999999999 110.636 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 80.9 t80 -57.63 -56.24 24.52 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.188 -0.46 . . . . 1.4399999999999999 111.162 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.56 -36.83 85.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.687 0.28 . . . . 1.1299999999999999 111.254 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.63 -55.81 23.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.45 -0.341 . . . . 1.46 111.395 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 124' ' ' LYS . 14.6 t -73.01 -23.04 60.58 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.956 0.354 . . . . 1.53 111.956 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -63.97 -27.41 69.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.163 0.506 . . . . 1.53 110.37 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -102.23 1.84 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.886 -0.597 . . . . 1.6100000000000001 110.936 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.447 ' OG ' ' HA ' ' A' ' 128' ' ' THR . 47.0 m -82.2 153.26 26.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.103 -0.499 . . . . 1.49 110.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.74 -24.21 66.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.864 -0.607 . . . . 1.3999999999999999 110.977 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.32 -43.43 64.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.47 . . . . 0.92000000000000004 111.649 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 41.1 mm -79.61 -38.91 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.01 0.433 . . . . 1.1899999999999999 110.135 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -58.1 -43.09 86.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.657 . . . . 1.8999999999999999 111.136 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.73 -37.66 95.17 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.123 -0.56 . . . . 0.75 112.548 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -75.6 -28.15 58.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 1.6699999999999999 110.273 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.3 mmm -63.02 -53.28 56.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.765 -0.652 . . . . 1.8500000000000001 110.593 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -68.1 -30.88 70.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.39 . . . . 2.0299999999999998 110.528 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -62.44 -41.59 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.139 -0.482 . . . . 3.0800000000000001 110.366 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.58 -33.48 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.268 -0.424 . . . . 0.34999999999999998 110.939 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.6 -49.12 78.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.6899999999999999 110.995 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -66.02 -24.88 66.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 2.1000000000000001 111.221 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.86 -36.43 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.697 0.284 . . . . 0.56000000000000005 110.54 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.92 -44.53 86.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 111.221 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 20.6 ptp -80.16 -14.8 58.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.03 -0.532 . . . . 2.5699999999999998 110.737 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.79 -31.76 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 0.42999999999999999 110.082 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.514 ' HB3' HG21 ' A' ' 157' ' ' VAL . 18.0 m-85 -80.54 5.07 16.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.681 -0.69 . . . . 0.63 110.012 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.467 ' HG3' ' HB3' ' A' ' 15' ' ' LEU . 16.2 mm-40 58.58 35.03 24.32 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.148 -0.933 . . . . 1.4099999999999999 111.995 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.37 126.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.158 -0.474 . . . . 1.26 109.726 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.14 35.34 4.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.916 0.389 . . . . 1.25 111.853 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 157.87 179.18 32.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.551 -0.833 . . . . 0.68999999999999995 112.211 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.4 143.53 41.62 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.538 0.209 . . . . 0.64000000000000001 110.6 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.549 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 84.6 Cg_endo -81.66 166.93 71.55 Favored 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 123.201 -1.583 . . . . 0.66000000000000003 112.378 -0.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 m -156.73 133.09 9.9 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.277 -0.42 . . . . 0.56999999999999995 110.223 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.66 132.71 56.3 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.731 -0.47 . . . . 0.92000000000000004 109.731 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 148' ' ' TYR . 24.8 t -122.83 128.79 75.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.387 -0.37 . . . . 0.40000000000000002 110.037 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.533 HG22 HG12 ' A' ' 29' ' ' VAL . 68.9 t -106.5 116.61 50.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.575 -0.284 . . . . 0.58999999999999997 111.203 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 54.42 26.86 7.49 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.452 -0.795 . . . . 1.0800000000000001 112.842 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 57.98 29.62 62.4 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.014 -0.539 . . . . 0.48999999999999999 114.227 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -120.59 -56.11 1.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.306 0.574 . . . . 1.72 111.228 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.31 137.11 42.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.739 -0.664 . . . . 1.5 110.524 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.2 ttp85 -120.96 133.7 55.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.234 -0.439 . . . . 1.6599999999999999 110.383 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.456 ' HE1' HG23 ' A' ' 158' ' ' VAL . 25.9 p90 -149.02 170.02 19.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.172 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.6 176.54 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.564 -0.532 . . . . 1.3500000000000001 109.564 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.453 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 88.2 mt -56.15 -41.34 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 123.542 0.526 . . . . 0.68999999999999995 111.174 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.28 -47.38 58.7 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 121.002 -0.618 . . . . 0.72999999999999998 112.495 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.1 m -60.67 -43.54 97.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.025 0.44 . . . . 1.1499999999999999 110.978 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.14 -38.5 72.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.5 . . . . 0.71999999999999997 110.912 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 123.48 -32.12 4.4 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.734 -0.746 . . . . 1.1000000000000001 112.258 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.33 171.53 41.37 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.062 -0.589 . . . . 0.72999999999999998 112.055 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -54.71 -52.84 7.16 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.277 2.652 . . . . 0.84999999999999998 112.315 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.08 -37.27 82.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.871 -0.604 . . . . 2.52 110.795 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -66.38 -29.73 69.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 1.8200000000000001 110.593 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 166' ' ' ILE . 9.2 m -64.85 -38.68 91.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 0.62 109.923 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.99 -32.75 73.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.72999999999999998 110.159 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -61.97 -51.73 66.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 2.3399999999999999 110.463 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -61.9 -42.22 98.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 0.69999999999999996 110.682 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -58.86 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.65000000000000002 111.039 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -61.51 -42.2 98.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.98 -0.554 . . . . 1.9099999999999999 110.691 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -62.57 -45.32 93.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.999 -0.546 . . . . 1.8200000000000001 111.185 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.19 -31.11 72.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.403 -0.362 . . . . 0.75 111.062 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 179' ' ' ALA . 77.7 mt -61.36 -44.07 97.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.237 -0.653 . . . . 0.77000000000000002 109.237 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.98 -41.21 91.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.52 -0.764 . . . . 2.1699999999999999 110.389 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -56.97 -49.46 75.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.656 -0.702 . . . . 2.4100000000000001 111.172 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -74.11 -40.24 62.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 1.6399999999999999 111.585 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 183' ' ' ILE . 0.0 OUTLIER -62.8 -33.73 75.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.566 -0.288 . . . . 1.72 110.815 -179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.418 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -65.97 -33.14 75.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 1.1299999999999999 111.73 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -58.87 -24.44 62.18 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.044 0.387 . . . . 1.1699999999999999 112.044 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -137.75 37.21 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.965 0.412 . . . . 1.8400000000000001 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 19.6 tptm -86.22 65.91 9.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.173 -0.467 . . . . 6.4299999999999997 110.478 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.101 -0.952 . . . . 7.3200000000000003 110.646 -179.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.869 -0.492 . . . . 2.2000000000000002 111.869 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 66.69 104.69 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.21 0.604 . . . . 2.1299999999999999 111.319 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -128.77 6.52 5.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.335 0.588 . . . . 1.97 110.763 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -117.33 128.86 55.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.903 -0.589 . . . . 1.2 109.811 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 145.06 29.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.968 0.413 . . . . 1.29 112.019 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.52 131.84 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 1.03 110.116 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.63 -3.65 86.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.436 -0.887 . . . . 1.1399999999999999 111.509 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG2' ' OE2' ' A' ' 11' ' ' GLU . 47.4 tttm -119.07 -52.0 2.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.43 -0.581 . . . . 1.8899999999999999 109.43 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' OE2' ' HG2' ' A' ' 10' ' ' LYS . 4.3 mp0 -101.57 -48.4 4.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.026 -0.534 . . . . 1.55 110.635 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -130.02 159.41 36.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.165 -0.47 . . . . 1.03 110.49 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.31 122.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.289 -0.414 . . . . 0.91000000000000003 110.553 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -112.31 124.09 51.72 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.339 -0.615 . . . . 1.8200000000000001 109.339 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -92.34 145.86 24.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.986 0.422 . . . . 1.04 111.023 -179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -75.32 -11.48 60.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.95 -0.568 . . . . 1.54 111.183 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.81 77.67 22.21 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.474 -0.33 . . . . 1.28 110.752 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.4 156.23 62.13 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.215 1.943 . . . . 0.90000000000000002 111.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.86 121.66 39.09 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.208 -0.451 . . . . 0.81000000000000005 110.189 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -71.78 133.0 21.09 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.224 1.949 . . . . 1.0900000000000001 111.786 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.1 m -68.96 153.51 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.052 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -25.55 59.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 1.6399999999999999 111.539 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -142.76 126.09 9.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.533 -0.303 . . . . 3.3300000000000001 110.787 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.22 -174.92 2.15 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.397 2.065 . . . . 1.6599999999999999 111.574 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.28 -87.36 0.61 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.343 -0.932 . . . . 0.94999999999999996 111.652 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -81.6 141.13 34.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.935 -0.395 . . . . 2.4700000000000002 109.935 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.498 HG13 HG23 ' A' ' 183' ' ' ILE . 48.3 mm -70.79 111.47 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.352 -0.61 . . . . 0.70999999999999996 109.352 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.95 114.44 15.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.114 -0.494 . . . . 2.6899999999999999 110.731 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.99 102.54 14.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.701 -0.681 . . . . 0.55000000000000004 109.732 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.0 t -101.01 123.33 53.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.958 -0.565 . . . . 0.69999999999999996 110.644 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -115.84 136.25 53.22 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.343 -0.614 . . . . 2.4300000000000002 109.343 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.8 mp -115.52 130.69 56.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.923 0.392 . . . . 0.85999999999999999 110.447 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -127.4 172.58 10.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 1.3999999999999999 111.202 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -141.03 167.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.686 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -91.45 -13.11 32.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.802 0.297 . . . . 4.8099999999999996 111.802 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.9 1.41 31.77 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.184 -1.008 . . . . 1.6200000000000001 113.824 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 9.1 p -87.43 120.62 71.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.206 0.503 . . . . 0.93000000000000005 110.776 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.66 -39.17 5.01 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.734 2.29 . . . . 1.1000000000000001 112.88 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -62.96 -27.56 69.48 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.218 -0.446 . . . . 1.47 112.162 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.5 m -63.41 -40.08 96.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.763 0.316 . . . . 0.93999999999999995 110.961 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' OH ' ' HE3' ' A' ' 100' ' ' LYS . 10.8 t80 -68.18 -22.27 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 2.6299999999999999 111.308 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.04 -7.15 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.034 0.445 . . . . 0.97999999999999998 111.196 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB2' HD11 ' A' ' 166' ' ' ILE . 9.1 t80 -104.15 -21.61 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.19 -0.459 . . . . 0.76000000000000001 111.241 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 14.2 mm-40 -50.98 -55.12 30.36 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.797 0.666 . . . . 2.6899999999999999 112.797 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 44' ' ' GLU . 37.0 Cg_endo -65.15 -2.32 5.6 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.199 1.933 . . . . 0.81000000000000005 113.263 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.42 HG22 HD11 ' A' ' 176' ' ' LEU . 0.2 OUTLIER -110.81 -36.01 5.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.714 0.293 . . . . 0.70999999999999996 111.577 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 tp -84.08 -33.6 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.029 0.381 . . . . 0.83999999999999997 112.029 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -58.54 -55.52 45.0 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 112.191 0.441 . . . . 0.94999999999999996 112.191 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.42 1.64 4.04 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.87 1.713 . . . . 0.94999999999999996 113.003 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -107.81 -43.11 4.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.765 0.317 . . . . 0.81999999999999995 110.772 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -65.9 -32.08 73.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.982 0.42 . . . . 1.22 111.311 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -84.57 2.27 42.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.106 -0.497 . . . . 2.1400000000000001 110.63 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -124.09 21.48 8.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.223 0.535 . . . . 2.0899999999999999 110.02 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 mt -83.83 137.35 40.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.81000000000000005 110.433 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 57' ' ' ASP . 20.9 Cg_endo -62.69 165.17 16.5 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.792 2.328 . . . . 0.98999999999999999 112.895 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.95 24.12 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.321 0.582 . . . . 1.1399999999999999 111.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 55' ' ' PRO . 5.3 t0 -121.84 -0.48 9.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.581 0.705 . . . . 1.6499999999999999 109.81 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.4 t -124.82 141.16 45.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.456 -0.793 . . . . 0.68000000000000005 110.18 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -119.5 117.99 29.88 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.115 -0.698 . . . . 1.27 109.115 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -105.72 124.29 49.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.86 0.362 . . . . 1.3899999999999999 111.445 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.2 t -130.88 125.04 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.127 -0.488 . . . . 0.69999999999999996 109.843 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HG3' ' HG3' ' A' ' 31' ' ' GLU . 11.5 ttt180 -107.3 119.69 40.08 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.708 -0.479 . . . . 4.2300000000000004 109.708 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 92.7 mt -121.22 151.34 55.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.36 . . . . 0.60999999999999999 110.732 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.7 141.72 19.75 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.288 1.992 . . . . 0.48999999999999999 111.97 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -78.47 94.3 4.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.969 0.414 . . . . 0.45000000000000001 110.668 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 72' ' ' ASN . 21.7 mt -84.03 87.2 7.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.268 -0.423 . . . . 0.53000000000000003 110.844 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.463 ' HB2' ' CG ' ' A' ' 71' ' ' TRP . 3.8 m-30 -84.16 -4.53 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 1.71 111.232 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.63 -56.56 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.246 -0.978 . . . . 1.3899999999999999 114.139 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.75 -131.37 0.44 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.009 -0.615 . . . . 1.24 113.835 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.64 -22.45 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.02 0.438 . . . . 1.1599999999999999 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.573 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 37.8 m95 -57.66 -42.84 84.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.732 -0.667 . . . . 0.78000000000000003 110.7 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 66' ' ' LEU . 7.4 t30 -71.59 -46.46 59.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 1.99 111.259 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 t -60.57 -33.7 55.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.89000000000000001 111.012 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -89.1 5.73 43.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.29 -0.414 . . . . 1.46 111.426 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 -27.08 2.81 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.823 -0.703 . . . . 0.66000000000000003 111.73 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.11 -35.34 78.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.967 0.413 . . . . 2.1200000000000001 110.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 2.0 ttm -61.61 -42.87 99.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 110.764 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.39 -46.86 82.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.016 -0.538 . . . . 1.0600000000000001 110.777 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.63 110.786 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -64.35 -43.51 94.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.945 -0.571 . . . . 0.68999999999999995 110.758 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 77' ' ' MET . 90.8 mt -61.74 -47.9 83.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 1.6899999999999999 110.905 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.94 -30.61 70.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 2.1899999999999999 111.322 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m -87.15 -3.89 59.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 1.26 111.461 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 44.0 mtp -107.65 -3.45 19.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 1.7 111.41 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.47 0.77 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.604 -0.807 . . . . 2.2000000000000002 112.06 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 86' ' ' VAL . 9.5 p 39.95 92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.474 1.11 . . . . 2.3599999999999999 113.333 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.15 137.93 45.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.288 -0.869 . . . . 5.2800000000000002 110.728 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 9.6 m-70 -65.57 -17.11 64.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 5.2599999999999998 111.502 -179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.34 -34.44 76.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.768 0.318 . . . . 5.4500000000000002 111.043 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.74 24.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.152 0.427 . . . . 3.7599999999999998 112.152 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 88' ' ' HIS . 1.6 p80 -71.69 -20.02 61.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.87 0.322 . . . . 4.2599999999999998 111.87 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 3.7 t-20 -100.2 -25.52 14.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.62 0.248 . . . . 2.8799999999999999 110.631 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.41 -36.48 66.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.92 -0.582 . . . . 1.71 112.094 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.8 t -61.21 -41.67 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.177 -0.465 . . . . 1.7 111.162 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -72.34 -37.02 68.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.441 -0.345 . . . . 3.2999999999999998 110.71 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 5.0 mm-40 -65.13 -36.28 83.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.102 0.477 . . . . 2.6099999999999999 110.479 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.57 59.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 1.6699999999999999 111.59 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.54 -43.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 111.819 0.303 . . . . 1.9099999999999999 111.819 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -94.71 -50.37 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.643 0.609 . . . . 2.21 112.643 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.512 ' HE3' ' OH ' ' A' ' 41' ' ' TYR . 85.4 mttt -72.42 -65.02 0.83 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.94 0.4 . . . . 2.73 111.289 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.13 -45.21 50.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.856 -0.611 . . . . 2.5899999999999999 111.383 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 t60 59.59 65.17 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 2.1600000000000001 109.473 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -75.46 9.33 2.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.402 -0.817 . . . . 2.2400000000000002 112.664 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp 58.98 41.01 21.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.478 0.656 . . . . 2.6099999999999999 110.558 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.4 mt -77.99 76.24 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 1.24 110.475 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -97.06 -39.67 9.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.096 -0.502 . . . . 0.95999999999999996 110.612 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.482 ' O ' ' HG3' ' A' ' 111' ' ' MET . 1.1 p -95.7 146.44 31.32 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.757 -0.656 . . . . 1.21 110.948 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' SD ' ' A' ' 111' ' ' MET . 9.6 Cg_endo -54.91 -37.59 93.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.06 2.507 . . . . 0.97999999999999998 112.545 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -62.07 -45.33 93.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.234 -0.439 . . . . 2.6200000000000001 110.065 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.35 -39.43 93.87 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.402 -0.592 . . . . 2.5099999999999998 109.402 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 107' ' ' THR . 52.1 mtt -60.08 -56.69 18.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.576 -0.738 . . . . 0.93999999999999995 110.204 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 125' ' ' PHE . . . -61.35 -30.09 70.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.809 -0.632 . . . . 0.95999999999999996 111.33 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -35.3 78.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 1.8300000000000001 110.883 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -90.88 -40.69 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.28 -0.418 . . . . 1.52 110.478 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 120' ' ' VAL . 83.1 mt -63.73 -24.14 67.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.98999999999999999 111.685 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -57.67 -34.89 69.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 1.25 111.177 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.92 -12.1 84.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.812 -0.708 . . . . 1.6100000000000001 112.214 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -97.09 -2.67 42.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 2.9500000000000002 110.488 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.42 -17.39 26.17 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.756 -0.735 . . . . 1.47 112.799 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 115' ' ' LEU . 61.9 t -69.03 112.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.227 0.537 . . . . 1.2 110.534 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 123' ' ' GLU . 14.8 t70 -68.52 128.7 37.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.477 -0.783 . . . . 1.5600000000000001 110.927 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -67.15 -34.72 78.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.89 -0.595 . . . . 1.5700000000000001 111.32 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.536 ' HB2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 mm-40 -59.18 -57.06 14.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.373 -0.376 . . . . 2.29 110.788 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -64.24 -39.52 94.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.741 -0.663 . . . . 2.6099999999999999 111.18 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 112' ' ' ALA . 78.4 t80 -58.46 -57.36 13.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.313 -0.403 . . . . 1.4399999999999999 111.853 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.41 -38.33 86.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 1.1299999999999999 111.52 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.8 t -64.41 -46.56 82.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.219 -0.446 . . . . 1.46 111.345 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.5 m -76.31 -38.04 56.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.499 -0.319 . . . . 1.53 111.836 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -52.79 -50.49 63.49 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.87 0.367 . . . . 1.53 111.216 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.13 53.18 0.96 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.411 0.624 . . . . 1.6100000000000001 110.123 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 45.4 t -132.27 161.7 32.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.65 -0.705 . . . . 1.49 110.307 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -21.05 66.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.232 -0.44 . . . . 1.3999999999999999 110.716 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.98 69.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.118 0.485 . . . . 0.92000000000000004 111.021 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.74 -36.72 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.203 -0.453 . . . . 1.1899999999999999 109.908 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -58.03 -37.82 75.06 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.968 -0.56 . . . . 1.8999999999999999 110.977 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.88 -24.27 77.21 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.155 -0.545 . . . . 0.75 112.43 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -86.77 -29.82 22.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.101 0.476 . . . . 1.6699999999999999 110.654 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.9 mtp -63.3 -46.87 84.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 1.8500000000000001 111.615 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.398 -0.365 . . . . 2.0299999999999998 111.309 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 95.6 mttt -68.33 -45.61 72.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.338 -0.392 . . . . 3.0800000000000001 111.048 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.84 -38.46 73.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.444 . . . . 0.34999999999999998 111.255 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -60.24 -47.38 86.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.05 -0.523 . . . . 1.6899999999999999 111.793 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -67.21 -28.51 68.14 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.061 -0.256 . . . . 2.1000000000000001 111.324 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 140' ' ' LYS . 35.1 mt -73.12 -39.15 65.98 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.08 -0.248 . . . . 0.56000000000000005 110.756 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.56 93.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.884 0.374 . . . . 0.48999999999999999 111.14 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.1 ptm -75.68 -26.64 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 2.5699999999999998 111.196 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.68 -39.83 56.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.678 0.275 . . . . 0.42999999999999999 111.197 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -83.95 4.62 28.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.63 111.215 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 57.9 43.61 21.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.886 -0.597 . . . . 1.4099999999999999 111.601 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.97 109.75 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.359 . . . . 1.26 110.066 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 3.32 11.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.075 -0.511 . . . . 1.25 111.565 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.96 175.23 25.57 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.922 -0.656 . . . . 0.68999999999999995 111.88 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.69 132.65 9.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.689 0.281 . . . . 0.64000000000000001 110.491 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.57 175.81 46.2 Favored 'Cis proline' 0 C--O 1.236 0.383 0 C-N-CA 123.212 -1.578 . . . . 0.66000000000000003 112.294 0.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.2 m -159.48 118.4 2.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.908 0.385 . . . . 0.56999999999999995 110.368 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 80.7 mtp -100.99 128.53 46.98 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.069 -0.514 . . . . 0.92000000000000004 110.531 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -116.33 119.58 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.928 -0.578 . . . . 0.40000000000000002 110.094 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.66 117.9 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.896 0.379 . . . . 0.58999999999999997 111.351 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.1 t30 59.55 15.79 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.935 -1.03 . . . . 1.0800000000000001 112.485 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 67.54 13.89 63.85 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.204 -0.522 . . . . 0.48999999999999999 113.642 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.42 -38.95 4.52 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.449 -0.442 . . . . 1.72 111.426 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.5 140.47 48.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.369 -0.378 . . . . 1.5 110.544 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -128.99 130.04 46.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.942 -0.572 . . . . 1.6599999999999999 110.094 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -149.59 172.18 15.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.497 -0.32 . . . . 0.63 110.252 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -159.85 -178.26 6.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.98 -0.555 . . . . 1.3500000000000001 109.521 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 43' ' ' PHE . 53.0 mt -57.3 -41.42 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 O-C-N 123.472 0.482 . . . . 0.68999999999999995 110.995 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -67.72 -45.8 72.96 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.083 -0.58 . . . . 0.72999999999999998 112.604 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.3 m -61.75 -45.07 95.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.693 0.282 . . . . 1.1499999999999999 110.698 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.39 -37.97 68.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.71999999999999997 111.268 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 118.96 -38.73 2.75 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.983 -0.627 . . . . 1.1000000000000001 112.033 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.03 158.77 27.81 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.066 -0.588 . . . . 0.72999999999999998 111.749 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.82 -44.71 42.36 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.138 2.559 . . . . 0.84999999999999998 112.532 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.92 -32.38 71.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 2.52 110.212 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -69.35 -29.09 66.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.922 -0.581 . . . . 1.8200000000000001 110.029 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.1 m -62.0 -37.55 85.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.683 -0.689 . . . . 0.62 110.426 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD11 HG22 ' A' ' 46' ' ' THR . 77.8 mt -65.54 -33.67 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.908 -0.587 . . . . 0.72999999999999998 110.798 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.2 -47.4 79.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.209 0.528 . . . . 2.3399999999999999 110.742 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 178' ' ' LEU . 3.4 mm? -61.83 -43.12 99.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.616 -0.72 . . . . 0.69999999999999996 110.568 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 183' ' ' ILE . . . -60.41 -47.93 83.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.65000000000000002 110.96 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -61.97 -47.46 84.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.8 -0.636 . . . . 1.9099999999999999 111.218 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -62.22 -40.82 97.4 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.161 -0.472 . . . . 1.8200000000000001 111.494 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.46 -28.77 68.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.58 0.229 . . . . 0.75 111.122 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 27' ' ' ILE . 58.7 mt -62.3 -43.66 98.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.842 -0.799 . . . . 0.77000000000000002 108.842 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -70.52 -35.46 73.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.466 -0.788 . . . . 2.1699999999999999 110.522 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -62.29 -46.38 89.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.531 -0.759 . . . . 2.4100000000000001 110.627 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -76.78 -20.78 56.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.994 -0.548 . . . . 1.6399999999999999 111.175 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 187' ' ' ARG . 6.4 tpm_? -65.66 -29.21 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.583 -0.525 . . . . 1.72 109.583 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.31 -13.26 60.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.789 -0.641 . . . . 1.1299999999999999 111.717 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.18 -29.34 66.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.101 0.477 . . . . 1.1699999999999999 110.395 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -109.68 -31.44 7.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.693 -0.685 . . . . 1.8400000000000001 110.435 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.9 mttp 61.67 63.41 1.16 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.62 -0.718 . . . . 6.4299999999999997 111.221 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.5 mptt . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.432 -0.804 . . . . 7.3200000000000003 111.045 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.963 -0.455 . . . . 2.2000000000000002 111.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.93 109.75 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.301 0.64 . . . . 2.1299999999999999 110.538 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -134.48 2.07 3.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.998 -0.546 . . . . 1.97 111.801 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -129.53 175.81 8.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.661 0.267 . . . . 1.2 111.004 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.69 123.59 37.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.154 -0.476 . . . . 1.29 110.727 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.05 18.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.029 -0.532 . . . . 1.03 110.206 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.39 -14.15 51.06 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.458 -0.657 . . . . 1.1399999999999999 111.458 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -105.0 -80.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.48 -0.192 . . . . 1.8899999999999999 110.48 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 168' ' ' SER . 14.4 mp0 -68.36 -39.96 81.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.55 110.986 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -135.45 144.96 46.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.484 -0.326 . . . . 1.03 110.345 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.69 126.86 62.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.824 0.345 . . . . 0.91000000000000003 110.46 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -102.6 126.48 49.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.106 -0.497 . . . . 1.8200000000000001 109.984 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.01 143.53 28.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.337 -0.392 . . . . 1.04 110.297 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 50.1 m -80.92 -8.32 59.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.447 -0.342 . . . . 1.54 111.277 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 83.28 8.11 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.462 -0.57 . . . . 1.28 109.462 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 16' ' ' SER . 4.5 Cg_exo -78.87 156.16 27.0 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.815 2.343 . . . . 0.90000000000000002 113.053 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.09 132.64 22.61 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.396 -0.82 . . . . 0.81000000000000005 109.752 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -64.88 146.89 88.91 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.336 2.024 . . . . 1.0900000000000001 111.902 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.37 170.74 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.302 -0.408 . . . . 1.05 111.14 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -93.64 -36.84 12.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.299 -0.409 . . . . 1.6399999999999999 110.946 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.451 ' NE2' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -131.7 105.08 14.23 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.931 0.396 . . . . 3.3300000000000001 110.941 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 13.8 Cg_exo -70.21 106.2 1.7 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.781 2.321 . . . . 1.6599999999999999 111.928 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 151.74 -45.21 0.63 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.12 -0.792 . . . . 0.94999999999999996 111.12 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -105.02 140.13 38.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.221 -0.659 . . . . 2.4700000000000002 109.221 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -74.77 121.18 25.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.752 0.31 . . . . 0.70999999999999996 110.887 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' HG3' ' NE2' ' A' ' 23' ' ' GLN . 6.0 mt-10 -87.32 99.54 12.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 2.6899999999999999 110.162 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.81 106.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.813 -0.631 . . . . 0.55000000000000004 109.714 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.6 124.27 57.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.237 -0.438 . . . . 0.69999999999999996 111.102 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.56 130.83 54.26 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.879 -0.785 . . . . 2.4300000000000002 108.879 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 5.1 mp -109.18 113.29 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 0.85999999999999999 110.82 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -115.24 172.67 6.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.465 -0.789 . . . . 1.3999999999999999 110.214 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.504 ' HE1' ' HA ' ' A' ' 71' ' ' TRP . 3.2 t90 -147.74 164.51 33.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.98 0.419 . . . . 1.1599999999999999 110.341 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -79.25 -13.14 59.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.278 -0.419 . . . . 4.8099999999999996 111.276 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.62 17.46 23.23 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.256 -0.974 . . . . 1.6200000000000001 114.544 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.9 p -108.77 105.0 56.26 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 117.817 0.808 . . . . 0.93000000000000005 110.366 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.72 -28.24 60.14 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.505 2.137 . . . . 1.1000000000000001 112.905 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -22.24 63.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.446 -0.343 . . . . 1.47 111.193 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 154' ' ' PRO . 64.6 m -70.32 -37.88 74.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 0.93999999999999995 110.782 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -68.29 -38.26 81.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 2.6299999999999999 110.886 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -12.87 61.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.97999999999999998 111.31 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -92.71 -18.24 23.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.407 -0.36 . . . . 0.76000000000000001 111.074 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -50.84 -60.19 6.0 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 112.465 0.542 . . . . 2.6899999999999999 112.465 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 3.88 2.55 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.918 1.746 . . . . 0.81000000000000005 113.157 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -108.97 -30.96 7.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.337 -0.392 . . . . 0.70999999999999996 110.876 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.9 tt -94.05 -30.11 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.861 0.319 . . . . 0.83999999999999997 111.861 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 47.6 t -54.55 -56.22 29.33 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.47 0.544 . . . . 0.94999999999999996 112.47 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 53' ' ' LYS . 13.1 Cg_endo -56.84 -32.18 91.13 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.106 1.87 . . . . 0.94999999999999996 112.832 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.454 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 77.2 t90 -78.22 -48.36 15.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.28 -0.418 . . . . 0.81999999999999995 110.71 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.6 t -64.36 -37.72 88.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.351 0.5 . . . . 1.22 112.351 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -77.64 -9.24 58.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.716 0.293 . . . . 2.1400000000000001 111.281 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -118.47 34.7 5.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.916 0.389 . . . . 2.0899999999999999 110.787 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 50' ' ' TRP . 41.2 mt -95.33 147.92 33.8 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.917 -0.583 . . . . 0.81000000000000005 111.121 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.62 172.91 10.7 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.48 2.12 . . . . 0.98999999999999999 112.264 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.6 2.94 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 1.1399999999999999 111.864 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.11 -5.19 41.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 1.6499999999999999 111.045 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.01 128.38 69.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.097 0.475 . . . . 0.68000000000000005 111.606 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -113.2 103.05 10.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.058 -0.719 . . . . 1.27 109.058 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -86.43 132.13 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.176 -0.465 . . . . 1.3899999999999999 111.374 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.97 116.22 36.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.576 -0.738 . . . . 0.69999999999999996 109.94 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -99.28 122.82 42.97 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.796 -0.446 . . . . 4.2300000000000004 109.796 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 69.0 mt -138.09 151.61 70.24 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 0.60999999999999999 111.209 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.8 150.44 11.22 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.578 2.186 . . . . 0.48999999999999999 111.668 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 71' ' ' TRP . . . -77.26 93.49 4.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.129 0.49 . . . . 0.45000000000000001 110.883 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mt -92.26 92.58 8.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.044 -0.525 . . . . 0.53000000000000003 110.329 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -118.13 37.43 4.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.849 0.357 . . . . 1.71 111.723 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.01 -165.02 46.83 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.542 -0.837 . . . . 1.3899999999999999 112.227 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.55 -122.72 16.72 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.659 -0.305 . . . . 1.24 112.67 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.08 -5.39 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.215 0.531 . . . . 1.1599999999999999 109.947 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' ' 34' ' ' TRP . 39.8 m95 -60.21 -49.39 77.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.675 -0.693 . . . . 0.78000000000000003 110.622 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -66.86 -36.37 82.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 1.99 111.31 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.0 t -65.77 -38.59 82.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.89000000000000001 109.901 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -89.48 43.45 1.15 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.531 -0.759 . . . . 1.46 110.073 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.22 -35.13 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.878 -0.677 . . . . 0.66000000000000003 112.878 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.03 -33.76 62.93 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.851 0.358 . . . . 2.1200000000000001 111.543 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.2 ttt -53.64 -39.28 64.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 1.4299999999999999 111.49 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.61 -51.17 68.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 1.0600000000000001 111.378 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.83 -31.56 72.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.63 111.158 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' THR . 25.5 m -62.35 -39.91 94.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.68999999999999995 110.681 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.36 -46.6 76.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 1.6899999999999999 110.864 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -60.13 -39.85 87.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 2.1899999999999999 111.587 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.2 m -62.86 -18.13 62.49 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.415 0.524 . . . . 1.26 112.415 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 1.8 mtm -75.0 -16.05 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.915 0.388 . . . . 1.7 110.482 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.25 82.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.848 -0.691 . . . . 2.2000000000000002 113.197 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 m -82.66 144.04 10.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.785 0.326 . . . . 2.3599999999999999 110.776 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.27 154.93 48.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.274 -0.421 . . . . 5.2800000000000002 110.484 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.4 m80 56.06 41.45 29.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.004 -0.544 . . . . 5.2599999999999998 111.524 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.74 2.35 41.27 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 5.4500000000000002 110.147 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.5 t 68.92 90.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.315 -0.857 . . . . 3.7599999999999998 110.246 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.81 -22.05 54.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.758 -0.655 . . . . 4.2599999999999998 110.431 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.21 -35.31 75.12 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.671 -0.695 . . . . 2.8799999999999999 111.546 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.82 -34.76 71.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.026 0.441 . . . . 1.71 111.19 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -43.41 81.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 1.7 110.052 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.32 -34.1 75.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 3.2999999999999998 110.372 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -66.55 -42.65 86.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.989 -0.551 . . . . 2.6099999999999999 110.833 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.63 -22.35 66.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.113 0.482 . . . . 1.6699999999999999 111.387 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 72.0 mt -88.1 -39.56 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.16 -0.473 . . . . 1.9099999999999999 111.572 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -96.04 -53.71 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.278 0.844 . . . . 2.21 113.278 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -68.69 -51.46 41.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.73 0.3 . . . . 2.73 111.105 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -83.71 -43.28 15.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 2.5899999999999999 111.252 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 1.7 t-80 60.5 60.01 2.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.216 0.531 . . . . 2.1600000000000001 109.86 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -77.03 13.15 1.14 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.46 -0.791 . . . . 2.2400000000000002 112.897 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.7 tttt 54.55 58.0 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.306 0.574 . . . . 2.6099999999999999 110.505 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.1 mt -78.22 84.81 4.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.138 0.494 . . . . 1.24 110.464 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.44 -41.93 2.92 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.698 -0.683 . . . . 0.95999999999999996 110.572 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.31 141.25 42.49 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.908 -0.587 . . . . 1.21 110.743 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.26 -34.69 94.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.482 2.121 . . . . 0.97999999999999998 111.237 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 29.1 mt-10 -63.76 -42.15 97.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.439 -0.801 . . . . 2.6200000000000001 110.332 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.97 -40.41 95.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.081 -0.509 . . . . 2.5099999999999998 110.287 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 41.6 mtt -69.26 -55.77 9.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.165 -0.925 . . . . 0.93999999999999995 111.091 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.603 ' HB1' ' HG3' ' A' ' 122' ' ' LYS . . . -58.66 -42.28 88.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 0.95999999999999996 112.706 -178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -62.33 -35.13 78.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.719 0.295 . . . . 1.8300000000000001 111.534 -179.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.36 -43.57 18.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.057 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.21 -35.36 75.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.297 -0.411 . . . . 0.98999999999999999 111.555 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 120' ' ' VAL . . . -61.5 -24.84 66.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.344 -0.389 . . . . 1.25 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -11.49 85.22 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.042 -0.599 . . . . 1.6100000000000001 113.386 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -109.8 -15.67 14.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.575 0.688 . . . . 2.9500000000000002 111.885 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.06 40.27 0.26 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.132 -1.032 . . . . 1.47 113.487 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 88.0 t -126.55 130.05 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.556 -0.535 . . . . 1.2 109.556 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.729 ' OD2' ' HG2' ' A' ' 124' ' ' LYS . 20.7 t0 -75.49 123.8 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.12 0.486 . . . . 1.5600000000000001 110.593 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.603 ' HG3' ' HB1' ' A' ' 112' ' ' ALA . 23.4 ttmt -62.84 -34.09 76.62 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.283 -0.871 . . . . 1.5700000000000001 111.058 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -67.21 -49.24 65.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.397 -0.365 . . . . 2.29 111.091 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.729 ' HG2' ' OD2' ' A' ' 121' ' ' ASP . 45.6 mmtm -62.03 -43.94 97.76 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 2.6099999999999999 110.677 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 129' ' ' TYR . 77.7 t80 -55.02 -59.97 4.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 1.4399999999999999 111.276 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.3 mt -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.45 -0.341 . . . . 1.1299999999999999 111.863 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.4 t -62.08 -55.84 24.95 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.459 -0.337 . . . . 1.46 111.007 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 80' ' ' THR . 7.3 t -76.54 -20.18 57.15 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 120.796 -0.362 . . . . 1.53 111.859 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 28.4 t80 -62.69 -37.52 86.77 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.266 0.555 . . . . 1.53 110.115 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -103.0 32.82 3.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.505 -0.771 . . . . 1.6100000000000001 110.328 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.5 m -108.6 153.85 22.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.04 0.448 . . . . 1.49 111.396 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -67.72 -24.75 65.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.704 -0.68 . . . . 1.3999999999999999 110.62 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.34 -44.47 75.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 111.379 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.81 -37.09 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.204 -0.453 . . . . 1.1899999999999999 110.094 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -58.03 -41.94 84.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 1.8999999999999999 110.653 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.75 -25.63 71.82 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.18 -0.533 . . . . 0.75 112.672 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -83.33 -35.93 24.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 1.6699999999999999 110.146 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mmm -61.08 -50.39 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.614 -0.721 . . . . 1.8500000000000001 111.281 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -66.62 -36.59 82.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.368 -0.378 . . . . 2.0299999999999998 110.985 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -63.19 -37.87 88.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 3.0800000000000001 110.816 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.68 26.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.175 -0.466 . . . . 0.34999999999999998 110.971 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -59.22 -46.32 88.77 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.214 -0.448 . . . . 1.6899999999999999 111.837 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -65.71 -31.72 72.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.731 0.301 . . . . 2.1000000000000001 111.125 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.0 mt -77.06 -39.37 50.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.726 0.298 . . . . 0.56000000000000005 110.437 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.73 -46.49 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.48999999999999999 111.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -71.63 -25.15 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.338 -0.392 . . . . 2.5699999999999998 111.068 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -79.74 -23.57 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.42999999999999999 110.892 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 17.9 m-30 -80.55 2.38 25.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.63 110.97 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 61.87 29.43 17.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 111.219 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.1 t -74.96 114.32 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.295 -0.412 . . . . 1.26 110.313 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.66 27.54 7.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 1.25 111.042 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -177.32 170.18 42.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.866 -0.683 . . . . 0.68999999999999995 112.177 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.58 143.16 28.52 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 120.575 0.226 . . . . 0.64000000000000001 110.604 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.465 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.3 Cg_endo -77.95 166.83 79.99 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.277 -1.551 . . . . 0.66000000000000003 112.492 0.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.3 m -156.84 137.42 13.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.368 -0.378 . . . . 0.56999999999999995 110.713 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 92.4 mtp -117.33 134.16 55.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.448 -0.575 . . . . 0.92000000000000004 109.448 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.4 t -122.17 127.53 75.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.511 -0.313 . . . . 0.40000000000000002 110.476 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 28.1 t -107.88 118.05 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.304 -0.407 . . . . 0.58999999999999997 111.153 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 58.55 17.2 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.193 -0.912 . . . . 1.0800000000000001 112.92 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.03 27.24 64.49 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.225 -0.512 . . . . 0.48999999999999999 113.093 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -124.27 -32.86 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.985 0.421 . . . . 1.72 110.857 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -121.58 132.04 54.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 1.5 110.073 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -120.45 126.21 49.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 110.097 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -141.09 169.37 17.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.457 -0.338 . . . . 0.63 110.421 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -160.98 -177.46 6.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.144 -0.48 . . . . 1.3500000000000001 109.764 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.1 mt -62.2 -40.58 88.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.68999999999999995 111.888 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.87 -45.55 63.67 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.795 -0.717 . . . . 0.72999999999999998 112.501 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 11' ' ' GLU . 32.9 m -63.82 -47.51 80.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.726 0.298 . . . . 1.1499999999999999 110.735 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.355 -0.384 . . . . 0.71999999999999997 111.264 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 125.54 -38.54 2.25 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.985 -0.626 . . . . 1.1000000000000001 111.697 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.17 170.66 41.61 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.414 -0.675 . . . . 0.72999999999999998 111.414 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.55 -38.84 90.34 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.244 2.63 . . . . 0.84999999999999998 112.52 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -68.47 -36.06 78.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.001 -0.545 . . . . 2.52 110.392 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -72.98 -27.88 62.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.884 -0.598 . . . . 1.8200000000000001 110.766 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 2.6 m -60.44 -41.0 93.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.545 . . . . 0.62 110.741 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.88 -37.52 84.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.134 -0.485 . . . . 0.72999999999999998 110.619 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -63.41 -44.17 95.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.826 -0.625 . . . . 2.3399999999999999 110.981 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -66.8 -40.66 88.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.69999999999999996 110.483 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.19 74.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.65000000000000002 110.757 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -41.98 87.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.617 -0.72 . . . . 1.9099999999999999 111.005 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -62.6 -46.85 86.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.695 -0.684 . . . . 1.8200000000000001 111.526 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 0.75 111.158 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 66.3 mt -59.49 -47.41 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.152 0.501 . . . . 0.77000000000000002 109.898 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.72 -38.95 84.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.467 -0.788 . . . . 2.1699999999999999 110.454 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -57.54 -45.33 85.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 111.176 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -78.72 -39.05 37.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.207 -0.451 . . . . 1.6399999999999999 111.72 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -25.22 67.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.537 0.208 . . . . 1.72 111.079 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 191' ' ' LYS . . . -75.5 -13.54 60.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 1.1299999999999999 112.295 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.02 -15.35 61.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 1.1699999999999999 111.211 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -147.06 38.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.161 0.505 . . . . 1.8400000000000001 110.141 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 188' ' ' ALA . 17.3 tptm -86.16 54.21 3.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.441 . . . . 6.4299999999999997 110.943 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 17.4 pttp . . . . . 0 C--O 1.248 0.985 0 O-C-N 124.352 1.033 . . . . 7.3200000000000003 112.101 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 1YO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_